UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31, 2011
or
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period
from to
Commission File Number: 000-54371
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Maryland
|
|
26-4008719
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
4000 MacArthur Boulevard, West Tower, Suite 200,
Newport Beach, California
|
|
92660
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (949) 270-9200
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
None
|
|
None
|
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value per share
(Title of class)
Indicate by
check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
¨
Yes
x
No
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the Act.
¨
Yes
x
No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90
days.
x
Yes
¨
No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files).
x
Yes
¨
No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this
chapter) is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K.
x
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting
company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
Non-accelerated filer
|
|
x
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
¨
Yes
x
No
There is no established market for the registrants common stock. The registrant is currently conducting an ongoing initial public
offering of its shares of common stock pursuant to a Registration Statement on Form S-11, which shares are being sold at $10.00 per share, with discounts available for certain categories of purchasers. There were approximately 29,714,722 shares of
common stock held by non-affiliates as of June 30, 2011, the last business day of the registrants most recently completed second fiscal quarter, for an aggregate market value of $297,147,000, assuming a market value of $10.00 per share.
As of March 7, 2012, there were 53,752,796 shares of common stock of Griffin-American Healthcare REIT II, Inc.
outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
None
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(A Maryland Corporation)
TABLE OF CONTENTS
2
PART I
Item 1. Business.
The use of the words we, us or our refers to Griffin-American Healthcare REIT II, Inc. and its subsidiaries, including Griffin-American Healthcare REIT II Holdings,
LP, except where the context otherwise requires.
Our Company
Griffin-American Healthcare REIT II, Inc., a Maryland corporation, was incorporated as Grubb & Ellis Healthcare REIT II, Inc. on
January 7, 2009 and therefore we consider that our date of inception. We were initially capitalized on February 4, 2009. Our board of directors adopted an amendment to our charter, which was filed with the Maryland State Department of
Assessments and Taxation on January 3, 2012, to change our corporate name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American Healthcare REIT II, Inc. We intend to invest in a diversified portfolio of real estate
properties, focusing primarily on medical office buildings and healthcare-related facilities. We may also originate and acquire secured loans and real estate-related investments. We generally seek investments that produce current income. We
qualified to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, or the Code, for federal income tax purposes beginning with our taxable year ended December 31, 2010 and we intend to
continue to be taxed as a REIT.
We are conducting a best efforts initial public offering, or our offering, in which we are
offering to the public up to 300,000,000 shares of our common stock for $10.00 per share in our primary offering and 30,000,000 shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, for $9.50 per share, for a
maximum offering of up to $3,285,000,000. The United States Securities and Exchange Commission, or SEC, declared our registration statement effective as of August 24, 2009. We will sell shares of our common stock in our offering until the
earlier of August 24, 2012, or the date on which the maximum offering amount has been sold; provided, however, that our board of directors may extend our offering as permitted under applicable law, or we may extend our offering with respect to
shares of our common stock offered pursuant to the DRIP. However, we reserve the right to terminate our offering at any time prior to such termination date. As of December 31, 2011, we had received and accepted subscriptions in our offering for
47,831,458 shares of our common stock, or $477,306,000, excluding shares of our common stock issued pursuant to the DRIP.
We
conduct substantially all of our operations through Griffin-American Healthcare REIT II Holdings, LP, or our operating partnership. On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with
the Delaware Department of State to change the name of our operating partnership from Grubb & Ellis Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP. Until January 6, 2012, we were externally advised
by Grubb & Ellis Healthcare REIT II Advisor, LLC, or our former advisor, pursuant to an advisory agreement, as amended and restated, or the G&E Advisory Agreement, between us and our former advisor. From August 24, 2009 through
January 6, 2012, our former advisor supervised and managed our day-to-day operations and selected the properties and real estate-related investments we acquired, subject to the oversight and approval of our board of directors. Our former
advisor also provided marketing, sales and client services on our behalf and engaged affiliated entities to provide various services to us. Our former advisor is managed by and is a wholly owned subsidiary of Grubb & Ellis Equity Advisors,
LLC, or GEEA, which is a wholly owned subsidiary of Grubb & Ellis Company, or Grubb & Ellis, or our former sponsor.
On November 7, 2011, our independent directors determined that it is in the best interests of our company and its stockholders to transition advisory and dealer manager services rendered to us by
affiliates of Grubb & Ellis and to engage American Healthcare Investors LLC, or American Healthcare Investors, and Griffin Capital Corporation, or Griffin Capital, as replacement co-sponsors, or our co-sponsors. As a result, on
November 7, 2011, we notified our former advisor that we terminated the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty; however,
certain rights and obligations of the parties would survive during a 60-day transition period and beyond.
3
In addition, on November 7, 2011, we notified Grubb & Ellis Capital
Corporation that we terminated the Amended and Restated Dealer Manager Agreement dated June 1, 2011 between us and Grubb & Ellis Capital Corporation, or the G&E Dealer Manager Agreement, in accordance with the terms thereof. Until
January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
As a result of the co-sponsorship arrangement, an affiliate of Griffin Capital, Griffin-American Healthcare REIT Advisor, LLC, or Griffin-American Advisor, or our advisor, serves as our new advisor and
delegates advisory duties to Griffin-American Healthcare REIT Sub-Advisor, LLC, or Griffin-American Sub-Advisor, or our sub-advisor. Griffin-American Sub-Advisor is jointly owned by our co-sponsors. Our advisor, through our sub-advisor, uses its
best efforts, subject to the oversight, review and approval of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our
investment policies and objectives. Our advisor performs its duties and responsibilities under an advisory agreement, or the Advisory Agreement, as our fiduciary. Our sub-advisor performs its duties and responsibilities pursuant to a sub-advisory
agreement with our advisor and also acts as our fiduciary. Collectively, we refer to our advisor and our sub-advisor as our advisor entities. Griffin Capital Securities, Inc., or Griffin Securities, or our dealer manager, an affiliate of Griffin
Capital, serves as our new dealer manager pursuant to a dealer manager agreement, or the Dealer Manager Agreement. We are not affiliated with Griffin Capital, Griffin-American Advisor or Griffin Securities; however, we are affiliated with
Griffin-American Sub-Advisor and American Healthcare Investors, since American Healthcare Investors is wholly-owned by Jeffrey T. Hanson, our Chief Executive Officer and Chairman of the board of directors, Danny Prosky, our President and Chief
Operating Officer and director, and Mathieu B. Streiff, our Executive Vice President, and American Healthcare Investors owns a 75.0% interest in Griffin-American Sub-Advisor. See the organizational chart provided in Our Structure,
below.
American Healthcare Investors and Griffin Capital have agreed to pay the majority of the expenses we have incurred in
connection with the transition to our co-sponsors.
The Advisory Agreement with Griffin-American Advisor took effect on
January 7, 2012 upon the expiration of the 60-day transition period provided for in the G&E Advisory Agreement. The Dealer Manager Agreement with Griffin Securities also became effective January 7, 2012.
Key Developments during 2011 and 2012
|
|
|
On June 30, 2011, we entered into a loan agreement with KeyBank National Association, or KeyBank, to obtain a secured revolving credit facility
with an aggregate maximum principal amount of $71,500,000, or the KeyBank line of credit. On October 6, 2011, RBS Citizens, N.A., d/b/a Charter One, was added as a syndication agent to the KeyBank line of credit, whereby $35,750,000 of the
aggregate maximum principal amount of the KeyBank line of credit was assigned to Charter One. The proceeds of loans made under the KeyBank line of credit may be used to acquire, finance or refinance eligible properties or for other incidental
purposes as approved by KeyBank. The KeyBank line of credit matures on June 30, 2014 and may be extended by one 12-month period subject to the satisfaction of certain conditions, including payment of an extension
fee.
|
|
|
|
On November 7, 2011, our independent directors determined that it is in the best interests of our company and its stockholders to transition
advisory and dealer manager services rendered to us by affiliates of Grubb & Ellis and to engage American Healthcare Investors and Griffin Capital as replacement co-sponsors.
|
|
|
|
On November 7, 2011, we notified our former advisor that we terminated the G&E Advisory Agreement. The terms of the Advisory Agreement with
our advisor are substantially the same as the terms of the terminated G&E Advisory Agreement, except for the following:
|
4
|
|
|
the acquisition fee was reduced from 2.75% of the contract purchase price of each property we acquire to 2.60% of the contract purchase price of
each property we acquire;
|
|
|
|
the acquisition fee for property acquisitions will be paid with a combination of shares of our common stock and cash as follows: (i) shares
of common stock in an amount equal to 0.15% of the contract purchase price of the properties, at the then-established offering price, net of selling commissions or dealer manager fees, and (ii) the remainder in cash in an amount equal to 2.45%
of the contract purchase price of the properties; and
|
|
|
|
the monthly asset management fee is an amount equal to one-twelfth of 0.85% of the average invested assets existing as of January 6, 2012 and
one-twelfth of 0.75% of the average invested assets acquired after January 6, 2012.
|
|
|
|
On November 7, 2011, we notified Grubb & Ellis Capital Corporation that we terminated the G&E Dealer Manager Agreement. Until
January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
|
|
|
|
Effective as of December 9, 2011, our board of directors authorized an annualized distribution rate of 6.6% per share, assuming a purchase
price of $10.00 per share, to our stockholders of record as of the close of business on each day of the period commencing on January 1, 2012 and ending on March 31, 2012. Subsequently, our board of directors authorized a daily distribution
at the same annualized distribution rate of 6.6% per share, assuming a purchase price of $10.00 per share, to our stockholders of record as of the close of business on each day of the quarterly period commencing on April 1, 2012 and ending
on June 30, 2012. The distributions will be calculated based on 365 days in the calendar year and will be equal to $0.001808219 per share of common stock. The 6.6% per share annualized distribution rate represents an increase in our
distribution rate, which was an annualized rate of 6.5% per share, assuming a purchase price of $10.00 per share, prior to December 9, 2011.
|
|
|
|
Our board of directors adopted an amendment to our charter, which was filed with the Maryland State Department of Assessments and Taxation on
January 3, 2012, to change our corporate name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American Healthcare REIT II, Inc.
|
|
|
|
On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with the Delaware Department of State
to change the name of our operating partnership from Grubb & Ellis Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP.
|
|
|
|
As of March 7, 2012, we had received and accepted subscriptions in our offering for 52,415,020 shares of our common stock, or $523,074,000,
excluding shares of our common stock issued pursuant to the DRIP.
|
|
|
|
As of March 15, 2012, we had completed 28 acquisitions, 19 of which were acquisitions of medical office buildings, four of which were acquisitions
of hospitals and five of which were acquisitions of skilled nursing facilities. The aggregate purchase price of these properties was $662,735,000 and was comprised of 71 buildings and 2,654,000 square feet of gross leasable area, or GLA.
|
5
Our Structure
The following is a summary of our organizational structure as of March 15, 2012:
Our principal executive offices are located at 4000 MacArthur Boulevard, West Tower, Suite 200,
Newport Beach, California 92660, and the telephone number is (949) 270-9200. We maintain a web site at
http://www.healthcarereit2.com,
at which there is additional information about us and our affiliates. The contents of that site are
not incorporated by reference in, or otherwise a part of, this filing. We make our periodic and current reports, as well as our Registration Statement on Form S-11 (File No. 333-158111), and all amendments to those reports and to our
registration statement and supplements to our prospectus, available at
http://www.healthcarereit2.com
as soon as reasonably practicable after such materials are electronically filed with the SEC. They also are available for printing by any
stockholder upon request. In addition, copies of our filings with the SEC may be obtained from the SECs website, http://www.sec.gov. Access to these filings is free of charge.
6
Investment Objectives
Our investment objectives are:
|
|
|
to preserve, protect and return our stockholders capital contributions;
|
|
|
|
to pay regular cash distributions; and
|
|
|
|
to realize growth in the value of our investments upon our ultimate sale of such investments.
|
We may not attain these objectives. Our board of directors may change our investment objectives if it determines it is advisable and in
the best interest of our stockholders.
During the term of the Advisory Agreement, decisions relating to the purchase or sale
of investments will be made by our advisor entities, subject to the oversight and approval by our board of directors.
Investment Strategy
We intend to use substantially all of the net proceeds from our offering to invest in a diversified portfolio of real
estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We also may originate or acquire real estate-related investments such as mortgage, mezzanine, bridge and other loans, common and preferred stock of,
or other interests in, public or private unaffiliated real estate companies, commercial mortgage-backed securities, and certain other securities, including collateralized debt obligations and foreign securities. We generally seek investments that
produce current income. In order to maintain our exemption from regulation as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act, we may be required to limit our investments in certain types of
real estate-related investments.
We seek to maximize long-term stockholder value by generating sustainable growth in cash
flows and portfolio value. In order to achieve these objectives, we may invest using a number of investment structures which may include direct acquisitions, joint ventures, leveraged investments, issuing securities for property and direct and
indirect investments in real estate.
In addition, when and as determined appropriate by our advisor entities, our portfolio
may also include properties in various stages of development other than those producing current income. These stages include, without limitation, unimproved land both with and without entitlements and permits, property to be redeveloped and
repositioned, newly constructed properties and properties in lease-up or other stabilization scenarios, all of which have limited or no relevant operating histories and no current income. Our advisor entities will make this determination based upon
a variety of factors, including the available risk adjusted returns for such properties when compared with other available properties, the appropriate diversification of the portfolio, and our objectives of realizing both current income and capital
appreciation upon the ultimate sale of properties.
For each of our investments, regardless of property type, we seek to
invest in properties with the following attributes:
|
|
|
Quality.
We seek to acquire properties that are suitable for their intended use with a quality of construction that is capable of
sustaining the propertys investment potential for the long-term, assuming funding of budgeted maintenance, repairs and capital improvements.
|
|
|
|
Location.
We seek to acquire properties that are located in established or otherwise appropriate markets for comparable properties, with
access and visibility suitable to meet the needs of its occupants.
|
|
|
|
Market; Supply and Demand.
We focus on local or regional markets that have potential for stable and growing property level cash flows over
the long-term. These determinations will be based in part on an evaluation of local economic, demographic and regulatory factors affecting the property. For instance, we favor markets that indicate a growing population and employment base or markets
that exhibit potential limitations on additions to supply, such as barriers to new construction. Barriers to new construction include lack of available land and stringent zoning restrictions. In addition, we generally will seek to limit our
investments in areas that have limited potential for growth.
|
7
|
|
|
Predictable Capital Needs.
We seek to acquire properties where the future expected capital needs can be reasonably projected in a manner
that would enable us to meet our objectives of growth in cash flows and preservation of capital and stability.
|
|
|
|
Cash Flows.
We seek to acquire properties where the current and projected cash flows, including the potential for appreciation in value,
would enable us to meet our overall investment objectives. We evaluate cash flows as well as expected growth and the potential for appreciation.
|
We will not invest more than 10.0% of the offering proceeds available for investment in unimproved or non-income producing properties or in other investments relating to unimproved or non-income producing
property. A property will be considered unimproved or non-income producing property for purposes of this limitation if it: (1) is not acquired for the purpose of producing rental or other operating income, or (2) has no development or
construction in process at the date of acquisition or planned in good faith to commence within one year of the date of acquisition.
We will not invest more than 10.0% of the offering proceeds available for investment in commercial mortgage-backed securities. In addition, we will not invest more than 10.0% of the offering proceeds
available for investment in equity securities of public or private real estate companies.
We are not limited as to the
geographic area where we may acquire properties. We are not specifically limited in the number or size of properties we may acquire or on the percentage of our assets that we may invest in a single property or investment. The number and mix of
properties and real estate-related investments we will acquire will depend upon real estate and market conditions and other circumstances existing at the time we are acquiring our properties and making our investments, and the amount of proceeds we
raise in our offering and potential future offerings.
Real Estate Investments
We intend to invest in a diversified portfolio of real estate investments, focusing primarily on medical office buildings and
healthcare-related facilities. We generally seek investments that produce current income. Our investments may include:
|
|
|
medical office buildings;
|
|
|
|
assisted living facilities;
|
|
|
|
skilled nursing facilities;
|
|
|
|
long-term acute care facilities;
|
|
|
|
memory care facilities;
|
|
|
|
specialty medical and diagnostic service facilities;
|
|
|
|
laboratories and research facilities;
|
|
|
|
pharmaceutical and medical supply manufacturing facilities; and
|
|
|
|
offices leased to tenants in healthcare-related industries.
|
8
We generally seek to acquire real estate of the types described above that will best enable
us to meet our investment objectives, taking into account the diversification of our portfolio at the time, relevant real estate and financial factors, the location, the income-producing capacity, and the prospects for long-term appreciation of a
particular property and other considerations. As a result, we may acquire properties other than the types described above. In addition, we may acquire properties that vary from the parameters described above for a particular property type.
The consideration for each real estate investment must be authorized by a majority of our independent directors or a duly
authorized committee of our board of directors, ordinarily based on the fair market value of the investment. If the majority of our independent directors or a duly authorized committee of our board of directors so determines, or if the investment is
to be acquired from an affiliate, the fair market value determination must be supported by an appraisal obtained from a qualified, independent appraiser selected by a majority of our independent directors.
Our real estate investments generally take the form of holding fee title or long-term leasehold interests. Our investments may be made
either directly through our operating partnership or indirectly through investments in joint ventures, limited liability companies, general partnerships or other co-ownership arrangements with the developers of the properties, affiliates of our
advisor entities or other persons.
In addition, we may purchase real estate investments and lease them back to the sellers of
such properties. Our advisor entities will use their best efforts to structure any such sale-leaseback transaction such that the lease will be characterized as a true lease and so that we will be treated as the owner of the property for
federal income tax purposes. However, we cannot assure our stockholders that the Internal Revenue Service, or the IRS, will not challenge such characterization. In the event that any such sale-leaseback transaction is re-characterized as a financing
transaction for federal income tax purposes, deductions for depreciation and cost recovery relating to such real estate investment would be disallowed or significantly reduced.
Our obligation to close a transaction involving the purchase of real estate is generally conditioned upon the delivery and verification
of certain documents from the seller or developer, including, where appropriate:
|
|
|
plans and specifications;
|
|
|
|
environmental reports (generally a minimum of a Phase I investigation);
|
|
|
|
building condition reports;
|
|
|
|
evidence of marketable title subject to such liens and encumbrances as are acceptable to our advisor entities;
|
|
|
|
audited financial statements covering recent operations of real properties having operating histories or audited financial statements or summarized
financial information of the lessee or guarantor, unless such statements are not required to be filed with the SEC and delivered to stockholders;
|
|
|
|
title insurance policies;
|
|
|
|
liability insurance policies; and
|
|
|
|
tenant leases and operating agreements.
|
9
In determining whether to purchase a particular real estate investment, we may, in
circumstances in which our advisor entities deem it appropriate, obtain an option on such property, including land suitable for development. The amount paid for an option is normally surrendered if the real estate is not purchased, and is normally
credited against the purchase price if the real estate is purchased. We also may enter into arrangements with the seller or developer of a real estate investment whereby the seller or developer agrees that if, during a stated period, the real estate
investment does not generate specified cash flows, the seller or developer will pay us cash in an amount necessary to reach the specified cash flow level, subject in some cases to negotiated dollar limitations.
We will not purchase or lease real estate in which our co-sponsors, our advisor entities, our directors or any of their affiliates have
an interest without a determination by a majority of our disinterested directors and a majority of our disinterested independent directors that such transaction is fair and reasonable to us and at a price to us no greater than the cost of the real
estate investment to the affiliated seller or lessor, unless there is substantial justification for the excess amount and the excess amount is reasonable. In no event will we acquire any such real estate investment at an amount in excess of its
current appraised value as determined by an independent expert selected by our disinterested independent directors.
We intend
to obtain adequate insurance coverage for all real estate investments in which we invest. However, there are types of losses, generally catastrophic in nature, for which we do not intend to obtain insurance unless we are required to do so by
mortgage lenders. See Item 1A. Risk Factors, Risks Related to Investments in Real Estate Uninsured losses relating to real estate and lender requirements to obtain insurance may reduce our stockholders returns.
We intend to acquire leased properties with long-term leases in-place and we do not intend to operate any healthcare-related
facilities directly. As a REIT, we are prohibited from operating healthcare-related facilities directly, however from time to time we may lease a healthcare-related facility that we acquire to a wholly-owned taxable REIT subsidiary, or TRS. In such
an event, our TRS will engage a third party in the business of operating healthcare-related facilities to manage the property.
Joint
Ventures
We may enter into joint ventures, general partnerships and other arrangements with one or more institutions
or individuals, including real estate developers, operators, owners, investors and others, some of whom may be affiliates of our advisor entities, for the purpose of acquiring real estate. Such joint ventures may be leveraged with debt financing or
unleveraged. We may enter into joint ventures to further diversify our investments or to access investments which meet our investment criteria that would otherwise be unavailable to us. In determining whether to invest in a particular joint venture,
our advisor entities will evaluate the real estate that such joint venture owns or is being formed to own under the same criteria used in the selection of our other properties. However, we will not participate in tenant-in-common syndications or
transactions.
Joint ventures with unaffiliated third parties may be structured such that the investment made by us and the
co-venturer are on substantially different terms and conditions. For example, while we and a co-venturer may invest an equal amount of capital in an investment, the investment may be structured such that we have a right to priority distributions of
cash flows up to a certain target return while the co-venturer may receive a disproportionately greater share of cash flows than we are to receive once such target return has been achieved. This type of investment structure may result in the
co-venturer receiving more of the cash flows, including appreciation, of an investment than we would receive.
We may only
enter into joint ventures with other Griffin Capital programs, future American Healthcare Investors programs, affiliates of our advisor entities or any of our directors for the acquisition of properties if:
|
|
|
a majority of our directors, including a majority of our independent directors, not otherwise interested in such transaction, approves the transaction
as being fair and reasonable to us; and
|
|
|
|
the investment by us and such affiliate are on substantially the same terms and conditions.
|
10
We may invest in general partnerships or joint ventures with other Griffin Capital programs,
future American Healthcare Investors programs or affiliates of our advisor entities to enable us to increase our equity participation in such venture as additional proceeds of our offering are received, so that ultimately we own a larger equity
percentage of the property. Our entering into joint ventures with our advisor entities or any of their affiliates will result in certain conflicts of interest. See Item 1A. Risk Factors, Risks Related to Conflicts of Interest If we
enter into joint ventures with affiliates, we may face conflicts of interest or disagreements with our joint venture partners that may not be resolved as quickly or on terms as advantageous to us as would be the case if the joint venture had been
negotiated at arms length with an independent joint venture partner.
Real Estate-Related Investments
In addition to our acquisition of medical office buildings and healthcare-related facilities, we also may invest in real estate-related
investments, including loans (mortgage, mezzanine, bridge and other loans) and securities investments (common and preferred stock of or other interests in public or private unaffiliated real estate companies, commercial mortgage-backed securities,
and certain other securities, including collateralized debt obligations and foreign securities).
Investing In and Originating Loans
We may originate loans from mortgage brokers or personal solicitations of suitable borrowers, or may purchase existing
loans that were originated by other lenders. We may purchase existing loans from affiliates and we may make or invest in loans in which the borrower is an affiliate. Our advisor entities will evaluate all potential loan investments to determine if
the security for the loan and the loan-to-value ratio meets our investment criteria and objectives. Most loans that we will consider for investment would provide for monthly payments of interest and some may also provide for principal amortization,
although many loans of the nature that we will consider provide for payments of interest only and a payment of principal in full at the end of the loan term. We will not originate loans with negative amortization provisions.
Securities Investments
We may invest in the following types of securities: (1) equity securities such as common stocks, preferred stocks and convertible
preferred securities of public or private unaffiliated real estate companies (including other REITs, real estate operating companies and other real estate companies); (2) debt securities such as commercial mortgage-backed securities and debt
securities issued by other unaffiliated real estate companies; and (3) certain other types of securities that may help us reach our diversification and other investment objectives. These other securities may include, but are not limited to,
various types of collateralized debt obligations and certain non-U.S. dollar denominated securities.
We have substantial
discretion with respect to the selection of specific securities investments. Our charter provides that we may not invest in equity securities unless a majority of our directors, including a majority of our independent directors, not otherwise
interested in the transaction approve such investment as being fair, competitive and commercially reasonable. Consistent with such requirements, in determining the types of securities investments to make, our advisor entities will adhere to a board
approved asset allocation framework consisting primarily of components such as: (1) target mix of securities across a range of risk/reward characteristics; (2) exposure limits to individual securities; and (3) exposure limits to
securities subclasses (such as common equities, debt securities and foreign securities). Within this framework, our advisor entities will evaluate specific criteria for each prospective securities investment including:
|
|
|
positioning the overall portfolio to achieve an optimal mix of real estate and real estate-related investments;
|
|
|
|
diversification benefits relative to the rest of the securities assets within our portfolio;
|
|
|
|
fundamental securities analysis;
|
|
|
|
quality and sustainability of underlying property cash flows;
|
11
|
|
|
broad assessment of macroeconomic data and regional property level supply and demand dynamics;
|
|
|
|
potential for delivering high current income and attractive risk-adjusted total returns; and
|
|
|
|
additional factors considered important to meeting our investment objectives.
|
We may invest in investment grade and non-investment grade commercial mortgage-backed securities classes. However, we will not invest
more than 10.0% of the offering proceeds available for investment in commercial mortgage-backed securities. Commercial mortgage-backed securities are subject to all of the risks of the underlying mortgage loans. Similarly, we will not invest more
than 10.0% of the offering proceeds available for investment in equity securities of public or private real estate companies. The specific number and mix of securities in which we invest will depend upon real estate market conditions, other
circumstances existing at the time we are investing in our securities and the amount of proceeds we raise in our offering. We will not invest in securities of other issuers for the purpose of exercising control and the first or second mortgages in
which we intend to invest will likely not be insured by the Federal Housing Administration or guaranteed by the Veterans Administration or otherwise guaranteed or insured. Real estate-related equity securities are generally unsecured and also may be
subordinated to other obligations of the issuer. Our investments in real estate-related equity securities will involve special risks relating to the particular issuer of the equity securities, including the financial condition and business outlook
of the issuer.
Development Strategy
We may engage our advisor entities or their affiliates to provide development-related services for all or some of the properties that we acquire for development or refurbishment. In those cases, we will
pay our advisor entities or their affiliates a development fee that is usual and customary for comparable services rendered for similar projects in the geographic market where the services are provided if a majority of our independent directors
determines that such development fees are fair and reasonable and on terms and conditions not less favorable than those available from unaffiliated third parties. However, we will not pay a development fee to our advisor entities or their affiliates
if our advisor entities or their affiliates elect to receive an acquisition fee based on the cost of such development. In the event that our advisor entities or their affiliates assist with planning and coordinating the construction of any tenant
improvements or capital improvements, the respective party may be paid a construction management fee of up to 5.0% of the cost of such improvements.
Disposition Strategy
We intend to hold each property or real
estate-related investment we acquire for an extended period. However, circumstances might arise which could result in a shortened holding period for certain investments. In general, the holding period for real estate-related investments other than
real property is expected to be shorter than the holding period for real property assets. A property or real estate-related investment may be sold before the end of the expected holding period if:
|
|
|
diversification benefits exist associated with disposing of the investment and rebalancing our investment portfolio;
|
|
|
|
an opportunity arises to pursue a more attractive investment;
|
|
|
|
in the judgment of our advisor entities, the value of the investment might decline;
|
|
|
|
with respect to properties, a major tenant involuntarily liquidates or is in default under its lease;
|
|
|
|
the investment was acquired as part of a portfolio acquisition and does not meet our general acquisition criteria;
|
|
|
|
an opportunity exists to enhance overall investment returns by raising capital through sale of the investment; or
|
|
|
|
in the judgment of our advisor entities, the sale of the investment is in the best interest of our stockholders.
|
12
The determination of whether a particular property or real estate-related investment should
be sold or otherwise disposed of will be made after consideration of relevant factors, including prevailing economic conditions, with a view toward maximizing our investment objectives. We cannot assure our stockholders that this objective will be
realized. The selling price of a property which is net leased will be determined in large part by the amount of rent payable under the lease(s) for such property. If a tenant has a repurchase option at a formula price, we may be limited in realizing
any appreciation. In connection with our sales of properties, we may lend the purchaser all or a portion of the purchase price. In these instances, our taxable income may exceed the cash received in the sale. The terms of payment will be affected by
custom practices in the area in which the investment being sold is located and the then-prevailing economic conditions.
Borrowing Policies
We intend to use secured and unsecured debt as a means of providing additional funds for the acquisition of properties
and other real estate-related assets. Our ability to enhance our investment returns and to increase our diversification by acquiring assets using additional funds provided through borrowing could be adversely affected if banks and other lending
institutions reduce the amount of funds available for the types of loans we seek. When interest rates are high or financing is otherwise unavailable on a timely basis, we may purchase certain assets for cash with the intention of obtaining debt
financing at a later time. We may also utilize derivative financial instruments such as fixed interest rate swaps and caps to add stability to interest expense and to manage our exposure to interest rate movements.
We anticipate that after our initial phase of operations (prior to the investment of all of the net proceeds of our offerings of shares
of our common stock) when we may employ greater amounts of leverage, aggregate borrowings, both secured and unsecured, will not exceed 60.0% of the combined fair market value of all of our real estate and real estate-related investments, as
determined at the end of each calendar year beginning with our first full year of operations. For these purposes, the fair market value of each asset will be equal to the purchase price paid for the asset or, if the asset was appraised subsequent to
the date of purchase, then the fair market value will be equal to the value reported in the most recent independent appraisal of the asset. Our policies do not limit the amount we may borrow with respect to any individual investment. As of
December 31, 2011, our aggregate borrowings were 18.4% of the combined fair market value of all of our real estate and real estate-related investments.
Our board of directors reviews our aggregate borrowings at least quarterly to ensure that such borrowings are reasonable in relation to our net assets. Our borrowing policies provide that the maximum
amount of such borrowings in relation to our net assets will not exceed 300.0% of our net assets, unless any excess in such borrowing is approved by a majority of our directors and is disclosed in our next quarterly report along with the
justification for such excess. For purposes of this determination, net assets are our total assets, other than intangibles, valued at cost before deducting depreciation, amortization, bad debt and other similar non-cash reserves, less total
liabilities. We compute our leverage at least quarterly on a consistently applied basis. Generally, the preceding calculation is expected to approximate 75.0% of the sum of the aggregate cost of our real estate and real estate-related assets before
depreciation, amortization, bad debt and other similar non-cash reserves. As of March 15, 2012 and December 31, 2011, our leverage did not exceed 300.0% of the value of our net assets.
By operating on a leveraged basis, we will have more funds available for our investments. This generally allows us to make more
investments than would otherwise be possible, potentially resulting in enhanced investment returns and a more diversified portfolio. However, our use of leverage increases the risk of default on loan payments and the resulting foreclosure of a
particular asset. In addition, lenders may have recourse to assets other than those specifically securing the repayment of the indebtedness.
13
We will use our best efforts to obtain financing on the most favorable terms available to us
and we will refinance assets during the term of a loan only in limited circumstances, such as when a decline in interest rates makes it beneficial to prepay an existing loan, when an existing loan matures or if an attractive investment becomes
available and the proceeds from the refinancing can be used to purchase such investment. The benefits of the refinancing may include an increased cash flow resulting from reduced debt service requirements, an increase in distributions from proceeds
of the refinancing and an increase in diversification of assets owned if all or a portion of the refinancing proceeds are reinvested.
Our charter restricts us from borrowing money from any of our directors or from our advisor entities or their affiliates unless such loan is approved by a majority of our directors, including a majority
of the independent directors, not otherwise interested in the transaction, as fair, competitive and commercially reasonable and no less favorable to us than comparable loans between unaffiliated parties.
Board Review of Our Investment Policies
Our board of directors has established written policies on investments and borrowing. Our board of directors is responsible for monitoring the administrative procedures, investment operations and
performance of our company and our advisor entities to ensure such policies are carried out. Our charter requires that our independent directors review our investment policies at least annually to determine that our policies are in the best interest
of our stockholders. Each determination and the basis thereof is required to be set forth in the minutes of our applicable meetings of our directors. Implementation of our investment policies also may vary as new investment techniques are developed.
Our investment policies may not be altered by our board of directors without the approval of our stockholders.
As required by
our charter, our independent directors have reviewed our policies outlined above and determined that they are in the best interest of our stockholders because: (1) they increase the likelihood that we will be able to acquire a diversified
portfolio of income-producing properties, thereby reducing risk in our portfolio; (2) there are sufficient property acquisition opportunities with the attributes that we seek; (3) our executive officers, directors and affiliates of our
advisor entities have expertise with the type of real estate investments we seek; and (4) our borrowings will enable us to purchase assets and earn rental income more quickly, thereby increasing our likelihood of generating income for our
stockholders and preserving stockholder capital.
Tax Status
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31, 2010. To maintain our qualification as a REIT, we must meet certain organizational and
operational requirements, including a requirement to currently distribute at least 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. As a REIT, we generally will not be subject to federal income tax on taxable
income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we
will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification
is lost unless the IRS grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to our stockholders.
Distribution Policy
In
order to maintain our qualification as a REIT for federal income tax purposes, among other things, we are required to distribute 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. We cannot predict if we will
generate sufficient cash flow to pay cash distributions to our stockholders on an ongoing basis or at all. The amount of any cash distributions will be determined by our board of directors and will depend on the amount of distributable funds,
current and projected cash requirements, tax considerations, any limitations imposed by the terms of indebtedness we may incur and other factors. If our investments produce sufficient cash flow, we expect to pay distributions to our stockholders on
a monthly basis. Because our cash available for distribution in any year may be less than 90.0% of our annual taxable income, excluding net capital gains, for the year, we may be required to borrow money, use proceeds from the issuance of securities
(in our offering or subsequent offerings, if any) or sell assets to pay out enough of our taxable income to satisfy the distribution
14
requirement. These methods of obtaining funds could affect future distributions by increasing operating costs. We have not established any limit on the amount of offering proceeds that may be
used to fund distributions, except that, in accordance with our organizational documents and Maryland law, we may not make distributions that would: (1) cause us to be unable to pay our debts as they become due in the usual course of business;
(2) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences; or (3) jeopardize our ability to maintain our qualification as a REIT.
To the extent that distributions to our stockholders are paid out of our current or accumulated earnings and profits, such distributions
are taxable as ordinary income. To the extent that our distributions exceed our current and accumulated earnings and profits, such amounts constitute a return of capital to our stockholders for federal income tax purposes, to the extent of their
basis in their stock, and thereafter will constitute capital gain. All or a portion of a distribution to stockholders may be paid from net offering proceeds and thus, constitute a return of capital to our stockholders.
Monthly distributions are calculated with daily record dates so distribution benefits begin to accrue immediately upon becoming a
stockholder. However, our board of directors could, at any time, elect to pay distributions quarterly to reduce administrative costs. Subject to applicable REIT rules, generally we intend to reinvest proceeds from the sale, financing, refinancing or
other disposition of our properties through the purchase of additional properties, although we cannot assure our stockholders that we will be able to do so.
The amount of distributions we pay to our stockholders is determined by our board of directors and is dependent on a number of factors, including funds available for payment of distributions, our
financial condition, capital expenditure requirements, annual distribution requirements needed to maintain our status as a REIT under the Code and restrictions imposed by our organizational documents and Maryland Law.
See Part II, Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities Distributions, for a further discussion on distributions approved by our board of directors.
Competition
We compete with many other entities engaged in real estate investment activities for acquisitions of medical office
buildings and healthcare-related facilities, including national, regional and local operators, acquirers and developers of healthcare real estate properties. The competition for healthcare real estate properties may significantly increase the price
we must pay for medical office buildings and healthcare-related facilities or other assets we seek to acquire, and our competitors may succeed in acquiring those properties or assets themselves. In addition, our potential acquisition targets may
find our competitors to be more attractive because they may have greater resources, may be willing to pay more for the properties or may have a more compatible operating philosophy. In particular, larger healthcare real estate REITs may enjoy
significant competitive advantages that result from, among other things, a lower cost of capital and enhanced operating efficiencies. In addition, the number of entities and the amount of funds competing for suitable investment properties may
increase. This competition will result in increased demand for these assets, and therefore, increased prices paid for them. Due to an increased interest in single-property acquisitions among tax-motivated individual purchasers, we may pay higher
prices if we purchase single properties in comparison with portfolio acquisitions. If we pay higher prices for medical office buildings or healthcare-related facilities, our business, financial condition, results of operations and our ability to pay
distributions to our stockholders may be materially and adversely affected and our stockholders may experience a lower return on their investment.
15
Government Regulations
Many laws and governmental regulations are applicable to our properties and changes in these laws and regulations, or their interpretation by agencies and the courts, occur frequently.
Costs of Compliance with the Americans with Disabilities Act.
Under the Americans with Disabilities Act of 1990, as amended,
or the ADA, all public accommodations must meet federal requirements for access and use by disabled persons. Although we believe that we are in substantial compliance with present requirements of the ADA, none of our properties have been audited,
nor have investigations of our properties been conducted to determine compliance. Additional federal, state and local laws also may require modifications to our properties or restrict our ability to renovate our properties. We cannot predict the
cost of compliance with the ADA or other legislation. We may incur substantial costs to comply with the ADA or any other legislation.
Costs of Government Environmental Regulation and Private Litigation.
Environmental laws and regulations hold us liable for the costs of removal or remediation of certain hazardous or toxic
substances which may be on our properties. These laws could impose liability without regard to whether we are responsible for the presence or release of the hazardous materials. Government investigations and remediation actions may have substantial
costs and the presence of hazardous substances on a property could result in personal injury or similar claims by private plaintiffs. Various laws also impose liability on a person who arranges for the disposal or treatment of hazardous or toxic
substances and such person often must incur the cost of removal or remediation of hazardous substances at the disposal or treatment facility. These laws often impose liability whether or not the person arranging for the disposal ever owned or
operated the disposal facility. As the owner and operator of our properties, we may be deemed to have arranged for the disposal or treatment of hazardous or toxic substances.
Other Federal, State and Local Regulations.
Our properties are subject to various federal, state and local regulatory requirements, such as state and local fire and life safety requirements.
If we fail to comply with these various requirements, we may incur governmental fines or private damage awards. While we believe that our properties are and will be in material compliance with all of these regulatory requirements, we do not know
whether existing requirements will change or whether future requirements will require us to make significant unanticipated expenditures that will adversely affect our ability to make distributions to our stockholders. We believe, based in part on
engineering reports which are generally obtained at the time we acquire the properties, that all of our properties comply in all material respects with current regulations. However, if we were required to make significant expenditures under
applicable regulations, our financial condition, results of operations, cash flows and ability to satisfy our debt service obligations and to pay distributions could be adversely affected.
Significant Tenants
As of December 31, 2011, one of our tenants at
our consolidated properties accounted for 10.0% or more of our aggregate annualized base rent, as set forth below. The loss of this tenant or their inability to pay rent could have a material adverse effect on our business and results of operations.
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Tenant
|
|
2011 Annualized
Base Rent
(1)
|
|
|
Percentage of
Annualized
Base Rent
|
|
|
Property
|
|
|
GLA
(Sq Ft)
|
|
|
Lease Expiration
Date
|
|
PA Holdings SNF, L.P. (Mid- Atlantic Health Care, LLC)
|
|
$
|
7,516,000
|
|
|
|
18.4
|
%
|
|
|
Philadelphia SNF Portfolio
|
|
|
|
392,000
|
|
|
|
06/30/26
|
|
(1)
|
Annualized base rent is based on contractual base rent from leases in effect as of December 31, 2011.
|
Geographic Concentration
Based on leases in effect as of December 31, 2011, we owned properties in three states for which each state accounted for 10.0% or
more of our annualized base rent. Pennsylvania accounted for 18.4% of annualized base rent, Texas accounted for 13.4% of annualized base rent and Virginia accounted for 10.7% of annualized base rent. Accordingly, there is a geographic concentration
of risk subject to fluctuations in each states economy. For a further discussion, see Item 2. Properties Geographic Diversification/Concentration Table.
16
Employees
We have no employees and our executive officers are all employees of affiliates of our advisor entities. Our day-to-day management is performed by our advisor entities and their affiliates. We cannot
determine at this time if or when we might hire any employees, although we do not anticipate hiring any employees for the next twelve months. We do not directly compensate our executive officers for services rendered to us. However, our executive
officers, consultants and the executive officers and key employees of our advisor entities are eligible for awards pursuant to the 2009 Incentive Plan, or our incentive plan. As of December 31, 2011, no awards had been granted to our executive
officers, consultants or the executive officers or key employees of our former advisor or our advisor entities under this plan.
Financial
Information About Industry Segments
Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or
ASC, Topic 280,
Segment Reporting
, establishes standards for reporting financial and descriptive information about a public entitys reportable segments. As of December 31, 2011, we operate through three reportable business segments
medical office buildings, hospitals and skilled nursing facilities. With the continued expansion of our portfolio, we believe segregation of our operations into three reporting segments would be useful in assessing the performance of our
business in the same way that management intends to review our performance and make operating decisions. Prior to 2011, we operated through one reportable segment. For a discussion of our segment reporting for years ended December 31, 2011 and
2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, see Note 17, Segment Reporting, to our Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Item 1A. Risk Factors.
Investment Risks
There is no public market for the shares of our common stock.
Therefore, it will be difficult for our stockholders to sell their shares of our common stock and, if our stockholders are able to sell their shares of our common stock, they will likely sell them at a substantial discount.
There currently is no public market for shares of our common stock. We do not expect a public market for our stock to develop prior to
the listing of the shares of our common stock on a national securities exchange, which we do not expect to occur in the near future and which may not occur at all. Additionally, our charter contains restrictions on the ownership and transfer of
shares of our stock, and these restrictions may inhibit our stockholders ability to sell their shares of our common stock. Our charter provides that no person may own more than 9.9% in value of our issued and outstanding shares of capital
stock or more than 9.9% in value or in number of shares, whichever is more restrictive, of the issued and outstanding shares of our common stock. Any purported transfer of the shares of our common stock that would result in a violation of either of
these limits will result in such shares being transferred to a trust for the benefit of a charitable beneficiary or such transfer being declared null and void. We have adopted a share repurchase plan, but it is limited in terms of the amount of
shares of our common stock which may be repurchased annually and subject to our board of directors discretion. Our board of directors may also amend, suspend or terminate our share repurchase plan upon 30 days written notice. Therefore,
it will be difficult for our stockholders to sell their shares of our common stock promptly or at all. If our stockholders are able to sell their shares of our common stock, they may only be able to sell them at a substantial discount from the price
they paid. This may be the result, in part, of the fact that, at the time we make our investments, the amount of funds available for investment may be reduced by up to 11.0% of the gross offering proceeds, which will be used to pay selling
commissions, a dealer manager fee and other organizational and offering expenses. We also will be required to use the gross proceeds from our offering to pay acquisition fees, acquisition expenses and asset management fees. Unless our aggregate
investments increase in value to compensate for these fees and expenses, which may not occur, it is unlikely that our stockholders will be able to sell their shares of our common stock, whether pursuant to our share repurchase plan or otherwise,
without incurring a substantial loss. We cannot assure our stockholders that their shares of our common stock will ever appreciate in value to equal the price they paid for their shares of our common stock. Therefore, our stockholders should
consider the purchase of shares of our common stock as illiquid and a long-term investment, and they must be prepared to hold their shares of our common stock for an indefinite length of time.
17
Our offering is considered a blind pool offering because we have not identified all of the
real estate or real estate-related investments to acquire with the net proceeds from our offering.
We have not
identified all of the real estate or real estate-related investments to acquire with the net proceeds of our offering. As a result, our offering is considered a blind pool offering because investors in our offering are unable to evaluate
the manner in which our net proceeds are invested and the economic merits of our investments prior to subscribing for shares of our common stock. Additionally, stockholders will not have the opportunity to evaluate the transaction terms or other
financial or operational data concerning the real estate or real estate-related investments we acquire in the future.
We have a limited
operating history; therefore, our stockholders may not be able to adequately evaluate our ability to achieve our investment objectives, and the prior performance of other programs sponsored by Griffin Capital may not be an accurate predictor of our
future results.
We were formed in January 2009, did not engage in any material business operations prior to our
offering and acquired our first property in March 2010. As a result, an investment in shares of our common stock may entail more risks than the shares of common stock of a REIT with a more substantial operating history. In addition, this is the
first real estate program sponsored by American Healthcare Investors, and you should not rely on the past performance of other Griffin Capital-sponsored programs to predict our future results. Our stockholders should consider our prospects in light
of the risks, uncertainties and difficulties frequently encountered by companies like ours that do not have a substantial operating history, many of which may be beyond our control. Therefore, to be successful in this market, we must, among other
things:
|
|
|
identify and acquire investments that further our investment strategy;
|
|
|
|
rely on our dealer manager to build, expand and maintain its network of licensed securities brokers and other agents in order to sell shares of our
common stock;
|
|
|
|
respond to competition both for investment opportunities and potential investors in us; and
|
|
|
|
build and expand our operations structure to support our business.
|
We cannot guarantee that we will succeed in achieving these goals, and our failure to do so could cause our stockholders to lose all or a
portion of their investment.
We have experienced losses in the past, and we may experience additional losses in the future.
Historically, we have experienced net losses and we may not be profitable or realize growth in the value of our
investments. Many of our losses can be attributed to start-up costs and general and administrative expenses, as well as acquisition expenses incurred in connection with purchasing properties or making other investments. For a further discussion of
our operational history and the factors for our losses, see Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations and our consolidated financial statements and the notes thereto.
If we raise proceeds substantially less than the maximum offering, we may not be able to invest in a diverse portfolio of real estate and real
estate-related investments, and the value of an investment in us may fluctuate more widely with the performance of specific investments.
We are dependent upon the net proceeds to be received from our offering to conduct our proposed activities. Our stockholders, rather than us or our affiliates, will incur the bulk of the risk if we are
unable to raise substantial funds. Our offering is being made on a best efforts basis, whereby our dealer manager and the broker-dealers participating in our offering are only required to use their best efforts to sell shares of our
common stock and have no firm commitment or obligation to purchase any of the shares of our common stock. As a result, we cannot assure stockholders as to the amount of proceeds that will be raised in our offering or that we will achieve sales of
the
18
maximum offering amount. If we are unable to raise substantially more than the amount we have received to date, we will have limited diversification in terms of the number of investments owned,
the geographic regions in which our investments are located and the types of investments that we make. An investment in shares of our common stock will be subject to greater risk to the extent that we lack a diversified portfolio of investments. In
such event, the likelihood of our profitability being affected by the poor performance of any single investment will increase. In addition, our fixed operating expenses, as a percentage of gross income, would be higher, and our financial condition
and ability to pay distributions could be adversely affected if we are unable to raise substantial funds.
If we are unable to find
suitable investments, we may not have sufficient cash flows available for distributions to our stockholders.
Our
ability to achieve our investment objectives and to pay distributions to our stockholders is dependent upon the performance of our advisor entities in selecting investments for us to acquire, selecting tenants for our properties and securing
financing arrangements. Except for stockholders who purchased shares of our common stock in our offering after such time as we supplemented our prospectus to describe one or more identified investments, our stockholders generally have no opportunity
to evaluate the terms of transactions or other economic or financial data concerning our investments. Our stockholders must rely entirely on the management ability of our advisor entities and the oversight of our board of directors. Our advisor
entities may not be successful in identifying suitable investments on financially attractive terms or that, if they identify suitable investments, our investment objectives will be achieved. If we, through our advisor entities, are unable to find
suitable investments, we will hold the net proceeds of our offering in an interest-bearing account or invest the net proceeds in short-term, investment-grade investments. In such an event, our ability to pay distributions to our stockholders would
be adversely affected.
We face competition for the acquisition of medical office buildings and other healthcare-related facilities,
which may impede our ability to make acquisitions or may increase the cost of these acquisitions and may reduce our profitability and could cause our stockholders to experience a lower return on their investment.
We compete with many other entities engaged in real estate investment activities for acquisitions of medical office buildings and
healthcare-related facilities, including national, regional and local operators, acquirers and developers of healthcare real estate properties. The competition for healthcare real estate properties may significantly increase the price we must pay
for medical office buildings and healthcare-related facilities or other assets we seek to acquire, and our competitors may succeed in acquiring those properties or assets themselves. In addition, our potential acquisition targets may find our
competitors to be more attractive because they may have greater resources, may be willing to pay more for the properties or may have a more compatible operating philosophy. In particular, larger healthcare real estate REITs may enjoy significant
competitive advantages that result from, among other things, a lower cost of capital and enhanced operating efficiencies. In addition, the number of entities and the amount of funds competing for suitable investment properties may increase. This
competition will result in increased demand for these assets, and therefore, increased prices paid for them. Due to an increased interest in single-property acquisitions among tax-motivated individual purchasers, we may pay higher prices if we
purchase single properties in comparison with portfolio acquisitions. If we pay higher prices for medical office buildings or healthcare-related facilities, our business, financial condition and results of operations and our ability to pay
distributions to our stockholders may be materially and adversely affected and our stockholders may experience a lower return on their investment.
Our stockholders may be unable to sell their shares of our common stock because their ability to have their shares of our common stock repurchased pursuant to our share repurchase plan is subject to
significant restrictions and limitations.
Our share repurchase plan includes significant restrictions and
limitations. Except in cases of death or qualifying disability, our stockholders must hold their shares of our common stock for at least one year. Requesting stockholders must present at least 25.0% of their shares of our common stock for repurchase
and until they have held their shares of our common stock for at least four years, repurchases will be made for less than our stockholders paid for their shares of our common stock. Shares of our common stock may be repurchased quarterly, at our
discretion, on a pro rata basis, and are limited during any calendar year to 5.0% of the weighted average number of shares of our common stock outstanding during the prior calendar year; provided however, that shares of our
19
common stock subject to a repurchase requested upon the death of a stockholder will not be subject to this cap. Funds for the repurchase of shares of our common stock will come exclusively from
the cumulative proceeds we receive from the sale of shares of our common stock pursuant to the DRIP. In addition, our board of directors may reject share repurchase requests in its sole discretion and reserves the right to amend, suspend or
terminate our share repurchase plan at any time upon 30 days written notice. Therefore, in making a decision to purchase shares of our common stock, our stockholders should not assume that they will be able to sell any of their shares of our common
stock back to us pursuant to our share repurchase plan and they also should understand that the repurchase price will not necessarily correlate to the value of our real estate holdings or other assets. If our board of directors terminates our share
repurchase plan, our stockholders may not be able to sell their shares of our common stock even if our stockholders deem it necessary or desirable to do so.
Due to our transition to American Healthcare Investors and Griffin Capital as our co-sponsors, our success is increasingly dependent on the performance of our Chairman of the board of directors and
Chief Executive Officer, and our President and Chief Operating Officer.
Since our transition to American Healthcare
Investors and Griffin Capital as our co-sponsors, Griffin-American Sub-Advisor has been responsible for managing our day-to-day operations. Through Griffin-American Sub-Advisors affiliation with American Healthcare Investors, we are
increasingly dependent upon the services of Messrs. Hanson and Prosky to manage our operations. We have no prior experience working with Griffin Capital or its affiliates, most of whom are unfamiliar with our company and our operations. Accordingly,
in connection with our transition to American Healthcare Investors and Griffin Capital as our co-sponsors, our ability to achieve our investment objectives and to pay distributions depends upon the ability of Mr. Hanson and Mr. Prosky to
manage the identification and acquisition of investments, the determination of any financing arrangements and the management of our investments. We currently do not have an employment agreement with either Mr. Hanson or Mr. Prosky. If we
were to lose the benefit of either of Mr. Hansons or Mr. Proskys experience, efforts and abilities, we may not be able to achieve our investment objectives and our operating results could suffer.
The transfer of our dealer manager services to Griffin Securities may adversely affect our ability to raise capital pursuant to our offering, which
could reduce the amount of cash available to pay distributions to stockholders.
On November 7, 2011, we entered
into an agreement with Griffin Securities, whereby Griffin Securities assumed the role of dealer manager after the termination of a 60-day transition period with Grubb & Ellis Capital Corporation for the remainder of our offering. Effective
January 6, 2012, the 60-day transition period ended, however, the soliciting dealer agreements between Grubb & Ellis Capital Corporation and the participating broker-dealers in our offering were not transferable to Griffin Securities.
If Griffin Securities is not able to enter into as many new soliciting dealer agreements with participating broker-dealers that previously sold our offering, or there is a delay in the execution of soliciting dealer agreements between Griffin
Securities and participating broker-dealers, our ability to raise capital in our offering would be adversely affected.
Similarly, we are not able to use any supplemental sales material bearing the Grubb & Ellis logo. We intend to prepare
additional supplemental sales material for use in the future, but we cannot make any assurances regarding when, or if, such material will be available for use in connection with our offering. While any supplemental sales material must be accompanied
by or preceded by the delivery of a prospectus related to our offering, the inability to use supplemental sales material may adversely affect our ability to raise capital in our offering.
Any delay in the execution of new soliciting dealer agreements with participating broker-dealers would adversely affect our ability to
raise capital. In addition, we have used, and may continue to use, proceeds of our offering as a source of cash to pay, in part, distributions to our stockholders in anticipation of future cash flows. Therefore, an adverse affect on our ability to
raise capital could also adversely affect our ability to pay distributions to stockholders.
20
Griffin-American Advisor and certain of its key personnel face competing demands relating to their
time, and this may cause our operating results to suffer.
Griffin-American Advisor and certain of its key personnel,
and their respective affiliates, serve as key personnel, advisors, managers and sponsors of 16 other Griffin Capital-sponsored real estate programs, including Griffin Capital Net Lease REIT, Inc., a publicly registered, non-traded real estate
investment trust, and may have other business interests as well. Because these persons have competing demands on their time and resources, they may have conflicts of interest in allocating their time between our business and these other activities.
During times of intense activity in other programs and ventures, they may devote less time and fewer resources to our business than is necessary or appropriate. If this occurs, the returns on an investment may suffer.
In addition, executive officers of Griffin Capital also are officers of Griffin Securities and other affiliated entities. As a result,
these individuals owe fiduciary duties to these other entities and their owners, which fiduciary duties may conflict with the duties that they owe to our stockholders and us. Their loyalties to these other entities could result in actions or
inactions that are detrimental to our business, which could harm the implementation of our investment objectives. Conflicts with our business and interests are most likely to arise from involvement in activities related to allocation of management
time and services between us and the other entities. Griffin Securities currently also serves as dealer manager for Griffin Capital Net Lease REIT, Inc. If Griffin Securities is unable to devote sufficient time and effort to the distribution of
shares of our common stock, we may not be able to raise significant additional proceeds for investment in real estate. Accordingly, competing demands of Griffin Capital personnel may cause us to be unable to successfully implement our investment
objectives, or generate cash needed to make distributions to stockholders, and to maintain or increase the value of our assets.
Our
advisor entities may be entitled to receive significant compensation in the event of our liquidation or in connection with a termination of the Advisory Agreement.
We are externally advised by our advisor entities pursuant to an Advisory Agreement between us and our advisor, and a sub-advisory agreement between our advisor and our sub-advisor, each of which has a
one-year term that expires January 7, 2013 and is subject to successive one-year renewals upon the mutual consent of us and our advisor entities. In the event of a partial or full liquidation of our assets, our advisor entities will be entitled
to receive an incentive distribution equal to 15.0% of the net proceeds of the liquidation, after we have received and paid to our stockholders the sum of the gross proceeds from the sale of shares of our common stock and any shortfall in an annual
8.0% cumulative, non-compounded return to stockholders in the aggregate; provided however, that any amounts owed to our advisor entities shall be reduced by the amounts paid, if any, to our former advisor pursuant to its limited partnership interest
in our operating partnership. In the event of a termination of the Advisory Agreement in connection with the listing of our common stock on a national securities exchange, the partnership agreement provides that our advisor entities will receive an
incentive distribution equal to 15.0% of the amount, if any, by which (1) the market value of our outstanding common stock plus distributions paid by us prior to the listing of the shares of our common stock on a national securities exchange,
exceeds (2) the sum of the gross proceeds from the sale of shares of our common stock plus an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock; provided however, that any amounts
owed to our advisor entities shall be reduced by the amounts paid, if any, to our former advisor pursuant to its limited partnership interest in our operating partnership. Upon our advisors receipt of the incentive distribution upon listing,
our advisors limited partnership units will be redeemed and our advisor entities will not be entitled to receive any further incentive distributions upon sales of our properties. Further, in connection with the termination of the Advisory
Agreement, other than due to a listing of the shares of our common stock on a national securities exchange, our advisor entities shall be entitled to receive a distribution equal to the amount that would be payable as an incentive distribution upon
sales of properties, which equals 15.0% of the net proceeds if we liquidated all of our assets at fair market value, after we have received and paid to our stockholders the sum of the gross proceeds from the sale of shares of our common stock and
any shortfall in the annual 8.0% cumulative, non-compounded return to our stockholders in the aggregate; provided however, that any amounts owed to our advisor entities shall be reduced by the amounts paid, if any, to our former advisor pursuant to
its subordinated distribution upon termination described in Part III, Item 13. Certain Relationships and Related Transactions, and Director Independence, of this report. Upon our advisors receipt of this distribution, our
advisors limited partnership units will be redeemed and our advisor entities will not be entitled to receive any further incentive distributions upon sales of our properties. Any amounts to be paid to our advisor entities in connection with
the termination of the Advisory Agreement cannot be determined at the present time, but such amounts, if paid, will reduce the cash available for distribution to our stockholders.
21
We may not effect a liquidity event within our targeted time frame of five years after the completion
of our offering stage, or at all. If we do not effect a liquidity event, our stockholders may have to hold their investment in shares of our common stock for an indefinite period of time.
On a limited basis, our stockholders may be able to sell shares of our common stock through our share repurchase plan. However, in the
future we may also consider various forms of liquidity events, including but not limited to: (1) the listing of the shares of our common stock on a national securities exchange; (2) our sale or merger in a transaction that provides our
stockholders with a combination of cash and/or securities of a publicly traded company; and (3) the sale of all or substantially all of our real estate and real estate-related investments for cash or other consideration. We presently intend to
effect a liquidity event within five years after the completion of our offering stage, which we deem to be the completion of our offering and any subsequent public offerings, or our offerings, excluding any offerings pursuant to the DRIP or that is
limited to any benefit plans. However, we are not obligated, through our charter or otherwise, to effectuate a liquidity event and may not effect a liquidity event within such time or at all. If we do not effect a liquidity event, it will be very
difficult for our stockholders to have liquidity for their investment in the shares of our common stock other than limited liquidity through our share repurchase plan.
Because a portion of the offering price from the sale of shares of our common stock in our offering is used to pay expenses and fees, the full offering price paid by our stockholders is not invested in
real estate investments. As a result, our stockholders will only receive a full return of their invested capital if we either (1) sell our assets or our company for a sufficient amount in excess of the original purchase price of our assets, or
(2) list the shares of our common stock on a national securities exchange and the market value of our company after we list is substantially in excess of the original purchase price of our assets.
Our board of directors may change our investment objectives without seeking our stockholders approval.
Our board of directors may change our investment objectives without seeking our stockholders approval if our directors, in
accordance with their fiduciary duties to our stockholders, determine that a change is in our stockholders best interest. A change in our investment objectives could reduce our payment of cash distributions to our stockholders or cause a
decline in the value of our investments.
Risks Related to Our Business
We have not had sufficient cash available from operations to pay distributions, and, therefore, we have paid distributions from the net proceeds of our offering, from borrowings in anticipation of
future cash flows or from other sources. Any such distributions may reduce the amount of capital we ultimately invest in assets and negatively impact the value of our stockholders investment.
Distributions payable to our stockholders may include a return of capital, rather than a return on capital. We have not established any
limit on the amount of proceeds from our offering that may be used to fund distributions, except that, in accordance with our organizational documents and Maryland law, we may not make distributions that would: (i) cause us to be unable to pay
our debts as they become due in the usual course of business; (ii) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences; or (iii) jeopardize our ability to maintain our qualification
as a REIT. The actual amount and timing of distributions are determined by our board of directors in its sole discretion and typically will depend on the amount of funds available for distribution, which will depend on items such as our financial
condition, current and projected capital expenditure requirements, tax considerations and annual distribution requirements needed to maintain our qualification as a REIT. As a result, our distribution rate and payment frequency vary from time to
time.
We have used, and in the future may use, the net proceeds from our offering, borrowed funds, or other sources, to pay
cash distributions to our stockholders, which may reduce the amount of proceeds available for investment and operations or cause us to incur additional interest expense as a result of borrowed funds. As a result, the amount of net proceeds available
for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds. Further, if the aggregate amount of cash distributed in any given year exceeds the amount of our current and accumulated
earnings and profits, the excess amount will be deemed a return of capital.
22
Our board of directors authorized a daily distribution to our stockholders of record as of
the close of business on each day of the period commencing on January 1, 2010 and ending on June 30, 2010, as a result of our former sponsor, Grubb & Ellis, advising us that it intended to fund these distributions until we
acquired our first property. We acquired our first property, Lacombe Medical Office Building, on March 5, 2010. Our former sponsor did not receive any additional shares of our common stock or other consideration for funding these distributions,
and we will not repay the funds provided by our former sponsor for these distributions. Subsequently, our board of directors authorized, on a quarterly basis, a daily distribution to our stockholders of record as of the close of business on each day
of the quarterly periods commencing on July 1, 2010 and ending on June 30, 2012.
For distributions declared for
each record date in the January 2010 through December 2011 periods, the distributions were calculated based on 365 days in the calendar year and were equal to $0.001780822 per day per share of common stock, which is equal to an annualized
distribution rate of 6.5%, assuming a purchase price of $10.00 per share. For distributions declared for each record date in the January 2012 through June 2012 periods, the distributions are calculated based on 365 days in the calendar year and are
equal to $0.001808219 per day per share of common stock, which is equal to an annualized distribution rate of 6.6%, assuming a purchase price of $10.00 per share. These distributions are aggregated and paid in cash or shares of our common stock
pursuant to the DRIP monthly in arrears. The distributions declared for each record date are paid only from legally available funds. We can provide no assurance that we will be able to continue this distribution rate or pay any subsequent
distributions.
The distributions paid for the years ended December 31, 2011 and 2010, along with the amount of
distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to cash flows from operations are as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Distributions paid in cash
|
|
$
|
9,375,000
|
|
|
|
|
|
|
$
|
2,087,000
|
|
|
|
|
|
Distributions reinvested
|
|
|
8,817,000
|
|
|
|
|
|
|
|
1,985,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
|
|
|
$
|
4,072,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sources of distributions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operations
|
|
$
|
9,264,000
|
|
|
|
50.9
|
%
|
|
$
|
|
|
|
|
|
%
|
Funds from our former sponsor
|
|
|
|
|
|
|
|
%
|
|
|
259,000
|
|
|
|
6.4
|
%
|
Offering proceeds
|
|
|
8,928,000
|
|
|
|
49.1
|
%
|
|
|
3,813,000
|
|
|
|
93.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
100
|
%
|
|
$
|
4,072,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not
pay any distributions.
Under accounting principles generally accepted in the United States of America, or GAAP, acquisition
related expenses are expensed, and therefore, subtracted from cash flows from operations. However, these expenses are paid from offering proceeds.
For a further discussion of distributions, see Part II, Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Distributions and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Liquidity and Capital Resources Distributions.
As of December 31, 2011, we had an amount payable of $520,000 to our former advisor or its affiliates for asset and property
management fees, operating expenses, lease commissions, on-site personnel payroll and acquisition related expenses, which will be paid from cash flows from operations in the future as they become due and payable by us in the ordinary course of
business consistent with our past practice.
23
As of December 31, 2011, no amounts due to our former advisor or its affiliates have
been deferred, waived or forgiven. Our former advisor and its affiliates and our advisor and its affiliates have no obligations to defer, waive or forgive amounts due to them. In the future, if our advisor or its affiliates do not defer, waive or
forgive amounts due to them, this would negatively affect our cash flows from operations, which could result in us paying distributions, or a portion thereof, with the net proceeds from our offering, funds from our sponsor or borrowed funds. As a
result, the amount of proceeds available for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds.
The distributions paid for the years ended December 31, 2011 and 2010, along with the amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to funds
from operations, or FFO, are as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Distributions paid in cash
|
|
$
|
9,375,000
|
|
|
|
|
|
|
$
|
2,087,000
|
|
|
|
|
|
Distributions reinvested
|
|
|
8,817,000
|
|
|
|
|
|
|
|
1,985,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
|
|
|
$
|
4,072,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sources of distributions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FFO
|
|
$
|
9,040,000
|
|
|
|
49.7
|
%
|
|
$
|
|
|
|
|
|
%
|
Funds from our former sponsor
|
|
|
|
|
|
|
|
%
|
|
|
259,000
|
|
|
|
6.4
|
%
|
Offering proceeds
|
|
|
9,152,000
|
|
|
|
50.3
|
%
|
|
|
3,813,000
|
|
|
|
93.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
100
|
%
|
|
$
|
4,072,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not
pay any distributions.
The payment of distributions from sources other than FFO may reduce the amount of proceeds available
for investment and operations or cause us to incur additional interest expense as a result of borrowed funds. For a further discussion of FFO, which includes a reconciliation of our GAAP net loss to FFO, see Part II, Item 6. Selected
Financial Data.
We may suffer from delays in locating suitable investments, which could reduce our ability to pay distributions to our
stockholders and reduce their return on their investment.
There may be a substantial period of time before all of the
proceeds of our offering are invested in suitable investments, particularly as a result of the current economic environment and capital constraints. Because we are conducting our offering on a best efforts basis over time, our ability to
commit to purchase specific assets will also depend, in part, on the amount of proceeds we have received at a given time. If we are delayed or unable to find suitable investments, we may not be able to achieve our investment objectives or pay
distributions to our stockholders.
The availability and timing of cash distributions to our stockholders is uncertain. If we fail to
pay distributions, our stockholders investment in shares of our common stock could suffer.
We expect to
continue to pay monthly distributions to our stockholders. However, we bear all expenses incurred in our operations, which are deducted from cash flows generated by operations prior to computing the amount of cash distributions to our stockholders.
In addition, our board of directors, in its discretion, may retain any portion of such funds for working capital. We cannot assure our stockholders that sufficient cash will be available to pay distributions to them monthly, or at all. Should we
fail for any reason to distribute at least 90.0% of our annual taxable income, excluding net capital gains, we would not qualify for the favorable tax treatment accorded to REITs.
24
We are uncertain of all of our sources of debt or equity for funding our capital needs. If we cannot
obtain funding on acceptable terms, our ability to acquire and make necessary capital improvements to properties may be impaired or delayed.
We intend to use the gross proceeds of our offering to buy a diversified portfolio of real estate and real estate-related investments and to pay various fees and expenses. In addition, to maintain our
qualification as a REIT, we generally must distribute to our stockholders at least 90.0% of our annual taxable income, excluding net capital gains, each year, excluding capital gains. Because of this distribution requirement, it is not likely that
we will be able to fund a significant portion of our capital needs from retained earnings. We have not identified all of our sources of debt or equity for funding, and such sources of funding may not be available to us on favorable terms or at all.
If we do not have access to sufficient funding in the future, we may not be able to acquire and make necessary capital improvements to properties, pay other expenses or expand our business.
We intend to incur mortgage indebtedness and other borrowings, which may increase our business risks, could hinder our ability to pay distributions and could decrease the value of our
stockholders investment.
We have financed and will continue to finance a portion of the purchase price of our
investments in real estate and real estate-related investments by borrowing funds. We anticipate that, after an initial phase of our operations (prior to the investment of all of the net proceeds of our offerings of shares of our common stock) when
we may employ greater amounts of leverage to enable us to purchase properties more quickly, and therefore, generate distributions for our stockholders sooner, our overall leverage will not exceed 60.0% of the combined market value of our real estate
and real estate-related investments, as determined at the end of each calendar year beginning with our first full year of operations. Under our charter, we have a limitation on borrowing that precludes us from borrowing in excess of 300.0% of our
net assets without the approval of a majority of our independent directors. Net assets for purposes of this calculation are defined to be our total assets (other than intangibles), valued at cost prior to deducting depreciation, amortization, bad
debt and other non-cash reserves, less total liabilities. Generally speaking, the preceding calculation is expected to approximate 75.0% of the aggregate cost of our real estate and real estate-related investments before depreciation, amortization,
bad debt and other similar non-cash reserves. In addition, we may incur mortgage debt and pledge some or all of our real properties as security for that debt to obtain funds to acquire additional real properties or for working capital. We may also
borrow funds to satisfy the REIT tax qualification requirement that we distribute at least 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. Furthermore, we may borrow if we otherwise deem it necessary or
advisable to ensure that we maintain our qualification as a REIT for federal income tax purposes.
High debt levels may cause
us to incur higher interest charges, which would result in higher debt service payments and could be accompanied by restrictive covenants. If there is a shortfall between the cash flows from a property and the cash flows needed to service mortgage
debt on that property, then the amount available for distributions to our stockholders may be reduced. In addition, incurring mortgage debt increases the risk of loss since defaults on indebtedness secured by a property may result in lenders
initiating foreclosure actions. In that case, we could lose the property securing the loan that is in default, thus reducing the value of our stockholders investment. For tax purposes, a foreclosure on any of our properties will be treated as
a sale of the property for a purchase price equal to the outstanding balance of the debt secured by the mortgage. If the outstanding balance of the debt secured by the mortgage exceeds our tax basis in the property, we will recognize taxable income
on foreclosure, but we would not receive any cash proceeds. We may give full or partial guarantees to lenders of mortgage debt to the entities that own our properties. When we give a guaranty on behalf of an entity that owns one of our properties,
we will be responsible to the lender for satisfaction of the debt if it is not paid by such entity. If any mortgage contains cross collateralization or cross default provisions, a default on a single property could affect multiple properties. If any
of our properties are foreclosed upon due to a default, our ability to pay cash distributions to our stockholders will be adversely affected.
25
Higher mortgage rates may make it more difficult for us to finance or refinance properties, which
could reduce the number of properties we can acquire and the amount of cash available for distribution to our stockholders.
If mortgage debt is unavailable on reasonable terms as a result of increased interest rates or other factors, we may not be able to finance the purchase of properties. In addition, if we place mortgage
debt on properties, we run the risk of being unable to refinance such debt when the loans come due, or of being unable to refinance on favorable terms. If interest rates are higher when we refinance debt, our income could be reduced. We may be
unable to refinance debt at appropriate times, which may require us to sell properties on terms that are not advantageous to us, or could result in the foreclosure of such properties. If any of these events occur, our cash flows would be reduced.
This, in turn, would reduce cash available for distribution to our stockholders and may hinder our ability to raise more capital by issuing securities or by borrowing more money.
Financial market disruptions may adversely affect our operating results and financial condition.
The global financial markets have undergone pervasive and fundamental disruptions over the past number of years. The continuation or intensification of any such volatility may have an adverse impact on
the availability of credit to businesses generally and could lead to a further weakening of the U.S. and global economies. To the extent that turmoil in the financial markets continues and/or intensifies, it has the potential to materially
affect the value of our properties and other investments, the availability or the terms of financing that we may anticipate utilizing, our ability to make principal and interest payments on, or refinance, any outstanding debt when due and/or the
ability of our tenants to enter into new leasing transactions or satisfy rental payments under existing leases. Financial market disruptions could also affect our operating results and financial condition as follows:
|
|
|
Debt and Equity Markets
Our results of operations are sensitive to the volatility of the credit markets. The real estate debt
markets have been experiencing volatility as a result of certain factors, including the tightening of underwriting standards by lenders and credit rating agencies and the significant inventory of unsold commercial mortgage-backed securities in the
market. Credit spreads for major sources of capital have widened significantly as investors have demanded a higher risk premium. This is resulting in lenders increasing the cost for debt financing. Should the overall cost of borrowings increase,
either by increases in the index rates or by increases in lender spreads, we will need to factor such increases into the economics of our acquisitions, developments and property contributions. This may result in our property operations generating
lower overall economic returns and a reduced level of cash flows, which could potentially impact our ability to pay distributions to our stockholders. In addition, the ongoing dislocations in the debt markets have reduced the amount of capital that
is available to finance real estate, which, in turn: (1) limits the ability of real estate investors to benefit from reduced real estate values or to realize enhanced returns on real estate investments; (2) has slowed real estate
transaction activity; and (3) may result in an inability to refinance debt as it becomes due, all of which may reasonably be expected to have a material impact, favorable or unfavorable, on revenues, income and/or cash flows from the
acquisition and operations of real estate and mortgage loans. In addition, the state of the debt markets could have an impact on the overall amount of capital being invested in real estate, which may result in price or value decreases of real estate
assets and impact our ability to raise equity capital.
|
|
|
|
Valuations
Any persistent market volatility will likely make the valuation of our properties more difficult. There may be
significant uncertainty in the valuation, or in the stability of the value, of our properties that could result in a substantial decrease in the value of our properties. As a result, we may not be able to recover the carrying amount of our
properties, which may require us to recognize an impairment charge in earnings.
|
|
|
|
Government Intervention
The pervasive and fundamental disruptions that the global financial markets have been undergoing have led to
extensive and unprecedented governmental intervention. Although the government intervention is intended to stimulate the flow of capital and to undergird the U.S. economy in the short term, it is impossible to predict the actual effect of the
government intervention and what effect, if any, additional interim or permanent governmental intervention may have on the financial markets and/or the effect of such intervention on us and our results of operations. In addition, there is a high
likelihood that regulation of the financial markets will be significantly increased in the future, which could have a material impact on our operating results and financial condition.
|
26
Our results of operations, our ability to pay distributions to our stockholders and our ability to
dispose of our investments are subject to international, national and local economic factors we cannot control or predict.
Our results of operations are subject to the risks of an international or national economic slowdown or downturn and other changes in international, national and local economic conditions. The following
factors may affect income from our properties, our ability to acquire and dispose of properties, and yields from our properties:
|
|
|
poor economic times may result in defaults by tenants of our properties due to bankruptcy, lack of liquidity, or operational failures. We may also be
required to provide rent concessions or reduced rental rates to maintain or increase occupancy levels;
|
|
|
|
reduced values of our properties may limit our ability to dispose of assets at attractive prices or to obtain debt financing secured by our properties
and may reduce the availability of unsecured loans;
|
|
|
|
the value and liquidity of our short-term investments and cash deposits could be reduced as a result of a deterioration of the financial condition of
the institutions that hold our cash deposits or the institutions or assets in which we have made short-term investments, the dislocation of the markets for our short-term investments, increased volatility in market rates for such investment or other
factors;
|
|
|
|
our lender under our line of credit could refuse to fund their financing commitment to us or could fail and we may not be able to replace the financing
commitment of such lender on favorable terms, or at all;
|
|
|
|
one or more counterparties to our interest rate swaps could default on their obligations to us or could fail, increasing the risk that we may not
realize the benefits of these instruments;
|
|
|
|
increases in supply of competing properties or decreases in demand for our properties may impact our ability to maintain or increase occupancy levels
and rents;
|
|
|
|
constricted access to credit may result in tenant defaults or non-renewals under leases;
|
|
|
|
job transfers and layoffs may cause vacancies to increase and a lack of future population and job growth may make it difficult to maintain or increase
occupancy levels; and
|
|
|
|
increased insurance premiums, real estate taxes or utilities or other expenses may reduce funds available for distribution or, to the extent such
increases are passed through to tenants, may lead to tenant defaults. Also, any such increased expenses may make it difficult to increase rents to tenants on turnover, which may limit our ability to increase our returns.
|
The length and severity of any economic slowdown or downturn cannot be predicted. Our results of
operations, our ability to pay distributions to our stockholders and our ability to dispose of our investments may be negatively impacted to the extent an economic slowdown or downturn is prolonged or becomes more severe.
Increasing vacancy rates for commercial real estate resulting from ongoing disruptions in the financial markets and deteriorating economic
conditions could reduce revenue and the resale value of our properties.
We depend upon tenants for a majority of our
revenue from real property investments. Ongoing disruptions in the financial markets and deteriorating economic conditions have resulted in a trend toward increasing vacancy rates for virtually all classes of commercial real estate, including
medical office buildings and healthcare-related facilities, due to generally lower demand for rentable space, as well as potential oversupply of rentable space. Increased unemployment rates have led to reduced demand for medical services, causing
physician groups and hospitals to delay expansion plans, leaving a growing number of vacancies in new buildings. Reduced demand for medical office buildings and healthcare-related facilities could require us to increase concessions, tenant
improvement expenditures or reduce rental rates to maintain occupancies beyond those anticipated at the time we acquire the property. In addition, the market value of a particular property could be diminished by prolonged vacancies. The continuation
of disruptions in the financial markets and deteriorating economic conditions could impact certain properties we acquire and such properties could experience higher levels of vacancy than anticipated at the time we acquire them. The value of our
real estate investments could decrease below the amounts we paid for the
27
investments. Revenues from properties could decrease due to lower occupancy rates, reduced rental rates and potential increases in uncollectible rent. We will incur expenses, such as for
maintenance costs, insurance costs and property taxes, even though a property is vacant. The longer the period of significant vacancies for a property, the greater the potential negative impact on our revenues and results of operations.
We are dependent on tenants for our revenue, and lease terminations could reduce our distributions to our stockholders.
The successful performance of our real estate investments is materially dependent on the financial stability of our tenants. Lease
payment defaults by tenants would cause us to lose the revenue associated with such leases and could cause us to reduce the amount of distributions to our stockholders. If the property is subject to a mortgage, a default by a significant tenant on
its lease payments to us may result in a foreclosure on the property if we are unable to find an alternative source of revenue to meet mortgage payments. In the event of a tenant default, we may experience delays in enforcing our rights as landlord
and may incur substantial costs in protecting our investment and re-leasing our property. Further, we cannot assure our stockholders that we will be able to re-lease the property for the rent previously received, if at all, or that lease
terminations will not cause us to sell the property at a loss.
If a tenant declares bankruptcy, we may be unable to collect balances
due under relevant leases.
Any of our current or future tenants, or any guarantor of one of our current or future
tenants lease obligations, could be subject to a bankruptcy proceeding pursuant to Title 11 of the bankruptcy laws of the U.S. Such a bankruptcy filing would bar us from attempting to collect pre-bankruptcy debts from the bankrupt tenant
or its properties unless we receive an enabling order from the bankruptcy court. Post-bankruptcy debts would be paid currently. If we assume a lease, all pre-bankruptcy balances owing under it must be paid in full. If a lease is rejected by a tenant
in bankruptcy, we would have a general unsecured claim for damages. If a lease is rejected, it is unlikely we would receive any payments from the tenant because our claim would be capped at the rent reserved under the lease, without acceleration,
for the greater of one year or 15.0% of the remaining term of the lease, but not greater than three years, plus rent already due but unpaid. This claim could be paid only in the event funds were available, and then only in the same percentage as
that realized on other unsecured claims.
The bankruptcy of a tenant or lease guarantor could delay our efforts to collect
past due balances under the relevant lease, and could ultimately preclude full collection of these sums. Such an event also could cause a decrease or cessation of current rental payments, reducing our cash flows and the amount available for
distributions to our stockholders. In the event a tenant or lease guarantor declares bankruptcy, the tenant or its trustee may not assume our lease or its guaranty. If a given lease or guaranty is not assumed, our cash flows and the amounts
available for distributions to our stockholders may be adversely affected.
Long-term leases may not result in fair market lease rates
over time; therefore, our income and our distributions could be lower than if we did not enter into long-term leases.
We may enter into long-term leases with tenants of certain of our properties. Our long-term leases would likely provide for rent to
increase over time. However, if we do not accurately judge the potential for increases in market rental rates, we may set the terms of these long-term leases at levels such that even after contractual rental increases, the rent under our long-term
leases is less than then-current market rental rates. Further, we may have no ability to terminate those leases or to adjust the rent to then-prevailing market rates. As a result, our income and distributions could be lower than if we did not enter
into long-term leases.
We may incur additional costs in acquiring or re-leasing properties, which could adversely affect the cash
available for distribution to our stockholders.
We have and may continue to invest in properties designed or built
primarily for a particular tenant of a specific type of use known as a single-user facility. If the tenant fails to renew its lease or defaults on its lease obligations, we may not be able to readily market a single-user facility to a new tenant
without making substantial capital improvements or incurring other significant re-leasing costs. We also may incur significant litigation costs in enforcing our rights as a landlord against the defaulting tenant. These consequences could adversely
affect our revenues and reduce the cash available for distribution to our stockholders.
28
We may be unable to secure funds for future tenant or other capital improvements, which could limit
our ability to attract, or replace or retain tenants and decrease our stockholders return on their investment.
When tenants do not renew their leases or otherwise vacate their space, it is common that, in order to attract replacement tenants, we
will be required to expend substantial funds for tenant improvements and leasing commissions related to the vacated space. Such tenant improvements may require us to incur substantial capital expenditures. If we have not established capital reserves
for such tenant or other capital improvements, we will have to obtain financing from other sources and we have not identified any sources for such financing. We may also have future financing needs for other capital improvements to refurbish or
renovate our properties. If we need to secure financing sources for tenant improvements or other capital improvements in the future, but are unable to secure such financing or are unable to secure financing on terms we feel are acceptable, we may be
unable to make tenant and other capital improvements or we may be required to defer such improvements. If this happens, it may cause one or more of our properties to suffer from a greater risk of obsolescence or a decline in value, or a greater risk
of decreased cash flows as a result of fewer potential tenants being attracted to the property or existing tenants not renewing their leases. If we do not have access to sufficient funding in the future, we may not be able to make necessary capital
improvements to our properties, pay other expenses or pay distributions to stockholders.
Our success is dependent on the performance of
our advisor entities and certain key personnel.
Our ability to achieve our investment objectives and to conduct our
operations is dependent upon the performance of our advisor entities in identifying and acquiring investments, the determination of any financing arrangements, the asset management of our investments and the management of our day-to-day activities.
Our advisor entities have broad discretion over the use of proceeds from our offering and our stockholders will have no opportunity to evaluate the terms of transactions or other economic or financial data concerning our investments that are not
described in our prospectus or other periodic filings with the SEC. We rely on the management ability of our advisor entities, subject to the oversight and approval of our board of directors. Accordingly, investors should not purchase shares of our
common stock unless they are willing to entrust all aspects of our day-to-day management to our advisor entities. If our advisor entities suffer or are distracted by adverse financial or operational problems in connection with their own operations
or the operations of American Healthcare Investors or Griffin Capital unrelated to us, our advisor entities may be unable to allocate time and/or resources to our operations. If our advisor entities are unable to allocate sufficient resources to
oversee and perform our operations for any reason, we may be unable to achieve our investment objectives or to pay distributions to our stockholders. In addition, our success depends to a significant degree upon the continued contributions of our
advisor entities principals, officers and certain of the principals, officers and employees of American Healthcare Investors, who manage our sub-advisor, in particular Mr. Hanson and Mr. Prosky, each of whom would be difficult to
replace. In the event that Mr. Hanson or Mr. Prosky are no longer affiliated with American Healthcare Investors, for any reason, it could have a material adverse effect on our success and American Healthcare Investors may not be able to
attract and hire as capable individuals to replace Mr. Hanson and/or Mr. Prosky. We do not have key man life insurance on any of our co-sponsors key personnel. If our advisor entities or American Healthcare Investors were to lose the
benefit of the experience, efforts and abilities of one or more of these individuals, our operating results could suffer.
Our advisor
may terminate the Advisory Agreement, which could require us to pay substantial fees and may require us to find a new advisor.
Either we or our advisor, with the consent of the sub-advisor, can terminate the Advisory Agreement subject to a 60-day transition period with respect to certain provisions of the Advisory Agreement.
However, if the Advisory Agreement is terminated in connection with the listing of shares of our common stock on a national securities exchange, the partnership agreement provides that our advisor will receive an incentive distribution equal to
15.0% of the amount, if any, by which (1) the market value of the outstanding shares of our common stock plus distributions paid by us prior to listing, exceeds (2) the sum of the gross proceeds from the sale of shares of our common stock
plus an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock; provided however, that any amounts owed to our advisor shall be reduced by any
29
amounts paid to our former advisor pursuant to its limited partnership interest in our operating partnership. Upon our advisors receipt of the incentive distribution upon listing, our
advisors limited partnership units will be redeemed and our advisor will not be entitled to receive any further incentive distributions upon sales of our properties. Further, in connection with the termination of the Advisory Agreement, other
than due to a listing of the shares of our common stock on a national securities exchange, our advisor entities shall be entitled to receive a distribution equal to the amount that would be payable to our advisor entities pursuant to the incentive
distribution upon sales if we liquidated all of our assets for their fair market value; provided however, that any amounts owed to our advisor entities shall be reduced by any amounts paid to our former advisor pursuant to its limited partnership
interest in our operating partnership. Upon our advisors receipt of this distribution, our advisors limited partnership units will be redeemed and our advisor will not be entitled to receive any further incentive distributions upon sales
of our properties. Any amounts to be paid to our advisor entities upon termination of the Advisory Agreement cannot be determined at the present time.
If our advisor entities were to terminate the Advisory Agreement, we would need to find another advisor to provide us with day-to-day management services or have employees to provide these services
directly to us. There can be no assurances that we would be able to find new advisors or employees or enter into agreements for such services on acceptable terms.
If we internalize our management functions, we could incur significant costs associated with being self-managed.
Our strategy may involve internalizing our management functions. If we internalize our management functions, we would no longer bear the costs of the various fees and expenses we expect to pay to our
advisor entities under the Advisory Agreement; however our direct expenses would include general and administrative costs, including legal, accounting, and other expenses related to corporate governance, SEC reporting and compliance. We would also
incur the compensation and benefits costs of our officers and other employees and consultants that are now paid by our advisor entities or their affiliates. In addition, we may issue equity awards to officers, employees and consultants, which awards
would decrease net income and FFO, and may further dilute our stockholders investment. We cannot reasonably estimate the amount of fees to our advisor entities that we would save and the costs we would incur if we became self-managed. If the
expenses we assume as a result of an internalization are higher than the expenses we no longer pay to our advisor entities, our net income per share and FFO per share may be lower as a result of the internalization than they otherwise would have
been, potentially decreasing the amount of funds available to distribute to our stockholders.
As currently organized, we do
not directly have any employees. If we elect to internalize our operations, we would employ personnel and would be subject to potential liabilities commonly faced by employers, such as workers disability and compensation claims, potential
labor disputes and other employee-related liabilities and grievances. Upon any internalization of our advisor entities, certain key personnel of our advisor or American Healthcare Investors may not be employed by us, but instead may remain employees
of our co-sponsors or their affiliates.
If we internalize our management functions, we could have difficulty integrating
these functions as a stand-alone entity. Currently, our advisor entities and their affiliates perform asset management and general and administrative functions, including accounting and financial reporting, for multiple entities. They have a great
deal of know-how and can experience economies of scale. We may fail to properly identify the appropriate mix of personnel and capital needs to operate as a stand-alone entity. An inability to manage an internalization transaction effectively could,
therefore, result in our incurring additional costs and/or experiencing deficiencies in our disclosure controls and procedures or our internal control over financial reporting. Such deficiencies could cause us to incur additional costs, and our
managements attention could be diverted from most effectively managing our properties.
Our success is dependent on the
performance of our co-sponsors.
Our ability to achieve our investment objectives and to conduct our operations is
dependent upon the performance of our sub-advisor which has assumed responsibility for the day to day management of our company from our advisor. The sub-advisor is a joint venture between our two co-sponsors. Our sub-advisors and
co-sponsors ability to manage our operations successfully will be impacted by trends in the general economy, as well
30
as the commercial real estate and credit markets. The current macroeconomic environment may negatively impact the value of commercial real estate assets and contribute to a general slow-down in
our industry, which could put downward pressure on our co-sponsors revenues and operating results. To the extent that any decline in our co-sponsors revenues and operating results impacts the performance of our advisor entities, our
results of operations and financial condition could also suffer.
Our advisor, sub-advisor and their affiliates have no obligation to
defer or forgive fees or loans or advance any funds to us, which could reduce our ability to acquire investments or pay distributions.
In the past, our former sponsor or its affiliates have, in certain circumstances, deferred or forgiven fees and loans payable by programs sponsored or managed by our former sponsor or its affiliates. Our
advisor entities and their affiliates, including our co-sponsors, have no obligation to defer or forgive fees owed by us to our advisor entities or their affiliates or to advance any funds to us. As a result, we may have less cash available to
acquire investments or pay distributions.
We may structure acquisitions of property in exchange for limited partnership units in our
operating partnership on terms that could limit our liquidity or our flexibility.
We may acquire properties by
issuing limited partnership units in our operating partnership in exchange for a property owner contributing property to the partnership. If we enter into such transactions, in order to induce the contributors of such properties to accept units in
our operating partnership, rather than cash, in exchange for their properties, it may be necessary for us to provide them additional incentives. For instance, our operating partnerships limited partnership agreement provides that any holder of
units may exchange limited partnership units on a one-for-one basis for shares of our common stock, or, at our option, cash equal to the value of an equivalent number of shares of our common stock. We may, however, enter into additional contractual
arrangements with contributors of property under which we would agree to redeem a contributors units for shares of our common stock or cash, at the option of the contributor, at set times. If the contributor required us to redeem units for
cash pursuant to such a provision, it would limit our liquidity and thus our ability to use cash to make other investments, satisfy other obligations or pay distributions to our stockholders. Moreover, if we were required to redeem units for cash at
a time when we did not have sufficient cash to fund the redemption, we might be required to sell one or more properties to raise funds to satisfy this obligation. Furthermore, we might agree that if distributions the contributor received as a
limited partner in our operating partnership did not provide the contributor with a defined return, then upon redemption of the contributors units we would pay the contributor an additional amount necessary to achieve that return. Such a
provision could further negatively impact our liquidity and flexibility. Finally, in order to allow a contributor of a property to defer taxable gain on the contribution of property to our operating partnership, we might agree not to sell a
contributed property for a defined period of time or until the contributor exchanged the contributors units for cash or shares of our common stock. Such an agreement would prevent us from selling those properties, even if market conditions
made such a sale favorable to us.
The failure of any bank in which we deposit our funds could reduce the amount of cash we have
available to pay distributions and acquire investments.
We have cash and cash equivalents and restricted cash
deposited in certain financial institutions in excess of federally-insured levels. If any banking institution in which we have deposited funds ultimately fails, we may lose the amount of our deposits over any federally-insured amount. The loss of
our deposits could reduce the amount of cash we have available to distribute or invest and could result in a decline in the value of our stockholders investment.
Our former sponsor has filed for bankruptcy protection and, in connection with its reorganization or liquidation, may assert claims for payment of additional fees or reimbursement of expenses from
us or otherwise seek claims against us and our affiliates. In such event, our officers and directors may be required to devote time to resolve any such claims by our former sponsor, and therefore, the time they are able to devote to our business may
decline.
31
On February 20, 2012, Grubb & Ellis, our former sponsor, filed for Chapter 11
bankruptcy protection and announced that it signed an agreement to sell substantially all of its assets to BGC Partners, Inc. In connection with such reorganization, our former sponsor may assert claims for payment from us with respect to services
performed by Grubb & Ellis and its affiliates during the time that Grubb & Ellis served as our sponsor, or otherwise seek claims against us and our affiliates. Any such payments made to our former sponsor may reduce the amount of
expenses for which we reimburse our current advisor entities in connection with our offering. While we believe the amount of such payments to our former sponsor, if any, would be immaterial, our officers and directors may be
required to devote significant time to resolve any claims asserted against us or our affiliates. If this were to occur, the time that our officers and directors devote to our business may decline during any period where these claims are being
resolved, and our business and operations may suffer as a result.
Risks Related to Conflicts of Interest
We are subject to conflicts of interest arising out of relationships among us, our officers, our advisor entities and their affiliates,
including the material conflicts discussed below.
We may compete with other programs sponsored by our co-sponsors for investment
opportunities. As a result, our advisor entities may not cause us to invest in favorable investment opportunities, which may reduce our returns on our investments.
Griffin Capital or its affiliates have sponsored existing programs with investment objectives and strategies similar to ours, and either of our co-sponsors may sponsor other similar programs in the
future. As a result, we may be buying properties at the same time as one or more other Griffin Capital or future American Healthcare Investors programs that are managed or advised by affiliates of our advisor entities. Officers and employees of our
advisor entities may face conflicts of interest in allocating investment opportunities between us and these other programs. For instance, our advisor entities may select properties for us that provide lower returns to us than properties that their
affiliates select to be purchased by another Griffin Capital program or future American Healthcare Investor programs. We cannot be sure that officers and employees acting for or on behalf of our advisor entities and on behalf of managers of other
Griffin Capital programs or future American Healthcare Investors programs will act in our best interest when deciding whether to allocate any particular investment to us. We are subject to the risk that as a result of the conflicts of interest
between us, our advisor, our sub-advisor and other entities or programs managed by their affiliates, our advisor entities may not cause us to invest in favorable investment opportunities that our advisor entities locate when it would be in our best
interest to make such investments. As a result, we may invest in less favorable investments, which may reduce our returns on our investments and ability to pay distributions.
The conflicts of interest faced by our officers may cause us not to be managed solely in our stockholders best interest, which may adversely affect our results of operations and the value of
our stockholders investment.
All of our officers also are principals, officers or employees of American
Healthcare Investors or other affiliated entities that will receive fees in connection with our offering and our operations. These relationships are described in Part III, Item 10, Directors, Executive Officers and Corporate Governance of this
Annual Report on Form 10-K. These persons are not precluded from working with, or investing in, any program American Healthcare Investors may sponsor in the future. Their loyalties to these other entities could result in actions or inactions that
are detrimental to our business, which could harm the implementation of our investment strategy and our investment opportunities. Furthermore, they may have conflicts of interest in allocating their time and resources between our business and these
other activities. During times of intense activity in other programs, the time they devote to our business may decline and be less than we require. If our officers, for any reason, are not able to provide sufficient resources to manage our business,
our business will suffer and this may adversely affect our results of operations and the value of our stockholders investment.
32
American Healthcare Investors and our advisor entities officers face conflicts of interest
relating to the allocation of their time and other resources among the various entities that they serve or have interests in, and such conflicts may not be resolved in our favor.
Certain of the officers of American Healthcare Investors and our advisor entities face competing demands relating to their time and
resources because they are also or may become affiliated with entities with investment programs similar to ours, and they may have other business interests as well, including business interests that currently exist and business interests they
develop in the future. Because these persons have competing interests for their time and resources, they may have conflicts of interest in allocating their time between our business and these other activities. Further, during times of intense
activity in other programs, those executives may devote less time and fewer resources to our business than are necessary or appropriate to manage our business. Poor or inadequate management of our business would adversely affect our results of
operations and the ownership value of shares of our common stock.
Our advisor entities face conflicts of interest relating to their
compensation structure, which could result in actions that are not necessarily in our stockholders long-term best interest.
Under the Advisory Agreement and sub-advisory agreement, and pursuant to the subordinated participation interest our advisor holds in our operating partnership, our advisor entities are entitled to fees
and distributions that are structured in a manner intended to provide incentives to our advisor entities to perform in both our and our stockholders long-term best interests. The fees to which our advisor entities or their affiliates are
entitled include acquisition fees, asset management fees, property management fees, disposition fees and other fees as provided for under the Advisory Agreement and agreement of limited partnership with our operating partnership. The distributions
our advisor entities may become entitled to receive would be payable upon distribution of net sales proceeds to our stockholders, the listing of the shares of our common stock on a national securities exchange, certain merger transactions or the
termination of the Advisory Agreement. See Part III, Item 13. Certain Relationships and Related Transactions, and Director Independence, of this Annual Report on Form 10-K for a description of the fees and distributions payable to our
advisor entities and their affiliates. However, because our advisor entities are entitled to receive substantial minimum compensation regardless of our performance, our advisor entities interests may not be wholly aligned with our
stockholders. In that regard, our advisor entities or their affiliates receive an asset management fee with respect to the ongoing operation and management of properties based on the amount of our initial investment and not the performance of those
investments, which could result in our advisor entities not having adequate incentive to manage our portfolio to provide profitable operations during the period we hold our investments. On the other hand, our advisor entities could be motivated to
recommend riskier or more speculative investments in order to increase the fees payable to our advisor entities or for us to generate the specified levels of performance or net sales proceeds that would entitle our advisor entities to fees or
distributions.
Our advisor may receive economic benefits from its status as a limited partner without bearing any of the investment
risk.
Our advisor is a limited partner in our operating partnership. Our advisor is entitled to receive an incentive
distribution equal to 15.0% of net sales proceeds of properties after we have received and paid to our stockholders a return of their invested capital and an annual 8.0% cumulative, non-compounded return on the gross proceeds of the sale of shares
of our common stock. We bear all of the risk associated with the properties but, as a result of the incentive distributions to our advisor, we are not entitled to all of our operating partnerships proceeds from property dispositions.
The distribution payable to our advisor entities may influence our decisions about listing the shares of our common stock on a national
securities exchange, merging our company with another company and acquisition or disposition of our investments.
Our
advisor entities entitlement to fees upon the sale of our assets and to participate in net sales proceeds could result in our advisor recommending sales of our investments at the earliest possible time at which sales of investments would
produce the level of return which would entitle our advisor entities to compensation relating to such sales, even if continued ownership of those investments might be in our stockholders long-term best interest. The subordinated participation
interest may require our operating partnership to make a distribution to our advisor entities upon the listing of the shares of our common stock on a national securities exchange or the merger of our company with another company in which our
stockholders receive shares that are traded on a national securities exchange, if our advisor entities meet the performance thresholds included in our operating partnerships limited partnership agreement even if our advisor or sub-advisor are
no longer serving as our advisor or sub-advisor. To avoid making this distribution, our independent directors may decide against listing the shares of our common stock
33
or merging with another company even if, but for the requirement to make this distribution, such listing or merger would be in our stockholders best interest. In addition, the requirement
to pay these fees could cause our independent directors to make different investment or disposition decisions than they would otherwise make, in order to satisfy our obligation to our advisor entities.
We may acquire assets from, or dispose of assets to, affiliates of our advisor entities, which could result in us entering into transactions on
less favorable terms than we would receive from a third party or that negatively affect the publics perception of us.
We may acquire assets from affiliates of our advisor entities. Further, we may also dispose of assets to affiliates of our advisor entities. Affiliates of our advisor entities may make substantial profits
in connection with such transactions and may owe fiduciary and/or other duties to the selling or purchasing entity in these transactions, and conflicts of interest between us and the selling or purchasing entities could exist in such transactions.
Because our independent directors would rely on our advisor entities in identifying and evaluating any such transaction, these conflicts could result in transactions based on terms that are less favorable to us than we would receive from a third
party. Also, the existence of conflicts, regardless of how they are resolved, might negatively affect the publics perception of us.
If we enter into joint ventures with affiliates, we may face conflicts of interest or disagreements with our joint venture partners that may not be
resolved as quickly or on terms as advantageous to us as would be the case if the joint venture had been negotiated at arms length with an independent joint venture partner.
In the event that we enter into a joint venture with any other program sponsored or advised by one of our co-sponsors or one of their
affiliates, we may face certain additional risks and potential conflicts of interest. For example, securities issued by the other Griffin Capital programs or future American Healthcare Investors programs may never have an active trading market.
Therefore, if we were to become listed on a national securities exchange, we may no longer have similar goals and objectives with respect to the resale of properties in the future. Joint ventures between us and other Griffin Capital programs or
future American Healthcare Investors programs will not have the benefit of arms-length negotiation of the type normally conducted between unrelated co-venturers. Under these joint venture agreements, none of the co-venturers may have the power
to control the venture, and an impasse could occur regarding matters pertaining to the joint venture, including determining when and whether to buy or sell a particular property and the timing of a liquidation, which might have a negative impact on
the joint venture and decrease returns to our stockholders.
Risks Related to Our Organizational Structure
Several potential events could cause our stockholders investment in us to be diluted, which may reduce the overall value of their investment.
Our stockholders investment in us could be diluted by a number of factors, including:
|
|
|
future offerings of our securities, including issuances pursuant to the DRIP and up to 200,000,000 shares of any preferred stock that our board of
directors may authorize;
|
|
|
|
private issuances of our securities to other investors, including institutional investors;
|
|
|
|
issuances of our securities pursuant to our incentive plan; or
|
|
|
|
redemptions of units of limited partnership interest in our operating partnership in exchange for shares of our common stock.
|
To the extent we issue additional equity interests after our stockholders purchase shares of our common
stock in our offering, their percentage ownership interest in us will be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our real estate and real estate-related investments, our stockholders
may also experience dilution in the book value and fair market value of their shares of our common stock.
34
Our ability to issue preferred stock may include a preference in distributions superior to our common
stock and also may deter or prevent a sale of shares of our common stock in which our stockholders could profit.
Our
charter authorizes our board of directors to issue up to 200,000,000 shares of preferred stock. Our board of directors has the discretion to establish the preferences and rights, including a preference in distributions superior to our common
stockholders, of any issued preferred stock. If we authorize and issue preferred stock with a distribution preference over our common stock, payment of any distribution preferences of outstanding preferred stock would reduce the amount of funds
available for the payment of distributions on our common stock. Further, holders of preferred stock are normally entitled to receive a preference payment in the event we liquidate, dissolve or wind up before any payment is made to our common
stockholders, likely reducing the amount our common stockholders would otherwise receive upon such an occurrence. In addition, under certain circumstances, the issuance of preferred stock or a separate class or series of common stock may render more
difficult or tend to discourage:
|
|
|
a merger, tender offer or proxy contest;
|
|
|
|
assumption of control by a holder of a large block of our securities; or
|
|
|
|
removal of incumbent management.
|
The limit on the percentage of shares of our common stock that any person may own may discourage a takeover or business combination that may have benefited our stockholders.
Our charter restricts the direct or indirect ownership by one person or entity to no more than 9.9% of the value of our then outstanding
capital stock (which includes common stock and any preferred stock we may issue) and no more than 9.9% of the value or number of shares, whichever is more restrictive, of our then outstanding common stock. This restriction may discourage a change of
control of us and may deter individuals or entities from making tender offers for shares of our stock on terms that might be financially attractive to our stockholders or which may cause a change in our management. This ownership restriction may
also prohibit business combinations that would have otherwise been approved by our board of directors and our stockholders. In addition to deterring potential transactions that may be favorable to our stockholders, these provisions may also decrease
their ability to sell their shares of our common stock.
Our stockholders ability to control our operations is severely limited.
Our board of directors determines our major strategies, including our strategies regarding investments, financing,
growth, debt capitalization, REIT qualification and distributions. Our board of directors may amend or revise these and other strategies without a vote of the stockholders. Our charter sets forth the stockholder voting rights required to be set
forth therein under the Statement of Policy Regarding Real Estate Investment Trusts adopted by the North American Securities Administrators Association, or the NASAA Guidelines. Under our charter and Maryland law, our stockholders have a right to
vote only on the following matters:
|
|
|
the election or removal of directors;
|
|
|
|
any amendment of our charter, except that our board of directors may amend our charter without stockholder approval to change our name or the name of
other designation or the par value of any class or series of our stock and the aggregate par value of our stock, increase or decrease the aggregate number of our shares of stock, increase or decrease the number of our shares of any class or series
that we have the authority to issue, effect certain reverse stock splits, or qualify as a REIT under the Code;
|
|
|
|
certain mergers, consolidations and sales or other dispositions of all or substantially all of our assets.
|
All other matters are subject to the discretion of our board of directors.
35
Limitations on share ownership and transfer may deter a sale of our common stock in which our
stockholders could profit.
The limits on ownership and transfer of our equity securities in our charter may have the
effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for our stockholders common stock. The ownership limits and restrictions on transferability will continue to apply until our
board of directors determines that it is no longer in our best interest to continue to qualify as a REIT.
Maryland takeover statutes
may deter others from seeking to acquire us and prevent our stockholders from making a profit in such transaction.
The Maryland General Corporation Law, or the MGCL, contains many provisions, such as the business combination statute and the control
share acquisition statute, that are designed to prevent, or have the effect of preventing, someone from acquiring control of us. Our bylaws exempt us from the control share acquisition statute (which eliminates voting rights for certain levels of
shares that could exercise control over us) and our board of directors has adopted a resolution opting out of the business combination statute (which, among other things, prohibits a merger or consolidation with a 10.0% stockholder for a period of
time) with respect to our affiliates. However, if the bylaw provisions exempting us from the control share acquisition statute or our board resolution opting out of the business combination statute were repealed, these provisions of Maryland law
could delay or prevent offers to acquire us and increase the difficulty of consummating any such offers, even if such a transaction would be in our stockholders best interest.
The MGCL and our organizational documents limit our stockholders right to bring claims against our officers and directors.
The MGCL provides that a director will not have any liability as a director so long as he or she performs his or her duties in good
faith, in a manner he or she reasonably believes to be in our best interest, and with the care that an ordinarily prudent person in a like position would use under similar circumstances. In addition, our charter provides that, subject to the
applicable limitations set forth therein or under the MGCL, no director or officer will be liable to us or our stockholders for monetary damages. Our charter also provides that we will generally indemnify our directors, our officers, our advisor and
its affiliates for losses they may incur by reason of their service in those capacities unless: (1) their act or omission was material to the matter giving rise to the proceeding and was committed in bad faith or was the result of active and
deliberate dishonesty; (2) they actually received an improper personal benefit in money, property or services; or (3) in the case of any criminal proceeding, they had reasonable cause to believe the act or omission was unlawful. Moreover,
we have entered into separate indemnification agreements with each of our directors and executive officers. As a result, we and our stockholders may have more limited rights against these persons than might otherwise exist under common law. In
addition, we may be obligated to fund the defense costs incurred by these persons in some cases. However, our charter also provides that we may not indemnify or hold harmless our directors, our advisor and its affiliates unless they have determined
that the course of conduct that caused the loss or liability was in our best interest, they were acting on our behalf or performing services for us, the liability was not the result of negligence or misconduct by our non-independent directors, our
advisor and its affiliates or gross negligence or willful misconduct by our independent directors, and the indemnification is recoverable only out of our net assets or the proceeds of insurance and not from our stockholders.
Maryland law prohibits certain business combinations, which may make it more difficult for us to be acquired and may limit our stockholders
ability to dispose of their shares of our common stock.
Under Maryland law, business combinations between
a Maryland corporation and an interested stockholder or an affiliate of an interested stockholder are prohibited for five years after the most recent date on which the interested stockholder becomes an interested stockholder. These business
combinations include a merger, consolidation, share exchange or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities. An interested stockholder is defined as:
36
|
|
|
any person who beneficially owns 10.0% or more of the voting power of the corporations outstanding voting stock; or
|
|
|
|
an affiliate or associate of the corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of
10.0% or more of the voting power of the then outstanding stock of the corporation.
|
A person is not an
interested stockholder under the statute if the board of directors approved in advance the transaction by which he or she otherwise would have become an interested stockholder. However, in approving a transaction, the board of directors may provide
that its approval is subject to compliance, at or after the time of approval, with any terms and conditions determined by the board.
After the five-year prohibition, any business combination between the Maryland corporation and an interested stockholder generally must be recommended by the board of directors of the corporation and
approved by the affirmative vote of at least:
|
|
|
80.0% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation; and
|
|
|
|
two-thirds of the votes entitled to be cast by holders of voting stock of the corporation other than shares of stock held by the interested stockholder
with whom or with whose affiliate the business combination is to be effected or held by an affiliate or associate of the interested stockholder.
|
These super-majority vote requirements do not apply if the corporations common stockholders receive a minimum price, as defined under Maryland law, for their shares of our common stock in the form
of cash or other consideration in the same form as previously paid by the interested stockholder for its shares of our common stock. The business combination statute permits various exemptions from its provisions, including business combinations
that are exempted by the board of directors prior to the time that the interested stockholder becomes an interested stockholder. Our board of directors has adopted a resolution providing that any business combination between us and any other person
is exempted from this statute, provided that such business combination is first approved by our board of directors. This resolution, however, may be altered or repealed in whole or in part at any time. If this resolution is repealed or our board of
directors fails to first approve the business combination, the business combination statute may discourage others from trying to acquire control of us and increase the difficulty of consummating any offer.
Our charter includes a provision that may discourage a stockholder from launching a tender offer for shares of our common stock.
Our charter requires that any tender offer made by a person, including any mini-tender offer, must comply
with Regulation 14D of the Securities Exchange Act of 1934, as amended. The offeror must provide us notice of the tender offer at least ten business days before initiating the tender offer. If the offeror does not comply with these
requirements, we will have the right to repurchase that persons shares of our stock and any shares of our stock acquired in such tender offer. In addition, the non-complying offeror shall be responsible for all of our expenses in connection
with that stockholders noncompliance. This provision of our charter may discourage a person from initiating a tender offer for shares of our common stock and prevent our stockholders from receiving a premium price for their shares of our
common stock in such a transaction.
37
Our stockholders investment return may be reduced if we are required to register as an
investment company under the Investment Company Act. To avoid registration as an investment company, we may not be able to operate our business successfully. If we become subject to registration under the Investment Company Act, we may not be able
to continue our business.
We are not registered, and do not intend to register, as an investment company under the
Investment Company Act. If for any reason, we were required to register as an investment company, we would have to comply with a variety of substantive requirements under the Investment Company Act imposing, among other things:
|
|
|
limitations on capital structure;
|
|
|
|
restrictions on specified investments;
|
|
|
|
prohibitions on transactions with affiliates; and
|
|
|
|
compliance with reporting, record keeping, voting, proxy disclosure and other rules and regulations that would significantly change our operations.
|
In order for us not to be subject to regulation under the Investment Company Act, we intend to engage,
through our operating partnership and subsidiaries, primarily in the business of buying real estate. We expect that investments in real estate will represent the substantial majority of our total asset mix, which would not subject us to the
Investment Company Act by virtue of the definition of investment company provided in Section 3(a)(1) of the Investment Company Act.
In the event that any of our subsidiaries are deemed to be an investment company pursuant to Section 3(a)(1) of the Investment Company Act, such subsidiaries would have to rely on the exclusion from
the definition of investment company provided by Section 3(c)(5)(C) of the Investment Company Act. To rely upon Section 3(c)(5)(C) of the Investment Company Act such subsidiaries would have to invest at least 55.0% of its
respective portfolio in mortgage and other liens on and interests in real estate, which we refer to as qualifying real estate investments and maintain an additional 25.0% of assets in qualifying real estate investments or
other real estate-related assets. The remaining 20.0% of the portfolios assets can consist of miscellaneous assets. What we buy and sell is therefore limited to these criteria. How we classify our assets for purposes of the Investment Company
Act will be based in large measure upon no-action letters issued by the SEC staff in the past and other SEC interpretive guidance. These no-action positions were issued in accordance with factual situations that may be substantially different from
the factual situations we may face, and a number of these no-action positions were issued more than ten years ago. Pursuant to this guidance, and depending on the characteristics of the specific investments, certain mortgage loans, participations in
mortgage loans, mortgage-backed securities, mezzanine loans, joint venture investments and the equity securities of other entities may not constitute qualifying real estate assets, and therefore, investments in these types of assets may be limited.
The SEC may not concur with our classification of our assets. Future revisions to the Investment Company Act or further guidance from the SEC may cause us to lose our exclusion from registration or force us to re-evaluate our portfolio and our
investment strategy. Such changes may prevent us from operating our business successfully.
We may determine to operate
through our majority owned operating partnership or other wholly owned or majority owned subsidiaries. If so, our subsidiaries will be subject to investment restrictions so that the respective majority owned or wholly owned subsidiary does not come
within the definition of an investment company, or cause us to come within the definition of an investment company, under the Investment Company Act.
To ensure that neither we, nor our operating partnership, nor any of our other wholly owned or majority owned subsidiaries are required to register as an investment company, each entity may be unable to
sell assets we would otherwise want to sell and may need to sell assets we would otherwise wish to retain. In addition, we, our operating partnership or any of our other wholly owned or majority owned subsidiaries may be required to acquire
additional income- or loss-generating assets that we might not otherwise acquire or forego opportunities to acquire interests in companies that we would otherwise want to acquire. Although we intend to monitor our portfolio periodically and prior to
each acquisition, any of these entities may not be able to maintain an exclusion from registration as an investment company. If we, our operating partnership or any of our other subsidiaries are required to register as an investment company but fail
to do so, the unregistered entity would be prohibited from engaging in our business, and criminal and civil actions could be brought against such entity. In addition, the contracts of such entity would be unenforceable unless a court required
enforcement, and a court could appoint a receiver to take control of the entity and liquidate its business.
38
As part of our advisors obligations under the Advisory Agreement, our advisor agrees
to refrain from taking any action which, in its sole judgment made in good faith, would subject us to regulation under the Investment Company Act. Failure to maintain an exclusion from registration under the Investment Company Act would require us
to significantly restructure our business plan. For example, because affiliate transactions generally are prohibited under the Investment Company Act, we would not be able to enter into transactions with any of our affiliates if we are required to
register as an investment company, and we may be required to terminate the Advisory Agreement and any other agreements with affiliates, which could have a material adverse effect on our ability to operate our business and pay distributions.
Risks Related to Investments in Real Estate
Changes in national, regional or local economic, demographic or real estate market conditions may adversely affect our results of operations and our ability to pay distributions to our stockholders
or reduce the value of their investment.
We are subject to risks generally incidental to the ownership of real
estate, including changes in national, regional or local economic, demographic or real estate market conditions. We are unable to predict future changes in national, regional or local economic, demographic or real estate market conditions. For
example, a recession or rise in interest rates could make it more difficult for us to lease real properties or dispose of them. In addition, rising interest rates could also make alternative interest-bearing and other investments more attractive,
and therefore, potentially lower the relative value of our existing real estate investments. These conditions, or others we cannot predict, may adversely affect our results of operations, our ability to pay distributions to our stockholders or
reduce the value of their investment.
If we acquire real estate at a time when the real estate market is experiencing substantial
influxes of capital investment and competition for income-producing properties, such real estate investments may not appreciate or may decrease in value.
Although the real estate market has been experiencing severe dislocations, in the future the market may experience a substantial influx of capital from investors. Any substantial flow of capital, combined
with significant competition for income-producing real estate, may result in inflated purchase prices for such assets. To the extent we purchase real estate in such an environment in the future, we will be subject to the risk that the value of such
investments may not appreciate or may decrease significantly below the amount we paid for such investment.
We may obtain only limited
warranties when we purchase a property and would have only limited recourse in the event our due diligence did not identify any issues that lower the value of our property.
The seller of a property often sells such property in its as is condition on a where is basis and with all
faults, without any warranties of merchantability or fitness for a particular use or purpose. In addition, purchase and sale agreements may contain only limited warranties, representations and indemnifications that will only survive for a
limited period after the closing. The purchase of properties with limited warranties increases the risk that we may lose some or all of our invested capital in the property, as well as the loss of rental income from that property.
Acquiring or attempting to acquire multiple properties in a single transaction may adversely affect our operations.
From time to time, we may attempt to acquire multiple properties in a single transaction. Portfolio acquisitions are more complex and
expensive than single property acquisitions, and the risk that a multiple-property acquisition does not close may be greater than in a single-property acquisition. Portfolio acquisitions may also result in us owning investments in geographically
dispersed markets, placing additional demands on our ability to manage the properties in the portfolio. In addition, a seller may require that a group of properties be purchased as a package even though we may not want to purchase one or more
properties in the portfolio. In these situations, if we are unable to identify another person or entity to acquire the unwanted properties, we may be required to operate or attempt to dispose of these properties. To acquire multiple properties in a
single transaction, we may be required to accumulate a large amount of cash. We would expect the returns that we earn on such cash to be less than the ultimate returns on real property; therefore, accumulating such cash could reduce our funds
available for distributions to our stockholders. Any of the foregoing events may have an adverse effect on our operations.
39
Uninsured losses relating to real estate and lender requirements to obtain insurance may reduce our
stockholders returns.
There are types of losses relating to real estate, generally catastrophic in nature, such
as losses due to wars, acts of terrorism, earthquakes, floods, hurricanes, pollution or environmental matters, for which we do not intend to obtain insurance unless we are required to do so by mortgage lenders. If any of our properties incurs a
casualty loss that is not fully covered by insurance, the value of our assets will be reduced by any such uninsured loss. In addition, other than any reserves we may establish, we have no source of funding to repair or reconstruct any uninsured
damaged property, and we cannot assure our stockholders that any such sources of funding will be available to us for such purposes in the future. Also, to the extent we must pay unexpectedly large amounts for uninsured losses, we could suffer
reduced earnings that would result in less cash to be distributed to our stockholders. In cases where we are required by mortgage lenders to obtain casualty loss insurance for catastrophic events or terrorism, such insurance may not be available, or
may not be available at a reasonable cost, which could inhibit our ability to finance or refinance our properties. Additionally, if we obtain such insurance, the costs associated with owning a property would increase and could have a material
adverse effect on the net income from the property, and, thus, the cash available for distribution to our stockholders.
Terrorist
attacks and other acts of violence or war may affect the markets in which we operate and have a material adverse effect on our financial condition, results of operations and ability to pay distributions to our stockholders.
Terrorist attacks may negatively affect our operations and our stockholders investment. We may acquire real estate assets located
in areas that are susceptible to attack. These attacks may directly impact the value of our assets through damage, destruction, loss or increased security costs. Although we may obtain terrorism insurance, we may not be able to obtain sufficient
coverage to fund any losses we may incur. Risks associated with potential acts of terrorism could sharply increase the premiums we pay for coverage against property and casualty claims. Further, certain losses resulting from these types of events
are uninsurable or not insurable at reasonable costs.
More generally, any terrorist attack, other act of violence or war,
including armed conflicts, could result in increased volatility in, or damage to, the U.S. and worldwide financial markets and economy, all of which could adversely affect our tenants ability to pay rent on their leases or our ability to
borrow money or issue capital stock at acceptable prices, which could have a material adverse effect on our financial condition, results of operations and ability to pay distributions to our stockholders.
Dramatic increases in insurance rates could adversely affect our cash flows and our ability to pay distributions to our stockholders.
We may not be able to obtain insurance coverage at reasonable rates due to high premium and/or deductible amounts. As
a result, our cash flows could be adversely impacted due to these higher costs, which would adversely affect our ability to pay distributions to our stockholders.
Delays in the acquisition, development and construction of real properties may have adverse effects on our results of operations and our ability to pay distributions to our stockholders.
Delays we encounter in the selection, acquisition and development of real properties could adversely affect our
stockholders returns. Where properties are acquired prior to the start of construction or during the early stages of construction, it will typically take several months to complete construction and rent available space. If we engage in
development or construction projects, we will be subject to uncertainties associated with re-zoning for development, environmental concerns of governmental entities and/or community groups, and our builders ability to build in conformity with
plans, specifications, budgeted costs, and timetables. If a builder fails to perform, we may resort to legal action to rescind the purchase or the construction contract or to compel performance. A builders performance may also be affected or
delayed by conditions beyond the builders control. Therefore, our stockholders
40
could suffer delays in the receipt of cash distributions attributable to those particular real properties. Delays in completion of construction could give tenants the right to terminate
preconstruction leases for space at a newly developed project. We may incur additional risks when we make periodic progress payments or other advances to builders prior to completion of construction. These and other such factors can result in
increased costs of a project or loss of our investment. In addition, we will be subject to normal lease-up risks relating to newly constructed projects. We also must rely on rental income and expense projections and estimates of the fair market
value of property upon completion of construction when agreeing upon a price at the time we acquire the property. If our projections are inaccurate, we may pay too much for a property, and our return on our investment could suffer.
While we do not currently intend to do so, we may invest in unimproved real property. Returns from development of unimproved properties
are also subject to risks associated with re-zoning the land for development and environmental concerns of governmental entities and/or community groups. Although we intend to limit any investment in unimproved real property to real property we
intend to develop, our stockholders investment, nevertheless, is subject to the risks associated with investments in unimproved real property.
If we contract with a development company for newly developed property, our earnest money deposit made to the development company may not be fully refunded.
We may acquire one or more properties under development. We anticipate that if we do acquire properties that are under development, we
will be obligated to pay a substantial earnest money deposit at the time of contracting to acquire such properties, and that we will be required to close the purchase of the property upon completion of the development of the property. We may enter
into such a contract with the development company even if at the time we enter into the contract, we have not yet raised sufficient proceeds in our offering to enable us to close the purchase of such property. However, we may not be required to
close a purchase from the development company, and may be entitled to a refund of our earnest money, in the following circumstances:
|
|
|
the development company fails to develop the property;
|
|
|
|
all or a specified portion of the pre-leased tenants fail to take possession under their leases for any reason; or
|
|
|
|
we are unable to raise sufficient proceeds from our offering to pay the purchase price at closing.
|
The obligation of the development company to refund our earnest money deposit will be unsecured, and we may not be able to obtain a
refund of such earnest money deposit from it under these circumstances since the development company may be an entity without substantial assets or operations.
Uncertain market conditions relating to the future disposition of properties could cause us to sell our properties at a loss in the future.
We intend to hold our various real estate investments until such time as our advisor entities determines that a sale or other disposition
appears to be advantageous to achieve our investment objectives. Our advisor, through our sub-advisor and subject to the oversight and approval of our board of directors, may exercise its discretion as to whether and when to sell a property, and we
will have no obligation to sell properties at any particular time. We generally intend to hold properties for an extended period of time, and we cannot predict with any certainty the various market conditions affecting real estate investments that
will exist at any particular time in the future. Because of the uncertainty of market conditions that may affect the future disposition of our properties, we cannot assure our stockholders that we will be able to sell our properties at a profit in
the future. Additionally, we may incur prepayment penalties in the event we sell a property subject to a mortgage earlier than we otherwise had planned. Accordingly, the extent to which our stockholders will receive cash distributions and realize
potential appreciation on our real estate investments will, among other things, be dependent upon fluctuating market conditions.
41
Our inability to sell a property when we desire to do so could adversely impact our ability to pay
cash distributions to our stockholders.
The real estate market is affected by many factors, such as general economic
conditions, availability of financing, interest rates, supply and demand, and other factors that are beyond our control. We cannot predict whether we will be able to sell any property for the price or on the terms set by us, or whether any price or
other terms offered by a prospective purchaser would be acceptable to us. We may be required to expend funds to correct defects or to make improvements before a property can be sold. We may not have adequate funds available to correct such defects
or to make such improvements. Moreover, in acquiring a property, we may agree to restrictions that prohibit the sale of that property for a period of time or impose other restrictions, such as a limitation on the amount of debt that can be placed or
repaid on that property. We cannot predict the length of time needed to find a willing purchaser and to close the sale of a property. Our inability to sell a property when we desire to do so may cause us to reduce our selling price for the property.
Any delay in our receipt of proceeds, or diminishment of proceeds, from the sale of a property could adversely impact our ability to pay distributions to our stockholders.
If we sell properties by providing financing to purchasers, defaults by the purchasers would adversely affect our cash flows from operations.
If we decide to sell any of our properties, we intend to use our best efforts to sell them for cash. However, in some instances we may
sell our properties by providing financing to purchasers. When we provide financing to purchasers, we will bear the risk that the purchaser may default on its obligations under the financing, which could negatively impact cash flows from operations.
Even in the absence of a purchaser default, the distribution of sale proceeds, or their reinvestment in other assets, will be delayed until the promissory notes or other property we may accept upon the sale are actually paid, sold, refinanced or
otherwise disposed of. In some cases, we may receive initial down payments in cash and other property in the year of sale in an amount less than the selling price, and subsequent payments will be spread over a number of years. If any purchaser
defaults under a financing arrangement with us, it could negatively impact our ability to pay cash distributions to our stockholders.
Our stockholders may not receive any profits resulting from the sale of one of our properties, or receive such profits in a timely manner, because
we may provide financing to the purchaser of such property.
If we sell one of our properties during liquidation, our
stockholders may experience a delay before receiving their share of the proceeds of such liquidation. In a forced or voluntary liquidation, we may sell our properties either subject to or upon the assumption of any then outstanding mortgage debt or,
alternatively, may provide financing to purchasers. We may take a purchase money obligation secured by a mortgage as partial payment. We do not have any limitations or restrictions on our taking such purchase money obligations. To the extent we
receive promissory notes or other property instead of cash from sales, such proceeds, other than any interest payable on those proceeds, will not be included in net sale proceeds until and to the extent the promissory notes or other property are
actually paid, sold, refinanced or otherwise disposed of. In many cases, we will receive initial down payments in the year of sale in an amount less than the selling price and subsequent payments will be spread over a number of years. Therefore, our
stockholders may experience a delay in the distribution of the proceeds of a sale until such time.
We face possible liability for
environmental cleanup costs and damages for contamination related to properties we acquire, which could substantially increase our costs and reduce our liquidity and cash distributions to our stockholders.
Because we own and operate real estate, we are subject to various federal, state and local environmental laws, ordinances and
regulations. Under these laws, ordinances and regulations, a current or previous owner or operator of real estate may be liable for the cost of removal or remediation of hazardous or toxic substances on, under or in such property. The costs of
removal or remediation could be substantial. Such laws often impose liability whether or not the owner or operator knew of, or was responsible for, the presence of such hazardous or toxic substances. Environmental laws also may impose restrictions
on the manner in which property may be used or businesses may be operated, and these restrictions may require substantial expenditures. Environmental laws provide for sanctions in the event of noncompliance and may be enforced by governmental
agencies or, in certain circumstances, by private parties. Certain environmental laws and common law principles could be used to impose liability for release of and exposure to hazardous substances, including the release of asbestos-containing
materials into the air, and third parties may seek recovery from owners or operators of real estate for personal injury or property damage associated with exposure to released hazardous substances. In addition, new or more stringent laws or stricter
interpretations of
42
existing laws could change the cost of compliance or liabilities and restrictions arising out of such laws. The cost of defending against these claims, complying with environmental regulatory
requirements, conducting remediation of any contaminated property, or of paying personal injury claims could be substantial, which would reduce our liquidity and cash available for distribution to our stockholders. In addition, the presence of
hazardous substances on a property or the failure to meet environmental regulatory requirements may materially impair our ability to use, lease or sell a property, or to use the property as collateral for borrowing.
Our real estate investments are concentrated in medical office buildings or other healthcare-related facilities, making us more vulnerable
economically than if our investments were diversified.
As a REIT, we invest primarily in real estate. Within the real
estate industry, we have acquired and will continue to acquire or selectively develop and own medical office buildings and healthcare-related facilities. We are subject to risks inherent in concentrating investments in real estate. These risks
resulting from a lack of diversification become even greater as a result of our business strategy to invest to a substantial degree in healthcare-related facilities.
A downturn in the commercial real estate industry generally could significantly adversely affect the value of our properties. A downturn in the healthcare industry could negatively affect our
lessees ability to make lease payments to us and our ability to pay distributions to our stockholders. These adverse effects could be more pronounced than if we diversified our investments outside of real estate or if our portfolio did not
include a substantial concentration in medical office buildings and healthcare-related facilities.
A high concentration of our
properties in a particular geographic area would magnify the effects of downturns in that geographic area.
Although
we intend to continue to acquire real estate throughout the U.S., it is likely that a significant portion of our portfolio will be located in southern and western states. In the event that we have a concentration of properties in any particular
geographic area, any adverse situation that disproportionately effects that geographic area would have a magnified adverse effect on our portfolio.
Certain of our properties may not have efficient alternative uses, so the loss of a tenant may cause us not to be able to find a replacement or cause us to spend considerable capital to adapt the
property to an alternative use.
Some of the properties we have acquired and will seek to acquire are specialized
medical facilities. If we or our tenants terminate the leases for these properties or our tenants lose their regulatory authority to operate such properties, we may not be able to locate suitable replacement tenants to lease the properties for their
specialized uses. Alternatively, we may be required to spend substantial amounts to adapt the properties to other uses. Any loss of revenues or additional capital expenditures required as a result may have a material adverse effect on our business,
financial condition and results of operations and our ability to pay distributions to our stockholders.
Our medical office buildings,
healthcare-related facilities and tenants may be unable to compete successfully.
Our medical office buildings and
healthcare-related facilities often face competition from nearby hospitals and other medical office buildings that provide comparable services. Some of those competing facilities are owned by governmental agencies and supported by tax revenues, and
others are owned by nonprofit corporations and may be supported to a large extent by endowments and charitable contributions. These types of support are not available to our buildings.
Similarly, our tenants face competition from other medical practices in nearby hospitals and other medical facilities. Our tenants
failure to compete successfully with these other practices could adversely affect their ability to make rental payments, which could adversely affect our rental revenues. Further, from time to time and for reasons beyond our control, referral
sources, including physicians and managed care organizations, may change their lists of hospitals or physicians to which they refer patients. This could adversely affect our tenants ability to make rental payments, which could adversely affect
our rental revenues.
Any reduction in rental revenues resulting from the inability of our medical office buildings and
healthcare-related facilities and our tenants to compete successfully may have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
43
A proposed change in U.S. accounting standards for leases could reduce the overall demand to lease our
properties.
The existing accounting standards for leases require lessees to classify their leases as either capital
or operating leases. Under a capital lease, both the leased asset, which represents the tenants right to use the property, and the contractual lease obligation are recorded on the tenants balance sheet if one of the following criteria
are met: (i) the lease transfers ownership of the property to the lessee by the end of the lease term; (ii) the lease contains a bargain purchase option; (iii) the non-cancellable lease term is more than 75.0% of the useful life
of the asset; or (iv) if the present value of the minimum lease payments equals 90.0% or more of the leased propertys fair value. If the terms of the lease do not meet these criteria, the lease is considered an operating lease, and no
leased asset or contractual lease obligation is recorded by the tenant.
In order to address concerns raised by the SEC
regarding the transparency of contractual lease obligations under the existing accounting standards for operating leases, the FASB and the International Accounting Standards Board, or the IASB, initiated a joint project to develop new guidelines to
lease accounting. The FASB and IASB, or collectively, the Boards, issued an Exposure Draft on August 17, 2010, or the Exposure Draft, which proposes substantial changes to the current lease accounting standards, primarily by eliminating the
concept of operating lease accounting. As a result, a lease asset and obligation will be recorded on the tenants balance sheet for all lease arrangements. In addition, the Exposure Draft will impact the method in which contractual lease
payments will be recorded. In order to mitigate the effect of the proposed lease accounting, tenants may seek to negotiate certain terms within new lease arrangements or modify terms in existing lease arrangements, such as shorter lease terms or
fewer extension options, which would generally have less impact on tenant balance sheets. Also, tenants may reassess their lease-versus-buy strategies. This could result in a greater renewal risk, a delay in investing our offering proceeds, or
shorter lease terms, all of which may negatively impact our operations and ability to pay distributions.
The Exposure Draft
does not include a proposed effective date; however, the Boards plan to issue a revised Exposure Draft regarding lease accounting in the second half of 2012.
Our costs associated with complying with the Americans with Disabilities Act may reduce our cash available for distributions.
The properties we acquire may be subject to the ADA. Under the ADA, all places of public accommodation are required to comply with
federal requirements related to access and use by disabled persons. The ADA has separate compliance requirements for public accommodations and commercial facilities that generally require that buildings and services be made
accessible and available to people with disabilities. The ADAs requirements could require removal of access barriers and could result in the imposition of injunctive relief, monetary penalties or, in some cases, an award of damages. We attempt
to acquire properties that comply with the ADA or place the burden on the seller or other third party, such as a tenant, to ensure compliance with the ADA. However, we cannot assure our stockholders that we will be able to acquire properties or
allocate responsibilities in this manner. If we cannot, our funds used for ADA compliance may reduce cash available for distributions and the amount of distributions to our stockholders.
Increased operating expenses could reduce cash flows from operations and funds available to acquire investments or pay distributions.
Any property that we have acquired or may acquire will be subject to operating risks common to real estate in general, any or all of
which may negatively affect us. If any property is not fully occupied or if rents are being paid in an amount that is insufficient to cover operating expenses, we could be required to expend funds with respect to that property for operating
expenses. The properties will be subject to increases in tax rates, utility costs, insurance costs, repairs and maintenance costs, administrative costs and other operating expenses. While we expect that many of our property leases will require the
tenants to pay all or a portion of these expenses, some of our leases or future
44
leases may not be negotiated on that basis, in which event we may have to pay these costs. If we are unable to lease properties on terms that require the tenants to pay all or some of the
properties operating expenses, if our tenants fail to pay these expenses as required or if expenses we are required to pay exceed our expectations, we could have less funds available for future acquisitions or cash available for distributions
to our stockholders.
Our operating properties are subject to real and personal property taxes that may increase in the future, which
could adversely affect our cash flows.
Our operating properties are subject to real and personal property taxes that
may increase as tax rates change and as the operating properties are assessed or reassessed by taxing authorities. Some of our leases generally provide that the property taxes or increases therein are charged to the tenants as an expense related to
the operating properties that they occupy, while other leases will generally provide that we are responsible for such taxes. In any case, as the owner of the properties, we will be ultimately responsible for payment of the taxes to the applicable
government authorities. If real property taxes increase, our tenants may be unable to make the required tax payments, ultimately requiring us to pay the taxes even if otherwise stated under the terms of the lease. If we fail to pay any such taxes,
the applicable taxing authority may place a lien on the operating property and the operating property may be subject to a tax sale. In addition, we are generally responsible for real property taxes related to any vacant space.
Costs of complying with governmental laws and regulations related to environmental protection and human health and safety may be high.
All real property investments and the operations conducted in connection with such investments are subject to
federal, state and local laws and regulations relating to environmental protection and human health and safety. Some of these laws and regulations may impose joint and several liability on customers, owners or operators for the costs to investigate
or remediate contaminated properties, regardless of fault or whether the acts causing the contamination were legal.
Under
various federal, state and local environmental laws, a current or previous owner or operator of real property may be liable for the cost of removing or remediating hazardous or toxic substances on such real property. Such laws often impose liability
whether or not the owner or operator knew of, or was responsible for, the presence of such hazardous or toxic substances. In addition, the presence of hazardous substances, or the failure to properly remediate those substances, may adversely affect
our ability to sell, rent or pledge such real property as collateral for future borrowings. Environmental laws also may impose restrictions on the manner in which real property may be used or businesses may be operated. Some of these laws and
regulations have been amended so as to require compliance with new or more stringent standards as of future dates. Compliance with new or more stringent laws or regulations or stricter interpretation of existing laws may require us to incur material
expenditures. Future laws, ordinances or regulations may impose material environmental liability. Additionally, our tenants operations, the existing condition of land when we buy it, operations in the vicinity of our real properties, such as
the presence of underground storage tanks, or activities of unrelated third parties may affect our real properties. In addition, there are various local, state and federal fire, health, life-safety and similar regulations with which we may be
required to comply, and which may subject us to liability in the form of fines or damages for noncompliance. In connection with the acquisition and ownership of our real properties, we may be exposed to such costs in connection with such
regulations. The cost of defending against environmental claims, of any damages or fines we must pay, of compliance with environmental regulatory requirements or of remediating any contaminated real property could materially and adversely affect our
business, lower the value of our assets or results of operations and, consequently, lower the amounts available for distribution to our stockholders.
Risks Related to the Healthcare Industry
The healthcare industry is heavily
regulated and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of our tenants to make rent payments to us.
The healthcare industry is heavily regulated by federal, state and local governmental bodies. Our tenants generally are subject to laws
and regulations covering, among other things, licensure, certification for participation in government programs, and relationships with physicians and other referral sources. Changes in these laws and regulations could negatively affect the ability
of our tenants to make lease payments to us and our ability to pay distributions to our stockholders.
45
Many of our medical properties and their tenants may require a license or certificate of
need, or CON, to operate. Failure to obtain a license or CON, or loss of a required license or CON would prevent a facility from operating in the manner intended by the tenant. These events could materially adversely affect our tenants ability
to make rent payments to us. State and local laws also may regulate expansion, including the addition of new beds or services or acquisition of medical equipment, and the construction of healthcare-related facilities, by requiring a CON or other
similar approval. State CON laws are not uniform throughout the U.S. and are subject to change; therefore, this may adversely impact our tenants ability to provide services in different states. We cannot predict the impact of state CON laws on
our development of facilities or the operations of our tenants.
In addition, state CON laws often materially impact the
ability of competitors to enter into the marketplace of our facilities. The repeal of CON laws could allow competitors to freely operate in previously closed markets. This could negatively affect our tenants abilities to make rent payments to
us.
In limited circumstances, loss of state licensure or certification or closure of a facility could ultimately result in
loss of authority to operate the facility and require new CON authorization to re-institute operations. As a result, a portion of the value of the facility may be reduced, which would adversely impact our business, financial condition and results of
operations and our ability to pay distributions to our stockholders.
Reductions in reimbursement from third party payors, including
Medicare and Medicaid, could adversely affect the profitability of our tenants and hinder their ability to make rent payments to us.
Sources of revenue for our tenants may include the federal Medicare program, state Medicaid programs, private insurance carriers and health maintenance organizations, among others. Efforts by such payors
to reduce healthcare costs will likely continue, which may result in reductions or slower growth in reimbursement for certain services provided by some of our tenants. In addition, the healthcare billing rules and regulations are complex, and the
failure of any of our tenants to comply with various laws and regulations could jeopardize their ability to continue participating in Medicare, Medicaid and other government sponsored payment programs. Moreover, the state and federal governmental
healthcare programs are subject to reductions by state and federal legislative actions. At the end of 2011 and in February 2012, Congress passed separate laws which delayed the Medicare payment reduction for physician reimbursement by Medicare of
approximately 21.0% to 25.0%, which was supposed to occur on January 1, 2012, for one year. If Congress does not address the sustainable growth rate by January 1, 2013, physician Medicare payments may be reduced by approximately 25.0% to 29.0%,
which may adversely impact our tenants ability to make rental payments.
The healthcare industry continues to face
various challenges, including increased government and private payor pressure on healthcare providers to control or reduce costs. It is possible that our tenants will continue to experience a shift in payor mix away from fee-for-service payors,
resulting in an increase in the percentage of revenues attributable to managed care payors, and general industry trends that include pressures to control healthcare costs. Pressures to control healthcare costs and a shift away from traditional
health insurance reimbursement to managed care plans have resulted in an increase in the number of patients whose healthcare coverage is provided under managed care plans, such as health maintenance organizations and preferred provider
organizations. In addition, the healthcare legislation passed in 2010 included new payment models with new shared savings programs and demonstration programs that include bundled payment models and payments contingent upon reporting on satisfaction
of quality benchmarks. The new payment models will likely change how physicians are paid for services. These changes could have a material adverse effect on the financial condition of some or all of our tenants. The financial impact on our tenants
could restrict their ability to make rent payments to us, which would have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
46
Some tenants of our medical office buildings and healthcare-related facilities will be subject to
fraud and abuse laws, the violation of which by a tenant may jeopardize the tenants ability to make rent payments to us.
There are various federal and state laws prohibiting fraudulent and abusive business practices by healthcare providers who participate in, receive payments from or are in a position to make referrals in
connection with government-sponsored healthcare programs, including the Medicare and Medicaid programs. Our lease arrangements with certain tenants may also be subject to these fraud and abuse laws.
These laws include:
|
|
|
the Federal Anti-Kickback Statute, which prohibits, among other things, the offer, payment, solicitation or receipt of any form of remuneration in
return for, or to induce, the referral of any item or service reimbursed by Medicare or Medicaid;
|
|
|
|
the Federal Physician Self-Referral Prohibition, which, subject to specific exceptions, restricts physicians from making referrals for specifically
designated health services for which payment may be made under Medicare or Medicaid programs to an entity with which the physician, or an immediate family member, has a financial relationship;
|
|
|
|
the False Claims Act, which prohibits any person from knowingly presenting false or fraudulent claims for payment to the federal government, including
claims paid by the Medicare and Medicaid programs; and
|
|
|
|
the Civil Monetary Penalties Law, which authorizes the U.S. Department of Health and Human Services to impose monetary penalties for certain
fraudulent acts.
|
Each of these laws includes criminal and/or civil penalties for violations that range from
punitive sanctions, damage assessments, penalties, imprisonment, denial of Medicare and Medicaid payments and/or exclusion from the Medicare and Medicaid programs. Certain laws, such as the False Claims Act, allow for individuals to bring
whistleblower actions on behalf of the government for violations thereof. Additionally, states in which the facilities are located may have similar fraud and abuse laws. Investigation by a federal or state governmental body for violation of fraud
and abuse laws or imposition of any of these penalties upon one of our tenants could jeopardize that tenants ability to operate or to make rent payments, which may have a material adverse effect on our business, financial condition and results
of operations and our ability to pay distributions to our stockholders.
Adverse trends in healthcare provider operations may negatively
affect our lease revenues and our ability to pay distributions to our stockholders.
The healthcare industry is
currently experiencing:
|
|
|
changes in the demand for and methods of delivering healthcare services;
|
|
|
|
changes in third party reimbursement policies;
|
|
|
|
significant unused capacity in certain areas, which has created substantial competition for patients among healthcare providers in those areas;
|
|
|
|
increased expense for uninsured patients;
|
|
|
|
increased competition among healthcare providers;
|
|
|
|
increased liability insurance expense;
|
|
|
|
continued pressure by private and governmental payors to reduce payments to providers of services;
|
|
|
|
increased scrutiny of billing, referral and other practices by federal and state authorities;
|
|
|
|
changes in federal and state healthcare program payment models; and
|
|
|
|
increased emphasis on compliance with privacy and security requirements related to personal health information.
|
These factors may adversely affect the economic performance of some or all of our tenants and, in turn, our lease revenues and our
ability to pay distributions to our stockholders.
47
Our healthcare-related tenants may be subject to significant legal actions that could subject them to
increased operating costs and substantial uninsured liabilities, which may affect their ability to pay their rent payments to us.
As is typical in the healthcare industry, our healthcare-related tenants may often become subject to claims that their services have resulted in patient injury or other adverse effects. Many of these
tenants may have experienced an increasing trend in the frequency and severity of professional liability and general liability insurance claims and litigation asserted against them. The insurance coverage maintained by these tenants may not cover
all claims made against them nor continue to be available at a reasonable cost, if at all. In some states, insurance coverage for the risk of punitive damages arising from professional liability and general liability claims and/or litigation may
not, in certain cases, be available to these tenants due to state law prohibitions or limitations of availability. As a result, these types of tenants of our medical office buildings and healthcare-related facilities operating in these states may be
liable for punitive damage awards that are either not covered or are in excess of their insurance policy limits. We also believe that there has been, and will continue to be, an increase in governmental investigations of certain healthcare
providers, particularly in the area of Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Insurance is not available to cover such losses. Any adverse determination in a legal
proceeding or governmental investigation, whether currently asserted or arising in the future, could have a material adverse effect on a tenants financial condition. If a tenant is unable to obtain or maintain insurance coverage, if judgments
are obtained in excess of the insurance coverage, if a tenant is required to pay uninsured punitive damages, or if a tenant is subject to an uninsurable government enforcement action, the tenant could be exposed to substantial additional
liabilities, which may affect the tenants ability to pay rent, which in turn could have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
Comprehensive healthcare reform legislation, the effects of which are not yet known, could materially adversely affect our business,
financial condition and results of operations and our ability to pay distributions to our stockholders.
On
March 23, 2010, the President signed into law the Patient Protection and Affordable Care Act of 2010, or the Patient Protection and Affordable Care Act, and on March 30, 2010, the President signed into law the Health Care and Education
Reconciliation Act of 2010, or the Reconciliation Act, which in part modified the Patient Protection and Affordable Care Act. Together, the two acts will serve as the primary vehicle for comprehensive healthcare reform in the U.S. The acts are
intended to reduce the number of individuals in the U.S. without health insurance and effect significant other changes to the ways in which healthcare is organized, delivered and reimbursed. Included within the legislation is a limitation on
physician-owned hospitals from expanding, unless the facility satisfies very narrow federal exceptions to this limitation. Therefore, if our tenants are physicians that own and refer to a hospital, the hospital would be limited in its operations and
expansion potential, which may limit the hospitals services and resulting revenues and may impact the owners ability to make rental payments. The legislation will become effective through a phased approach, beginning in 2010 and
concluding in 2018. At this time, the effects of healthcare reform and its impact on our properties are not yet known but could materially adversely affect our business, financial condition, results of operations and ability to pay distributions to
our stockholders.
48
Risks Related to Debt Financing
Increases in interest rates could increase the amount of our debt payments, and therefore, negatively impact our operating results.
Interest we will pay on our debt obligations will reduce cash available for distributions. Whenever we incur variable rate debt,
increases in interest rates would increase our interest costs, which would reduce our cash flows and our ability to pay distributions to our stockholders. If we need to repay existing debt during periods of rising interest rates, we could be
required to liquidate one or more of our investments in properties at times which may not permit realization of the maximum return on such investments.
To the extent we borrow at fixed rates or enter into fixed interest rate swaps, we will not benefit from reduced interest expense if interest rates decrease.
We are exposed to the effects of interest rate changes primarily as a result of borrowings used to maintain liquidity and fund expansion
and refinancing of our real estate investment portfolio and operations. To limit the impact of interest rate changes on earnings, prepayment penalties and cash flows and to lower overall borrowing costs while taking into account variable interest
rate risk, we have and may continue to borrow at fixed rates or variable rates depending upon prevailing market conditions. We have and may continue to also enter into derivative financial instruments such as interest rate swaps and caps in order to
mitigate our interest rate risk on a related financial instrument.
Hedging activity may expose us to risks.
When we use derivative financial instruments to hedge against interest rate fluctuations, we are exposed to credit risk and legal
enforceability risks. In this context, credit risk is the failure of the counterparty to perform under the terms of the derivative contract. If the fair value of a derivative contract is positive, the counterparty owes us, which creates credit risk
for us. Legal enforceability risks encompass general contractual risks, including the risk that the counterparty will breach the terms of, or fail to perform its obligations under, the derivative contract. If we are unable to manage these risks
effectively, our results of operations, financial condition and ability to pay distributions to our stockholders will be adversely affected.
Lenders may require us to enter into restrictive covenants relating to our operations, which could limit our ability to pay distributions to our
stockholders.
When providing financing, a lender may impose restrictions on us that affect our ability to incur
additional debt and affect our distribution and operating strategies. We have and may continue to enter into loan documents that contain covenants that limit our ability to further mortgage the property, discontinue insurance coverage, or replace
our advisor entities. These or other limitations may adversely affect our flexibility and our ability to achieve our investment objectives.
Interest-only indebtedness may increase our risk of default and ultimately may reduce our funds available for distribution to our stockholders.
We have and may continue to finance or refinance our properties using interest-only mortgage indebtedness. During the
interest-only period, the amount of each scheduled payment will be less than that of a traditional amortizing mortgage loan. The principal balance of the mortgage loan will not be reduced (except in the case of prepayments) because there are no
scheduled monthly payments of principal during this period. After the interest-only period, we will be required either to make scheduled payments of amortized principal and interest or to make a lump-sum or balloon payment at maturity.
These required principal or balloon payments will increase the amount of our scheduled payments and may increase our risk of default under the related mortgage loan. If the mortgage loan has an adjustable interest rate, the amount of our scheduled
payments also may increase at a time of rising interest rates. Increased payments and substantial principal or balloon maturity payments will reduce the funds available for distribution to our stockholders because cash otherwise available for
distribution will be required to pay principal and interest associated with these mortgage loans.
49
If we enter into financing arrangements involving balloon payment obligations, it may adversely affect
our ability to refinance or sell properties on favorable terms, and to pay distributions to our stockholders.
Some
of our current and future financing arrangements will require us to make a lump-sum or balloon payment at maturity. Our ability to make a balloon payment at maturity is uncertain and may depend upon our ability to obtain additional
financing or our ability to sell the particular property. At the time the balloon payment is due, we may or may not be able to refinance the balloon payment on terms as favorable as the original loan or sell the particular property at a price
sufficient to make the balloon payment. The refinancing or sale could affect the rate of return to our stockholders and the projected time of disposition of our assets. In an environment of increasing mortgage rates, if we place mortgage debt on
properties, we run the risk of being unable to refinance such debt if mortgage rates are higher at a time a balloon payment is due. In addition, payments of principal and interest made to service our debts, including balloon payments, may leave us
with insufficient cash to pay the distributions that we are required to pay to maintain our qualification as a REIT. Any of these results would have a significant, negative impact on our stockholders investment.
Risks Related to Real Estate-Related Investments
The mortgage loans in which we may invest and the mortgage loans underlying the mortgage-backed securities in which we may invest may be impacted by unfavorable real estate market conditions, which
could decrease their value.
If we acquire investments in mortgage loans or mortgage-backed securities, such
investments will involve special risks relating to the particular borrower or issuer of the mortgage-backed securities and we will be at risk of loss on those investments, including losses as a result of defaults on mortgage loans. These losses may
be caused by many conditions beyond our control, including economic conditions affecting real estate values, tenant defaults and lease expirations, interest rate levels and the other economic and liability risks associated with real estate. If we
acquire property by foreclosure following defaults under our mortgage loan investments, we will have the economic and liability risks as the owner described above. We do not know whether the values of the property securing any of our real
estate-related investments will remain at the levels existing on the dates we initially make the related investment. If the values of the underlying properties drop, our risk will increase and the values of our interests may decrease.
Delays in liquidating defaulted mortgage loan investments could reduce our investment returns.
If there are defaults under our mortgage loan investments, we may not be able to foreclose on or obtain a suitable remedy with respect to
such investments. Specifically, we may not be able to repossess and sell the underlying properties quickly, which could reduce the value of our investment. For example, an action to foreclose on a property securing a mortgage loan is regulated by
state statutes and rules and is subject to many of the delays and expenses of lawsuits if the defendant raises defenses or counterclaims. Additionally, in the event of default by a mortgagor, these restrictions, among other things, may impede our
ability to foreclose on or sell the mortgaged property or to obtain proceeds sufficient to repay all amounts due to us on the mortgage loan.
The commercial mortgage-backed securities in which we may invest are subject to several types of risks.
Commercial mortgage-backed securities are bonds which evidence interests in, or are secured by, a single commercial mortgage loan or a
pool of commercial mortgage loans. Accordingly, the mortgage-backed securities in which we may invest are subject to all the risks of the underlying mortgage loans.
In a rising interest rate environment, the value of commercial mortgage-backed securities may be adversely affected when payments on underlying mortgages do not occur as anticipated, resulting in the
extension of the securitys effective maturity and the related increase in interest rate sensitivity of a longer-term instrument. The value of commercial mortgage-backed securities may also change due to shifts in the markets perception
of issuers and regulatory or tax changes adversely affecting the mortgage securities markets as a whole. In addition, commercial mortgage-backed securities are subject to the credit risk associated with the performance of the underlying mortgage
properties.
50
Commercial mortgage-backed securities are also subject to several risks created through the
securitization process. Subordinate commercial mortgage-backed securities are paid interest-only to the extent that there are funds available to make payments. To the extent the collateral pool includes a large percentage of delinquent loans, there
is a risk that interest payments on subordinate commercial mortgage-backed securities will not be fully paid. Subordinate securities of commercial mortgage-backed securities are also subject to greater credit risk than those commercial
mortgage-backed securities that are more highly rated.
The mezzanine loans in which we may invest would involve greater risks of loss
than senior loans secured by income-producing real estate.
We may invest in mezzanine loans that take the form of
subordinated loans secured by second mortgages on the underlying real estate or loans secured by a pledge of the ownership interests of either the entity owning the real estate or the entity that owns the interest in the entity owning the real
estate. These types of investments involve a higher degree of risk than long-term senior mortgage lending secured by income-producing real estate because the investment may become unsecured as a result of foreclosure by the senior lender. In the
event of a bankruptcy of the entity providing the pledge of its ownership interests as security, we may not have full recourse to the assets of such entity, or the assets of the entity may not be sufficient to satisfy our mezzanine loan. If a
borrower defaults on our mezzanine loan or debt senior to our loan, or in the event of a borrower bankruptcy, our mezzanine loan will be satisfied only after the senior debt. As a result, we may not recover some or all of our investment. In
addition, mezzanine loans may have higher loan-to-value ratios than conventional mortgage loans, resulting in less equity in the real estate and increasing the risk of loss of principal.
Real estate-related equity securities in which we may invest are subject to specific risks relating to the particular issuer of the securities and may be subject to the general risks of investing in
real estate or real estate-related assets.
We may invest in the common and preferred stock of both publicly traded
and private unaffiliated real estate companies, which involves a higher degree of risk than debt securities due to a variety of factors, including the fact that such investments are subordinate to creditors and are not secured by the issuers
property. Our investments in real estate-related equity securities will involve special risks relating to the particular issuer of the equity securities, including the financial condition and business outlook of the issuer. Issuers of real
estate-related equity securities generally invest in real estate or real estate-related assets and are subject to the inherent risks associated with acquiring real estate-related investments discussed in these risk factors, including risks relating
to rising interest rates.
We expect a portion of our real estate-related investments to be illiquid and we may not be able to adjust
our portfolio in response to changes in economic and other conditions.
We may acquire real estate-related investments
in connection with privately negotiated transactions which are not registered under the relevant securities laws, resulting in a prohibition against their transfer, sale, pledge or other disposition except in a transaction that is exempt from the
registration requirements of, or is otherwise in accordance with, those laws. As a result, our ability to vary our portfolio in response to changes in economic and other conditions may be relatively limited. The mezzanine and bridge loans we may
purchase will be particularly illiquid investments due to their short life, their unsuitability for securitization and the greater difficulty of recoupment in the event of a borrowers default.
Interest rate and related risks may cause the value of our real estate-related investments to be reduced.
Interest rate risk is the risk that fixed income securities such as preferred and debt securities, and to a lesser extent dividend paying
common stocks, will decline in value because of changes in market interest rates. Generally, when market interest rates rise, the market value of such securities will decline, and vice versa. Our investment in such securities means that the net
asset value and market price of the common stock may tend to decline if market interest rates rise.
During periods of rising
interest rates, the average life of certain types of securities may be extended because of slower than expected principal payments. This may lock in a below-market interest rate, increase the securitys duration and reduce the value of the
security. This is known as extension risk. During periods of declining interest
51
rates, an issuer may be able to exercise an option to prepay principal earlier than scheduled, which is generally known as call or prepayment risk. If this occurs, we may be forced to reinvest in
lower yielding securities. This is known as reinvestment risk. Preferred and debt securities frequently have call features that allow the issuer to repurchase the security prior to its stated maturity. An issuer may redeem an obligation if the
issuer can refinance the debt at a lower cost due to declining interest rates or an improvement in the credit standing of the issuer. These risks may reduce the value of our real estate-related investments.
If we liquidate prior to the maturity of our real estate-related investments, we may be forced to sell those investments on unfavorable terms or at
a loss.
Our board of directors may choose to effect a liquidity event in which we liquidate our assets, including
our real estate-related investments. If we liquidate those investments prior to their maturity, we may be forced to sell those investments on unfavorable terms or at a loss. For instance, if we are required to liquidate mortgage loans at a time when
prevailing interest rates are higher than the interest rates of such mortgage loans, we would likely sell such loans at a discount to their stated principal values.
Risks Related to Joint Ventures
The terms of joint venture agreements or other
joint ownership arrangements into which we have entered and may enter could impair our operating flexibility and our results of operations.
In connection with the purchase of real estate, we may enter into joint ventures with third parties, including affiliates of our advisor entities. We may also purchase or develop properties in
co-ownership arrangements with the sellers of the properties, developers or other persons. These structures involve participation in the investment by other parties whose interests and rights may not be the same as ours. Our joint venture partners
may have rights to take some actions over which we have no control and may take actions contrary to our interests. Joint ownership of an investment in real estate may involve risks not associated with direct ownership of real estate, including the
following:
|
|
|
a venture partner may at any time have economic or other business interests or goals which become inconsistent with our business interests or goals,
including inconsistent goals relating to the sale of properties held in a joint venture or the timing of the termination and liquidation of the venture;
|
|
|
|
a venture partner might become bankrupt and such proceedings could have an adverse impact on the operation of the partnership or joint venture;
|
|
|
|
actions taken by a venture partner might have the result of subjecting the property to liabilities in excess of those contemplated; and
|
|
|
|
a venture partner may be in a position to take action contrary to our instructions or requests or contrary to our policies or objectives, including our
policy with respect to qualifying and maintaining our qualification as a REIT.
|
Under certain joint venture
arrangements, neither venture partner may have the power to control the venture, and an impasse could occur, which might adversely affect the joint venture and decrease potential returns to our stockholders. If we have a right of first refusal or
buy/sell right to buy out a venture partner, we may be unable to finance such a buy-out or we may be forced to exercise those rights at a time when it would not otherwise be in our best interest to do so. If our interest is subject to a buy/sell
right, we may not have sufficient cash, available borrowing capacity or other capital resources to allow us to purchase an interest of a venture partner subject to the buy/sell right, in which case we may be forced to sell our interest when we would
otherwise prefer to retain our interest. In addition, we may not be able to sell our interest in a joint venture on a timely basis or on acceptable terms if we desire to exit the venture for any reason, particularly if our interest is subject to a
right of first refusal of our venture partner.
52
We may structure our joint venture relationships in a manner which may limit the amount we participate
in the cash flows or appreciation of an investment.
We may enter into joint venture agreements, the economic terms of
which may provide for the distribution of income to us otherwise than in direct proportion to our ownership interest in the joint venture. For example, while we and a co-venturer may invest an equal amount of capital in an investment, the investment
may be structured such that we have a right to priority distributions of cash flows up to a certain target return while the co-venturer may receive a disproportionately greater share of cash flows than we are to receive once such target return has
been achieved. This type of investment structure may result in the co-venturer receiving more of the cash flows, including appreciation, of an investment than we would receive. If we do not accurately judge the appreciation prospects of a particular
investment or structure the venture appropriately, we may incur losses on joint venture investments or have limited participation in the profits of a joint venture investment, either of which could reduce our ability to pay cash distributions to our
stockholders.
Federal Income Tax Risks
Failure to maintain our qualification as a REIT for federal income tax purposes would subject us to federal income tax on our taxable income at regular corporate rates, which would substantially
reduce our ability to pay distributions to our stockholders.
We qualified and elected to be taxed as a REIT under the
Code beginning with our taxable year ended December 31, 2010. To continue to maintain our qualification as a REIT, we must meet various requirements set forth in the Code concerning, among other things, the ownership of our outstanding common
stock, the nature of our assets, the sources of our income and the amount of our distributions to our stockholders. The REIT qualification requirements are extremely complex, and interpretations of the federal income tax laws governing qualification
as a REIT are limited. Accordingly, we cannot be certain that we will be successful in operating so as to maintain our qualification as a REIT. At any time, new laws, interpretations or court decisions may change the federal tax laws relating to, or
the federal income tax consequences of, qualification as a REIT. It is possible that future economic, market, legal, tax or other considerations may cause our board of directors to determine that it is not in our best interest to maintain our
qualification as a REIT or revoke our REIT election, which it may do without stockholder approval.
If we fail to maintain our
qualification as a REIT for any taxable year, we will be subject to federal income tax on our taxable income at corporate rates. In addition, we would generally be disqualified from treatment as a REIT for the four taxable years following the year
of losing our REIT status. Losing our REIT status would reduce our net earnings available for investment or distribution to our stockholders because of the additional tax liability. In addition, distributions would no longer qualify for the
distributions paid deduction, and we would no longer be required to pay distributions. If this occurs, we might be required to borrow funds or liquidate some investments in order to pay the applicable tax.
As a result of all these factors, our failure to maintain our qualification as a REIT could impair our ability to expand our business and
raise capital, and would substantially reduce our ability to pay distributions to our stockholders.
To maintain our qualification as a
REIT and to avoid the payment of federal income and excise taxes, we may be forced to borrow funds, use proceeds from the issuance of securities (including our offering), or sell assets to pay distributions, which may result in our distributing
amounts that may otherwise be used for our operations.
To obtain the favorable tax treatment accorded to REITs, we
normally will be required each year to distribute to our stockholders at least 90.0% of our annual taxable income, determined without regard to the deduction for distributions paid and by excluding net capital gains. We will be subject to federal
income tax on our undistributed taxable income and net capital gain and to a 4.0% nondeductible excise tax on any amount by which distributions we pay with respect to any calendar year are less than the sum of (1) 85.0% of our ordinary income,
(2) 95.0% of our capital gain net income and (3) 100% of our undistributed income from prior years. These requirements could cause us to distribute amounts that otherwise would be spent on acquisitions of properties and it is possible that
we might be required to borrow funds, use proceeds from the issuance of securities (including our offering) or sell assets in order to distribute enough of our taxable income to maintain our qualification as a REIT and to avoid the payment of
federal income and excise taxes.
53
Our investment strategy may cause us to incur penalty taxes, lose our REIT status, or own and sell
properties through taxable REIT subsidiaries, each of which would diminish the return to our stockholders.
In light
of our investment strategy, it is possible that one or more sales of our properties may be prohibited transactions under provisions of the Code. If we are deemed to have engaged in a prohibited transaction (i.e., we sell a
property held by us primarily for sale in the ordinary course of our trade or business), all income that we derive from such sale would be subject to a 100% tax. The Code sets forth a safe harbor for REITs that wish to sell property without risking
the imposition of the 100% tax. A principal requirement of the safe harbor is that the REIT must hold the applicable property for not less than two years prior to its sale. Given our investment strategy, it is entirely possible, if not likely, that
the sale of one or more of our properties will not fall within the prohibited transaction safe harbor.
If we desire to sell a
property pursuant to a transaction that does not fall within the safe harbor, we may be able to avoid the 100% penalty tax if we acquired the property through a TRS or acquired the property and transferred it to a TRS for a non-tax business purpose
prior to the sale (i.e., for a reason other than the avoidance of taxes). However, there may be circumstances that prevent us from using a TRS in a transaction that does not qualify for the safe harbor. Additionally, even if it is possible to effect
a property disposition through a TRS, we may decide to forego the use of a TRS in a transaction that does not meet the safe harbor based on our own internal analysis, the opinion of counsel or the opinion of other tax advisors that the disposition
will not be subject to the 100% penalty tax. In cases where a property disposition is not effected through a TRS, the Internal Revenue Service, or IRS, could successfully assert that the disposition constitutes a prohibited transaction, in which
event all of the net income from the sale of such property will be payable as a tax and none of the proceeds from such sale will be distributable by us to our stockholders or available for investment by us.
If we acquire a property that we anticipate will not fall within the safe harbor from the 100% penalty tax upon disposition, then we may
acquire such property through a TRS in order to avoid the possibility that the sale of such property will be a prohibited transaction and subject to the 100% penalty tax. If we already own such a property directly or indirectly through an entity
other than a TRS, we may contribute the property to a TRS if there is another, non-tax-related business purpose for the contribution of such property to the TRS. Following the transfer of the property to a TRS, the TRS will operate the property and
may sell such property and distribute the net proceeds from such sale to us, and we may distribute the net proceeds distributed to us by the TRS to our stockholders. Though a sale of the property by a TRS likely would eliminate the danger of the
application of the 100% penalty tax, the TRS itself would be subject to a tax at the federal level, and potentially at the state and local levels, on the gain realized by it from the sale of the property as well as on the income earned while the
property is operated by the TRS. This tax obligation would diminish the amount of the proceeds from the sale of such property that would be distributable to our stockholders. As a result, the amount available for distribution to our stockholders
would be substantially less than if the REIT had not operated and sold such property through the TRS and such transaction was not successfully characterized as a prohibited transaction. The maximum federal income tax rate currently is 35.0%.
Federal, state and local corporate income tax rates may be increased in the future, and any such increase would reduce the amount of the net proceeds available for distribution by us to our stockholders from the sale of property through a TRS after
the effective date of any increase in such tax rates.
If we own too many properties through one or more of our TRSs, then we
may lose our status as a REIT. If we fail to maintain our qualification as a REIT for any taxable year, we will be subject to federal income tax on our taxable income at corporate rates. In addition, we would generally be disqualified from treatment
as a REIT for the four taxable years following the year of losing our REIT status. Losing our REIT status would reduce our net earnings available for investment or distribution to stockholders because of the additional tax liability. In addition,
distributions to stockholders would no longer qualify for the distributions paid deduction, and we would no longer be required to pay distributions. If this occurs, we might be required to borrow funds or liquidate some investments in order to pay
the applicable tax. As a REIT, the value of the securities we hold in all of our TRSs may not exceed 25.0% of the value of all of our assets at the end of any calendar quarter. If the IRS were to determine that the value
54
of our interests in all of our TRSs exceeded 25.0% of the value of total assets at the end of any calendar quarter, then we would fail to qualify as a REIT. If we determine it to be in our best
interest to own a substantial number of our properties through one or more TRSs, then it is possible that the IRS may conclude that the value of our interests in our TRSs exceeds 25.0% of the value of our total assets at the end of any calendar
quarter, and therefore, cause us to fail to qualify as a REIT. Additionally, as a REIT, no more than 25.0% of our gross income with respect to any year may be from sources other than real estate. Distributions paid to us from a TRS are considered to
be non-real estate income. Therefore, we may fail to qualify as a REIT if distributions from all of our TRSs, when aggregated with all other non-real estate income with respect to any one year, are more than 25.0% of our gross income with respect to
such year. We will use all reasonable efforts to structure our activities in a manner intended to satisfy the requirements for our qualification as a REIT. Our failure to maintain our qualification as a REIT would adversely affect our
stockholders return on their investment.
Our stockholders may have a current tax liability on distributions they elect to
reinvest in shares of our common stock.
If our stockholders participate in the DRIP, they will be deemed to have
received, and for income tax purposes will be taxed on, the amount reinvested in shares of our common stock to the extent the amount reinvested was not a tax-free return of capital. As a result, unless our stockholders are a tax-exempt entity, they
may have to use funds from other sources to pay their tax liability on the value of the shares of common stock received.
Legislative or
regulatory action with respect to taxes could adversely affect the returns to our investors.
In recent years,
numerous legislative, judicial and administrative changes have been made in the provisions of the federal and state income tax laws applicable to investments similar to an investment in shares of our common stock. On March 30, 2010, the
President signed into law the Reconciliation Act. The Reconciliation Act will require certain U.S. stockholders who are individuals, estates or trusts to pay a 3.8% Medicare tax on, among other things, dividends on and capital gains from the sale or
other disposition of stock, subject to certain exceptions. This additional tax will apply broadly to essentially all dividends and all gains from dispositions of stock, including dividends from REITs and gains from dispositions of REIT shares, such
as our common stock. As enacted, the tax will apply for taxable years beginning after December 31, 2012.
Additional
changes to the tax laws are likely to continue to occur, and we cannot assure our stockholders that any such changes will not adversely affect the taxation of a stockholder. Any such changes could have an adverse effect on an investment in our stock
or on the market value or the resale potential of our assets. Our stockholders are urged to consult with their own tax advisor with respect to the impact of recent legislation on their investment in our stock and the status of legislative,
regulatory or administrative developments and proposals and their potential effect on an investment in shares of our common stock.
Congress passed major federal tax legislation in 2003, with modifications to that legislation in 2005 and an extension of that legislation by the Tax Relief, Unemployment Insurance Reauthorization, and
Job Creation Act of 2010. One of the changes effected by that legislation generally reduced the maximum tax rate on qualified dividends paid by corporations to individuals to 15.0% through 2012. REIT distributions, however, generally do not
constitute qualified dividends and consequently are not eligible for this reduced maximum tax rate. Therefore, our stockholders will pay federal income tax on our distributions (other than capital gains dividends or distributions which represent a
return of capital for tax purposes) at the applicable ordinary income rate, the maximum of which is currently 35.0%. However, as a REIT, we generally would not be subject to federal or state corporate income taxes on that portion of our
ordinary income or capital gain that we distribute currently to our stockholders, and we thus expect to avoid the double taxation to which other corporations are typically subject.
The tax rate changes contained in the Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010 are currently
scheduled to expire at the end of 2012. It is widely anticipated that this expiration will provoke a legislative response from Congress for tax years beginning after December 31, 2012. It is impossible to anticipate the effects of any
such legislation at this time.
55
Although REITs continue to receive substantially better tax treatment than entities taxed as
corporations, it is possible that future legislation would result in a REIT having fewer tax advantages, and it could become more advantageous for a company that invests in real estate to elect to be taxed for federal income tax purposes as a
corporation. As a result, our charter provides our board of directors with the power, under certain circumstances, to revoke or otherwise terminate our REIT election and cause us to be taxed as a corporation, without the vote of our stockholders.
Our board of directors has fiduciary duties to us and our stockholders and could only cause such changes in our tax treatment if it determines in good faith that such changes are in our stockholders best interest.
In certain circumstances, we may be subject to federal and state income taxes as a REIT, which would reduce our cash available for distribution to
our stockholders.
Even if we qualify as a REIT, we may be subject to federal income taxes or state taxes. For
example, net income from a prohibited transaction will be subject to a 100% tax. We may not be able to make sufficient distributions to avoid excise taxes applicable to REITs. We may also decide to retain capital gains we earn from the
sale or other disposition of our property and pay income tax directly on such income. In that event, our stockholders would be treated as if they earned that income and paid the tax on it directly. However, our stockholders that are tax-exempt, such
as charities or qualified pension plans, would have no benefit from their deemed payment of such tax liability. We may also be subject to state and local taxes on our income or property, either directly or at the level of the companies through which
we indirectly own our assets. Any federal or state taxes we pay will reduce our cash available for distribution to our stockholders.
Distributions to tax-exempt stockholders may be classified as UBTI.
Neither ordinary nor capital gain distributions with respect to the shares of our common stock nor gain from the sale of the shares of
our common stock should generally constitute unrelated business taxable income, or UBTI, to a tax-exempt stockholder. However, there are certain exceptions to this rule. In particular:
|
|
|
part of the income and gain recognized by certain qualified employee pension trusts with respect to our common stock may be treated as UBTI if the
shares of our common stock are predominately held by qualified employee pension trusts, and we are required to rely on a special look-through rule for purposes of meeting one of the REIT share ownership tests, and we are not operated in a manner to
avoid treatment of such income or gain as UBTI;
|
|
|
|
part of the income and gain recognized by a tax exempt stockholder with respect to the shares of our common stock would constitute UBTI if the
stockholder incurs debt in order to acquire the shares of our common stock; and
|
|
|
|
part or all of the income or gain recognized with respect to the shares of our common stock by social clubs, voluntary employee benefit associations,
supplemental unemployment benefit trusts and qualified group legal services plans which are exempt from federal income taxation under Sections 501(c)(7), (9), (17) or (20) of the Internal Revenue Code may be treated as UBTI.
|
Complying with the REIT requirements may cause us to forego otherwise attractive opportunities.
To maintain our qualification as a REIT for federal income tax purposes, we must continually satisfy tests concerning, among other
things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of shares of our common stock. We may be required to pay distributions to our stockholders at
disadvantageous times or when we do not have funds readily available for distribution, or we may be required to liquidate otherwise attractive investments in order to comply with the REIT tests. Thus, compliance with the REIT requirements may hinder
our ability to operate solely on the basis of maximizing profits.
56
Foreign purchasers of shares of our common stock may be subject to FIRPTA tax upon the sale of their
shares of our common stock.
A foreign person disposing of a U.S. real property interest, including shares of
stock of a U.S. corporation whose assets consist principally of U.S. real property interests, is generally subject to the Foreign Investment in Real Property Tax Act of 1980, as amended, or FIRPTA, on the gain recognized on the
disposition. Such FIRPTA tax does not apply, however, to the disposition of stock in a REIT if the REIT is domestically controlled. A REIT is domestically controlled if less than 50.0% of the REITs stock, by value, has
been owned directly or indirectly by persons who are not qualifying U.S. persons during a continuous five-year period ending on the date of disposition or, if shorter, during the entire period of the REITs existence. We cannot assure our
stockholders that we will qualify as a domestically controlled REIT. If we were to fail to so qualify, gain realized by foreign investors on a sale of shares of our common stock would be subject to FIRPTA tax, unless the shares of our
common stock were traded on an established securities market and the foreign investor did not at any time during a specified testing period directly or indirectly own more than 5.0% of the value of our outstanding common stock.
Foreign stockholders may be subject to FIRPTA tax upon the payment of a capital gains dividend.
A foreign stockholder also may be subject to FIRPTA upon the payment of any capital gain dividends by us, which dividend is attributable
to gain from sales or exchanges of U.S. real property interests. Additionally, capital gains dividends paid to foreign stockholders, if attributable to gain from sales or exchanges of U.S. real property interests, would not be exempt from
FIRPTA and would be subject to FIRPTA tax.
Employee Benefit Plan, IRA, and Other Tax-Exempt Investor Risks
We, and our stockholders that are employee benefit plans, individual retirement accounts, or IRAs, annuities described in
Sections 403(a) or (b) of the Internal Revenue Code, Archer MSAs, health savings accounts, or Coverdell education savings accounts (referred to generally as Benefit Plans and IRAs) will be subject to risks relating specifically to our
having such Benefit Plan and IRA stockholders, which risks are discussed below.
If our stockholders fail to meet the fiduciary and
other standards under ERISA or the Code as a result of an investment in shares of our common stock, our stockholders could be subject to criminal and civil penalties.
There are special considerations that apply to Benefit Plans or IRAs investing in shares of our common stock. If our stockholders are investing the assets of a Benefit Plan or IRA in us, they should
consider:
|
|
|
whether their investment is consistent with the applicable provisions of the Employee Retirement Income Security Act of 1974, as amended, or ERISA, and
the Code, or any other applicable governing authority in the case of a government plan;
|
|
|
|
whether their investment is made in accordance with the documents and instruments governing their Benefit Plan or IRA, including their Benefit Plan or
IRAs investment policy;
|
|
|
|
whether their investment satisfies the prudence, diversification and other requirements of Sections 404(a)(1)(B) and 404(a)(1)(C) of ERISA;
|
|
|
|
whether their investment will impair the liquidity needs and distribution requirements of the Benefit Plan or IRA;
|
|
|
|
whether their investment will constitute a prohibited transaction under Section 406 of ERISA or Section 4975 of the Code;
|
|
|
|
whether their investment will produce or result in UBTI, as defined in Sections 511 through 514 of the Code, to the Benefit Plan or IRA; and
|
|
|
|
their need to value the assets of the Benefit Plan or IRA annually in accordance with ERISA and the Code.
|
57
In addition to considering their fiduciary responsibilities under ERISA and the prohibited
transaction rules of ERISA and the Code, a Benefit Plan or IRA purchasing shares of our common stock should consider the effect of the plan asset regulations of the U.S. Department of Labor. To avoid our assets from being considered plan assets
under those regulations, our charter prohibits benefit plan investors from owning 25.0% or more of the shares of our common stock prior to the time that the common stock qualifies as a class of publicly-offered securities, within the
meaning of the ERISA plan asset regulations. However, we cannot assure our stockholders that those provisions in our charter will be effective in limiting benefit plan investor ownership to less than the 25.0% limit. For example, the limit could be
unintentionally exceeded if a benefit plan investor misrepresents its status as a benefit plan. Even if our assets are not considered to be plan assets, a prohibited transaction could occur if we or any of our affiliates is a fiduciary (within the
meaning of ERISA and/or the Code) with respect to a Benefit Plan or IRA purchasing shares of our common stock, and, therefore, in the event any such persons are fiduciaries (within the meaning of ERISA and/or the Code) of our stockholders
Benefit Plan or IRA, they should not purchase shares of our common stock unless an administrative or statutory exemption applies to their purchase.
Item 1B. Unresolved Staff Comments.
Not applicable.
Item 2. Properties.
As of December 31, 2011, our principal executive offices are located at 4000
MacArthur Boulevard, West Tower, Suite 200, Newport Beach, California 92660. We do not have an address separate from our advisor entities or our co-sponsors. Since we pay our advisor entities fees for their services, we do not pay rent for the
use of their space.
Real Estate Investments
As of December 31, 2011, we had completed 25 acquisitions, 17 of which were acquisitions of medical office buildings, four of which were acquisitions of hospitals and four of which were acquisitions
of skilled nursing facilities. The aggregate purchase price of these properties was $438,625,000 and was comprised of 56 buildings and 1,987,000 square feet of GLA.
58
The following table presents certain additional information about our properties as of
December 31, 2011:
|
|
Septe
|
|
Septe
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
Property
(1)
|
|
Property Location
|
|
Type of Property
|
|
GLA
(Sq Ft)
|
|
|
% of
GLA
|
|
|
Date Acquired
|
|
|
Purchase
Price
|
|
|
Annualized
Base
Rent
(2)
|
|
|
% of
Annualized
Base Rent
|
|
|
Occupancy
(3)
|
|
|
Annual Rent
Per Leased
Sq Ft
(4)
|
|
Lacombe Medical Office Building
|
|
Lacombe, LA
|
|
Medical Office Building
|
|
|
34,000
|
|
|
|
1.7
|
%
|
|
|
03/05/10
|
|
|
$
|
6,970,000
|
|
|
$
|
637,000
|
|
|
|
1.6
|
%
|
|
|
100
|
%
|
|
$
|
18.66
|
|
Center for Neurosurgery and Spine
|
|
Sartell, MN
|
|
Medical Office Building
|
|
|
33,000
|
|
|
|
1.7
|
|
|
|
03/31/10
|
|
|
|
6,500,000
|
|
|
|
576,000
|
|
|
|
1.4
|
|
|
|
100
|
%
|
|
$
|
17.40
|
|
Parkway Medical Center
|
|
Beachwood, OH
|
|
Medical Office Building
|
|
|
88,000
|
|
|
|
4.4
|
|
|
|
04/12/10
|
|
|
|
10,900,000
|
|
|
|
1,762,000
|
|
|
|
4.3
|
|
|
|
91.7
|
%
|
|
$
|
21.85
|
|
Highlands Ranch Medical Pavilion
|
|
Highlands Ranch,
CO
|
|
Medical Office Building
|
|
|
37,000
|
|
|
|
1.9
|
|
|
|
04/30/10
|
|
|
|
8,400,000
|
|
|
|
808,000
|
|
|
|
2.0
|
|
|
|
100
|
%
|
|
$
|
21.91
|
|
Muskogee Long-Term Acute Care Hospital
|
|
Muskogee, OK
|
|
Hospital
|
|
|
37,000
|
|
|
|
1.9
|
|
|
|
05/27/10
|
|
|
|
11,000,000
|
|
|
|
1,021,000
|
|
|
|
2.5
|
|
|
|
100
|
%
|
|
$
|
27.26
|
|
St. Vincent Medical Office Building
|
|
Cleveland, OH
|
|
Medical Office Building
|
|
|
51,000
|
|
|
|
2.6
|
|
|
|
06/25/10
|
|
|
|
10,100,000
|
|
|
|
1,130,000
|
|
|
|
2.8
|
|
|
|
95.4
|
%
|
|
$
|
23.00
|
|
Livingston Medical Arts Pavilion
|
|
Livingston, TX
|
|
Medical Office Building
|
|
|
29,000
|
|
|
|
1.5
|
|
|
|
06/28/10
|
|
|
|
6,350,000
|
|
|
|
595,000
|
|
|
|
1.5
|
|
|
|
100
|
%
|
|
$
|
20.70
|
|
Pocatello East Medical Office Building
|
|
Pocatello, ID
|
|
Medical Office Building
|
|
|
76,000
|
|
|
|
3.8
|
|
|
|
07/27/10
|
|
|
|
15,800,000
|
|
|
|
1,423,000
|
|
|
|
3.5
|
|
|
|
100
|
%
|
|
$
|
18.62
|
|
Monument Long-Term Acute Care Hospital Portfolio
|
|
Cape Girardeau,
Joplin, Columbia,
MO and
Athens,
GA
|
|
Hospital
|
|
|
115,000
|
|
|
|
5.8
|
|
|
|
Various
|
|
|
|
41,695,000
|
|
|
|
3,717,000
|
|
|
|
9.1
|
|
|
|
100
|
%
|
|
$
|
32.35
|
|
Virginia Skilled Nursing Facility Portfolio
|
|
Charlottesville,
Bastian,
Lebanon, Fincastle,
Low
Moor,
Midlothian and
Hot Springs, VA
|
|
Skilled Nursing Facility
|
|
|
232,000
|
|
|
|
11.7
|
|
|
|
09/16/10
|
|
|
|
45,000,000
|
|
|
|
4,361,000
|
|
|
|
10.7
|
|
|
|
100
|
%
|
|
$
|
18.81
|
|
Sylva Medical Office Building
|
|
Sylva, NC
|
|
Medical Office Building
|
|
|
45,000
|
|
|
|
2.3
|
|
|
|
11/15/10
|
|
|
|
11,400,000
|
|
|
|
957,000
|
|
|
|
2.3
|
|
|
|
100
|
%
|
|
$
|
21.17
|
|
Surgical Hospital of Humble
|
|
Humble, TX
|
|
Hospital
|
|
|
30,000
|
|
|
|
1.5
|
|
|
|
12/10/10
|
|
|
|
13,100,000
|
|
|
|
1,190,000
|
|
|
|
2.9
|
|
|
|
100
|
%
|
|
$
|
39.18
|
|
Lawton Medical Office Building Portfolio
|
|
Lawton, OK
|
|
Medical Office Building
|
|
|
62,000
|
|
|
|
3.1
|
|
|
|
12/22/10
|
|
|
|
11,550,000
|
|
|
|
956,000
|
|
|
|
2.3
|
|
|
|
100
|
%
|
|
$
|
15.33
|
|
Ennis Medical Office Building
|
|
Ennis, TX
|
|
Medical Office Building
|
|
|
30,000
|
|
|
|
1.5
|
|
|
|
12/22/10
|
|
|
|
7,100,000
|
|
|
|
611,000
|
|
|
|
1.5
|
|
|
|
94.8
|
%
|
|
$
|
21.57
|
|
St. Anthony North Medical Office Building
|
|
Westminster, CO
|
|
Medical Office Building
|
|
|
60,000
|
|
|
|
3.0
|
|
|
|
03/29/11
|
|
|
|
11,950,000
|
|
|
|
1,039,000
|
|
|
|
2.5
|
|
|
|
88.5
|
%
|
|
$
|
19.45
|
|
Loma Linda Pediatric Specialty Hospital
|
|
Loma Linda, CA
|
|
Skilled Nursing Facility
|
|
|
34,000
|
|
|
|
1.7
|
|
|
|
03/31/11
|
|
|
|
13,000,000
|
|
|
|
1,300,000
|
|
|
|
3.2
|
|
|
|
100
|
%
|
|
$
|
37.94
|
|
Yuma Skilled Nursing Facility
|
|
Yuma, AZ
|
|
Skilled Nursing Facility
|
|
|
40,000
|
|
|
|
2.0
|
|
|
|
04/13/11
|
|
|
|
11,000,000
|
|
|
|
1,078,000
|
|
|
|
2.6
|
|
|
|
100
|
%
|
|
$
|
27.17
|
|
Hardy Oak Medical Office Building
|
|
San Antonio, TX
|
|
Medical Office Building
|
|
|
42,000
|
|
|
|
2.1
|
|
|
|
04/14/11
|
|
|
|
8,070,000
|
|
|
|
719,000
|
|
|
|
1.8
|
|
|
|
100
|
%
|
|
$
|
17.10
|
|
Lakewood Ranch Medical Office Building
|
|
Bradenton, FL
|
|
Medical Office Building
|
|
|
58,000
|
|
|
|
2.9
|
|
|
|
04/15/11
|
|
|
|
12,500,000
|
|
|
|
1,204,000
|
|
|
|
2.9
|
|
|
|
94.4
|
%
|
|
$
|
22.14
|
|
Dixie-Lobo Medical Office Building Portfolio
|
|
Alice, Lufkin,
Victoria and
Wharton, TX,
Carlsbad and
Hobbs, NM, Hope,
AR and Lake
Charles, LA
|
|
Medical Office Building
|
|
|
156,000
|
|
|
|
7.9
|
|
|
|
05/12/11
|
|
|
|
30,050,000
|
|
|
|
2,861,000
|
|
|
|
7.0
|
|
|
|
100.0
|
%
|
|
$
|
18.35
|
|
Milestone Medical Office Building Portfolio
|
|
Jersey City, NJ and
Bryant and Benton,
AR
|
|
Medical Office Building
|
|
|
179,000
|
|
|
|
9.0
|
|
|
|
05/26/11
|
|
|
|
44,050,000
|
|
|
|
3,057,000
|
|
|
|
7.5
|
|
|
|
74.6
|
%
|
|
$
|
22.89
|
|
Philadelphia SNF Portfolio
|
|
Philadelphia, PA
|
|
Skilled Nursing Facility
|
|
|
392,000
|
|
|
|
19.7
|
|
|
|
06/30/11
|
|
|
|
75,000,000
|
|
|
|
7,516,000
|
|
|
|
18.4
|
|
|
|
100
|
%
|
|
$
|
19.19
|
|
Maxfield Medical Office Building
|
|
Sarasota, FL
|
|
Medical Office Building
|
|
|
41,000
|
|
|
|
2.0
|
|
|
|
07/11/11
|
|
|
|
7,200,000
|
|
|
|
638,000
|
|
|
|
1.5
|
|
|
|
90.5
|
%
|
|
$
|
17.15
|
|
Lafayette Physical Rehabilitation Hospital
|
|
Lafayette, LA
|
|
Hospital
|
|
|
26,000
|
|
|
|
1.3
|
|
|
|
09/30/11
|
|
|
|
12,100,000
|
|
|
|
1,060,000
|
|
|
|
2.6
|
|
|
|
100
|
%
|
|
$
|
40.10
|
|
Sierra Providence East Medical Plaza I
|
|
El Paso, TX
|
|
Medical Office Building
|
|
|
60,000
|
|
|
|
3.0
|
|
|
|
12/22/11
|
|
|
|
7,840,000
|
|
|
|
654,000
|
|
|
|
1.6
|
|
|
|
89.2
|
%
|
|
$
|
12.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total/Weighted Average
|
|
|
|
|
|
|
1,987,000
|
|
|
|
100
|
%
|
|
|
|
|
|
$
|
438,625,000
|
|
|
$
|
40,870,000
|
|
|
|
100
|
%
|
|
|
96.1
|
%
|
|
$
|
21.37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
We own 100% of all of our properties, except for Pocatello East Medical Office Building, of which we own 98.75%.
|
(2)
|
Annualized base rent is based on contractual base rent from leases in effect as of December 31, 2011.
|
(3)
|
Occupancy includes all leased space of the respective acquisition including master leases.
|
(4)
|
Average annual rent per leased square foot based on leases in effect as of December 31, 2011.
|
We own fee simple interests in all of our properties except Dixie-Lobo Medical Office Building Portfolio, Lakewood Ranch Medical Office
Building, Lawton Medical Office Building Portfolio, Livingston Medical Arts Pavilion, four of the five buildings of Milestone Medical Office Building Portfolio, Pocatello East Medical Office Building, Sierra Providence East Medical Plaza I, St.
Anthony North Medical Office Building and Sylva Medical Office Building for which we own fee simple interests in the building and improvements of such properties subject to the respective ground leases.
59
The following information generally applies to our properties:
|
|
|
we believe all of our properties are adequately covered by insurance and are suitable for their intended purposes;
|
|
|
|
we have no plans for any material renovations, improvements or development with respect to any of our properties, except in accordance with planned
budgets;
|
|
|
|
our properties are located in markets where we are subject to competition for attracting new tenants and retaining current tenants; and
|
|
|
|
depreciation is provided on a straight-line basis over the estimated useful lives of the buildings, 39 years, and over the shorter of the lease term or
useful lives of the tenant improvements.
|
Lease Expirations
The following table presents the sensitivity of our annual base rent due to lease expirations for the next 10 years at our
properties, by number, square feet, percentage of leased area, annual base rent and percentage of annual rent of expiring leases as of December 31, 2011:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Number of Expiring
Leases
|
|
|
Total Sq. Ft. of
Expiring Leases
|
|
|
% of Leased Area
Represented by
Expiring Leases
|
|
|
Annual Rent Under
Expiring Leases
|
|
|
% of Total Annual
Rent Represented
by Expiring
Leases
(1)
|
|
2012
|
|
|
26
|
|
|
|
62,000
|
|
|
|
3.3
|
%
|
|
$
|
1,313,000
|
|
|
|
2.7
|
%
|
2013
|
|
|
25
|
|
|
|
76,000
|
|
|
|
4.0
|
|
|
|
1,729,000
|
|
|
|
3.6
|
|
2014
|
|
|
23
|
|
|
|
77,000
|
|
|
|
4.0
|
|
|
|
1,577,000
|
|
|
|
3.3
|
|
2015
|
|
|
33
|
|
|
|
125,000
|
|
|
|
6.5
|
|
|
|
2,454,000
|
|
|
|
5.1
|
|
2016
|
|
|
22
|
|
|
|
190,000
|
|
|
|
9.9
|
|
|
|
3,952,000
|
|
|
|
8.2
|
|
2017
|
|
|
9
|
|
|
|
55,000
|
|
|
|
2.9
|
|
|
|
1,084,000
|
|
|
|
2.3
|
|
2018
|
|
|
10
|
|
|
|
85,000
|
|
|
|
4.5
|
|
|
|
1,662,000
|
|
|
|
3.4
|
|
2019
|
|
|
6
|
|
|
|
84,000
|
|
|
|
4.4
|
|
|
|
1,903,000
|
|
|
|
4.0
|
|
2020
|
|
|
21
|
|
|
|
83,000
|
|
|
|
4.3
|
|
|
|
2,434,000
|
|
|
|
5.0
|
|
2021
|
|
|
10
|
|
|
|
69,000
|
|
|
|
3.6
|
|
|
|
2,044,000
|
|
|
|
4.2
|
|
Thereafter
|
|
|
23
|
|
|
|
1,005,000
|
|
|
|
52.6
|
|
|
|
28,049,000
|
|
|
|
58.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
208
|
|
|
|
1,911,000
|
|
|
|
100
|
%
|
|
$
|
48,201,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The annual rent percentage is based on the total annual contractual base rent based on leases in effect as of December 31, 2011.
|
60
Geographic Diversification/Concentration Table
The following table lists the states in which our properties are located and provides certain information regarding our portfolios
geographic diversification/concentration as of December 31, 2011:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
State
|
|
Number of
Buildings
|
|
|
GLA (Sq Ft)
|
|
|
% of GLA
|
|
|
Annualized Base Rent
(1)
|
|
|
% of
Annualized
Base
Rent
|
|
|
|
|
|
|
|
Arizona
|
|
|
1
|
|
|
|
40,000
|
|
|
|
2.0
|
%
|
|
$
|
1,078,000
|
|
|
|
2.6
|
%
|
Arkansas
|
|
|
5
|
|
|
|
121,000
|
|
|
|
6.1
|
|
|
|
1,324,000
|
|
|
|
3.2
|
|
California
|
|
|
3
|
|
|
|
34,000
|
|
|
|
1.7
|
|
|
|
1,300,000
|
|
|
|
3.2
|
|
Colorado
|
|
|
2
|
|
|
|
97,000
|
|
|
|
4.9
|
|
|
|
1,847,000
|
|
|
|
4.5
|
|
Florida
|
|
|
2
|
|
|
|
99,000
|
|
|
|
5.0
|
|
|
|
1,842,000
|
|
|
|
4.5
|
|
Georgia
|
|
|
1
|
|
|
|
31,000
|
|
|
|
1.6
|
|
|
|
1,106,000
|
|
|
|
2.7
|
|
Idaho
|
|
|
1
|
|
|
|
76,000
|
|
|
|
3.8
|
|
|
|
1,423,000
|
|
|
|
3.5
|
|
Louisiana
|
|
|
3
|
|
|
|
75,000
|
|
|
|
3.8
|
|
|
|
1,972,000
|
|
|
|
4.8
|
|
Minnesota
|
|
|
2
|
|
|
|
33,000
|
|
|
|
1.7
|
|
|
|
576,000
|
|
|
|
1.4
|
|
Missouri
|
|
|
3
|
|
|
|
84,000
|
|
|
|
4.2
|
|
|
|
2,611,000
|
|
|
|
6.4
|
|
North Carolina
|
|
|
1
|
|
|
|
45,000
|
|
|
|
2.3
|
|
|
|
957,000
|
|
|
|
2.3
|
|
New Jersey
|
|
|
1
|
|
|
|
68,000
|
|
|
|
3.4
|
|
|
|
1,911,000
|
|
|
|
4.7
|
|
New Mexico
|
|
|
2
|
|
|
|
39,000
|
|
|
|
2.0
|
|
|
|
710,000
|
|
|
|
1.7
|
|
Ohio
|
|
|
3
|
|
|
|
139,000
|
|
|
|
7.0
|
|
|
|
2,892,000
|
|
|
|
7.1
|
|
Oklahoma
|
|
|
3
|
|
|
|
99,000
|
|
|
|
5.0
|
|
|
|
1,977,000
|
|
|
|
4.8
|
|
Pennsylvania
|
|
|
5
|
|
|
|
392,000
|
|
|
|
19.7
|
|
|
|
7,516,000
|
|
|
|
18.4
|
|
Texas
|
|
|
11
|
|
|
|
283,000
|
|
|
|
14.2
|
|
|
|
5,467,000
|
|
|
|
13.4
|
|
Virginia
|
|
|
7
|
|
|
|
232,000
|
|
|
|
11.6
|
|
|
|
4,361,000
|
|
|
|
10.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
56
|
|
|
|
1,987,000
|
|
|
|
100
|
%
|
|
$
|
40,870,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Annualized base rent is based on contractual base rent from leases in effect as of December 31, 2011.
|
Indebtedness
For a
discussion of our indebtedness, see Note 6, Mortgage Loans Payable, Net, Note 7, Derivative Financial Instruments, and Note 8, Lines of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on
Form 10-K.
Item 3. Legal Proceedings.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
61
PART II
Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Market Information
There is no established public trading market for shares of our common stock.
In
order for members of the Financial Industry Regulatory Authority, or FINRA, and their associated persons to participate in the offering and sale of shares of our common stock, we are required to disclose in each annual report distributed to
stockholders a per share estimated value of the shares, the method by which it was developed, and the date of the data used to develop the estimated value. In addition, we will prepare annual statements of estimated share values to assist
fiduciaries of retirement plans subject to the annual reporting requirements of ERISA in the preparation of their reports relating to an investment in shares of our common stock. For these purposes, our advisor entities estimated value of the
shares is $10.00 per share as of December 31, 2011. The basis for this valuation is the fact that the current public offering price for shares of our common stock is $10.00 per share (ignoring purchase price discounts for certain categories of
purchasers). However, there is no public trading market for the shares of our common stock at this time, and there can be no assurance that stockholders could receive $10.00 per share if such a market did exist and they sold their shares of our
common stock or that they will be able to receive such amount for their shares of our common stock in the future. Until 18 months after the later of the completion of our offering or any subsequent offering of shares of our common stock, we
intend to continue to use the offering price of shares of our common stock in our most recent offering as the estimated per share value reported in our Annual Reports on Form 10-K distributed to stockholders. Beginning 18 months after the
last offering of shares of our common stock, the value of the properties and our other assets will be determined in a manner deemed appropriate by our board of directors, and we will disclose the resulting estimated per share value in our Annual
Reports on Form 10-K distributed to stockholders.
Stockholders
As of March 7, 2012, we had approximately 14,400 stockholders of record.
Distributions
Our board of directors authorized a daily distribution to
our stockholders of record as of the close of business on each day of the period commencing on January 1, 2010 and ending on June 30, 2010, as a result of our former sponsor advising us that it intended to fund these distributions until we
acquired our first property. We acquired our first property, Lacombe Medical Office Building, on March 5, 2010. Our former sponsor did not receive any additional shares of our common stock or other consideration for funding these distributions,
and we will not repay the funds provided by our former sponsor for these distributions. Subsequently, our board of directors authorized, on a quarterly basis, a daily distribution to our stockholders of record as of the close of business on each day
of the quarterly periods commencing on July 1, 2010 and ending on June 30, 2012.
For distributions declared for
each record date in the January 2010 through December 2011 periods, the distributions were calculated based on 365 days in the calendar year and were equal to $0.001780822 per day per share of common stock, which is equal to an annualized
distribution rate of 6.5%, assuming a purchase price of $10.00 per share. For distributions declared for each record date in the January 2012 through June 2012 periods, the distributions are calculated based on 365 days in the calendar year and are
equal to $0.001808219 per day per share of common stock, which is equal to an annualized distribution rate of 6.6%, assuming a purchase price of $10.00 per share. These distributions are aggregated and paid in cash or shares of our common stock
pursuant to the DRIP monthly in arrears. The distributions declared for each record date are paid only from legally available funds.
The amount of the distributions to our stockholders is determined quarterly by our board of directors and is dependent on a number of factors, including funds available for payment of distributions, our
financial condition, capital expenditure requirements and annual distribution requirements needed to maintain our qualification as a REIT under the Code. We have not established any limit on the amount of offering proceeds that may be used to fund
distributions, except that, in accordance with our organizational documents and Maryland law, we may not make distributions that would: (i) cause us to be unable to pay our debts as they become due in the usual course of business;
(ii) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences; or (iii) jeopardize our ability to maintain our qualification as a REIT.
62
The distributions paid for the years ended December 31, 2011 and 2010, along with the
amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to cash flows from operations are as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Distributions paid in cash
|
|
$
|
9,375,000
|
|
|
|
|
|
|
$
|
2,087,000
|
|
|
|
|
|
Distributions reinvested
|
|
|
8,817,000
|
|
|
|
|
|
|
|
1,985,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
|
|
|
$
|
4,072,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sources of distributions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operations
|
|
$
|
9,264,000
|
|
|
|
50.9
|
%
|
|
$
|
|
|
|
|
|
%
|
Funds from our former sponsor
|
|
|
|
|
|
|
|
%
|
|
|
259,000
|
|
|
|
6.4
|
%
|
Offering proceeds
|
|
|
8,928,000
|
|
|
|
49.1
|
%
|
|
|
3,813,000
|
|
|
|
93.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
100
|
%
|
|
$
|
4,072,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not
pay any distributions.
Under GAAP, acquisition related expenses are expensed, and therefore, subtracted from cash flows from
operations. However, these expenses are paid from offering proceeds.
Our distributions of amounts in excess of our current
and accumulated earnings and profits have resulted in a return of capital to our stockholders, and all or any portion of a distribution to our stockholders may be paid from offering proceeds. The payment of distributions from our offering proceeds
could reduce the amount of capital we ultimately invest in assets and negatively impact the amount of income available for future distributions.
As of December 31, 2011, we had an amount payable of $520,000 to our former advisor or its affiliates for asset and property management fees, operating expenses, lease commissions, on-site personnel
payroll and acquisition related expenses, which will be paid from cash flows from operations in the future as they become due and payable by us in the ordinary course of business consistent with our past practice.
As of December 31, 2011, no amounts due to our former advisor or its affiliates have been deferred, waived or forgiven. Our former
advisor and its affiliates and our advisor entities and their affiliates have no obligations to defer, waive or forgive amounts due to them. In the future, if our former advisor and its affiliates and our advisor entities and their affiliates do not
defer, waive or forgive amounts due to them, this would negatively affect our cash flows from operations, which could result in us paying distributions, or a portion thereof, with net proceeds from our offering, funds from our co-sponsors or
borrowed funds. As a result, the amount of proceeds available for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds.
63
The distributions paid for the years ended December 31, 2011 and 2010, along with the
amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to FFO are as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Distributions paid in cash
|
|
$
|
9,375,000
|
|
|
|
|
|
|
$
|
2,087,000
|
|
|
|
|
|
Distributions reinvested
|
|
|
8,817,000
|
|
|
|
|
|
|
|
1,985,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
|
|
|
$
|
4,072,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sources of distributions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FFO
|
|
$
|
9,040,000
|
|
|
|
49.7
|
%
|
|
$
|
|
|
|
|
|
%
|
Funds from our former sponsor
|
|
|
|
|
|
|
|
%
|
|
|
259,000
|
|
|
|
6.4
|
%
|
Offering proceeds
|
|
|
9,152,000
|
|
|
|
50.3
|
%
|
|
|
3,813,000
|
|
|
|
93.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,192,000
|
|
|
|
100
|
%
|
|
$
|
4,072,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not
pay any distributions.
The payment of distributions from sources other than FFO may reduce the amount of proceeds available
for investment and operations or cause us to incur additional interest expense as a result of borrowed funds. For a further discussion of FFO, including a reconciliation of our GAAP net loss to FFO, see Funds from Operations and Modified Funds from
Operations in Item 6. Selected Financial Data.
Securities Authorized for Issuance under Equity Compensation Plans
We adopted our incentive plan, pursuant to which our board of directors or a committee of our independent directors may make grants of
options, restricted shares of common stock, stock purchase rights, stock appreciation rights, or SARs, or other awards to our independent directors, employees and consultants. The maximum number of shares of our common stock that may be issued
pursuant to our incentive plan is 2,000,000. For a further discussion of our incentive plan, see Note 12, Equity 2009 Incentive Plan, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K. The
following table provides information regarding our incentive plan as of December 31, 2011:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Plan Category
|
|
Number of Securities
to be Issued upon
Exercise of
Outstanding Options,
Warrants
and Rights
|
|
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and
Rights
|
|
|
Number of Securities
Remaining
Available for
Future Issuance
|
|
|
|
|
|
Equity compensation plans approved by security holders(1)
|
|
|
|
|
|
|
|
|
|
|
1,970,000
|
|
Equity compensation plans not approved by security holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
1,970,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
On October 21, 2009, we granted an aggregate of 15,000 shares of our restricted common stock, as defined in our incentive plan, to our independent directors in
connection with their initial election to our board of directors, of which 20.0% vested on the grant date and 20.0% will vest on each of the first four anniversaries of the date of grant. On each of June 8, 2010 and June 14, 2011, in
connection with their re-election, we granted an aggregate of 7,500 shares of our restricted common stock, as defined in our incentive plan, to our independent directors, which will vest over the same period described above. The fair value of each
share of our restricted common stock was estimated at the date of grant at $10.00 per share, the per share price of shares in our offering, and with respect to the initial 20.0% of shares that vested on the grant date, expensed as compensation
immediately, and with respect to the remaining shares, amortized on a straight-line basis over the vesting period. Shares of our restricted common stock may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise
encumbered. Such restrictions expire upon vesting. Shares of our restricted common stock have full voting rights and rights to dividends. Such shares are not shown in the chart above as they are deemed outstanding shares of our common stock;
however, such grants reduce the number of securities remaining available for future issuance.
|
64
Use of Public Offering Proceeds
Our Registration Statement on Form S-11 (File No. 333-158111), registering a public offering of up to 330,000,000 shares of our
common stock, was declared effective under the Securities Act of 1933, as amended, or the Securities Act, on August 24, 2009. Pursuant to our Registration Statement on Form S-11, we are offering to the public up to 300,000,000 shares of our
common stock for $10.00 per share in our primary offering and 30,000,000 shares of our common stock pursuant to the DRIP for $9.50 per share, for a maximum offering of up to $3,285,000,000. Until April 18, 2011, Grubb & Ellis
Securities, Inc., or Grubb & Ellis Securities, served as the dealer manager of our offering. Effective as of April 19, 2011, the G&E Dealer Manager Agreement with Grubb & Ellis Securities was assigned to, and assumed by,
Grubb & Ellis Capital Corporation, a wholly owned subsidiary of our former sponsor. On November 7, 2011, we entered into the Dealer Manager Agreement with Griffin Securities, whereby Griffin Securities began serving as the dealer
manager of our offering effective January 7, 2012. The terms of the Dealer Manager Agreement with Griffin Securities are substantially the same as the terms of the terminated G&E Dealer Manager Agreement.
As of December 31, 2011, we had received and accepted subscriptions in our offering for 47,831,458 shares of our common stock, or
$477,306,000, excluding shares of our common stock issued pursuant to the DRIP. As of December 31, 2011, a total of $10,802,000 in distributions were reinvested and 1,137,013 shares of our common stock were issued pursuant to the DRIP.
As of December 31, 2011, we had incurred selling commissions of $32,500,000 and dealer manager fees of $14,290,000 in
connection with our offering. We had also incurred other offering expenses of $4,783,000 as of such date. Such commissions, fees and reimbursements were incurred to our former affiliates and are charged to stockholders equity as such amounts
are reimbursed from the gross proceeds of our offering. The cost of raising funds in our offering as a percentage of gross proceeds received in our primary offering was 10.8% as of December 31, 2011 and will not exceed 11.0% in the aggregate.
As of December 31, 2011, net offering proceeds were $436,535,000, including proceeds from the DRIP and after deducting offering expenses.
As of December 31, 2011, $527,000 remained payable to Grubb & Ellis Capital Corporation, our former advisor or its affiliates for offering related costs.
As of December 31, 2011, we had used $301,864,000 in proceeds from our offering to acquire properties from unaffiliated parties,
$12,116,000 to pay acquisition related expenses to affiliated parties, $2,289,000 for lender required restricted cash accounts to unaffiliated parties, $4,438,000 for deferred financing costs to unaffiliated parties, $5,034,000 to pay acquisition
related expenses to unaffiliated parties, $55,674,000 to repay borrowings from unaffiliated parties incurred in connection with previous acquisitions and $7,550,000 to pay real estate deposits to unaffiliated parties for proposed future
acquisitions.
Purchase of Equity Securities by the Issuer and Affiliated Purchasers
Our share repurchase plan allows for repurchases of shares of our common stock by us when certain criteria are met. Share repurchases
will be made at the sole discretion of our board of directors. All repurchases are subject to a one-year holding period, except for repurchases made in connection with a stockholders death or qualifying disability, as defined in
our share repurchase plan. Funds for the repurchase of shares of our common stock will come exclusively from the cumulative proceeds we receive from the sale of shares of our common stock pursuant to the DRIP.
The prices per share at which we will repurchase shares of our common stock will range, depending on the length of time the stockholder
held such shares, from 92.5% to 100% of the price paid per share to acquire such shares from us. However, if shares of our common stock are to be repurchased in connection with a stockholders death or qualifying disability, the repurchase
price will be no less than 100% of the price paid to acquire the shares of our common stock from us.
65
During the three months ended December 31, 2011, we repurchased shares of our common
stock as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Period
|
|
(a)
Total Number of
Shares Purchased
|
|
|
(b)
Average Price
Paid per Share
|
|
|
(c)
Total Number of Shares
Purchased As Part of
Publicly Announced
Plan
or Program
(1)
|
|
|
(d)
Maximum Approximate
Dollar Value
of Shares that May
Yet Be Purchased
Under
the
Plans or Programs
|
|
|
|
|
|
|
October 1, 2011 to October 31, 2011
|
|
|
51,290
|
|
|
$
|
9.35
|
|
|
|
51,290
|
|
|
|
(2
|
)
|
November 1, 2011 to November 30, 2011
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
(2
|
)
|
December 1, 2011 to December 31, 2011
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
51,290
|
|
|
|
|
|
|
|
51,290
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Our board of directors adopted a share repurchase plan effective August 24, 2009.
|
(2)
|
Subject to funds being available, we will limit the number of shares of our common stock repurchased during any calendar year to 5.0% of the weighted average number of
shares of our common stock outstanding during the prior calendar year; provided however, shares of our common stock subject to a repurchase requested upon the death of a stockholder will not be subject to this cap.
|
Item 6. Selected Financial Data.
The following should be read with Part I, Item 1A. Risk Factors and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations and our accompanying
consolidated financial statements and the notes thereto. Our historical results are not necessarily indicative of results for any future period. We had limited results of operations for the period from January 7, 2009 (Date of Inception)
through December 31, 2009 and for the year ended December 31, 2010, and therefore, our results of operations for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009 are not comparable.
66
The following selected financial data is derived from our consolidated financial statements
in Part IV, Item 15. Exhibits, Financial Statement Schedules that is a part of this Annual Report on Form 10-K.
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
Selected Financial Data
|
|
2011
|
|
|
2010
|
|
|
2009
|
|
|
|
|
|
BALANCE SHEET DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
499,152,000
|
|
|
$
|
203,996,000
|
|
|
$
|
13,809,000
|
|
Mortgage loans payable, net
|
|
$
|
80,466,000
|
|
|
$
|
58,331,000
|
|
|
$
|
|
|
Lines of credit
|
|
$
|
|
|
|
$
|
11,800,000
|
|
|
$
|
|
|
Stockholders' equity
|
|
$
|
397,357,000
|
|
|
$
|
125,240,000
|
|
|
$
|
13,283,000
|
|
|
|
|
|
|
Years Ended
December
31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
STATEMENT OF OPERATIONS DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
40,457,000
|
|
|
$
|
8,682,000
|
|
|
$
|
|
|
Loss from continuing operations
|
|
$
|
(5,774,000
|
)
|
|
$
|
(7,423,000
|
)
|
|
$
|
(282,000
|
)
|
Net loss attributable to controlling interest
|
|
$
|
(5,776,000
|
)
|
|
$
|
(7,424,000
|
)
|
|
$
|
(281,000
|
)
|
Net loss per common share basic and diluted(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from continuing operations
|
|
$
|
(0.19
|
)
|
|
$
|
(0.99
|
)
|
|
$
|
(1.51
|
)
|
Net loss attributable to controlling interest
|
|
$
|
(0.19
|
)
|
|
$
|
(0.99
|
)
|
|
$
|
(1.51
|
)
|
|
|
|
|
STATEMENT OF CASH FLOWS DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
$
|
9,264,000
|
|
|
$
|
(2,881,000
|
)
|
|
$
|
(40,000
|
)
|
Net cash used in investing activities
|
|
$
|
(223,689,000
|
)
|
|
$
|
(186,342,000
|
)
|
|
$
|
|
|
Net cash provided by financing activities
|
|
$
|
253,089,000
|
|
|
$
|
181,468,000
|
|
|
$
|
13,813,000
|
|
|
|
|
|
OTHER DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions declared
|
|
$
|
20,037,000
|
|
|
$
|
4,866,000
|
|
|
$
|
|
|
Distributions declared per share
|
|
$
|
0.65
|
|
|
$
|
0.65
|
|
|
$
|
|
|
Funds from operations(2)
|
|
$
|
9,040,000
|
|
|
$
|
(3,837,000
|
)
|
|
$
|
(281,000
|
)
|
Modified funds from operations(2)
|
|
$
|
17,577,000
|
|
|
$
|
2,909,000
|
|
|
$
|
(263,000
|
)
|
Net operating income(3)
|
|
$
|
32,127,000
|
|
|
$
|
6,481,000
|
|
|
$
|
|
|
(1)
|
Net loss per common share is based upon the weighted average number of shares of our common stock outstanding. Distributions by us of our current and accumulated
earnings and profits for federal income tax purposes are taxable to stockholders as ordinary income. Distributions in excess of these earnings and profits generally are treated as a non-taxable reduction of the stockholders basis in the shares
of our common stock to the extent thereof (a return of capital for tax purposes) and, thereafter, as taxable gain. These distributions in excess of earnings and profits will have the effect of deferring taxation of the distributions until the sale
of the stockholders common stock.
|
(2)
|
Funds from Operations and Modified Funds from Operations:
|
Due to certain unique operating characteristics of real estate companies, the National Association of Real Estate Investment Trusts, or NAREIT, an industry trade group, has promulgated a measure known as
FFO, which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. The use of FFO is recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to our net income (loss)
as determined under GAAP.
67
We define FFO, a non-GAAP measure, consistent with the standards established by the White
Paper on FFO approved by the Board of Governors of NAREIT, as revised in February 2004, or the White Paper. The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from sales of property and asset
impairment writedowns, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO. Our FFO calculation
complies with NAREITs policy described above.
The historical accounting convention used for real estate assets requires
straight-line depreciation of buildings and improvements, which implies that the value of real estate assets diminishes predictably over time, which is the case if such assets are not adequately maintained or repaired and renovated as required by
relevant circumstances and/or as requested or required by lessees for operational purposes in order to maintain the value disclosed. We believe that, since real estate values historically rise and fall with market conditions, including inflation,
interest rates, the business cycle, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation may be less informative. In addition, we believe it is appropriate to disregard
impairment charges, as this is a fair value adjustment that is largely based on market fluctuations and assessments regarding general market conditions which can change over time. An asset will only be evaluated for impairment if certain impairment
indications exist, and if the carrying, or book value, exceeds the total estimated undiscounted future cash flows (including net rental and lease revenues, net proceeds on the sale of the property, and any other ancillary cash flows at a property or
group level under GAAP) from such asset an impairment charge would be recognized. Testing for impairment charges is a continuous process and is analyzed on a quarterly basis. Investors should note, however, that determinations of whether impairment
charges have been incurred are based partly on anticipated operating performance, because estimated undiscounted future cash flows from a property, including estimated future net rental and lease revenues, net proceeds on the sale of the property,
and certain other ancillary cash flows, are taken into account in determining whether an impairment charge has been incurred. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that due to
the fact that impairments are based on estimated future undiscounted cash flows and that we intend to have a relatively limited term of our operations, it could be difficult to recover any impairment charges through the eventual sale of the
property.
Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such
as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related
depreciation and amortization and impairments, provides a more complete understanding of our performance to investors and to our management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates,
rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income (loss).
However, FFO and modified funds from operations, or MFFO, as described below, should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income (loss) or
in its applicability in evaluating our operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more
prominently than the non-GAAP FFO and MFFO measures and the adjustments to GAAP in calculating FFO and MFFO.
Changes in the
accounting and reporting rules under GAAP that were put into effect and other changes to GAAP accounting for real estate subsequent to the establishment of NAREITs definition of FFO have prompted an increase in cash-settled expenses,
specifically acquisition fees and expenses, as items that are expensed as operating expenses under GAAP. We believe these fees and expenses do not affect our overall long-term operating performance. Publicly registered, non-listed REITs typically
have a significant amount of acquisition activity and are substantially more dynamic during their initial years of investment and operation. While other start up entities may also experience significant acquisition activity during their initial
years, we believe that publicly registered, non-listed REITs are unique in that they have a limited life with targeted exit strategies within a relatively limited time frame after the acquisition activity ceases. As disclosed in the prospectus for
our offering, we will use the proceeds raised in our offering to acquire properties, and we intend to begin the process of achieving a liquidity event (
i.e.
, listing of our shares of common stock on a national securities exchange, a merger or
sale, the sale of all or substantially all of our assets, or another similar
68
transaction) within five years after the completion of our offering stage, which is generally comparable to other publicly registered, non-traded REITs. Thus, we do not intend to continuously
purchase assets and intend to have a limited life. Due to the above factors and other unique features of publicly registered, non-listed REITs, the Investment Program Association, or the IPA, an industry trade group, has standardized a measure known
as MFFO, which the IPA has recommended as a supplemental measure for publicly registered, non-listed REITs and which we believe to be another appropriate supplemental measure to reflect the operating performance of a publicly registered, non-listed
REIT having the characteristics described above. MFFO is not equivalent to our net income (loss) as determined under GAAP, and MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to
operate with a limited life and targeted exit strategy, as currently intended. We believe that, because MFFO excludes acquisition fees and expenses that affect our operations only in periods in which properties are acquired and that we consider more
reflective of investing activities, as well as other non-operating items included in FFO, MFFO can provide, on a going forward basis, an indication of the sustainability (that is, the capacity to continue to be maintained) of our operating
performance after the period in which we are acquiring our properties and once our portfolio is in place. By providing MFFO, we believe we are presenting useful information that assists investors and analysts to better assess the sustainability of
our operating performance after our offering has been completed and our properties have been acquired. We also believe that MFFO is a recognized measure of sustainable operating performance by the publicly registered, non-listed REIT industry.
Further, we believe MFFO is useful in comparing the sustainability of our operating performance after our offering and acquisitions are completed with the sustainability of the operating performance of other real estate companies that are not as
involved in acquisition activities. Investors are cautioned that MFFO should only be used to assess the sustainability of our operating performance after our offering has been completed and properties have been acquired, as it excludes acquisition
fees and expenses that have a negative effect on our operating performance during the periods in which properties are acquired.
We define MFFO, a non-GAAP measure, consistent with the IPAs Guideline 2010-01, Supplemental Performance Measure for Publicly
Registered, Non-Listed REITs: Modified Funds from Operations, or the Practice Guideline, issued by the IPA in November 2010. The Practice Guideline defines MFFO as FFO further adjusted for the following items included in the determination of GAAP
net income (loss): acquisition fees and expenses; amounts relating to deferred rent receivables and amortization of above and below market leases and liabilities (which are adjusted in order to reflect such payments from a GAAP accrual basis to
closer to an expected to be received cash basis of disclosing the rent and lease payments); accretion of discounts and amortization of premiums on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included
in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan, unrealized gains or losses resulting from
consolidation from, or deconsolidation to, equity accounting, and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect MFFO on the same basis. The accretion of discounts
and amortization of premiums on debt investments, unrealized gains and losses on hedges, foreign exchange, derivatives or securities holdings, unrealized gains and losses resulting from consolidations, as well as other listed cash flow adjustments
are adjustments made to net income (loss) in calculating cash flows from operations and, in some cases, reflect gains or losses which are unrealized and may not ultimately be realized. We are responsible for managing interest rate, hedge and foreign
exchange risk, and we do not rely on another party to manage such risk. Inasmuch as interest rate hedges are not a fundamental part of our operations, we believe it is appropriate to exclude such gains and losses in calculating MFFO, as such gains
and losses are based on market fluctuations and may not be directly related or attributable to our operations.
Our MFFO
calculation complies with the IPAs Practice Guideline described above. In calculating MFFO, we exclude acquisition related expenses, amortization of above and below market leases, fair value adjustments of derivative financial instruments,
gains or losses from the extinguishment of debt, change in deferred rent receivables and the adjustments of such items related to noncontrolling interests. The other adjustments included in the IPAs Practice Guideline are not applicable to us
for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009. Acquisition fees and expenses are paid in cash by us, and we have not set aside or put into escrow
any specific amount of proceeds from our offering to be used to fund acquisition fees and expenses. We do not intend to fund
69
acquisition fees and expenses in the future from operating revenues and cash flows, nor from the sale of properties and subsequent re-deployment of capital and concurrent incurring of acquisition
fees and expenses. Acquisition fees and expenses include payments to our former advisor, our advisor entities or their affiliates and third parties. Acquisition related expenses under GAAP are considered operating expenses and as expenses included
in the determination of net income (loss) and income (loss) from continuing operations, both of which are performance measures under GAAP. All paid and accrued acquisition fees and expenses will have negative effects on returns to investors, the
potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property, these fees and expenses and
other costs related to such property. In the future, if we are not able to raise additional proceeds from our offering, this could result in us paying acquisition fees or reimbursing acquisition expenses due to our former advisor, our advisor
entities and their affiliates, or a portion thereof, with net proceeds from borrowed funds, operational earnings or cash flows, net proceeds from the sale of properties, or ancillary cash flows. As a result, the amount of proceeds available for
investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds. Nevertheless, our former advisor, our advisor entities or their affiliates will not accrue any claim on our assets if acquisition
fees and expenses are not paid from the proceeds of our offering.
Further, under GAAP, certain contemplated non-cash fair
value and other non-cash adjustments are considered operating non-cash adjustments to net income (loss) in determining cash flows from operations. In addition, we view fair value adjustments of derivatives and gains and losses from dispositions of
assets as items which are unrealized and may not ultimately be realized or as items which are not reflective of on-going operations and are therefore typically adjusted for when assessing operating performance.
We use MFFO and the adjustments used to calculate it in order to evaluate our performance against other publicly registered, non-listed
REITs which intend to have limited lives with short and defined acquisition periods and targeted exit strategies shortly thereafter. As noted above, MFFO may not be a useful measure of the impact of long-term operating performance if we do not
continue to operate in this manner. We believe that our use of MFFO and the adjustments used to calculate it allow us to present our performance in a manner that reflects certain characteristics that are unique to publicly registered, non-listed
REITs, such as their limited life, limited and defined acquisition period and targeted exit strategy, and hence that the use of such measures may be useful to investors. For example, acquisition fees and expenses are intended to be funded from the
proceeds of our offering and other financing sources and not from operations. By excluding expensed acquisition fees and expenses, the use of MFFO provides information consistent with managements analysis of the operating performance of the
properties. Additionally, fair value adjustments, which are based on the impact of current market fluctuations and underlying assessments of general market conditions, but can also result from operational factors such as rental and occupancy rates,
may not be directly related or attributable to our current operating performance. By excluding such charges that may reflect anticipated and unrealized gains or losses, we believe MFFO provides useful supplemental information.
Presentation of this information is intended to provide useful information to investors as they compare the operating performance of
different REITs, although it should be noted that not all REITs calculate FFO and MFFO the same way, so comparisons with other REITs may not be meaningful. Furthermore, FFO and MFFO are not necessarily indicative of cash flow available to fund cash
needs and should not be considered as an alternative to net income (loss) or income (loss) from continuing operations as an indication of our performance, as an alternative to cash flows from operations, which is an indication of our liquidity, or
indicative of funds available to fund our cash needs including our ability to make distributions to our stockholders. FFO and MFFO should be reviewed in conjunction with other measurements as an indication of our performance. MFFO has limitations as
a performance measure in an offering such as ours where the price of a share of common stock is a stated value and there is no net asset value determination during the offering stage and for a period thereafter. MFFO may be useful in assisting
management and investors in assessing the sustainability of operating performance in future operating periods, and in particular, after the offering and acquisition stages are complete and net asset value is disclosed. FFO and MFFO are not useful
measures in evaluating net asset value because impairments are taken into account in determining net asset value but not in determining FFO and MFFO.
70
Neither the SEC, NAREIT nor any other regulatory body has passed judgment on the
acceptability of the adjustments that we use to calculate FFO or MFFO. In the future, the SEC, NAREIT or another regulatory body may decide to standardize the allowable adjustments across the publicly registered, non-listed REIT industry and we
would have to adjust our calculation and characterization of FFO or MFFO.
The following is a reconciliation of net loss,
which is the most directly comparable GAAP financial measure, to FFO and MFFO for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years
Ended
December 31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Net loss
|
|
$
|
(5,774,000
|
)
|
|
$
|
(7,423,000
|
)
|
|
$
|
(282,000
|
)
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization consolidated properties
|
|
|
14,826,000
|
|
|
|
3,591,000
|
|
|
|
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (income) loss attributable to noncontrolling interests
|
|
|
(2,000
|
)
|
|
|
(1,000
|
)
|
|
|
1,000
|
|
Depreciation and amortization related to noncontrolling interests
|
|
|
(10,000
|
)
|
|
|
(4,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FFO
|
|
$
|
9,040,000
|
|
|
$
|
(3,837,000
|
)
|
|
$
|
(281,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition related expenses(a)
|
|
$
|
10,389,000
|
|
|
$
|
7,099,000
|
|
|
$
|
18,000
|
|
Amortization of above and below market leases(b)
|
|
|
298,000
|
|
|
|
79,000
|
|
|
|
|
|
Loss in fair value of derivative financial instruments(c)
|
|
|
366,000
|
|
|
|
143,000
|
|
|
|
|
|
|
|
|
|
Loss on extinguishment of debt(d)
|
|
|
44,000
|
|
|
|
|
|
|
|
|
|
Change in deferred rent receivables related to noncontrolling interests(e)
|
|
|
2,000
|
|
|
|
1,000
|
|
|
|
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in deferred rent receivables(e)
|
|
|
(2,562,000
|
)
|
|
|
(576,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MFFO
|
|
$
|
17,577,000
|
|
|
$
|
2,909,000
|
|
|
$
|
(263,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding basic and diluted
|
|
|
30,808,725
|
|
|
|
7,471,184
|
|
|
|
186,330
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share basic and diluted
|
|
$
|
(0.19
|
)
|
|
$
|
(0.99
|
)
|
|
$
|
(1.51
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FFO per common share basic and diluted
|
|
$
|
0.29
|
|
|
$
|
(0.51
|
)
|
|
$
|
(1.51
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MFFO per common share basic and diluted
|
|
$
|
0.57
|
|
|
$
|
0.39
|
|
|
$
|
(1.41
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
In evaluating investments in real estate, we differentiate the costs to acquire the investment from the operations derived from the investment. Such information would
be comparable only for publicly registered, non-listed REITs that have completed their acquisition activity and have other similar operating characteristics. By excluding expensed acquisition related expenses, we believe MFFO provides useful
supplemental information that is comparable for each type of real estate investment and is consistent with managements analysis of the investing and operating performance of our properties. Acquisition fees and expenses include payments to our
former advisor, our advisor entities or their affiliates and third parties. Acquisition related expenses under GAAP are considered operating expenses and as expenses included in the determination of net income (loss) and income (loss) from
continuing operations, both of which are performance measures under GAAP. All paid and accrued acquisition fees and expenses will have negative effects on returns to investors, the potential for future distributions, and cash flows generated by us,
unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property, these fees and expenses and other costs related to such property.
|
71
|
(b)
|
Under GAAP, above and below market leases are assumed to diminish predictably in value over time and amortized, similar to depreciation and amortization of other real
estate related assets that are excluded from FFO. However, because real estate values and market lease rates historically rise or fall with market conditions, including inflation, interest rates, the business cycle, unemployment and consumer
spending, we believe that by excluding charges relating to the amortization of above and below market leases, MFFO may provide useful supplemental information on the performance of the real estate.
|
|
(c)
|
Under GAAP, we are required to record our derivative financial instruments at fair value at each reporting period. We believe that adjusting for the change in fair
value of our derivative financial instruments is appropriate because such adjustments may not be reflective of on-going operations and reflect unrealized impacts on value based only on then current market conditions, although they may be based upon
general market conditions. The need to reflect the change in fair value of our derivative financial instruments is a continuous process and is analyzed on a quarterly basis in accordance with GAAP.
|
|
(d)
|
We believe that adjusting for the gain or loss on extinguishment of debt provides useful information because such gain or loss on extinguishment of debt may not be
reflective of on-going operations.
|
|
(e)
|
Under GAAP, rental revenue is recognized on a straight-line basis over the terms of the related lease (including rent holidays). This may result in income recognition
that is significantly different than the underlying contract terms. By adjusting for the change in deferred rent receivables, MFFO may provide useful supplemental information on the realized economic impact of lease terms, providing insight on the
expected contractual cash flows of such lease terms, and aligns results with our analysis of operating performance.
|
(3)
|
Net Operating Income:
|
Net
operating income is a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, acquisition related expenses, depreciation and
amortization, interest expense and interest income. We believe that net operating income is useful for investors as it provides an accurate measure of the operating performance of our operating assets because net operating income excludes certain
items that are not associated with the management of the properties. Additionally, we believe that net operating income is a widely accepted measure of comparative operating performance in the real estate community. However, our use of the term net
operating income may not be comparable to that of other real estate companies as they may have different methodologies for computing this amount.
72
The following is a reconciliation of net loss, which is the most directly comparable GAAP
financial measure, to net operating income for the year ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years
Ended
December 31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Net loss
|
|
$
|
(5,774,000
|
)
|
|
$
|
(7,423,000
|
)
|
|
$
|
(282,000
|
)
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
5,992,000
|
|
|
|
1,670,000
|
|
|
|
268,000
|
|
Acquisition related expenses
|
|
|
10,389,000
|
|
|
|
7,099,000
|
|
|
|
18,000
|
|
Depreciation and amortization
|
|
|
14,826,000
|
|
|
|
3,591,000
|
|
|
|
|
|
Interest expense
|
|
|
6,711,000
|
|
|
|
1,559,000
|
|
|
|
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
(17,000
|
)
|
|
|
(15,000
|
)
|
|
|
(4,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating income
|
|
$
|
32,127,000
|
|
|
$
|
6,481,000
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73
Item 7. Managements Discussion and Analysis of Financial Condition
and Results of Operations.
The use of the words we, us or our refers to
Griffin-American Healthcare REIT II, Inc. and its subsidiaries, including Griffin-American Healthcare REIT II Holdings, LP, except where the context otherwise requires.
The following discussion should be read in conjunction with our accompanying consolidated financial statements and notes thereto appearing elsewhere in this Annual Report on Form 10-K. Such consolidated
financial statements and information have been prepared to reflect our financial position as of December 31, 2011 and 2010, together with our results of operations for the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009 and cash flows for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009.
Forward-Looking Statements
Historical results and trends should not be taken as indicative of future operations. Our statements contained in this report that are not historical facts are forward-looking. Actual results may differ
materially from those included in the forward-looking statements. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies and expectations, are generally identifiable by use of the words
expect, project, may, will, should, could, would, intend, plan, anticipate, estimate, believe,
continue, predict, potential or the negative of such terms and other comparable terminology. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which
could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions generally and the real estate market specifically; legislative and regulatory
changes, including changes to laws governing the taxation of real estate investment trusts, or REITs; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in
our proposed market areas; changes in accounting principles generally accepted in the United States of America, or GAAP, policies and guidelines applicable to REITs; the success of our best efforts initial public offering; the availability of
properties to acquire; the availability of financing; and our ongoing relationship with American Healthcare Investors LLC, or American Healthcare Investors, and Griffin Capital Corporation, or Griffin Capital, or our co-sponsors, and their
affiliates. These risks and uncertainties should be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. Additional information concerning us and our business, including additional factors
that could materially affect our financial results, is included herein and in our other filings with the United States Securities and Exchange Commission, or SEC.
Overview and Background
Griffin-American Healthcare REIT II, Inc., a
Maryland corporation, was incorporated as Grubb & Ellis Healthcare REIT II, Inc. on January 7, 2009 and therefore we consider that our date of inception. We were initially capitalized on February 4, 2009. Our board of directors
adopted an amendment to our charter, which was filed with the Maryland State Department of Assessments and Taxation on January 3, 2012, to change our corporate name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American
Healthcare REIT II, Inc. We intend to invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We may also originate and acquire secured loans and real
estate-related investments. We generally seek investments that produce current income. We qualified to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, or the Code, for federal income tax purposes beginning with our taxable
year ended December 31, 2010 and we intend to continue to be taxed as a REIT.
We are conducting a best efforts initial
public offering, or our offering, in which we are offering to the public up to 300,000,000 shares of our common stock for $10.00 per share in our primary offering and 30,000,000 shares of our common stock pursuant to our distribution reinvestment
plan, or the DRIP, for $9.50 per share, for a maximum offering of up to $3,285,000,000. The SEC declared our registration statement effective as of August 24, 2009. We will sell shares of our common stock in our offering until the earlier of
August 24, 2012, or the date on which the maximum offering amount has been sold; provided, however, that our board of directors may extend our offering as permitted under applicable law, or we may extend our offering with respect to shares of
our common stock offered pursuant to the DRIP. However, we reserve the right to terminate our offering at any time prior to such termination date. As of December 31, 2011, we had received and accepted subscriptions in our offering for
47,831,458 shares of our common stock, or $477,306,000, excluding shares of our common stock issued pursuant to the DRIP.
74
We conduct substantially all of our operations through Griffin-American Healthcare REIT II
Holdings, LP, or our operating partnership. On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with the Delaware Department of State to change its name from Grubb & Ellis
Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP. Until January 6, 2012, we were externally advised by Grubb & Ellis Healthcare REIT II Advisor, LLC, or our former advisor, pursuant to an advisory
agreement, as amended and restated, or the G&E Advisory Agreement, between us and our former advisor. From August 24, 2009 through January 6, 2012, our former advisor supervised and managed our day-to-day operations and selected the
properties and real estate-related investments we acquired, subject to the oversight and approval of our board of directors. Our former advisor also provided marketing, sales and client services on our behalf and engaged affiliated entities to
provide various services to us. Our former advisor is managed by and is a wholly owned subsidiary of Grubb & Ellis Equity Advisors, LLC, or GEEA, which is a wholly owned subsidiary of Grubb & Ellis Company, or Grubb &
Ellis, or our former sponsor.
On November 7, 2011, our independent directors determined that it is in the best interests
of our company and its stockholders to transition advisory and dealer manager services rendered to us by affiliates of Grubb & Ellis and to engage American Healthcare Investors and Griffin Capital as replacement co-sponsors. As a result, on
November 7, 2011, we notified our former advisor that we terminated the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty; however,
certain rights and obligations of the parties would survive during a 60-day transition period and beyond.
In addition, on
November 7, 2011, we notified Grubb & Ellis Capital Corporation that we terminated the dealer manager agreement dated June 1, 2011 between us and Grubb & Ellis Capital Corporation, or the G&E Dealer Manager Agreement,
in accordance with the terms thereof. Until January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
As a result of the co-sponsorship arrangement, an affiliate of Griffin Capital, Griffin-American Healthcare REIT Advisor, LLC, or
Griffin-American Advisor, or our advisor, serves as our new advisor and delegates advisory duties to Griffin-American Healthcare REIT Sub-Advisor, LLC, or Griffin-American Sub-Advisor, or our sub-advisor. Griffin-American Sub-Advisor is jointly
owned by our co-sponsors. Our advisor, through our sub-advisor, uses its best efforts, subject to the oversight, review and approval of our board of directors, to, among other things, research, identify, review and make investments in and
dispositions of properties and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under an advisory agreement, or the Advisory Agreement, as our fiduciary. Our
sub-advisor performs its duties and responsibilities pursuant to a sub-advisory agreement with our advisor and also acts as our fiduciary. Collectively, we refer to our advisor and our sub-advisor as our advisor entities. Griffin Capital Securities,
Inc., or Griffin Securities, or our dealer manager, an affiliate of Griffin Capital, serves as our new dealer manager pursuant to a dealer manager agreement, or the Dealer Manager Agreement. We are not affiliated with Griffin Capital,
Griffin-American Advisor or Griffin Securities; however, we are affiliated with Griffin-American Sub-Advisor and American Healthcare Investors.
American Healthcare Investors and Griffin Capital have agreed to pay the majority of the expenses we have incurred in connection with the transition to our co-sponsors.
The Advisory Agreement with Griffin-American Advisor took effect on January 7, 2012 upon the expiration of the 60-day transition
period provided for in the G&E Advisory Agreement. The Dealer Manager Agreement with Griffin Securities also became effective January 7, 2012.
We currently operate through three reportable business segments medical office buildings, hospitals and skilled nursing facilities. As of December 31, 2011, we had completed 25 acquisitions
comprising 56 buildings and approximately 1,987,000 square feet of gross leasable area, or GLA, for an aggregate purchase price of $438,625,000.
75
Investment Strategy
We intend to use substantially all of the net proceeds from our offering to invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and
healthcare-related facilities. We also may originate or acquire real estate-related investments such as mortgage, mezzanine, bridge and other loans, common and preferred stock of, or other interests in, public or private unaffiliated real estate
companies, commercial mortgage-backed securities, and certain other securities, including collateralized debt obligations and foreign securities. We generally seek investments that produce current income. In order to maintain our exemption from
regulation as an investment company under the Investment Company Act of 1940, as amended, we may be required to limit our investments in certain types of real estate-related investments.
We seek to maximize long-term stockholder value by generating sustainable growth in cash flows and portfolio value. In order to achieve
these objectives, we may invest using a number of investment structures which may include direct acquisitions, joint ventures, leveraged investments, issuing securities for property and direct and indirect investments in real estate.
In addition, when and as determined appropriate by our advisor entities, our portfolio may also include properties in various stages of
development other than those producing current income. These stages would include, without limitation, unimproved land both with and without entitlements and permits, property to be redeveloped and repositioned, newly constructed properties and
properties in lease-up or other stabilization, all of which will have limited or no relevant operating histories and no current income. Our advisor entities make this determination based upon a variety of factors, including the available risk
adjusted returns for such properties when compared with other available properties, the appropriate diversification of the portfolio, and our objectives of realizing both current income and capital appreciation upon the ultimate sale of properties.
For each of our investments, regardless of property type, we seek to invest in properties with the following attributes:
|
|
|
Quality.
We seek to acquire properties that are suitable for their intended use with a quality of construction that is capable of
sustaining the propertys investment potential for the long-term, assuming funding of budgeted maintenance, repairs and capital improvements.
|
|
|
|
Location.
We seek to acquire properties that are located in established or otherwise appropriate markets for comparable properties, with
access and visibility suitable to meet the needs of its occupants.
|
|
|
|
Market; Supply and Demand.
We focus on local or regional markets that have potential for stable and growing property level cash flows over
the long-term. These determinations are based in part on an evaluation of local economic, demographic and regulatory factors affecting the property. For instance, we favor markets that indicate a growing population and employment base or markets
that exhibit potential limitations on additions to supply, such as barriers to new construction. Barriers to new construction include lack of available land and stringent zoning restrictions. In addition, we generally seek to limit our investments
in areas that have limited potential for growth.
|
|
|
|
Predictable Capital Needs.
We seek to acquire properties where the future expected capital needs can be reasonably projected in a manner
that would enable us to meet our objectives of growth in cash flows and preservation of capital and stability.
|
|
|
|
Cash Flows.
We seek to acquire properties where the current and projected cash flows, including the potential for appreciation in value,
would enable us to meet our overall investment objectives. We evaluate cash flows as well as expected growth and the potential for appreciation.
|
We will not invest more than 10.0% of the offering proceeds available for investment in unimproved or non-income producing properties or in other investments relating to unimproved or non-income producing
property. A property will be considered unimproved or non-income producing property for purposes of this limitation if it: (1) is not acquired for the purpose of producing rental or other operating income, or (2) has no development or
construction in process at the date of acquisition or planned in good faith to commence within one year of the date of acquisition.
76
We will not invest more than 10.0% of the offering proceeds available for investment in
commercial mortgage-backed securities. In addition, we will not invest more than 10.0% of the offering proceeds available for investment in equity securities of public or private real estate companies.
We are not limited as to the geographic area where we may acquire properties. We are not specifically limited in the number or size of
properties we may acquire or on the percentage of our assets that we may invest in a single property or investment. The number and mix of properties and real estate-related investments we will acquire will depend upon real estate and market
conditions and other circumstances existing at the time we are acquiring our properties and making our investments, and the amount of proceeds we raise in our offering and potential future offerings.
Critical Accounting Policies
We believe that our critical accounting policies are those that require significant judgments and estimates such as those related to revenue recognition, tenant receivables, allowance for uncollectible
accounts, capitalization of expenditures, depreciation of assets, impairment of real estate, properties held for sale, accounting for property acquisitions, and qualification as a REIT. These estimates are made and evaluated on an on-going basis
using information that is available as well as various other assumptions believed to be reasonable under the circumstances.
Use of
Estimates
The preparation of our consolidated financial statements in conformity with GAAP requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates are made and evaluated on an on-going basis using information
that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under
different assumptions or conditions.
Revenue Recognition, Tenant Receivables and Allowance for Uncollectible Accounts
We recognize revenue in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards
Codification, or ASC, Topic 605,
Revenue Recognition
, or ASC Topic 605. ASC Topic 605 requires that all four of the following basic criteria be met before revenue is realized or realizable and earned: (1) there is persuasive evidence
that an arrangement exists; (2) delivery has occurred or services have been rendered; (3) the sellers price to the buyer is fixed and determinable; and (4) collectability is reasonably assured.
In accordance with ASC Topic 840,
Leases
, minimum annual rental revenue will be recognized on a straight-line basis over the term
of the related lease (including rent holidays). Differences between rental income recognized and amounts contractually due under the lease agreements are credited or charged, as applicable, to deferred rent receivable or deferred rent liability, as
applicable. Tenant reimbursement revenue, which is comprised of additional amounts recoverable from tenants for common area maintenance expenses and certain other recoverable expenses, is recognized as revenue in the period in which the related
expenses are incurred. Tenant reimbursements are recognized and presented in accordance with ASC Subtopic 605-45,
Revenue Recognition Principal Agent Consideration
, or ASC Subtopic 605-45. ASC Subtopic 605-45 requires that these
reimbursements be recorded on a gross basis, as we are generally the primary obligor with respect to purchasing goods and services from third-party suppliers, have discretion in selecting the supplier and have credit risk. We recognize lease
termination fees at such time when there is a signed termination letter agreement, all of the conditions of the agreement have been met and the tenant is no longer occupying the property.
77
Tenant receivables and unbilled deferred rent receivables are carried net of an allowance
for uncollectible amounts. An allowance is maintained for estimated losses resulting from the inability of certain tenants to meet the contractual obligations under their lease agreements. We maintain an allowance for deferred rent receivables
arising from the straight line recognition of rents. Such allowance is charged to bad debt expense which is included in general and administrative in our accompanying consolidated statements of operations. Our determination of the adequacy of these
allowances is based primarily upon evaluations of historical loss experience, the tenants financial condition, security deposits, letters of credit, lease guarantees and current economic conditions and other relevant factors.
Capitalization of Expenditures and Depreciation of Assets
The cost of operating properties includes the cost of land and completed buildings and related improvements. Expenditures that increase the service life of properties are capitalized and the cost of
maintenance and repairs is charged to expense as incurred. The cost of building and improvements is depreciated on a straight-line basis over the estimated useful lives. The cost of improvements is depreciated on a straight-line basis over the
shorter of the lease term or useful life. Furniture, fixtures and equipment, if any, is depreciated over the estimated useful lives. When depreciable property is retired or disposed of, the related costs and accumulated depreciation is removed from
the accounts and any gain or loss is reflected in operations.
As part of the leasing process, we may provide the lessee with
an allowance for the construction of leasehold improvements. These leasehold improvements are capitalized and recorded as tenant improvements, and depreciated over the shorter of the useful life of the improvements or the lease term. If the
allowance represents a payment for a purpose other than funding leasehold improvements, or in the event we are not considered the owner of the improvements, the allowance is considered to be a lease inducement and is recognized over the lease term
as a reduction of rental revenue on a straight-line basis. Factors considered during this evaluation include, among other things, who holds legal title to the improvements as well as other controlling rights provided by the lease agreement and
provisions for substantiation of such costs (e.g. unilateral control of the tenant space during the build-out process). Determination of the appropriate accounting for the payment of a tenant allowance is made on a lease-by-lease basis, considering
the facts and circumstances of the individual tenant lease. Recognition of lease revenue commences when the lessee is given possession of the leased space upon completion of tenant improvements when we are the owner of the leasehold improvements.
However, when the leasehold improvements are owned by the tenant, the lease inception date (and the date on which recognition of lease revenue commences) is the date the tenant obtains possession of the leased space for purposes of constructing its
leasehold improvements.
Impairment
We carry our operating properties at historical cost less accumulated depreciation. We assess the impairment of an operating property when events or changes in circumstances indicate that its carrying
value may not be recoverable. Indicators we consider important and that we believe could trigger an impairment review include, among others, the following:
|
|
|
significant negative industry or economic trends;
|
|
|
|
a significant underperformance relative to historical or projected future operating results; and
|
|
|
|
a significant change in the extent or manner in which the asset is used or significant physical change in the asset.
|
In the event that the carrying amount of an operating property exceeds the sum of the future undiscounted cash flows expected to result
from the use and eventual disposition of the property, we would recognize an impairment loss to the extent the carrying amount exceeded the estimated fair value of the property. The estimation of expected future net cash flows is inherently
uncertain and relies on subjective assumptions dependent upon future and current market conditions and events that affect the ultimate value of the property. It requires us to make assumptions related to discount rates, future rental rates, tenant
allowances, operating expenditures, property taxes, capital improvements, occupancy levels and the estimated proceeds generated from the future sale of the property.
78
Properties Held for Sale
We will account for our properties held for sale in accordance with ASC Topic 360
, Property, Plant, and Equipment,
or ASC Topic
360, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets and requires that, in a period in which a component of an entity either has been disposed of or is classified as held for sale, the income
statements for current and prior periods shall report the results of operations of the component as discontinued operations.
In accordance with ASC Topic 360
,
at such time as a property is held for sale, such property is carried at the lower of
(1) its carrying amount or (2) fair value less costs to sell. In addition, a property being held for sale ceases to be depreciated. We will classify operating properties as property held for sale in the period in which all of the following
criteria are met:
|
|
|
management, having the authority to approve the action, commits to a plan to sell the asset;
|
|
|
|
the asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;
|
|
|
|
an active program to locate a buyer and other actions required to complete the plan to sell the asset has been initiated;
|
|
|
|
the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year;
|
|
|
|
the asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and
|
|
|
|
given the actions required to complete the plan to sell the asset, it is unlikely that significant changes to the plan would be made or that the plan
would be withdrawn.
|
Accounting for Property Acquisitions
In accordance with ASC Topic 805,
Business Combinations
, we, with assistance from independent valuation specialists, measure the
fair value of tangible and identified intangible assets and liabilities based on their respective fair values for acquired properties. The determination of the fair value of land is based upon comparable sales data. In cases where a leasehold
interest in the land is acquired, the value of the leasehold interest is determined by discounting the difference between the contract ground lease payments and a market ground lease payment back to a present value as of the acquisition date. The
market ground lease payment is estimated as a percentage of the land value. The fair value of buildings is based upon our determination of the value as if it were to be replaced and vacant using cost data and discounted cash flow models similar to
those used by independent appraisers. We would also recognize the fair value of furniture, fixtures and equipment on the premises, if any, as well as the above or below market value of in-place leases, the value of in-place lease costs, tenant
relationships, master leases and above or below market debt and derivative financial instruments assumed. Factors considered by us include an estimate of carrying costs during the expected lease-up periods considering current market conditions and
costs to execute similar leases.
The value of the above or below market component of the acquired in-place leases is
determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference between: (1) the contractual amounts to be paid pursuant to the lease over its remaining term and
(2) our estimate of the amounts that would be paid using fair market rates over the remaining term of the lease (including considering the impact of renewal options). The amounts related to above market leases are included in identified
intangible assets, net in our accompanying consolidated balance sheets and are amortized to rental income over the remaining non-cancelable lease term of the acquired leases with each property. The amounts related to below market leases are included
in identified intangible liabilities, net in our accompanying consolidated balance sheets and are amortized to rental income over the remaining non-cancelable lease term plus any below market renewal options of the acquired leases with each
property.
79
The value of in-place lease costs and the value of tenant relationships is based on
managements evaluation of the specific characteristics of the tenants lease and our overall relationship with the tenants. Characteristics considered by us in allocating these values include the nature and extent of the credit quality
and expectations of lease renewals, among other factors. The amounts related to in-place lease costs are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized to depreciation and amortization
expense over the average remaining non-cancelable lease term of the acquired leases with each property. The amounts related to the value of tenant relationships are included in identified intangible assets, net in our accompanying consolidated
balance sheets and are amortized to depreciation and amortization expense over the average remaining non-cancelable lease term of the acquired leases plus the market renewal lease term. The value of a master lease, in which a previous owner or a
tenant is relieved of specific rental obligations as additional space is leased, is determined by discounting the expected rental income associated with the master lease space over the assumed lease-up period.
The value of above or below market debt is determined based upon the present value of the difference between the cash flow stream of the
assumed mortgage and the cash flow stream of a market rate mortgage at the time of assumption. The value of above or below market debt is included in mortgage loans payable, net in our accompanying consolidated balance sheets and is amortized to
interest expense over the remaining term of the assumed mortgage.
The value of derivative financial instruments is determined
in accordance with ASC Topic 820,
Fair Value Measurements and Disclosures
, or ASC Topic 820, and is included in derivative financial instruments in our accompanying consolidated balance sheets.
The values of contingent consideration assets and liabilities are analyzed at the time of acquisition. For contingent purchase options,
the fair market value of the asset is compared to the specified option price at the exercise date. If the option price is below market, it is assumed to be exercised and the difference between the fair market value and the option price is
discounted to the present value at the time of acquisition.
The fair values are subject to change based on information
received within one year of the purchase related to one or more events identified at the time of purchase which confirm the value of an asset or liability received in an acquisition of property.
Qualification as a REIT
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31, 2010. To maintain our qualification as a REIT, we must meet certain organizational and
operational requirements, including a requirement to currently distribute at least 90.0% of our annual taxable income, excluding net capital gains, to stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income
that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we will then
be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost
unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could have a material adverse effect on our net income and net cash available for distribution to our stockholders. Because of our election of
REIT status for 2010, we did not benefit from the loss incurred for the year ended December 31, 2009.
Recently Issued Accounting
Pronouncements
For a discussion of recently issued accounting pronouncements, see Note 2, Summary of Significant
Accounting Policies Recently Issued Accounting Pronouncements, to our accompanying Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
80
Acquisitions in 2012, 2011 and 2010
For a discussion of acquisitions in 2012, 2011 and 2010, see Note 3, Real Estate Investments, and Note 21, Subsequent Events
Property Acquisitions, to our accompanying Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Factors
Which May Influence Results of Operations
We are not aware of any material trends or uncertainties, other than national
economic conditions affecting real estate generally, that may reasonably be expected to have a material impact, favorable or unfavorable, on revenues or income from the acquisition, management and operation of properties other than those listed in
Part I, Item 1A. Risk Factors, of this Annual Report on Form 10-K.
Rental Income
The amount of rental income generated by our properties depends principally on our ability to maintain the occupancy rates of currently
leased space and to lease currently available space and space available from lease terminations at the then existing rental rates. Negative trends in one or more of these factors could adversely affect our rental income in future periods.
Offering Proceeds
If we fail to raise substantially more proceeds from the sale of shares of our common stock in our offering than the amount we have raised to date, we will have limited diversification in terms of the
number of investments owned, the geographic regions in which our investments are located and the types of investments that we make. As a result, our real estate portfolio would be concentrated in a small number of properties, which would increase
exposure to local and regional economic downturns and the poor performance of one or more of our properties, whereby our stockholders would be exposed to increased risk. In addition, many of our expenses are fixed regardless of the size of our real
estate portfolio. Therefore, depending on the amount of proceeds we raise from our offering, we would expend a larger portion of our income on operating expenses. This would reduce our profitability and, in turn, the amount of net income available
for distribution to our stockholders.
Scheduled Lease Expirations
As of December 31, 2011, our consolidated properties were 96.1% occupied. During 2012, 3.3% of the occupied GLA is scheduled to
expire. Our leasing strategy focuses on negotiating renewals for leases scheduled to expire during the remainder of the year. In the future, if we are unable to negotiate renewals, we will try to identify new tenants or collaborate with existing
tenants who are seeking additional space to occupy.
As of December 31, 2011, our remaining weighted average lease term
is 9.7 years.
Sarbanes-Oxley Act
The Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, and related laws, regulations and standards relating to corporate governance and disclosure requirements applicable to public
companies have increased the costs of compliance with corporate governance, reporting and disclosure practices. These costs may have a material adverse effect on our results of operations and could impact our ability to pay distributions at current
rates to our stockholders. Furthermore, we expect that these costs will increase in the future due to our continuing implementation of compliance programs mandated by these requirements. Any increased costs may affect our ability to distribute funds
to our stockholders. As part of our compliance with the Sarbanes-Oxley Act, we have provided managements assessment of our internal control over financial reporting as of December 31, 2011 and will continue to comply with such
regulations.
In addition, these laws, rules and regulations create new legal bases for potential administrative enforcement,
civil and criminal proceedings against us in the event of non-compliance, thereby increasing the risks of liability and potential sanctions against us. We expect that our efforts to comply with these laws and regulations will continue to involve
significant and potentially increasing costs, and that our failure to comply with these laws could result in fees, fines, penalties or administrative remedies against us.
81
Results of Operations
Comparison of the Years Ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009
Our operating results for the years ended December 31, 2011 and 2010 are primarily comprised of income derived from our portfolio of
properties and acquisition related expenses in connection with such acquisitions.
We had limited results of operations for
the period from January 7, 2009 (Date of Inception) through December 31, 2009, and therefore, our results of operations for years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception)
through December 31, 2009 are not comparable. In general, we expect all amounts to increase in the future based on a full year of operations as well as increased activity as we acquire additional real estate investments. Our results of
operations are not indicative of those expected in future periods.
As of December 31, 2011, we operate through three
reportable business segments medical office buildings, hospitals and skilled nursing facilities. With the continued expansion of our portfolio, we believe segregation of our operations into three reporting segments would be useful in
assessing the performance of our business in the same way that management intends to review our performance and make operating decisions. Prior to 2011, we operated through one reportable segment.
Except where otherwise noted, the change in our results of operations is primarily due to our 25 acquisitions as of December 31,
2011, as compared to 14 acquisitions as of December 31, 2010, as compared to not owning any properties as of December 31, 2009. As of December 31, 2011 and 2010, we owned the following types of properties:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
As of December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
Number of
Acquisitions
|
|
|
Aggregate
Purchase Price
|
|
|
Leased
%
|
|
|
Number of
Acquisitions
|
|
|
Aggregate
Purchase Price
|
|
|
Leased
%
|
|
|
|
|
|
|
|
|
Medical office buildings
|
|
|
17
|
|
|
$
|
216,730,000
|
|
|
|
92.9
|
%
|
|
|
10
|
|
|
$
|
95,070,000
|
|
|
|
96.9
|
%
|
Hospitals
|
|
|
4
|
|
|
|
77,895,000
|
|
|
|
100
|
%
|
|
|
3
|
|
|
|
53,372,000
|
|
|
|
100
|
%
|
Skilled nursing facilities
|
|
|
4
|
|
|
|
144,000,000
|
|
|
|
100
|
%
|
|
|
1
|
|
|
|
45,000,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total/Weighted Average
|
|
|
25
|
|
|
$
|
438,625,000
|
|
|
|
96.1
|
%
|
|
|
14
|
|
|
$
|
193,442,000
|
|
|
|
98.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We did not own any properties as of December 31, 2009.
82
Rental Income
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, rental income was $40,457,000, $8,682,000 and $0,
respectively, and was primarily comprised of base rent of $31,506,000, $6,786,000 and $0, respectively, and expense recoveries of $6,175,000, $1,314,000 and $0, respectively.
Rental income by operating segment consisted of the following for the periods then ended:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years
Ended
December 31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Medical office buildings
|
|
$
|
21,479,000
|
|
|
$
|
5,635,000
|
|
|
$
|
|
|
Hospitals
|
|
|
7,651,000
|
|
|
|
1,684,000
|
|
|
|
|
|
Skilled nursing facilities
|
|
|
11,327,000
|
|
|
|
1,363,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
40,457,000
|
|
|
$
|
8,682,000
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental Expenses
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, rental expenses were $8,330,000, $2,201,000 and $0,
respectively. Rental expenses consisted of the following for the periods then ended:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years
Ended
December 31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Real estate taxes
|
|
$
|
3,709,000
|
|
|
$
|
804,000
|
|
|
$
|
|
|
Building maintenance
|
|
|
1,582,000
|
|
|
|
539,000
|
|
|
|
|
|
Utilities
|
|
|
1,361,000
|
|
|
|
427,000
|
|
|
|
|
|
Property management fees
|
|
|
843,000
|
|
|
|
245,000
|
|
|
|
|
|
Administration
|
|
|
319,000
|
|
|
|
105,000
|
|
|
|
|
|
Insurance
|
|
|
180,000
|
|
|
|
41,000
|
|
|
|
|
|
Amortization of leasehold interests
|
|
|
139,000
|
|
|
|
2,000
|
|
|
|
|
|
Other
|
|
|
197,000
|
|
|
|
38,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
8,330,000
|
|
|
$
|
2,201,000
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental expenses and rental expenses as a percentage of revenue by operating segment consisted of the
following for the periods then ended:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
December
31,
|
|
|
Period from
January 7,
2009
(Date of
Inception)
through
December 31, 2009
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
Medical office buildings
|
|
$
|
6,575,000
|
|
|
|
30.6
|
%
|
|
$
|
2,003,000
|
|
|
|
35.5
|
%
|
|
$
|
|
|
|
|
|
%
|
Hospitals
|
|
|
725,000
|
|
|
|
9.5
|
%
|
|
|
119,000
|
|
|
|
7.1
|
%
|
|
|
|
|
|
|
|
%
|
Skilled nursing facilities
|
|
|
1,030,000
|
|
|
|
9.1
|
%
|
|
|
79,000
|
|
|
|
5.8
|
%
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total/weighted average
|
|
$
|
8,330,000
|
|
|
|
20.6
|
%
|
|
$
|
2,201,000
|
|
|
|
25.4
|
%
|
|
$
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Overall, as compared to 2010, the percentage of rental expenses as a percentage of revenue in 2011 is
lower as our portfolio in 2011 contains more hospitals and skilled nursing facilities, which typically have a lower expense to revenue ratio than medical office buildings. We did not own any properties as of December 31, 2009.
83
General and Administrative
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, general and administrative was $5,992,000, $1,670,000 and $268,000, respectively. General and administrative consisted of the following for the periods then ended:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years
Ended
December 31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Asset management fees
|
|
$
|
2,929,000
|
|
|
$
|
612,000
|
|
|
$
|
|
|
Professional and legal fees
|
|
|
1,466,000
|
|
|
|
442,000
|
|
|
|
50,000
|
|
Board of directors fees
|
|
|
377,000
|
|
|
|
163,000
|
|
|
|
55,000
|
|
Bad debt expense
|
|
|
261,000
|
|
|
|
5,000
|
|
|
|
|
|
Transfer agent services
|
|
|
311,000
|
|
|
|
111,000
|
|
|
|
59,000
|
|
Franchise taxes
|
|
|
170,000
|
|
|
|
3,000
|
|
|
|
|
|
Directors and officers liability insurance
|
|
|
164,000
|
|
|
|
177,000
|
|
|
|
64,000
|
|
Bank charges
|
|
|
115,000
|
|
|
|
32,000
|
|
|
|
2,000
|
|
Postage & delivery
|
|
|
99,000
|
|
|
|
38,000
|
|
|
|
|
|
Restricted stock compensation
|
|
|
66,000
|
|
|
|
54,000
|
|
|
|
35,000
|
|
Other
|
|
|
34,000
|
|
|
|
33,000
|
|
|
|
3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,992,000
|
|
|
$
|
1,670,000
|
|
|
$
|
268,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The increase in general and administrative in 2011 as compared to 2010 is primarily the result of
purchasing properties in 2011 and 2010 and thus incurring asset management fees, as well as incurring higher professional and legal fees as a result of our increase in assets.
The increase in general and administrative in 2010 as compared to 2009 is primarily the result of asset management fees incurred due to purchasing properties in 2010, legal and professional fees incurred
in connection with our SEC reporting requirements, where such requirements did not exist until our offering was declared effective on August 24, 2009, and directors and officers liability insurance and board of directors fees for a
full year in 2010 compared to four months in 2009.
Acquisition Related Expenses
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, we incurred acquisition related expenses of $10,389,000, $7,099,000 and $18,000 respectively. For the years ended December 31, 2011 and 2010, acquisition related expenses related primarily to expenses associated with our
11 and 14 acquisitions, respectively, completed during the period, including acquisition fees of $6,739,000 and $5,329,000, respectively, incurred to our former advisor or its affiliates. The increase in acquisition related expenses for the year
ended December 31, 2011 as compared to the year ended December 31, 2010 is due to purchasing $245,183,000 in acquisitions in 2011 as compared to $193,442,000 in acquisitions in 2010. The increase in acquisition related expenses for the
year ended December 31, 2010 as compared to the period from January 7, 2009 (Date of Inception) through December 31, 2009 is due to purchasing $193,442,000 in acquisitions in 2010 as compared to $0 in 2009.
Depreciation and Amortization
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, depreciation and amortization was $14,826,000,
$3,591,000 and $0, respectively, and consisted primarily of depreciation on our operating properties of $9,919,000, $2,070,000 and $0, respectively, and amortization on our identified intangible assets of $4,878,000, $1,520,000 and $0, respectively.
84
Interest Expense
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, interest expense including loss in fair value of
derivative financial instruments was $6,711,000, $1,559,000 and $0, respectively. Interest expense consisted of the following for the periods then ended:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years
Ended
December 31,
|
|
|
Period from
January 7, 2009
(Date of Inception)
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Interest expense mortgage loans payable and derivative financial instruments
|
|
$
|
4,065,000
|
|
|
$
|
942,000
|
|
|
$
|
|
|
Amortization of deferred financing costs mortgage loans payable
|
|
|
606,000
|
|
|
|
120,000
|
|
|
|
|
|
Loss on extinguishment of debt write-off of deferred financing costs and debt premium
|
|
|
44,000
|
|
|
|
|
|
|
|
|
|
Amortization of debt discount and premium
|
|
|
(47,000
|
)
|
|
|
27,000
|
|
|
|
|
|
Interest expense lines of credit
|
|
|
1,016,000
|
|
|
|
222,000
|
|
|
|
|
|
Amortization of deferred financing costs lines of credit
|
|
|
661,000
|
|
|
|
105,000
|
|
|
|
|
|
Loss in fair value of derivative financial instruments
|
|
|
366,000
|
|
|
|
143,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
6,711,000
|
|
|
$
|
1,559,000
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Income
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we had interest income of $17,000, $15,000 and $4,000,
respectively, related to interest earned on funds held in cash accounts.
Liquidity and Capital Resources
We are dependent upon the net proceeds from our offering to provide the capital required to acquire real estate and real estate-related
investments, net of any indebtedness that we may incur. Our ability to raise funds through our offering is dependent on general economic conditions, general market conditions for REITs and our operating performance. The capital required to purchase
real estate and real estate-related investments is obtained primarily from our offering and from any indebtedness that we may incur.
We expect to experience a relative increase in liquidity as additional subscriptions for shares of our common stock are received and a relative decrease in liquidity as net offering proceeds are expended
in connection with the acquisition, management and operation of our real estate and real estate-related investments.
Our
sources of funds will primarily be the net proceeds of our offering, operating cash flows and borrowings. We believe that these cash resources will be sufficient to satisfy our cash requirements for the foreseeable future, and we do not anticipate a
need to raise funds from other sources within the next 12 months. On November 7, 2011, we entered into an agreement with Griffin Capital Securities, Inc., or Griffin Securities, whereby Griffin Securities assumed the role of dealer manager for
the remainder of our offering effective January 7, 2012, after a 60 day transition period following the termination of the G&E Dealer Manager Agreement. However, the soliciting dealer agreements between Grubb & Ellis Capital
Corporation and the participating broker-dealers in our offering were not transferable to Griffin Securities. If Griffin Securities is not able to enter into as many new soliciting dealer agreements with participating broker-dealers that previously
sold our offering, or there is a delay in the execution of soliciting dealer agreements between Griffin Securities and participating broker-dealers, our ability to raise capital in our offering would be adversely affected and could impact our
sources of funds. For a further discussion, see Item 1A. Risk Factors, of this Annual Report on Form 10-K.
Our principal
demands for funds are for acquisitions of real estate and real estate-related investments, to pay operating expenses and interest on our current and future indebtedness and to pay distributions to our stockholders. In addition, we require resources
to make certain payments to our former advisor and its affiliates and our advisor entities and their affiliates, which during our offering includes payments for reimbursement of other organizational and offering expenses, selling commissions and
dealer manager fees.
85
Generally, cash needs for items other than acquisitions of real estate and real
estate-related investments are met from operations, borrowings and the net proceeds of our offering. However, there may be a delay between the sale of shares of our common stock and our investments in real estate and real estate-related investments,
which could result in a delay in the benefits to our stockholders, if any, of returns generated from our investment operations.
Our advisor entities evaluate potential additional investments and engages in negotiations with real estate sellers, developers, brokers,
investment managers, lenders and others on our behalf. Until we invest the majority of the net proceeds of our offering in real estate and real estate-related investments, we may invest in short-term, highly liquid or other authorized investments.
Such short-term investments will not earn significant returns, and we cannot predict how long it will take to fully invest the proceeds from our offering in real estate and real estate-related investments. The number of properties we may acquire and
other investments we will make will depend upon the number of shares of our common stock sold in our offering and the resulting amount of net proceeds available for investment.
When we acquire a property, our advisor entities prepare a capital plan that contemplates the estimated capital needs of that investment.
In addition to operating expenses, capital needs may also include costs of refurbishment, tenant improvements or other major capital expenditures. The capital plan also sets forth the anticipated sources of the necessary capital, which may include a
line of credit or other loans established with respect to the investment, operating cash generated by the investment, additional equity investments from us or joint venture partners or, when necessary, capital reserves. Any capital reserve would be
established from the net proceeds of our offering, proceeds from sales of other investments, operating cash generated by other investments or other cash on hand. In some cases, a lender may require us to establish capital reserves for a particular
investment. The capital plan for each investment will be adjusted through ongoing, regular reviews of our portfolio or as necessary to respond to unanticipated additional capital needs.
Other Liquidity Needs
In the event that there is a shortfall in
net cash available due to various factors, including, without limitation, the timing of distributions or the timing of the collection of receivables, we may seek to obtain capital to pay distributions by means of secured or unsecured debt financing
through one or more third parties, or our advisor entities or their affiliates. There are currently no limits or restrictions on the use of proceeds from our advisor entities or their affiliates which would prohibit us from making the proceeds
available for distribution. We may also pay distributions from cash from capital transactions, including, without limitation, the sale of one or more of our properties.
Based on the properties we owned as of December 31, 2011, we estimate that our expenditures for capital improvements and tenant improvements will require up to $5,693,000 within the next
12 months. As of December 31, 2011, we had $2,107,000 of restricted cash in loan impounds and reserve accounts for such capital expenditures. We cannot provide assurance, however, that we will not exceed these estimated expenditure and
distribution levels or be able to obtain additional sources of financing on commercially favorable terms or at all.
If we
experience lower occupancy levels, reduced rental rates, reduced revenues as a result of asset sales, or increased capital expenditures and leasing costs compared to historical levels due to competitive market conditions for new and renewal leases,
the effect would be a reduction of net cash provided by operating activities. If such a reduction of net cash provided by operating activities is realized, we may have a cash flow deficit in subsequent periods. Our estimate of net cash available is
based on various assumptions which are difficult to predict, including the levels of leasing activity and related leasing costs. Any changes in these assumptions could impact our financial results and our ability to fund working capital and
unanticipated cash needs.
86
Cash Flows
Cash flows provided by (used in) operating activities for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009,
were $9,264,000, $(2,881,000), and $(40,000), respectively. For the years ended December 31, 2011 and 2010, cash flows provided by (used in) operating activities primarily related to the cash flows provided by our property operations, offset by
the payment of acquisition related expenses and general and administrative expenses. For the period from January 7, 2009 (Date of Inception) through December 31, 2009, cash flows used in operating activities primarily related to the
payment of general and administrative expenses. We anticipate cash flows from operating activities to increase as we purchase additional properties.
Cash flows used in investing activities for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, were
$223,689,000, $186,342,000 and $0, respectively. For the year ended December 31, 2011, cash flows used in investing activities related primarily to the acquisition of our properties in the amount of $213,856,000, the payment of $6,901,000 in
real estate and escrow deposits for the acquisition of real estate and capital expenditures of $3,459,000. For the year ended December 31, 2010, cash flows used in investing activities related primarily to the acquisition of our properties in
the amount of $182,818,000, restricted cash in the amount of $2,816,000 and the payment of $649,000 in real estate and escrow deposits. We anticipate cash flows used in investing activities to increase as we acquire additional properties.
Cash flows provided by financing activities for the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009, were $253,089,000, $181,468,000 and $13,813,000, respectively. For the year ended December 31, 2011, such cash flows related primarily to funds raised from investors in
our offering in the amount of $325,444,000 and borrowings on our mortgage loans payable in the amount of $43,700,000, partially offset by principal payments on our mortgage loans payable in the amount of $55,429,000, the payment of offering costs of
$35,297,000, net payments under our secured revolving credit facilities with Bank of America, N.A., or Bank of America, and KeyBank National Association, or KeyBank, or the lines of credit, in the amount of $11,800,000, and distributions of
$9,375,000. Additional cash outflows primarily related to deferred financing costs of $2,851,000 in connection with the debt financing for our acquisitions and our lines of credit with Bank of America and KeyBank and share repurchases of $1,198,000.
For a further discussion of our lines of credit, see Note 8, Lines of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K. Of the $55,429,000 in payments on our mortgage loans payable, $7,500,000
reflects the early extinguishment of a mortgage loan payable on Surgical Hospital of Humble using excess cash on hand, $23,132,000 reflects the early extinguishment of a mortgage loan payable on Dixie-Lobo Medical Office Building Portfolio using
borrowings from our line of credit with Bank of America and $22,039,000 reflects early payments made on a bridge loan on Virginia Skilled Nursing Facility Portfolio using borrowings on our line of credit with KeyBank. For the year ended
December 31, 2010, such cash flows related primarily to funds raised from investors in our offering in the amount of $136,944,000, borrowings on our mortgage loan payables in the amount of $51,110,000, and net borrowings under our line of
credit with Bank of America in the amount of $11,800,000, partially offset by the payment of offering costs of $14,442,000 and distributions of $2,087,000. Additional cash outflows primarily related to deferred financing costs of $1,587,000 in
connection with the debt financing for our acquisitions and our line of credit with Bank of America. For the period from January 7, 2009 (Date of Inception) through December 31, 2009, such cash flows related primarily to funds raised from
investors in our offering in the amount of $15,118,000, partially offset by the payment of offering costs of $1,307,000. We anticipate cash flows from financing activities to increase in the future as we raise additional funds from investors and
incur debt to acquire properties.
87
Distributions
The income tax treatment for distributions reportable for the years ended December 31, 2011 and 2010, was as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
December
31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Ordinary income
|
|
$
|
9,276,000
|
|
|
|
51
|
%
|
|
$
|
935,000
|
|
|
|
23
|
%
|
Capital gain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return of capital
|
|
|
8,912,000
|
|
|
|
49
|
|
|
|
3,128,000
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,188,000
|
|
|
|
100
|
%
|
|
$
|
4,063,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We began paying distributions in 2010. Amounts listed above do not include distributions paid on
nonvested shares of our restricted common stock which have been separately reported.
See Item 5. Market for
Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Distributions, for a further discussion of our distributions.
Financing
We anticipate that our aggregate borrowings, both
secured and unsecured, will not exceed 60.0% of all of our properties and other real estate-related assets combined fair market values, as defined, as determined at the end of each calendar year beginning with our first full year of
operations. For these purposes, the fair market value of each asset will be equal to the purchase price paid for the asset or, if the asset was appraised subsequent to the date of purchase, then the fair market value will be equal to the value
reported in the most recent independent appraisal of the asset. Our policies do not limit the amount we may borrow with respect to any individual investment. As of December 31, 2011, our borrowings were 18.4% of our properties combined
fair market values, as defined.
Under our charter, we have a limitation on borrowing that precludes us from borrowing in
excess of 300.0% of our net assets without the approval of a majority of our independent directors. Net assets for purposes of this calculation are defined to be our total assets (other than intangibles), valued at cost prior to deducting
depreciation, amortization, bad debt and other non-cash reserves, less total liabilities. Generally, the preceding calculation is expected to approximate 75.0% of the aggregate cost of our real estate and real estate-related investments before
depreciation, amortization, bad debt and other similar non-cash reserves. In addition, we may incur mortgage debt and pledge some or all of our real properties as security for that debt to obtain funds to acquire additional real estate or for
working capital. We may also borrow funds to satisfy the REIT tax qualification requirement that we distribute at least 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. Furthermore, we may borrow if we otherwise
deem it necessary or advisable to ensure that we maintain our qualification as a REIT for federal income tax purposes. As of March 15, 2012 and December 31, 2011, our leverage did not exceed 300.0% of the value of our net assets.
Mortgage Loans Payable, Net
For a discussion of our mortgage loans payable, net, see Note 6, Mortgage Loans Payable, Net, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Lines of Credit
For a
discussion of the lines of credit, see Note 8, Lines of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
REIT Requirements
In order to maintain our qualification as a REIT for
federal income tax purposes, we are required to make distributions to our stockholders of at least 90.0% of our annual taxable income, excluding net capital gains. In the event that there is a shortfall in net cash available due to factors
including, without limitation, the timing of such distributions or the timing of the collection of receivables, we may seek to obtain capital to pay distributions by means of secured debt financing through one or more unaffiliated parties. We may
also pay distributions from cash from capital transactions including, without limitation, the sale of one or more of our properties or from the proceeds of our offering.
88
Commitments and Contingencies
For a discussion of our commitments and contingencies, see Note 10, Commitments and Contingencies, to the Consolidated Financial
Statements that are a part of this Annual Report on Form 10-K.
Debt Service Requirements
Our principal liquidity need is the payment of principal and interest on our outstanding indebtedness. As of December 31, 2011, we
had $53,557,000 ($53,762,000, net of discount and premium) of fixed rate debt and $26,972,000 ($26,704,000, net of discount) of variable rate debt outstanding secured by our properties. As of December 31, 2011, we had no outstanding borrowings
under our lines of credit.
We are required by the terms of certain loan documents to meet certain covenants, such as
occupancy ratios, leverage ratios, net worth ratios, debt service coverage ratios, liquidity ratios, operating cash flow to fixed charges ratios, distribution ratios and reporting requirements. As of December 31, 2011, we were in compliance
with all such covenants and requirements on our mortgage loans payable and our lines of credit and we expect to remain in compliance with all such requirements for the next 12 months. As of December 31, 2011, the weighted average effective
interest rate on our outstanding debt, factoring in our fixed rate interest rate swaps, was 5.24% per annum.
Contractual Obligations
The following table provides information with respect to (i) the maturity and scheduled principal repayment of our
secured mortgage loans payable and our lines of credit, (ii) interest payments on our mortgage loans payable, lines of credit and fixed rate interest rate swaps, and (iii) obligations under our ground leases, as of December 31, 2011:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Payments Due by Period
|
|
|
|
Less than 1 Year
(2012)
|
|
|
1-3 Years
(2013-2014)
|
|
|
4-5 Years
(2015-2016)
|
|
|
More than 5 Years
(after 2016)
|
|
|
Total
|
|
|
|
|
|
|
|
Principal payments fixed rate debt
|
|
$
|
5,198,000
|
|
|
$
|
2,189,000
|
|
|
$
|
11,471,000
|
|
|
$
|
34,699,000
|
|
|
$
|
53,557,000
|
|
Interest payments fixed rate debt
|
|
|
2,863,000
|
|
|
|
5,086,000
|
|
|
|
4,373,000
|
|
|
|
2,593,000
|
|
|
|
14,915,000
|
|
Principal payments variable rate debt
|
|
|
13,070,000
|
(1)
|
|
|
694,000
|
|
|
|
7,009,000
|
|
|
|
6,199,000
|
|
|
|
26,972,000
|
|
Interest payments variable rate debt (based on rates in effect as of December 31, 2011)
|
|
|
832,000
|
|
|
|
803,000
|
|
|
|
575,000
|
|
|
|
220,000
|
|
|
|
2,430,000
|
|
Interest payments fixed rate interest rate swaps (based on rate in effect as of December 31,
2011)
|
|
|
204,000
|
|
|
|
305,000
|
|
|
|
47,000
|
|
|
|
|
|
|
|
556,000
|
|
Ground lease obligations
|
|
|
156,000
|
|
|
|
289,000
|
|
|
|
295,000
|
|
|
|
9,416,000
|
|
|
|
10,156,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
22,323,000
|
|
|
$
|
9,366,000
|
|
|
$
|
23,770,000
|
|
|
$
|
53,127,000
|
|
|
$
|
108,586,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Our variable rate mortgage loan payable in the outstanding principal amount of $2,964,000 ($2,696,000, net of discount) secured by Center for Neurosurgery and Spine as
of December 31, 2011, had a fixed rate interest rate swap, thereby effectively fixing our interest rate on this mortgage loan payable to an effective interest rate of 6.00% per annum. This mortgage loan payable is due August 15, 2021;
however, the principal balance is immediately due upon written request from the seller confirming that the seller agrees to pay any interest rate swap termination amount, if any. Assuming the seller does not exercise such right, interest payments,
using the 6.00% per annum effective interest rate, would be $168,000, $290,000, $218,000 and $216,000 in 2012, 2013-2014, 2015-2016 and thereafter, respectively.
|
89
The table above does not reflect any payments expected under our contingent consideration
obligations.
Off-Balance Sheet Arrangements
As of December 31, 2011, we had no off-balance sheet transactions, nor do we currently have any such arrangements or obligations.
Inflation
We are exposed to inflation risk as income from future
long-term leases will be the primary source of our cash flows from operations. There are provisions in the majority of our tenant leases that will protect us from the impact of inflation. These provisions include negotiated rental increases,
reimbursement billings for operating expense pass-through charges, and real estate tax and insurance reimbursements on a per square foot allowance. However, due to the long-term nature of the anticipated leases, among other factors, the leases may
not re-set frequently enough to cover inflation.
Subsequent Events
For a discussion of subsequent events, see Note 21, Subsequent Events, to the Consolidated Financial Statements that are a part of this
Annual Report on Form 10-K.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices,
equity prices and other market changes that affect market sensitive instruments. There were no material changes in our market risk exposures between the years ended December 31, 2011 and 2010. In pursuing our business plan, we expect that the
primary market risk to which we will be exposed is interest rate risk.
We are exposed to the effects of interest rate changes
primarily as a result of long-term debt used to acquire properties and other permitted investments. Our interest rate risk is monitored using a variety of techniques. Our interest rate risk management objectives are to limit the impact of interest
rate changes on earnings, prepayment penalties and cash flows and to lower overall borrowing costs while taking into account variable interest rate risk. To achieve our objectives, we may borrow at fixed or variable rates.
We also may enter into derivative financial instruments such as interest rate swaps or caps in order to mitigate our interest rate risk
on a related financial instrument. To the extent we do, we are exposed to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract
is positive, the counterparty owes us, which creates credit risk for us. When the fair value of a derivative contract is negative, we owe the counterparty and, therefore, it does not possess credit risk. It is our policy to enter into these
transactions with the same party providing the underlying financing. In the alternative, we will seek to minimize the credit risk associated with derivative instruments by entering into transactions with what we believe are high-quality
counterparties. We believe the likelihood of realized losses from counterparty non-performance is remote. Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates. We manage the market
risk associated with interest rate contracts by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. We do not enter into derivative or interest rate transactions for speculative purposes.
We have entered into, and in the future may continue to enter into, derivative instruments for which we have not and may not
elect hedge accounting treatment. Because we have not elected to apply hedge accounting treatment to these derivatives, the gains or losses resulting from their mark-to-market adjustment at the end of each reporting period are recognized as an
increase or decrease in interest expense in our accompanying consolidated statements of operations. Derivatives are recorded on our accompanying consolidated balance sheets at their fair value of $(819,000).
90
The table below presents, as of December 31, 2011, the principal amounts and weighted
average interest rates by year of expected maturity to evaluate the expected cash flows and sensitivity to interest rate changes.
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Septe
|
|
|
|
Expected Maturity Date
|
|
|
|
2012
|
|
|
2013
|
|
|
2014
|
|
|
2015
|
|
|
2016
|
|
|
Thereafter
|
|
|
Total
|
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
Fixed rate debt principal payments
|
|
$
|
5,198,000
|
|
|
$
|
963,000
|
|
|
$
|
1,226,000
|
|
|
$
|
5,668,000
|
|
|
$
|
5,803,000
|
|
|
$
|
34,699,000
|
|
|
$
|
53,557,000
|
|
|
$
|
55,054,000
|
|
Weighted average interest rate on maturing debt
|
|
|
5.84
|
%
|
|
|
5.68
|
%
|
|
|
5.47
|
%
|
|
|
5.24
|
%
|
|
|
6.37
|
%
|
|
|
5.17
|
%
|
|
|
5.39
|
%
|
|
|
|
|
Variable rate debt principal payments
|
|
$
|
13,070,000
|
|
|
$
|
343,000
|
|
|
$
|
351,000
|
|
|
$
|
359,000
|
|
|
$
|
6,650,000
|
|
|
$
|
6,199,000
|
|
|
$
|
26,972,00
|
|
|
$
|
25,974,000
|
|
Weighted average interest rate on maturing debt (based on rates in effect as of December 31, 2011)
|
|
|
4.50
|
%
|
|
|
2.92
|
%
|
|
|
2.91
|
%
|
|
|
2.91
|
%
|
|
|
3.15
|
%
|
|
|
2.67
|
%
|
|
|
3.68
|
%
|
|
|
|
|
Mortgage loans payable were $80,529,000 ($80,466,000, net of discount and premium) as of
December 31, 2011. As of December 31, 2011, we had six fixed rate and four variable rate mortgage loans payable with effective interest rates ranging from 1.38% to 6.60% per annum and a weighted average effective interest rate of
4.82% per annum. As of December 31, 2011, we had $53,557,000 ($53,762,000, net of discount and premium) of fixed rate debt, or 66.5% of mortgage loans payable, at a weighted average effective interest rate of 5.39% per annum and
$26,972,000 ($26,704,000, net of discount) of variable rate debt, or 33.5% of mortgage loans payable, at a weighted average effective interest rate of 3.68% per annum.
As of December 31, 2011, the weighted average effective interest rate on our outstanding debt, factoring in our fixed rate interest rate swaps, was 5.24% per annum. $2,964,000 of our variable
rate mortgage loans payable is due August 15, 2021; however, the principal balance is immediately due upon written request from the seller confirming that the seller agrees to pay the interest rate swap termination amount, if any, and as such,
the $2,964,000 principal balance is reflected in the 2012 column above.
An increase in the variable interest rate on our
lines of credit and our variable rate mortgage loans payable constitutes a market risk. As of December 31, 2011, a 0.50% increase in the London Interbank Offered Rate, or LIBOR, would have no effect on our overall annual interest expense as
either (1) we have a fixed rate interest rate swap on the variable rate mortgage loan payable or (2) we are paying the minimum interest rates under the applicable agreements whereby a 0.50% increase would still be below the minimum
interest rate.
In addition to changes in interest rates, the value of our future investments is subject to fluctuations based
on changes in local and regional economic conditions and changes in the creditworthiness of tenants, which may affect our ability to refinance our debt if necessary.
Item 8. Financial Statements and Supplementary Data.
See the index at Part IV, Item
15. Exhibits, Financial Statement Schedules.
Item 9. Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
(a)
Evaluation of disclosure controls and procedures.
We maintain disclosure controls and procedures that are designed
to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, or the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms,
and that such information is accumulated and communicated to us, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
As required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, an evaluation as of December 31, 2011 was conducted under the
supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act). Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures, as of December 31, 2011, were effective.
91
(b)
Managements Annual Report on Internal Control over Financial
Reporting.
Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision, and with
the participation, of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO.
Based
on our evaluation under the Internal Control-Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2011.
(c)
Changes in internal control over financial reporting.
There were no changes in internal control over financial
reporting that occurred during the fiscal quarter ended December 31, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information.
None.
92
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
The following table and biographical descriptions set forth certain information with respect to the individuals who are our officers and
directors.
|
|
|
|
|
|
|
Name
|
|
Age*
|
|
|
Position
|
|
|
|
Jeffrey T. Hanson
|
|
|
41
|
|
|
Chief Executive Officer and Chairman of the board of directors
|
Danny Prosky
|
|
|
46
|
|
|
President and Chief Operating Officer and Director
|
Shannon K S Johnson
|
|
|
34
|
|
|
Chief Financial Officer
|
Mathieu B. Streiff
|
|
|
36
|
|
|
Executive Vice President
|
Stefan Oh
|
|
|
41
|
|
|
Senior Vice President Acquisitions
|
Cora Lo
|
|
|
37
|
|
|
Secretary
|
Patrick R. Leardo
|
|
|
64
|
|
|
Independent Director
|
Gerald W. Robinson
|
|
|
64
|
|
|
Independent Director
|
Gary E. Stark
|
|
|
56
|
|
|
Independent Director
|
There are no family relationships among any directors and executive officers.
Jeffrey T. Hanson
has served as our Chief Executive Officer and Chairman of the board of directors since January 2009. He is also
one of the founders and owners of American Healthcare Investors, a newly-formed Newport Beach-based investment management firm that serves as one of our co-sponsors and owns a majority interest in or our sub-advisor. Since November 2011,
Mr. Hanson has also served as an Executive Vice President of our sub-advisor. He served as the Chief Executive Officer of Grubb & Ellis Healthcare REIT II Advisor, LLC, our former advisor, from January 2009 to November 2011 and as the
Chief Executive Officer and President of GEEA, from June 2009 to November 2011. He also served as the Executive Vice President, Investment Programs, of Grubb & Ellis from December 2007 to November 2011 and served in various capacities
within the Grubb & Ellis organization from July 2006 to November 2011. From 1997 to July 2006, prior to Grubb & Ellis merger with NNN Realty Advisors, Inc. in December 2007, Mr. Hanson served as Senior Vice President
with Grubb & Ellis Institutional Investment Group in the firms Newport Beach office. While with that entity, he managed investment sale assignments throughout the Western U.S., with a significant focus on leading acquisitions
and dispositions on healthcare-related properties, for major private and institutional clients. During that time, he also served as a member of the Grubb & Ellis Presidents Counsel and Institutional Investment Group Board of Advisors.
Mr. Hanson received a B.S. degree in Business from the University of Southern California with an emphasis in Real Estate Finance.
Our board of directors selected Mr. Hanson to serve as a director because he is our Chief Executive Officer and has served in various executive roles with a focus on property management and property
acquisitions. Mr. Hanson has profound insight into the development, marketing, finance, and operations aspects of our company. He has expansive knowledge of the real estate and healthcare industries and relationships with chief executives and
other senior management at real estate and healthcare companies. Our board of directors believes that Mr. Hanson brings a unique and valuable perspective to our board of directors.
Danny Prosky
has served as our director, President and Chief Operating Officer since January 2009. He is also one of the founders
and owners of American Healthcare Investors, which serves as one of our co-sponsors and owns a majority interest in our sub-advisor. Since November 2011, Mr. Prosky has also served as an Executive Vice President of our sub-advisor. He served as
the President and Chief Operating Officer of Grubb & Ellis Healthcare REIT II Advisor, LLC, our former advisor, from January 2009 to November 2011 and as Executive Vice President and Secretary of GEEA Property Management from June 2011 to
November 2011. He also served as the Executive
93
Vice President, Healthcare Real Estate of GEEA from September 2009 to November 2011, having served in various capacities within the Grubb & Ellis organization from March 2006 to November
2011, and was responsible for all medical property acquisitions, management and dispositions. He served as the Executive Vice President Acquisitions of Grubb & Ellis Healthcare REIT, Inc. (now known as Healthcare Trust of America,
Inc.) from April 2008 to June 2009, having served as its Vice President Acquisitions from September 2006 to April 2008. Mr. Prosky previously worked for Health Care Property Investors, Inc., a publicly traded healthcare REIT, where he
served as the Assistant Vice President Acquisitions & Dispositions from February 2005 to March 2006 and as Assistant Vice President Asset Management from November 1999 to February 2005. From 1992 to 1999, he served as the
Manager, Financial Operations, Multi-Tenant Facilities for American Health Properties, Inc. Mr. Prosky received a B.S. degree in Finance from the University of Colorado and an M.S. degree in Management from Boston University.
Our board of directors selected Mr. Prosky to serve as a director because he is our President and Chief Operating Officer and his
primary focus has been on the acquisition and operation of healthcare and healthcare-related properties. He has significant knowledge of, and relationships within, the real estate and healthcare industries, due in part to the 14 years he worked at
Health Care Property Investors, Inc. and American Health Properties, Inc. Our board of directors believes that his executive experience in the real estate industry coupled with his deep knowledge of our companys strategies and operations bring
strong financial and operational expertise to our board of directors.
Shannon K S Johnson
has served as our Chief
Financial Officer since January 2009. Ms. Johnson has also served as the Senior Vice President, Accounting and Finance of American Healthcare Investors since January 2012. Ms. Johnson served as the Financial Reporting Manager for
Grubb & Ellis Realty Investors, LLC, or Grubb & Ellis Realty Investors, an indirect wholly-owned subsidiary of Grubb & Ellis, from January 2006 to January 2012. Ms. Johnson served as Chief Financial Officer of
Grubb & Ellis Healthcare REIT, Inc. (now known as Healthcare Trust of America, Inc.) and Grubb & Ellis Apartment REIT, Inc. (now known as Apartment Trust of America, Inc.) from August 2006 to March 2009 and from April 2006 to
November 2010, respectively. From June 2002 to January 2006, Ms. Johnson gained public accounting and auditing experience while employed as an auditor with PricewaterhouseCoopers LLP. Prior to joining PricewaterhouseCoopers LLP, from September
1999 to June 2002, Ms. Johnson worked as an auditor with Arthur Andersen LLP, where she worked on the audits of a variety of public and private entities. Ms. Johnson is a Certified Public Accountant in the State of California and received
a B.A. degree in Business-Economics and a minor in Accounting from the University of California, Los Angeles, where she graduated summa cum laude.
Mathieu B. Streiff
has served as our Executive Vice President since January 2012. He is also one of the founders and owners of American Healthcare Investors, which serves as one of our co-sponsors
and owns a majority interest in our sub-advisor. Since November 2011, Mr. Streiff has also served as an Executive Vice President of our sub-advisor. He served as General Counsel, Executive Vice President and Secretary of Grubb & Ellis
from October 2010 to June 2011. Mr. Streiff joined Grubb & Ellis Realty Investors in March 2006 as the firms real estate counsel responsible for structuring and negotiating property acquisitions, financings, joint ventures and
disposition transactions. He was promoted to Chief Real Estate Counsel and Senior Vice President, Investment Operations in March 2009 and served in that position until October 2010. In this role, his responsibility was expanded to include the
structuring and strategic management of the companys securitized real estate investment platforms. From September 2002 until March 2006, Mr. Streiff was an associate in the real estate department of Latham & Watkins LLP in New
York. Mr. Streiff received a B.S. degree in Environmental Economics and Policy from the University of California, Berkeley and a J.D. degree from Columbia University Law School. He is a member of the New York State Bar Association.
Stefan Oh
has served as our Senior Vice President Acquisitions since January 2009. Mr. Oh has also served as the
Senior Vice President, Acquisitions of American Healthcare Investors since January 2012. Mr. Oh served as the Senior Vice President, Healthcare Real Estate of GEEA from January 2010 to January 2012, having served in the same capacity for
Grubb & Ellis Realty Investors since June 2007, where he was responsible for the acquisition and management of healthcare real estate. Prior to joining Grubb & Ellis, from August 1999 to June 2007, Mr. Oh worked for Health
Care Property Investors, Inc., a healthcare-focused REIT, where he served as Director of Asset
94
Management and later as Director of Acquisitions. From 1997 to 1999, he worked as an auditor and project manager for Ernst & Young AB in Stockholm, Sweden and from 1993 to 1997 as an
auditor within Ernst & Young LLPs EYKL Real Estate Group in Los Angeles, California. Mr. Oh received a B.S. degree in Accounting from Pepperdine University and is a Certified Public Accountant in the State of California
(inactive).
Cora Lo
has served as our Secretary since November 2010, having previously served as our Assistant
Secretary since March 2009. Ms. Lo has also served as the Senior Vice President, Securities Counsel of American Healthcare Investors since January 2012. Ms. Lo served as Senior Corporate Counsel for Grubb & Ellis from December
2007 to January 2012, having served as Senior Corporate Counsel and Securities Counsel for Grubb & Ellis Realty Investors since January 2007 and December 2005, respectively. She also served as the Assistant Secretary of Grubb &
Ellis Apartment REIT, Inc. (now known as Apartment Trust of America, Inc.) from June 2008 to November 2010. From September 2002 to December 2005, Ms. Lo served as General Counsel of I/OMagic Corporation, a publicly traded company. Prior to
2002, Ms. Lo practiced as a private attorney specializing in corporate and securities law. Ms. Lo also interned at the SEC, Division of Enforcement in 1998. Ms. Lo received a B.A. degree in Political Science from the University of
California, Los Angeles and received a J.D. degree from Boston University. Ms. Lo is a member of the California State Bar Association.
Patrick R. Leardo
has served as one of our independent directors since August 2009. Mr. Leardo has also served as the Managing Member of Domain Capital Advisors, LLC, a registered investment
advisor, since July 2008. From May 1986 to June 2008, Mr. Leardo served in various management roles at PricewaterhouseCoopers LLP, including serving as the partner in charge of the Global Real Estate Advisory practice. Prior to the merger of
PriceWaterhouse and Coopers & Lybrand in 1998, Mr. Leardo was also the Real Estate Industry Chairman for Coopers & Lybrands real estate activities, coordinating all lines of service including audit, tax and consulting.
Mr. Leardos industry memberships include the Pension Real Estate Association, National Realty Committee, Urban Land Institute, or ULI, and NAREIT. He also holds the prestigious Counselor of Real Estate designation and was honored by the
Royal Institute of Chartered Surveyors as a Fellow in May 2006. He recently completed a term as a Trustee of ULI and has been invited to become a Governor of ULI. Mr. Leardo has also served as a Board Trustee for the American Seniors Housing
Association, a member of the board of directors of Edens & Avant, a $2.5 billion market cap private REIT and a Board Trustee for Roanoke College located in Salem, Virginia. Mr. Leardo received a B.S. degree in Economics from Upsala
College.
Our board of directors selected Mr. Leardo to serve as a director in part due to his financial and accounting
expertise, particularly in the real estate industry. Our board of directors believes that his experience as a partner at a public accounting firm, as well as his previous service on the board of directors of a REIT, will bring value to us,
particularly in his role as the audit committee chairman and audit committee financial expert. With his extensive background in finance, accounting and business operations, Mr. Leardo has a unique portfolio of business skills.
Gerald W. Robinson
has served as one of our independent directors since August 2009. Mr. Robinson has also served as the
Executive Vice President of Pacific Life Insurance Company since January 1994 and as Chairman and Chief Executive Officer of Pacific Select Distributors, Inc. since March 1994. Prior to 1994, Mr. Robinson served in various executive positions
in the life insurance industry, including positions with Home Life Insurance Company, Anchor National Life Insurance Company and Private Ledger Financial Services. During Mr. Robinsons career, he has supervised and been a member of due
diligence committees responsible for the approval of all products offered by broker-dealers for sale through registered representatives including real estate limited partnership, REIT and mortgage-based products. In addition, while at Pacific Life
Insurance Company, Mr. Robinson was a member of the investment committee, which was responsible for the purchase and disposition of all assets of the insurance company which included numerous forms of real estate, mortgage, and REIT
investments. Mr. Robinson is a Certified Financial Planner and a Chartered Life Underwriter and received a B.S. degree in Business Administration from Central Michigan University.
95
Our board of directors selected Mr. Robinson to serve as a director due to his strong
relationships and understanding of the financial network through which we offer our shares of common stock in our offering. Mr. Robinsons vast experience in capital markets and business operations enhances his ability to contribute
insight on achieving business success in a diverse range of economic conditions and competitive environments. Our board of directors believes that this experience will bring valuable knowledge and insight to our company.
Gary E. Stark
has served as one of our independent directors since August 2009. From February 2010 through March 2011,
Mr. Stark acted as the chief operating officer of Whitten LLC, a healthcare company operating a luxury assisted living and memory care facility in La Habra, California. Since December 2007, Mr. Stark has been the owner and managing member
of Chateau DHAL Management, LLC, a healthcare management company that operated an assisted living facility exclusively dedicated to qualifying low income individuals with assisted living needs in Kansas City, Kansas. Since May 2005, Mr. Stark
has been the owner and managing member of Chateau Healthcare Management, LLC, a healthcare management company that operated luxury assisted living, senior residential care, memory care and Alzheimers care facilities in Overland Park and
Mission, Kansas. From November 2002 to July 2005, Mr. Stark co-owned Grace Long Term Care, LLC, a healthcare management company operating skilled nursing and assisted living facilities. Mr. Stark served as a private consultant from August
2001 to March 2004 to Health Care Property Investors, Inc., a publicly traded healthcare REIT. Mr. Stark also served as a Vice President and General Counsel of Nationwide Health Properties, Inc., another publicly traded healthcare REIT, from
March 1992 to August 2001. Prior to 2001, Mr. Stark also served as Vice President of Legal Affairs/General Counsel of Life Care Centers of America, Inc., one of the largest privately owned sub-acute/long-term care providers in the U.S., and as
General Counsel of Care Enterprises, Inc., a publicly traded healthcare corporation engaged in sub-acute/long-term care, ancillary healthcare services and products. Mr. Stark received a B.A. degree in Economics from the University of
California, Irvine and received a J.D. degree from the University of California, Hastings College of Law. Mr. Stark is a member of the California State Bar Association.
Our board of directors selected Mr. Stark to serve as a director due to his knowledge of the healthcare industry and his previous relationships with publicly traded REITs. Mr. Starks
extensive knowledge of our companys business sector combined with his executive experience at numerous other real estate companies focused on the healthcare industry is a significant asset to our company. Our board of directors believes that
Mr. Starks experience will result in assisting us in developing our long-term strategy in the healthcare industry.
Committees
of our Board of Directors
Our board of directors has established an audit committee and may establish other committees it
deems appropriate to address specific areas in more depth than may be possible at a full board meeting, provided that the majority of the members of each committee are independent directors.
Audit Committee.
We have established an audit committee which consists of all of our independent directors, with Patrick R. Leardo
serving as the audit committee financial expert. Our audit committees primary function is to assist the board of directors in fulfilling its oversight responsibilities by reviewing the financial information to be provided to the stockholders
and others, the system of internal controls which management has established, and the audit and financial reporting process. The audit committee: (1) makes recommendations to our board of directors concerning the engagement of an independent
registered public accounting firm; (2) reviews the plans and results of the audit engagement with our independent registered public accounting firm; (3) approves audit and non-audit professional services (including the fees and terms
thereof) provided by, and the independence of, our independent registered public accounting firm; and (4) consults with our independent registered public accounting firm regarding the adequacy of our internal controls. We expect that pursuant
to our audit committee charter, the audit committee will always be comprised solely of independent directors.
Compensation
Committee.
We currently do not have, but we may have in the future, a compensation committee comprised of a minimum of three directors, including at least two independent directors, to establish compensation strategies and programs for our
directors and executive officers. However, at a later date, the compensation committee may exercise all powers of our board of directors in connection with establishing and implementing compensation matters. Stock-based compensation plans will be
administered by the board of directors if the members of the compensation committee do not qualify as non-employee directors within the meaning of the Exchange Act.
96
Nominating and Corporate Governance Committee.
We do not have a
separate nominating and corporate governance committee. We believe that our board of directors is qualified to perform the functions typically delegated to a nominating and corporate governance committee and that the formation of a separate
committee is not necessary at this time. Instead, the full board of directors performs functions similar to those which might otherwise normally be delegated to such a committee, including, among other things, developing a set of corporate
governance principles, adopting a code of ethics, adopting objectives with respect to conflicts of interest, monitoring our compliance with corporate governance requirements of state and federal law, establishing criteria for prospective members of
the board of directors, conducting candidate searches and interviews, overseeing and evaluating the board of directors and our management, evaluating from time to time the appropriate size and composition of the board of directors and recommending,
as appropriate, increases, decreases and changes to the composition of the board of directors and formally proposing the slate of directors to be elected at each annual meeting of our stockholders.
Code of Business Conduct and Ethics
We have adopted our Code of Ethics, which contains general guidelines for conducting our business and is designed to help our directors, employees and independent consultants resolve ethical issues in an
increasingly complex business environment. Our Code of Ethics applies to our principal executive officer, principal financial officer, principal accounting officer, controller and persons performing similar functions and all members of our board of
directors. Our Code of Ethics covers topics including, but not limited to, conflicts of interest, confidentiality of information, and compliance with laws and regulations. Stockholders may request a copy of our Code of Ethics, which will be provided
without charge, by writing to: Griffin-American Healthcare REIT II, Inc., 4000 MacArthur Boulevard, West Tower, Suite 200, Newport Beach, California, 92660, Attention: Secretary. Our Code of Ethics is also available on our website,
http://www.healthcarereit2.com/corporate-governance
. If, in the future, we amend, modify or waive a provision in our Code of Ethics, we may, rather than filing a Current Report on Form 8-K, satisfy the disclosure requirement by posting such
information on our website, as necessary.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires each director, officer, and individual beneficially owning more than 10.0% of a
registered security of the company to file with the SEC, within specified time frames, initial statements of beneficial ownership (Form 3) and statements of changes in beneficial ownership (Forms 4 and 5) of common stock of the company. These
specified time frames require the reporting of changes in ownership within two business days of the transaction giving rise to the reporting obligation. Reporting persons are required to furnish us with copies of all Section 16(a) forms filed
with the SEC. Based solely on a review of the copies of such forms furnished to us during and with respect to the fiscal year ended December 31, 2011 or written representations that no additional forms were required, to the best of our
knowledge, all required Section 16(a) filings were timely and correctly made by reporting persons during 2011.
Our Co-Sponsors
American Healthcare Investors
American Healthcare Investors is a newly-formed Newport Beach-based investment management firm that specializes in the acquisition and management of healthcare-related real estate. The company was founded
and is majority owned by Jeffrey T. Hanson, our Chief Executive Officer, Chairman of our board of directors, and one of our largest individual stockholders; Danny Prosky, our President and Chief Operating Officer and a director; and Mathieu B.
Streiff, our Executive Vice President. Nationally recognized real estate executives, Messrs. Hanson, Prosky and Streiff have directly overseen in excess of $15.0 billion in combined acquisition and disposition transactions, more than $5.0 billion of
which has been healthcare-related.
97
For biographical information regarding Messrs. Hanson, Prosky and Streiff, see
Directors, Executive Officers and Corporate Governance above.
Griffin Capital
Los Angeles-based Griffin Capital is a privately-owned real estate company with a sixteen-year track record sponsoring real estate
investment vehicles and managing institutional capital. Led by senior executives, each with more than two decades of real estate experience who have collectively closed more than 400 transactions representing over $14.0 billion in transaction value,
Griffin Capital has acquired or constructed over 11 million square feet of space since 1996, and currently manages a portfolio of more than 8.5 million square feet located in 13 states, representing approximately $1 billion in asset value.
We are not affiliated with Griffin Capital.
Our Advisor
We will rely on our advisor, Griffin-American Advisor, a newly-formed subsidiary of Griffin Capital, to manage our day-to-day activities and to implement our investment strategy. We and our advisor are
parties to the Advisory Agreement, pursuant to which our advisor will perform its duties and responsibilities as our fiduciary. We are not affiliated with Griffin-American Advisor.
Pursuant to the Advisory Agreement, our advisor, through our sub-advisor, will use its best efforts, subject to the oversight, review and
approval of our board of directors, to perform the following duties pursuant to the terms of the Advisory Agreement:
|
|
|
participate in formulating an investment strategy and asset allocation framework consistent with achieving our investment objectives;
|
|
|
|
research, identify, review and recommend to our board of directors for approval of real estate and real estate-related acquisitions and dispositions
consistent with our investment policies and objectives;
|
|
|
|
structure and negotiate the terms and conditions of transactions pursuant to which acquisitions and dispositions of real properties will be made;
|
|
|
|
actively oversee and manage our real estate and real estate-related investment portfolio for purposes of meeting our investment objectives;
|
|
|
|
manage our day-to-day affairs, including financial accounting and reporting, investor relations, marketing, informational systems and other
administrative services on our behalf;
|
|
|
|
select joint venture partners, structure corresponding agreements and oversee and monitor these relationships;
|
|
|
|
arrange for financing and refinancing of our assets; and
|
|
|
|
recommend to our board of directors when appropriate various transactions which would provide liquidity to our stockholders (such as listing the shares
of our common stock on a national securities exchange, liquidating our portfolio, or the sale or merger of our company).
|
The above summary is provided to illustrate the material functions for which our advisor is responsible and it is not intended to include all of the services that may be provided to us by our advisor, our
sub-advisor or third parties.
98
Our Sub-Advisor
With our consent, Griffin-American Advisor has delegated all advisory duties and compensation therefore to Griffin-American Sub-Advisor, a newly-formed sub-advisor jointly owned by Griffin-American
Advisor and American Healthcare Investors. Our advisor and our sub-advisor are parties to a sub-advisory agreement, pursuant to which our sub-advisor has agreed to perform its duties and responsibilities as our fiduciary. We are affiliated with
Griffin-American Sub-Advisor and American Healthcare Investors, as described elsewhere in this Annual Report on Form 10-K.
The following
table sets forth information with respect to our sub-advisors executive officers:
|
|
|
|
|
|
|
Name
|
|
Age*
|
|
|
Position
|
|
|
|
Jeffrey T. Hanson
|
|
|
41
|
|
|
Executive Vice President
|
Danny Prosky
|
|
|
46
|
|
|
Executive Vice President
|
Mathieu B. Streiff
|
|
|
36
|
|
|
Executive Vice President
|
Kevin A. Shields
|
|
|
53
|
|
|
Executive Vice President
|
Michael J. Escalante
|
|
|
51
|
|
|
Executive Vice President
|
For
biographical information regarding Messrs. Hanson, Prosky and Streiff, see Directors and Executive Officers above.
Kevin A. Shields
has served as an Executive Vice President of our sub-advisor since November 2011. Mr. Shields also serves as the Chairman and Chief Executive Officer of Griffin Capital, which
he founded in 1995, and has been the President of Griffin Capital since August 2008. Mr. Shields has served as President and the Chairman of the board of directors of Griffin Capital Net Lease REIT, Inc., or GC REIT, since the companys
formation in August 2008. Additionally, Mr. Shields is the Chief Compliance Officer and sole stockholder of Griffin Securities. Before founding Griffin Capital, from 1993 to 1994, Mr. Shields was a Senior Vice President and head of the
structured real estate finance group at Jefferies & Company, Inc., a Los Angeles-based investment bank. During his tenure at Jefferies, Mr. Shields focused on originating structured lease bond product. From 1992 to 1993,
Mr. Shields was the President and Principal of Terrarius Incorporated, a firm engaged in the restructuring of real estate debt and equity on behalf of financial institutions, corporations, partnerships and developers. Prior to founding
Terrarius, from 1986 to 1992, Mr. Shields served as a Vice President in the real estate finance department of Salomon Brothers Inc. in both New York and Los Angeles. During his tenure at Salomon Brothers, Mr. Shields initiated, negotiated,
drafted and closed engagement, purchase and sale and finance agreements. Mr. Shields holds a J.D. degree, an M.B.A. and a B.S. degree in finance and real estate from the University of California at Berkeley. Mr. Shields is a Registered
Securities Principal of Griffin Securities, and holds Series 7, 63, 24 and 27 licenses, and is also a licensed California Real Estate Broker.
Our board of directors has agreed to invite Mr. Shields to attend, in a nonvoting observer capacity, meetings of the board of directors for the sole purpose of permitting Mr. Shields and his
affiliates, Griffin Capital, Griffin Securities, and Griffin-American Advisor, to have current information with respect to the affairs of our company and the actions taken by our board of directors.
Michael J. Escalante
has served as an Executive Vice President of our sub-advisor since November 2011. He has also served as Chief
Investment Officer of Griffin Capital since June 2006, where he is responsible for overseeing all acquisition and disposition activities. Mr. Escalante has served as Vice President and Chief Investment Officer of GC REIT since the
companys formation in August 2008. With more than 20 years of real estate-related investment experience, he has been responsible for completing in excess of $4.0 billion of commercial real estate transactions throughout the western United
States. Prior to joining Griffin Capital in June 2006, Mr.
99
Escalante founded Escalante Property Ventures in March 2005, a real estate investment management company, to invest in value-added and development-oriented infill properties within California and
other western states. From 1997 to March 2005, Mr. Escalante served eight years at Trizec Properties, Inc., one of the largest publicly-traded U.S. office REITs, with his final position being Executive Vice President Capital Transactions
and Portfolio Management. While at Trizec, Mr. Escalante was directly responsible for all capital transaction activity for the western United States, which included the acquisition of several prominent office projects. Mr. Escalantes
work experience at Trizec also included significant hands-on operations experience as the REITs western U.S. regional director with bottom-line responsibility for asset and portfolio management of a 4.6 million square foot office/retail
portfolio (11 projects/23 buildings) and associated administrative support personnel (110 total/65 company employees). Prior to joining Trizec, from 1987 to 1997, Mr. Escalante held various acquisitions, asset management and portfolio
management positions with The Yarmouth Group, an international investment advisor. Mr. Escalante holds an M.B.A. from the University of California at Los Angeles, and a B.S. in Commerce from the University of Santa Clara, which is located in
California. Mr. Escalante is a full member of ULI and active in many civic organizations.
Investment Committee
Our sub-advisor has established an investment committee to review all advisory recommendations made by our sub-advisor to our board of
directors. A majority of all members of the investment committee must approve the recommendations of the sub-advisor before such recommendations are provided to our board of directors for approval. The investment committee is comprised of five
persons, two of which are designated by our advisor and three of which are designated by American Healthcare Investors. Our advisor has initially designated Messrs. Shields and Escalante as members of the investment committee, and American
Healthcare Investors has initially designated Messrs. Hanson, Prosky and Streiff as members of the investment committee. Members of our sub-advisors investment committee are not separately compensated for their service as members of the
investment committee, nor are members of our investment committee reimbursed for their expenses associated with the investment committee.
Item 11. Executive Com
pensation.
Executive Compensation
We have no employees. Our executive officers are
all employees of affiliates of our advisor entities, and are compensated by these entities for their services to us. Our day-to-day management is performed by our advisor entities and their affiliates. We pay these entities fees and reimburse
expenses pursuant to the Advisory Agreement. We do not currently intend to pay any compensation directly to our executive officers. As a result, we do not have, and our board of directors has not considered, a compensation policy or program for our
executive officers and has not included a Compensation Discussion and Analysis, a Compensation Committee Report or a resolution subject to a stockholder advisory vote to approve the compensation of our executive officers in this Annual Report on
Form 10-K.
Compensation Committee Interlocks and Insider Participation
Other than Mr. Hanson and Mr. Prosky, no member of our board of directors during the year ended December 31, 2011 has
served as an officer, and no member of our board of directors served as an employee, of Griffin-American Healthcare REIT II, Inc. or any of our subsidiaries. In addition, during the year ended December 31, 2011, none of our executive officers
served as a director or member of a Compensation Committee (or other board committee performing equivalent functions) of any entity that has one or more executive officers serving as a member of our board of directors or Compensation Committee.
Option/SAR Grants in Last Fiscal Year
No option grants were made to our officers or directors for the year ended December 31, 2011.
100
Director Compensation
Our independent directors generally receive the following forms of compensation:
|
|
|
Annual Retainer.
Our independent directors receive an aggregate annual retainer of $36,000, which is paid on a quarterly basis at the
commencement of each quarter for which an individual serves as an independent director. The chairman of the Audit Committee receives an additional aggregate annual retainer of $5,000, which is paid on a quarterly basis at the commencement of each
quarter for which an individual serves as the chairman of the Audit Committee.
|
|
|
|
Meeting Fees.
Our independent directors receive $1,500 for each board of directors meeting attended in person or by telephone and $500 for each
committee meeting attended in person or by telephone. The chairman of each committee, other than the Audit Committee chairman, also may receive additional compensation. If a board of directors meeting is held on the same day as a committee meeting,
an additional fee will not be paid for attending the committee meeting.
|
|
|
|
Equity Compensation.
In connection with their initial election to our board of directors, each independent director receives 5,000 shares of
restricted common stock, and an additional 2,500 shares of restricted common stock in connection with his or her subsequent election each year. The restricted shares vest as to 20.0% of the shares on the date of grant and on each anniversary
thereafter over four years from the date of grant.
|
|
|
|
Other Compensation.
We reimburse our directors for reasonable out-of-pocket expenses incurred in connection with attendance at meetings,
including committee meetings, of our board of directors. Our independent directors do not receive other benefits from us.
|
In addition, on September 30, 2011, our board of directors approved a one-time special payment of $1,500 in cash to each of Mr. Leardo and Mr. Stark, in consideration of additional services
rendered by them as independent directors. Additionally, on October 19, 2011, our board of directors approved a one-time payment of $12,000 in cash to each of our independent directors on such date, in consideration of the services rendered by
our independent directors pertaining to the heightened supervision of our former advisor and additional duties necessitated by our former sponsors ongoing negotiations regarding a potential strategic transaction.
Our non-independent directors do not receive any compensation from us.
The following table sets forth certain information with respect to our director compensation for the year ended December 31, 2011:
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
Name
|
|
Fees
Earned or
Paid in
Cash($)
(1)
|
|
|
Stock
Awards
($)
(2)
|
|
|
Option
Awards ($)
|
|
|
Non-Equity Incentive Plan
Compensation
($)
|
|
|
Change in Pension
Value
and
Nonqualified
Deferred
Compensation
Earnings ($)
|
|
|
All
Other
Compensation ($)
|
|
|
Total ($)
|
|
|
|
|
|
|
|
|
|
Jeffrey T. Hanson(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Danny Prosky(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patrick R. Leardo
|
|
|
129,500
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154,500
|
|
Gerald W. Robinson
|
|
|
123,000
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
148,000
|
|
Gary E. Stark
|
|
|
124,500
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,500
|
|
(1)
|
Consists of the amounts described below.
|
101
|
|
September 30,
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Director
|
|
Role
|
|
Basic
Annual
Retainer
($)
|
|
|
Meeting Fees
($)
|
|
|
Additional
Special
Payments
($)
|
|
|
|
|
|
|
Hanson
|
|
Chairman of the Board
|
|
|
|
|
|
|
|
|
|
|
|
|
Prosky
|
|
Director
|
|
|
|
|
|
|
|
|
|
|
|
|
Leardo
|
|
Chairman, Audit Committee
|
|
|
41,000
|
|
|
|
75,000
|
|
|
|
13,500
|
|
Robinson
|
|
Member, Audit Committee
|
|
|
36,000
|
|
|
|
75,000
|
|
|
|
12,000
|
|
Stark
|
|
Member, Audit Committee
|
|
|
36,000
|
|
|
|
75,000
|
|
|
|
13,500
|
|
(2)
|
The amounts in this column represent the aggregate grant date fair value of the awards granted for the year ended December 31, 2011, as determined in accordance
with ASC Topic 718,
Compensation Stock Compensation
, or ASC Topic 718.
|
The following table
shows the shares of restricted common stock awarded to each director for the year ended December 31, 2011, and the aggregate grant date fair value for each award (computed in accordance with ASC Topic 718).
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Director
|
|
Grant Date
|
|
|
Number of Shares
of
Restricted
Common Stock
|
|
|
Full Grant
Date Fair
Value of
Award ($)
|
|
|
|
|
|
Hanson
|
|
|
|
|
|
|
|
|
|
|
|
|
Prosky
|
|
|
|
|
|
|
|
|
|
|
|
|
Leardo
|
|
|
06/14/11
|
|
|
|
2,500
|
|
|
|
25,000
|
|
Robinson
|
|
|
06/14/11
|
|
|
|
2,500
|
|
|
|
25,000
|
|
Stark
|
|
|
06/14/11
|
|
|
|
2,500
|
|
|
|
25,000
|
|
The following table shows the aggregate number of shares of nonvested restricted common stock held by
each director as of December 31, 2011:
|
|
|
September 30,
|
|
Director
|
|
Number of Shares
of
Nonvested
Restricted
Common
Stock
|
|
|
|
Hanson
|
|
|
|
|
Prosky
|
|
|
|
|
Leardo
|
|
|
5,500
|
|
Robinson
|
|
|
5,500
|
|
Stark
|
|
|
5,500
|
|
(3)
|
Mr. Hanson and Mr. Prosky are not independent directors.
|
2009 Incentive Plan
For a discussion of our incentive plan, see Note 12,
Equity 2009 Incentive Plan, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Amendment
and Termination of the 2009 Incentive Plan
Unless otherwise provided in an award certificate, upon the death or
disability of a participant, or upon a change in control, all of such participants outstanding awards pursuant to our incentive plan will become fully vested. Our incentive plan will automatically expire on the tenth anniversary of the date on
which it was adopted, unless extended or earlier terminated by our board of directors. Our board of directors may terminate our incentive plan at any time, but such termination will have no adverse impact on any award that is outstanding at the time
of such termination. Our board of directors may amend our incentive plan at any time, but any amendment would be subject to stockholder approval if, in the reasonable judgment of our board of directors, stockholder approval would be required by any
law, regulation or rule applicable to the plan. No termination or amendment of our incentive plan may, without the written consent of the participant, reduce or diminish the value of an outstanding award determined as if the award had been
exercised, vested, cashed in or otherwise settled on the date of such amendment or termination. Our board of directors may amend or terminate outstanding awards, but those amendments may require consent of the participant and, unless approved by our
stockholders or otherwise permitted by the antidilution provisions of the plan, the exercise price of an outstanding option may not be reduced, directly or indirectly, and the original term of an option may not be extended.
102
Item 12. Security Ownership of Certain Beneficial Owners and
Management and Related Stockholder Matters.
Principal Stockholders
The following table shows, as of March 7, 2012, the number of shares of our common stock beneficially owned by (1) any person
who is known by us to be the beneficial owner of more than 5.0% of the outstanding shares of our common stock; (2) our directors; (3) our named executive officers; and (4) all of our directors and executive officers as a group. The
percentage of common stock beneficially owned is based on 53,752,796 shares of our common stock outstanding as of March 7, 2012. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes securities
over which a person has voting or investment power and securities that a person has the right to acquire within 60 days.
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Name of Beneficial Owners
(1)
|
|
Number of Shares
of Common
Stock
Beneficially Owned
|
|
|
Percentage
|
|
|
|
|
Jeffrey T. Hanson(2)(3)
|
|
|
77,162
|
|
|
|
*
|
|
Shannon K S Johnson
|
|
|
|
|
|
|
*
|
|
Danny Prosky(2)(4)
|
|
|
30,558
|
|
|
|
*
|
|
Patrick R. Leardo(5)
|
|
|
10,000
|
|
|
|
*
|
|
Gerald W. Robinson(5)
|
|
|
10,000
|
|
|
|
*
|
|
Gary E. Stark(5)
|
|
|
10,000
|
|
|
|
*
|
|
All directors and officers as a group (9 persons)(2)(5)
|
|
|
131,007
|
|
|
|
*
|
|
*
|
Represents less than 1.0% of our outstanding common stock.
|
(1)
|
The address of each beneficial owner listed is c/o Griffin-American Healthcare REIT II, Inc., 4000 MacArthur Blvd, West Tower, Suite 200, Newport Beach, California
92660.
|
(2)
|
Includes 7,201 shares of our common stock owned directly by American Healthcare Investors, of which Messrs. Hanson, Prosky and Streiff are principals. Each of
Messrs. Hanson, Prosky and Streiff disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
|
(3)
|
Includes 14,405 shares of common stock Mr. Hanson purchased pursuant to Executive Stock Purchase Plans adopted by Mr. Hanson on April 7, 2011 and on
December 30, 2011. The shares of common stock were purchased through our offering at a price per share of $9.00.
|
(4)
|
Includes 10,856 shares of common stock Mr. Prosky purchased pursuant to Executive Stock Purchase Plans adopted by Mr. Prosky on April 7, 2011 and on
December 30, 2011. The shares of common stock were purchased through our offering at a price per share of $9.00.
|
(5)
|
Includes restricted and unrestricted shares of common stock.
|
None of the above shares have been pledged as security.
103
Securities Authorized for Issuance Under Equity Compensation Plans
We adopted our incentive plan, pursuant to which our board of directors or a committee of our independent directors may make grants of
options, restricted shares of common stock, stock purchase rights, SARs or other awards to our independent directors, employees and consultants. The maximum number of shares of our common stock that may be issued pursuant to our incentive plan is
2,000,000. The following table provides information regarding our incentive plan as of December 31, 2011:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Plan Category
|
|
Number of Securities
to be
Issued upon
Exercise
of
Outstanding Options,
Warrants and Rights
|
|
|
Weighted Average
Exercise Price
of
Outstanding Options,
Warrants and Rights
|
|
|
Number of
Securities
Remaining
Available for
Future Issuance
|
|
Equity compensation plans approved by security holders(1)
|
|
|
|
|
|
|
|
|
|
|
1,970,000
|
|
Equity compensation plans not approved by security holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
1,970,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
On October 21, 2009, we granted an aggregate of 15,000 shares of our restricted common stock, as defined in our incentive plan, to our independent directors in
connection with their initial election to our board of directors, of which 20.0% vested on the grant date and 20.0% will vest on each of the first four anniversaries of the date of grant. On each of June 8, 2010 and June 14, 2011, in
connection with their re-election, we granted an aggregate of 7,500 shares of our restricted common stock, as defined in our incentive plan, to our independent directors, which will vest as described above. The fair value of each share of our
restricted common stock was estimated at the date of grant at $10.00 per share, the per share price of shares of our common stock in our offering, and with respect to the initial 20.0% of shares of our restricted common stock that vested on the date
of grant, expensed as compensation immediately, and with respect to the remaining shares of our restricted common stock, amortized on a straight-line basis over the vesting period. Shares of our restricted common stock may not be sold, transferred,
exchanged, assigned, pledged, hypothecated or otherwise encumbered. Such restrictions expire upon vesting. Shares of our restricted common stock have full voting rights and rights to distributions. Such shares are not shown in the chart above as
they are deemed outstanding shares of our common stock; however, such grants reduce the number of securities remaining available for future issuance. For a discussion of our incentive plan, see Note 12, Equity 2009 Incentive Plan, to the
Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
|
Item 13. Certain Relationships and Related Transactions, and Director Independence.
Relationships Among Our Affiliates
As of December 31, 2011, some of our executive officers and our non-independent directors are also executive officers and employees and/or holders of direct or indirect interests in our former
advisor and its affiliates.
Fees and Expenses Paid to Affiliates
For a discussion of fees and expenses paid to affiliates, see Note 11, Related Party Transactions, to the Consolidated Financial
Statements that are a part of this Annual Report on Form 10-K.
Executive Stock Purchase Plans
On April 7, 2011, our Chairman of the board of directors and Chief Executive Officer, Jeffrey T. Hanson, and our President and Chief
Operating Officer, Danny Prosky, each executed an executive stock purchase plan, or the G&E Plan, whereby each executive had irrevocably agreed to invest 100% and 50.0%, respectively, of their net after-tax cash compensation as employees of our
sponsor directly into our company by purchasing shares of our common stock on a regular basis, corresponding to regular payroll periods and the payment of any other net after-tax cash compensation, including bonuses. Their first investment under the
G&E Plan began with their regularly
104
scheduled payroll payment on April 29, 2011 and was to terminate on the earlier of (i) December 31, 2011, (ii) the termination of our offering, (iii) any suspension of
our offering by our board of directors or regulatory body, or (iv) the date upon which the number of shares of our common stock owned by Mr. Hanson or Mr. Prosky, when combined with all their other investments in our common stock,
exceeds the ownership limits set forth in our charter. The shares were purchased pursuant to our offering at a price of $9.00 per share, reflecting the elimination of selling commissions and the dealer manager fee in connection with such
transactions. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, Mr. Hanson invested $121,000, $0 and $0, respectively, of his compensation and we
issued 13,436, 0 and 0 shares of our common stock, respectively, pursuant to his G&E Plan. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009,
Mr. Prosky invested $93,000, $0 and $0, respectively, of his compensation and we issued 10,313, 0 and 0 shares of our common stock, respectively, pursuant to his G&E Plan.
On November 7, 2011, Messrs. Hanson and Prosky tendered their resignations from our former sponsor. On December 30, 2011,
Messrs. Hanson and Prosky, as well as Mathieu B. Streiff, our Executive Vice President, each executed an executive stock purchase plan or a stock purchase plan, or the Plan, effective January 1, 2012, whereby each executive has irrevocably
agreed to invest 100%, 50.0% and 50.0%, respectively, of all of their net after-tax salary and cash bonus compensation that is earned on or after February 1, 2012 as employees of American Healthcare Investors directly into our company by
purchasing shares of our common stock beginning with their regularly scheduled payroll payment on February 17, 2012 and terminating on the earlier of (i) December 31, 2012, (ii) the termination of our offering, (iii) any
suspension of our offering by our board of directors or a regulatory body, or (iv) the date upon which the number of shares of our common stock owned by Mr. Hanson, Mr. Prosky or Mr. Streiff, when combined with all their other
investments in our common stock, exceeds the ownership limits set forth in our charter. The shares will be purchased pursuant to our offering at a price of $9.00 per share, reflecting the elimination of selling commissions and the dealer manager fee
in connection with such transactions.
For a further discussion of our Executive Stock Purchase Plans, see Note 21, Subsequent
Events Executive Stock Purchase Plans to the Consolidated Financial Statements that are part of this Annual Report on Form 10-K.
Certain Conflict Resolution Restrictions and Procedures
In order to reduce or eliminate certain potential conflicts of interest, our charter and the Advisory Agreement contain restrictions and conflict resolution procedures relating to (1) transactions we
enter into with our advisor entities, our directors or their respective affiliates, (2) certain future offerings and (3) allocation of properties among affiliated entities. Each of the restrictions and procedures that apply to transactions
with our advisor entities and their affiliates will also apply to any transaction with any entity or real estate program advised, managed or controlled by our advisor entities and their affiliates. These restrictions and procedures include, among
others, the following:
|
|
|
Except as otherwise disclosed in our prospectus for our offering, we will not accept goods or services from our advisor entities or their affiliates
unless a majority of our directors, including a majority of our independent directors, not otherwise interested in the transactions, approve such transactions as fair and reasonable to us and on terms and conditions not less favorable to us than
those available from unaffiliated third parties.
|
|
|
|
We will not purchase or lease any asset (including any property) in which our advisor entities, any of our directors or any of their respective
affiliates has an interest without a determination by a majority of our directors, including a majority of our independent directors, not otherwise interested in such transaction, that such transaction is fair and reasonable to us and at a price to
us no greater than the cost of the property to our advisor entities, such director or directors or any such affiliate, unless there is substantial justification for any amount that exceeds such cost and such excess amount is determined to be
reasonable. In no event will we acquire any such asset at an amount in excess of its appraised value. We will not sell or lease assets to our advisor entities, any of our directors or any of their respective affiliates unless a majority of our
directors, including a majority of our independent directors, not otherwise interested in the transaction, determine the transaction is fair and reasonable to us, which determination will be supported by an appraisal obtained from a qualified,
independent appraiser selected by a majority of our independent directors.
|
105
Director Independence
We have a five-member board of directors. Our charter provides that a majority of the directors must be independent
directors. Two of our directors, Jeffrey T. Hanson and Danny Prosky, are affiliated with us and we do not consider them to be independent directors. Our three remaining directors qualify as independent directors as defined in our
charter in compliance with the requirements of the North American Securities Administrators Associations Statement of Policy Regarding Real Estate Investment Trusts. As defined in our charter, the term independent director means a
director who is not on the date of determination, and within the last two years from the date of determination has not been, directly or indirectly associated with our co-sponsors or our advisor entities by virtue of: (i) ownership of an
interest in our co-sponsors, our advisor entities or any of their affiliates, other than in us; (ii) employment by our co-sponsors, our advisor entities or any of their affiliates; (iii) service as an officer or director of our
co-sponsors, our advisor entities or any of their affiliates, other than as our director or a director of any other REIT organized by our co-sponsors or advised by our advisor entities; (iv) performance of services, other than as a director for
us; (v) service as a director or trustee of more than three REITs organized by our co-sponsors or advised by our advisor entities; or (vi) maintenance of a material business or professional relationship with our co-sponsors, our advisor
entities or any of their affiliates. A business or professional relationship is considered material if the aggregate gross income derived by a director from our co-sponsors, our advisor entities and their affiliates (excluding fees for
serving as our director or director of another REIT or real estate program that is organized, advised or managed by our advisor or its affiliates) exceeds five percent of either the directors annual gross income during either of the last two
years or the directors net worth on a fair market value basis. An indirect association with our co-sponsors or our advisor entities shall include circumstances in which a directors spouse, parent, child, sibling, mother- or
father-in-law, son- or daughter-in-law or brother- or sister-in-law is or has been associated with our co-sponsors, our advisor entities, any of their affiliates or with us.
While our stock is not listed on the New York Stock Exchange, each of our independent directors would also qualify as independent under the rules of the New York Stock Exchange and our Audit Committee
members would qualify as independent under the New York Stock Exchanges rules applicable to Audit Committee members.
Item 14. Principal Accounting Fees and Services.
Ernst & Young has served as our independent
registered public accounting firm since February 4, 2009 and audited our consolidated financial statements for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009.
The following table lists the fees for services billed by our independent registered public
accounting firm in 2011 and 2010:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Services
|
|
2011
|
|
|
2010
|
|
|
|
|
Audit fees(1)
|
|
$
|
525,000
|
|
|
$
|
314,000
|
|
Audit-related fees(2)
|
|
|
|
|
|
|
|
|
Tax fees(3)
|
|
|
44,000
|
|
|
|
5,000
|
|
All other fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
569,000
|
|
|
$
|
319,000
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Audit fees billed in 2011 and 2010 consisted of fees related to the audit of our annual consolidated financial statements, reviews of our quarterly consolidated
financial statements, and statutory and regulatory audits, consents and other services related to filings with the SEC, including filings related to our offering. These amounts include fees paid by our former advisor and its affiliates for costs in
connection with our offering, and to the extent cumulative other organizational and offering expenses exceed 1.0% of the gross proceeds of our offering, these amounts are not included within our consolidated financial statements.
|
106
(2)
|
Audit-related fees related to financial accounting and reporting consultations, assurance and related services.
|
(3)
|
Tax services consist of tax compliance and tax planning and advice.
|
The Audit Committee pre-approves all auditing services and permitted non-audit services (including the fees and terms thereof) to be performed for us by our independent registered public accounting firm,
subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(b) of the Exchange Act and the rules and regulations of the SEC. All services rendered by Ernst & Young for the year ended December 31,
2011 were pre-approved in accordance with the policies and procedures described above.
107
PART IV
Item 15. Exhibits, Financial Statement Schedules.
(a)(1)
Financial Statements:
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page
|
|
Report of Independent Registered Public Accounting Firm
|
|
|
109
|
|
Consolidated Balance Sheets as of December 31, 2011 and 2010
|
|
|
110
|
|
Consolidated Statements of Operations for the Years Ended December
31, 2011 and 2010 and for the Period from January 7, 2009 (Date of Inception) through December 31, 2009
|
|
|
111
|
|
Consolidated Statements of Equity for the Years Ended December
31, 2011 and 2010 and for the Period from January 7, 2009 (Date of Inception) through December 31, 2009
|
|
|
112
|
|
Consolidated Statements of Cash Flows for the Years Ended December
31, 2011 and 2010 and for the Period from January 7, 2009 (Date of Inception) through December 31, 2009
|
|
|
113
|
|
Notes to Consolidated Financial Statements
|
|
|
114
|
|
(a)(2)
Financial Statement Schedule:
The following financial statement schedule for the year ended December 31, 2011 is submitted herewith:
All schedules other than the one listed above have been omitted as the required information is
inapplicable or the information is presented in our consolidated financial statements or related notes.
(a)(3)
Exhibits:
The exhibits listed on the Exhibit Index (following the signatures section of this report) are included, or
incorporated by reference, in this annual report.
(b)
Exhibits:
See Item 15(a)(3) above.
(c)
Financial Statement Schedule:
|
|
|
September 30,
|
|
|
|
Page
|
|
Real Estate and Accumulated Depreciation (Schedule III)
|
|
|
158
|
|
108
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of
Griffin-American Healthcare REIT II, Inc.
We have audited the accompanying
consolidated balance sheets of Griffin-American Healthcare REIT II, Inc. (the Company) as of December 31, 2011 and 2010, and the related consolidated statements of operations, equity and cash flows for the years ended
December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009. Our audits also included the financial statement schedule listed in the Index at Item 15(a). These financial
statements and the schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements and the schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Companys internal control over
financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position
of Griffin-American Healthcare REIT II, Inc. at December 31, 2011 and 2010 and the consolidated results of its operations and its cash flows for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date
of Inception) through December 31, 2009, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the financial statement schedule, when considered in relation to the basic financial statements taken as a whole,
presents fairly in all material respects the information set forth therein.
/s/ Ernst & Young LLP
Irvine, California
March 15, 2012
109
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
CONSOLIDATED BALANCE SHEETS
As of December 31, 2011 and 2010
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
Real estate investments:
|
|
|
|
|
|
|
|
|
Operating properties, net
|
|
$
|
369,317,000
|
|
|
$
|
163,335,000
|
|
Cash and cash equivalents
|
|
|
44,682,000
|
|
|
|
6,018,000
|
|
Accounts and other receivables, net
|
|
|
1,763,000
|
|
|
|
241,000
|
|
Accounts receivable due from affiliate
|
|
|
121,000
|
|
|
|
|
|
Restricted cash
|
|
|
2,289,000
|
|
|
|
2,816,000
|
|
Real estate and escrow deposits
|
|
|
7,550,000
|
|
|
|
649,000
|
|
Identified intangible assets, net
|
|
|
66,115,000
|
|
|
|
28,568,000
|
|
Other assets, net
|
|
|
7,315,000
|
|
|
|
2,369,000
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
499,152,000
|
|
|
$
|
203,996,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
Mortgage loans payable, net
|
|
$
|
80,466,000
|
|
|
$
|
58,331,000
|
|
Lines of credit
|
|
|
|
|
|
|
11,800,000
|
|
Accounts payable and accrued liabilities
|
|
|
7,703,000
|
|
|
|
3,356,000
|
|
Accounts payable due to affiliates
|
|
|
1,111,000
|
|
|
|
840,000
|
|
Derivative financial instruments
|
|
|
819,000
|
|
|
|
453,000
|
|
Identified intangible liabilities, net
|
|
|
623,000
|
|
|
|
502,000
|
|
Security deposits, prepaid rent and other liabilities
|
|
|
10,950,000
|
|
|
|
3,352,000
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
101,672,000
|
|
|
|
78,634,000
|
|
|
|
|
Commitments and contingencies (Note 10)
|
|
|
|
|
|
|
|
|
|
|
|
Equity:
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding
|
|
|
|
|
|
|
|
|
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 48,869,669 and 15,452,668 shares issued and
outstanding as of December 31, 2011 and 2010, respectively
|
|
|
489,000
|
|
|
|
154,000
|
|
Additional paid-in capital
|
|
|
435,252,000
|
|
|
|
137,657,000
|
|
Accumulated deficit
|
|
|
(38,384,000
|
)
|
|
|
(12,571,000
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
397,357,000
|
|
|
|
125,240,000
|
|
Noncontrolling interests (Note 12)
|
|
|
123,000
|
|
|
|
122,000
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
397,480,000
|
|
|
|
125,362,000
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
$
|
499,152,000
|
|
|
$
|
203,996,000
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
110
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Years Ended December 31, 2011 and 2010 and for the Period from
January 7, 2009 (Date of Inception) through December 31, 2009
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
|
|
|
|
|
Period from
|
|
|
|
|
|
|
|
|
|
January 7, 2009
|
|
|
|
Years Ended
|
|
|
(Date of Inception)
|
|
|
|
December 31,
|
|
|
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental income
|
|
$
|
40,457,000
|
|
|
$
|
8,682,000
|
|
|
$
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental expenses
|
|
|
8,330,000
|
|
|
|
2,201,000
|
|
|
|
|
|
General and administrative
|
|
|
5,992,000
|
|
|
|
1,670,000
|
|
|
|
268,000
|
|
Acquisition related expenses
|
|
|
10,389,000
|
|
|
|
7,099,000
|
|
|
|
18,000
|
|
Depreciation and amortization
|
|
|
14,826,000
|
|
|
|
3,591,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
39,537,000
|
|
|
|
14,561,000
|
|
|
|
286,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
920,000
|
|
|
|
(5,879,000
|
)
|
|
|
(286,000
|
)
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense (including amortization of deferred financing costs and debt discount and premium):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(6,345,000
|
)
|
|
|
(1,416,000
|
)
|
|
|
|
|
Loss in fair value of derivative financial instruments
|
|
|
(366,000
|
)
|
|
|
(143,000
|
)
|
|
|
|
|
Interest income
|
|
|
17,000
|
|
|
|
15,000
|
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(5,774,000
|
)
|
|
|
(7,423,000
|
)
|
|
|
(282,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net (income) loss attributable to noncontrolling interests
|
|
|
(2,000
|
)
|
|
|
(1,000
|
)
|
|
|
1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to controlling interest
|
|
$
|
(5,776,000
|
)
|
|
$
|
(7,424,000
|
)
|
|
$
|
(281,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share attributable to controlling interest basic and diluted
|
|
$
|
(0.19
|
)
|
|
$
|
(0.99
|
)
|
|
$
|
(1.51
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding basic and diluted
|
|
|
30,808,725
|
|
|
|
7,471,184
|
|
|
|
186,330
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
111
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
CONSOLIDATED STATEMENTS OF EQUITY
For the Years Ended December 31, 2011 and 2010 and for the Period from
January 7, 2009 (Date of Inception) through December 31, 2009
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Stockholders Equity
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
of
|
|
|
|
|
|
Additional
|
|
|
Preferred
|
|
|
Accumulated
|
|
|
Noncontrolling
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Paid-In Capital
|
|
|
Stock
|
|
|
Deficit
|
|
|
Interests
|
|
|
Total Equity
|
|
BALANCE - January 7, 2009 (Date of Inception)
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Issuance of common stock
|
|
|
1,517,268
|
|
|
|
15,000
|
|
|
|
15,103,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,118,000
|
|
Issuance of vested and nonvested restricted common stock
|
|
|
15,000
|
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
Offering costs
|
|
|
|
|
|
|
|
|
|
|
(1,589,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,589,000
|
)
|
Amortization of nonvested common stock compensation
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
Noncontrolling interest contribution to operating partnership
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
2,000
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(281,000
|
)
|
|
|
(1,000
|
)
|
|
|
(282,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE - December 31, 2009
|
|
|
1,532,268
|
|
|
|
15,000
|
|
|
|
13,549,000
|
|
|
|
|
|
|
|
(281,000
|
)
|
|
|
1,000
|
|
|
|
13,284,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock
|
|
|
13,724,945
|
|
|
|
137,000
|
|
|
|
136,807,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
136,944,000
|
|
Offering costs
|
|
|
|
|
|
|
|
|
|
|
(14,785,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14,785,000
|
)
|
Issuance of vested and nonvested restricted common stock
|
|
|
7,500
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
Issuance of common stock under the DRIP
|
|
|
208,955
|
|
|
|
2,000
|
|
|
|
1,983,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,985,000
|
|
Repurchase of common stock
|
|
|
(21,000
|
)
|
|
|
|
|
|
|
(210,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(210,000
|
)
|
Amortization of nonvested common stock compensation
|
|
|
|
|
|
|
|
|
|
|
39,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,000
|
|
Contribution from sponsor
|
|
|
|
|
|
|
|
|
|
|
259,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
259,000
|
|
Contribution from noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
|
|
200,000
|
|
Distribution to noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(80,000
|
)
|
|
|
(80,000
|
)
|
Distributions declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,866,000
|
)
|
|
|
|
|
|
|
(4,866,000
|
)
|
Net (loss) income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,424,000
|
)
|
|
|
1,000
|
|
|
|
(7,423,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCEDecember 31, 2010
|
|
|
15,452,668
|
|
|
$
|
154,000
|
|
|
$
|
137,657,000
|
|
|
$
|
|
|
|
$
|
(12,571,000
|
)
|
|
$
|
122,000
|
|
|
$
|
125,362,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock
|
|
|
32,609,245
|
|
|
|
327,000
|
|
|
|
325,117,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
325,444,000
|
|
Offering costs
|
|
|
|
|
|
|
|
|
|
|
(35,199,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35,199,000
|
)
|
Issuance of vested and nonvested restricted common stock
|
|
|
7,500
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
Issuance of common stock under the DRIP
|
|
|
928,058
|
|
|
|
9,000
|
|
|
|
8,808,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,817,000
|
|
Repurchase of common stock
|
|
|
(127,802
|
)
|
|
|
(1,000
|
)
|
|
|
(1,197,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,198,000
|
)
|
Amortization of nonvested common stock compensation
|
|
|
|
|
|
|
|
|
|
|
51,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51,000
|
|
Distribution to noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000
|
)
|
|
|
(1,000
|
)
|
Distributions declared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,037,000
|
)
|
|
|
|
|
|
|
(20,037,000
|
)
|
Net (loss) income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,776,000
|
)
|
|
|
2,000
|
|
|
|
(5,774,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCEDecember 31, 2011
|
|
|
48,869,669
|
|
|
$
|
489,000
|
|
|
$
|
435,252,000
|
|
|
$
|
|
|
|
$
|
(38,384,000
|
)
|
|
$
|
123,000
|
|
|
$
|
397,480,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
112
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2011 and 2010 and for the Period from
January 7, 2009 (Date of Inception) through December 31, 2009
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
|
|
|
|
|
Period from
|
|
|
|
|
|
|
|
|
|
January 7, 2009
|
|
|
|
Years Ended
|
|
|
(Date of Inception)
|
|
|
|
December 31,
|
|
|
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(5,774,000
|
)
|
|
$
|
(7,423,000
|
)
|
|
$
|
(282,000
|
)
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization (including deferred financing costs, above/below market leases, leasehold interests, debt discount
and premium and deferred rent receivables)
|
|
|
13,812,000
|
|
|
|
3,349,000
|
|
|
|
|
|
Stock based compensation
|
|
|
66,000
|
|
|
|
54,000
|
|
|
|
35,000
|
|
Bad debt expense
|
|
|
261,000
|
|
|
|
5,000
|
|
|
|
|
|
Changes in fair value of derivative financial instruments
|
|
|
366,000
|
|
|
|
143,000
|
|
|
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts and other receivables
|
|
|
(1,508,000
|
)
|
|
|
(246,000
|
)
|
|
|
|
|
Other assets
|
|
|
(468,000
|
)
|
|
|
(235,000
|
)
|
|
|
(36,000
|
)
|
Accounts payable and accrued liabilities
|
|
|
2,489,000
|
|
|
|
1,735,000
|
|
|
|
178,000
|
|
Accounts payable due to affiliates
|
|
|
326,000
|
|
|
|
129,000
|
|
|
|
65,000
|
|
Security deposits, prepaid rent and other liabilities
|
|
|
(306,000
|
)
|
|
|
(392,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
9,264,000
|
|
|
|
(2,881,000
|
)
|
|
|
(40,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of real estate operating properties
|
|
|
(213,856,000
|
)
|
|
|
(182,818,000
|
)
|
|
|
|
|
Capital expenditures
|
|
|
(3,459,000
|
)
|
|
|
(59,000
|
)
|
|
|
|
|
Restricted cash
|
|
|
527,000
|
|
|
|
(2,816,000
|
)
|
|
|
|
|
Real estate and escrow deposits
|
|
|
(6,901,000
|
)
|
|
|
(649,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(223,689,000
|
)
|
|
|
(186,342,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings on mortgage loans payable
|
|
|
43,700,000
|
|
|
|
51,110,000
|
|
|
|
|
|
Payments on mortgage loans payable
|
|
|
(55,429,000
|
)
|
|
|
(245,000
|
)
|
|
|
|
|
Borrowings under the lines of credit
|
|
|
284,551,000
|
|
|
|
76,850,000
|
|
|
|
|
|
Payments under the lines of credit
|
|
|
(296,351,000
|
)
|
|
|
(65,050,000
|
)
|
|
|
|
|
Proceeds from issuance of common stock
|
|
|
325,444,000
|
|
|
|
136,944,000
|
|
|
|
15,118,000
|
|
Deferred financing costs
|
|
|
(2,851,000
|
)
|
|
|
(1,587,000
|
)
|
|
|
|
|
Repurchase of common stock
|
|
|
(1,198,000
|
)
|
|
|
(210,000
|
)
|
|
|
|
|
Contribution from sponsor
|
|
|
|
|
|
|
259,000
|
|
|
|
|
|
Contribution from noncontrolling interest to our operating partnership
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
Distributions to noncontrolling interests
|
|
|
(1,000
|
)
|
|
|
(80,000
|
)
|
|
|
|
|
Security deposits
|
|
|
(104,000
|
)
|
|
|
6,000
|
|
|
|
|
|
Payments of offering costs
|
|
|
(35,297,000
|
)
|
|
|
(14,442,000
|
)
|
|
|
(1,307,000
|
)
|
Distributions paid
|
|
|
(9,375,000
|
)
|
|
|
(2,087,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
253,089,000
|
|
|
|
181,468,000
|
|
|
|
13,813,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS
|
|
|
38,664,000
|
|
|
|
(7,755,000
|
)
|
|
|
13,773,000
|
|
CASH AND CASH EQUIVALENTS Beginning of period
|
|
|
6,018,000
|
|
|
|
13,773,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS End of period
|
|
$
|
44,682,000
|
|
|
$
|
6,018,000
|
|
|
$
|
13,773,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
5,199,000
|
|
|
$
|
898,000
|
|
|
$
|
|
|
SUPPLEMENTAL DISCLOSURE OF NONCASH ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued capital expenditures
|
|
$
|
396,000
|
|
|
$
|
407,000
|
|
|
$
|
|
|
The following represents the increase in certain assets and liabilities in connection with our acquisitions of operating
properties:
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
$
|
451,000
|
|
|
$
|
153,000
|
|
|
$
|
|
|
Mortgage loans payable, net
|
|
$
|
33,941,000
|
|
|
$
|
7,439,000
|
|
|
$
|
|
|
Derivative financial instrument
|
|
$
|
|
|
|
$
|
310,000
|
|
|
$
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
315,000
|
|
|
$
|
233,000
|
|
|
$
|
|
|
Security deposits, prepaid rent and other liabilities
|
|
$
|
7,766,000
|
|
|
$
|
3,738,000
|
|
|
$
|
|
|
|
|
|
|
Financing Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under the DRIP
|
|
$
|
8,817,000
|
|
|
$
|
1,985,000
|
|
|
$
|
|
|
Distributions declared but not paid
|
|
$
|
2,639,000
|
|
|
$
|
794,000
|
|
|
$
|
|
|
Contribution from noncontrolling interest
|
|
$
|
|
|
|
$
|
200,000
|
|
|
$
|
|
|
Accrued offering costs
|
|
$
|
527,000
|
|
|
$
|
625,000
|
|
|
$
|
282,000
|
|
Accrued deferred financing costs
|
|
$
|
12,000
|
|
|
$
|
28,000
|
|
|
$
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
113
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb
& Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Years Ended December 31, 2011 and 2010 and for the Period from
January 7, 2009 (Date of Inception) through December 31, 2009
The use of the words we, us or our refers to Griffin-American Healthcare REIT II, Inc. and its
subsidiaries, including Griffin-American Healthcare REIT II Holdings, LP, except where the context otherwise requires.
1. Organization and Description of Business
Griffin-American Healthcare REIT II, Inc., a Maryland corporation, was incorporated as Grubb & Ellis
Healthcare REIT II, Inc. on January 7, 2009 and therefore we consider that our date of inception. We were initially capitalized on February 4, 2009. Our board of directors adopted an amendment to our charter, which was filed with the
Maryland State Department of Assessments and Taxation on January 3, 2012, to change our corporate name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American Healthcare REIT II, Inc. We intend to invest in a diversified
portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We may also originate and acquire secured loans and real estate-related investments. We generally seek investments that produce
current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, or the Code, for federal income tax purposes beginning with our taxable year ended December 31, 2010 and
we intend to continue to be taxed as a REIT.
We are conducting a best efforts initial public offering, or our offering, in
which we are offering to the public up to 300,000,000 shares of our common stock for $10.00 per share in our primary offering and 30,000,000 shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, for $9.50 per share,
for a maximum offering of up to $3,285,000,000. The United States Securities and Exchange Commission, or SEC, declared our registration statement effective as of August 24, 2009. We will sell shares of our common stock in our offering until the
earlier of August 24, 2012, or the date on which the maximum offering amount has been sold; provided, however, that our board of directors may extend our offering as permitted under applicable law, or we may extend our offering with respect to
shares of our common stock offered pursuant to the DRIP. However, we reserve the right to terminate our offering at any time prior to such termination date. As of December 31, 2011, we had received and accepted subscriptions in our offering for
47,831,458 shares of our common stock, or $477,306,000, excluding shares of our common stock issued pursuant to the DRIP.
We
conduct substantially all of our operations through Griffin-American Healthcare REIT II Holdings, LP, or our operating partnership. On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with
the Delaware Department of State to change its name from Grubb & Ellis Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP. Until January 6, 2012, we were externally advised by Grubb & Ellis
Healthcare REIT II Advisor, LLC, or our former advisor, pursuant to an advisory agreement, as amended and restated, or the G&E Advisory Agreement, between us and our former advisor. From August 24, 2009 through January 6, 2012, our
former advisor supervised and managed our day-to-day operations and selected the properties and real estate-related investments we acquired, subject to the oversight and approval of our board of directors. Our former advisor also provided marketing,
sales and client services on our behalf and engaged affiliated entities to provide various services to us. Our former advisor is managed by and is a wholly owned subsidiary of Grubb & Ellis Equity Advisors, LLC, or GEEA, which is a wholly
owned subsidiary of Grubb & Ellis Company, or Grubb & Ellis, or our former sponsor.
On November 7,
2011, our independent directors determined that it is in the best interests of our company and its stockholders to transition advisory and dealer manager services rendered to us by affiliates of Grubb & Ellis and to engage American
Healthcare Investors LLC, or American Healthcare Investors, and Griffin Capital Corporation, or Griffin Capital, as replacement co-sponsors, or our co-sponsors. As a result, on November 7, 2011, we notified our former advisor that we terminated
the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty; however, certain rights and obligations of the parties would survive during a 60-day
transition period and beyond.
114
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In addition, on November 7, 2011, we notified Grubb & Ellis Capital
Corporation that we terminated the Amended and Restated Dealer Manager Agreement dated June 1, 2011 between us and Grubb & Ellis Capital Corporation, or the G&E Dealer Manager Agreement, in accordance with the terms thereof. Until
January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
As a result of the co-sponsorship arrangement, an affiliate of Griffin Capital, Griffin-American Healthcare REIT Advisor, LLC, or Griffin-American Advisor, or our advisor, serves as our new advisor and
delegates advisory duties to Griffin-American Healthcare REIT Sub-Advisor, LLC, or Griffin-American Sub-Advisor, or our sub-advisor. Griffin-American Sub-Advisor is jointly owned by our co-sponsors. Our advisor, through our sub-advisor, uses its
best efforts, subject to the oversight, review and approval of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our
investment policies and objectives. Our advisor performs its duties and responsibilities under an advisory agreement, or the Advisory Agreement, as our fiduciary. Our sub-advisor performs its duties and responsibilities pursuant to a sub-advisory
agreement with our advisor and also acts as our fiduciary. Collectively, we refer to our advisor and our sub-advisor as our advisor entities. Griffin Capital Securities, Inc., or Griffin Securities, or our dealer manager, an affiliate of Griffin
Capital, serves as our new dealer manager pursuant to a dealer manager agreement, or the Dealer Manager Agreement. We are not affiliated with Griffin Capital, Griffin-American Advisor or Griffin Securities; however, we are affiliated with
Griffin-American Sub-Advisor and American Healthcare Investors.
American Healthcare Investors and Griffin Capital have agreed
to pay the majority of the expenses we have incurred in connection with the transition to our co-sponsors.
The Advisory
Agreement with Griffin-American Advisor took effect on January 7, 2012 upon the expiration of the 60-day transition period provided for in the G&E Advisory Agreement. The Dealer Manager Agreement with Griffin Securities also became
effective January 7, 2012.
We currently operate through three reportable business segments medical office
buildings, hospitals and skilled nursing facilities. As of December 31, 2011, we had completed 25 acquisitions comprising 56 buildings and approximately 1,987,000 square feet of gross leasable area, or GLA, for an aggregate purchase price of
$438,625,000.
2. Summary of Significant Accounting Policies
The summary of significant accounting policies presented below is designed to assist in understanding our consolidated
financial statements. Such consolidated financial statements and the accompanying notes thereto are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting
principles generally accepted in the United States of America, or GAAP, in all material respects, and have been consistently applied in preparing our accompanying consolidated financial statements.
Basis of Presentation
Our accompanying consolidated financial statements include our accounts and those of our operating partnership, the wholly owned subsidiaries of our operating partnership and all non-wholly owned
subsidiaries and any variable interest entities, or VIEs, as defined in Financial Accounting Standards Boards, or FASB, Accounting Standards Codification, or ASC, Topic 810,
Consolidation
, or ASC Topic 810, which we have concluded should be
consolidated pursuant to ASC Topic 810. We operate and intend to continue to operate in an umbrella partnership REIT structure in which our operating partnership, or wholly owned subsidiaries of our operating partnership, will own substantially all
of the properties acquired on our behalf. We are the sole general partner of our operating partnership and as of December 31, 2011 and 2010 own a 99.99% general partnership interest therein. Our former advisor is a limited partner and as of
December 31, 2011 and 2010 owns less than a 0.01% noncontrolling limited partnership interest in our operating partnership. Because we are the sole general partner of our operating partnership and have unilateral control over its management and
major operating decisions, the accounts of our operating partnership are consolidated in our consolidated financial statements. All significant intercompany accounts and transactions are eliminated in consolidation.
115
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In preparing our accompanying consolidated financial statements, management has
evaluated subsequent events through the financial statement issuance date. We believe that the disclosures contained herein are adequate to prevent the information presented from being misleading.
Use of Estimates
The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates are made and evaluated on an on-going basis using information that is currently available as
well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or
conditions.
Cash and Cash Equivalents
Cash and cash equivalents consist of all highly liquid investments with a maturity of three months or less when purchased.
Restricted Cash
Restricted cash is primarily comprised of lender
required accounts for property taxes, insurance, capital improvements and tenant improvements which are restricted as to use or withdrawal.
Restricted Cash Held in Escrow
Restricted funds held in escrow of $21,000 as of December 31, 2010 are not included in our assets in our accompanying consolidated balance sheets and consist of funds received from residents of
Pennsylvania in connection with subscription agreements to purchase shares of our common stock in connection with our offering. We were required to raise $164,250,000 in our offering, or the funds raised from residents of Pennsylvania, including
interest, would have been returned to the subscribers. Therefore, as of December 31, 2010, the funds from residents of Pennsylvania were held in an escrow account and were not released to or available to us until $164,250,000 was raised.
On January 21, 2011, we satisfied the $164,250,000 minimum offering amount required by the State of Pennsylvania in
connection with our offering and began accepting subscriptions from Pennsylvania investors.
Revenue Recognition, Tenant Receivables and
Allowance for Uncollectible Accounts
We recognize revenue in accordance with ASC Topic 605,
Revenue
Recognition
, or ASC Topic 605. ASC Topic 605 requires that all four of the following basic criteria be met before revenue is realized or realizable and earned: (1) there is persuasive evidence that an arrangement exists; (2) delivery
has occurred or services have been rendered; (3) the sellers price to the buyer is fixed and determinable; and (4) collectability is reasonably assured.
In accordance with ASC Topic 840,
Leases
, minimum annual rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). Differences
between rental income recognized and amounts contractually due under the lease agreements are credited or charged, as applicable, to deferred rent receivable or deferred rent liability, as applicable. Tenant reimbursement revenue, which is comprised
of additional amounts recoverable from tenants for common area maintenance expenses and certain other recoverable expenses, is recognized as revenue in the period in which the related expenses are incurred. Tenant reimbursements are recognized and
presented in accordance with ASC Subtopic 605-45,
Revenue Recognition Principal Agent
116
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Consideration
, or ASC Subtopic 605-45. ASC Subtopic 605-45 requires that these reimbursements be recorded on a gross basis, as we are generally the primary obligor with respect to
purchasing goods and services from third-party suppliers, have discretion in selecting the supplier and have credit risk. We recognize lease termination fees at such time when there is a signed termination letter agreement, all of the conditions of
such agreement have been met and the tenant is no longer occupying the property.
Tenant receivables and unbilled deferred
rent receivables are carried net of an allowance for uncollectible amounts. An allowance is maintained for estimated losses resulting from the inability of certain tenants to meet the contractual obligations under their lease agreements. We maintain
an allowance for deferred rent receivables arising from the straight line recognition of rents. Such allowance is charged to bad debt expense which is included in general and administrative in our accompanying consolidated statements of operations.
Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the tenants financial condition, security deposits, letters of credit, lease guarantees and current economic conditions
and other relevant factors. As of December 31, 2011 and 2010, we had $107,000 and $5,000, respectively, in allowance for uncollectible accounts which was determined necessary to reduce receivables to our estimate of the amount recoverable. For
the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, $154,000, $0 and $0, respectively of our deferred rent receivables were directly written off to bad debt
expense and none of our receivables were directly written off to bad debt expense.
Operating Properties, Net
We carry our operating properties at historical cost less accumulated depreciation. The cost of operating properties includes the cost of
land and completed buildings and related improvements. Expenditures that increase the service life of properties are capitalized and the cost of maintenance and repairs is charged to expense as incurred. The cost of buildings and capital
improvements is depreciated on a straight-line basis over the estimated useful lives of the buildings and capital improvements, up to 39 years, and the cost for tenant improvements is depreciated over the shorter of the lease term or useful
life, ranging from five months to 15.1 years. Furniture, fixtures and equipment is depreciated over the estimated useful life, ranging from five years to seven years. When depreciable property is retired, replaced or disposed of, the related costs
and accumulated depreciation will be removed from the accounts and any gain or loss will be reflected in earnings.
As part of
the leasing process, we may provide the lessee with an allowance for the construction of leasehold improvements. These leasehold improvements are capitalized and recorded as tenant improvements and depreciated over the shorter of the useful life of
the improvements or the lease term. If the allowance represents a payment for a purpose other than funding leasehold improvements, or in the event we are not considered the owner of the improvements, the allowance is considered to be a lease
inducement and is recognized over the lease term as a reduction of rental revenue on a straight-line basis. Factors considered during this evaluation include, among other things, who holds legal title to the improvements as well as other controlling
rights provided by the lease agreement and provisions for substantiation of such costs (e.g. unilateral control of the tenant space during the build-out process). Determination of the appropriate accounting for the payment of a tenant allowance is
made on a lease-by-lease basis, considering the facts and circumstances of the individual tenant lease. Recognition of lease revenue commences when the lessee is given possession of the leased space upon completion of tenant improvements when we are
the owner of the leasehold improvements. However, when the leasehold improvements are owned by the tenant, the lease inception date (and the date on which recognition of lease revenue commences) is the date the tenant obtains possession of the
leased space for purposes of constructing its leasehold improvements.
We assess the impairment of an operating property when
events or changes in circumstances indicate that its carrying amount may not be recoverable. Impairment losses are recorded on an operating property when indicators of impairment are present and the carrying amount exceeds the sum of the future
undiscounted cash flows expected to be generated to result from the use and eventual disposition of the property. We would recognize an impairment loss to the extent the carrying amount exceeded the estimated fair value of the property. For the
years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2010, there were no impairment losses recorded.
117
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Property Acquisitions
In accordance with ASC Topic 805,
Business Combinations
, we, with assistance from independent valuation specialists, measure the
fair value of tangible and identified intangible assets and liabilities based on their respective fair values for acquired properties. The determination of the fair value of land is based upon comparable sales data. In cases where a leasehold
interest in the land is acquired, the value of the leasehold interest is determined by discounting the difference between the contract ground lease payments and a market ground lease payment back to a present value as of the acquisition date. The
market ground lease payment is estimated as a percentage of the land value. The fair value of buildings is based upon our determination of the value as if it were to be replaced and vacant using cost data and discounted cash flow models similar to
those used by independent appraisers. We would also recognize the fair value of furniture, fixtures and equipment on the premises, if any, as well as the above or below market value of in-place leases, the value of in-place lease costs, tenant
relationships, master leases and above or below market debt and derivative financial instruments assumed. Factors considered by us include an estimate of carrying costs during the expected lease-up periods considering current market conditions and
costs to execute similar leases.
The value of the above or below market component of the acquired in-place leases is
determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference between: (1) the contractual amounts to be paid pursuant to the lease over its remaining term and
(2) our estimate of the amounts that would be paid using fair market rates over the remaining term of the lease (including considering the impact of renewal options). The amounts related to above market leases are included in identified
intangible assets, net in our accompanying consolidated balance sheets and are amortized to rental income over the remaining non-cancelable lease term of the acquired leases with each property. The amounts related to below market leases are included
in identified intangible liabilities, net in our accompanying consolidated balance sheets and are amortized to rental income over the remaining non-cancelable lease term plus any below market renewal options of the acquired leases with each
property.
The value of in-place lease costs and the value of tenant relationships is based on managements evaluation of
the specific characteristics of the tenants lease and our overall relationship with the tenants. Characteristics considered by us in allocating these values include the nature and extent of the credit quality and expectations of lease
renewals, among other factors. The amounts related to in-place lease costs are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized to depreciation and amortization expense over the average
remaining non-cancelable lease term of the acquired leases with each property. The amounts related to the value of tenant relationships are included in identified intangible assets, net in our accompanying consolidated balance sheets and are
amortized to depreciation and amortization expense over the average remaining non-cancelable lease term of the acquired leases plus the market renewal lease term. The value of a master lease, in which a previous owner or a tenant is relieved of
specific rental obligations as additional space is leased, is determined by discounting the expected rental income associated with the master lease space over the assumed lease-up period.
The value of above or below market debt is determined based upon the present value of the difference between the cash flow stream of the
assumed mortgage and the cash flow stream of a market rate mortgage at the time of assumption. The value of above or below market debt is included in mortgage loans payable, net in our accompanying consolidated balance sheets and is amortized to
interest expense over the remaining term of the assumed mortgage.
The value of derivative financial instruments is determined
in accordance with ASC Topic 820,
Fair Value Measurements and Disclosures
, or ASC Topic 820, and is included in derivative financial instruments in our accompanying consolidated balance sheets. See Note 13, Fair Value Measurements, for a
further discussion.
The values of contingent consideration assets and liabilities are analyzed at the time of acquisition.
For contingent purchase options, the fair market value of the asset is compared to the specified option price at the exercise date. If the option price is below market, it is assumed to be exercised and the difference between the fair market
value and the option price is discounted to the present value at the time of acquisition.
118
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The fair values are subject to change based on information received within one year of
the purchase related to one or more events identified at the time of purchase which confirm the value of an asset or liability received in an acquisition of property.
Derivative Financial Instruments
We are exposed to the effect of
interest rate changes in the normal course of business. We seek to mitigate these risks by following established risk management policies and procedures which include the occasional use of derivatives. Our primary strategy in entering into
derivative contracts is to add stability to interest expense and to manage our exposure to interest rate movements. We utilize derivative instruments, including interest rate swaps, to effectively convert a portion of our variable rate debt to fixed
rate debt. We do not enter into derivative instruments for speculative purposes.
Derivatives are recognized as either assets
or liabilities in our accompanying consolidated balance sheets and are measured at fair value in accordance with ASC Topic 815,
Derivatives and Hedging,
or ASC Topic 815. ASC Topic 815 establishes accounting and reporting standards for
derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Since our derivative instruments are not designated as hedge instruments, they do not qualify for hedge accounting under ASC
Topic 815, and accordingly, changes in fair value are included as a component of interest expense in gain (loss) in fair value of derivative financial instruments in our accompanying consolidated statements of operations.
See Note 7, Derivative Financial Instruments and Note 13, Fair Value Measurements, for a further discussion.
Fair Value Measurements
We follow ASC Topic 820 to account for the fair value of certain assets and liabilities. ASC Topic 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about
fair value measurements. ASC Topic 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements; accordingly, the standard does not require any new fair value measurements of
reported balances.
ASC Topic 820 emphasizes that fair value is a market-based measurement, not an entity-specific
measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value
measurements, ASC Topic 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within
Levels 1 and 2 of the hierarchy) and the reporting entitys own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that we have the ability to
access. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices
included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or
liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an
entitys own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value
hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value
measurement in its entirety requires judgment and considers factors specific to the asset or liability.
See Note 13, Fair
Value Measurements, for a further discussion.
119
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Real Estate and Escrow Deposits
Real estate and escrow deposits include funds held by escrow agents and others to be applied towards the purchase of real estate.
Other Assets, Net
Other assets, net consist primarily of deferred rent receivables, deferred financing costs, prepaid expenses and deposits, leasing commissions and contingent consideration asset. Deferred financing costs
include amounts paid to lenders and others to obtain financing. Such costs are amortized using the straight-line method over the term of the related loan, which approximates the effective interest rate method. Amortization of deferred financing
costs is included in interest expense in our accompanying consolidated statements of operations. Leasing commissions are amortized using the straight-line method over the term of the related lease. Amortization of leasing commissions is included in
depreciation and amortization in our accompanying consolidated statements of operations.
See Note 5, Other Assets, Net, for a
further discussion.
Other Liabilities
As of December 31, 2011 and 2010, included in security deposits, prepaid rent and other liabilities in our accompanying consolidated balance sheets is $6,058,000 and $0, respectively, of contingent
purchase price consideration in connection with the acquisition of Yuma Skilled Nursing Facility, Philadelphia SNF Portfolio and Maxfield Medical Office Building. Such amounts are due upon certain criteria being met within specified timeframes.
See Note 13, Fair Value Measurements Assets and Liabilities Reported at Fair Value Contingent Consideration,
for a further discussion.
Stock Compensation
We follow ASC Topic 718,
Compensation Stock Compensation
, or ASC Topic 718, to account for our stock compensation pursuant to the 2009 Incentive Plan, or our incentive plan. See
Note 12, Equity 2009 Incentive Plan, for a further discussion of grants under our incentive plan.
Income Taxes
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31,
2010. To maintain our qualification as a REIT, we must meet certain organizational and operational requirements, including a requirement to currently distribute at least 90.0% of our annual taxable income, excluding net capital gains, to
stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to
qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost unless the Internal Revenue Service, or the IRS, grants us relief under certain statutory provisions. Such an event
could materially adversely affect our net income and net cash available for distribution to stockholders. Because of our election of REIT status for 2010, we did not benefit from the loss incurred for the year ended December 31, 2009.
We follow ASC Topic 740,
Income Taxes
, to recognize, measure, present and disclose in our consolidated financial
statements uncertain tax positions that we have taken or expect to take on a tax return. As of December 31, 2011 and 2010, we did not have any liabilities for uncertain tax positions that we believe should be recognized in our consolidated
financial statements.
120
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Segment Disclosure
ASC Topic 280,
Segment Reporting
, establishes standards for reporting financial and descriptive information about a public
entitys reportable segments. As of December 31, 2011, we operate through three reportable business segments medical office buildings, hospitals and skilled nursing facilities. With the continued expansion of our portfolio, we
believe segregation of our operations into three reporting segments would be useful in assessing the performance of our business in the same way that management intends to review our performance and make operating decisions. Prior to 2011, we
operated through one reportable segment. See Note 17, Segment Reporting, for a further discussion.
Square Footage
Square footage used to describe real estate investments included in our accompanying consolidated financial statements are presented on
an unaudited basis.
Recently Issued Accounting Pronouncements
In January 2010, the FASB issued Accounting Standards Update, or ASU, 2010-06,
Improving Disclosures about Fair Value
Measurements
, or ASU 2010-06. ASU 2010-06 amends ASC Topic 820,
Fair Value Measurements and Disclosures
, or ASC Topic 820, to require additional disclosure and clarify existing disclosure requirements about fair value measurements. ASU
2010-06 requires entities to provide fair value disclosures by each class of assets and liabilities, which may be a subset of assets and liabilities within a line item in the statement of financial position. The additional requirements also include
disclosure regarding the amounts and reasons for significant transfers in and out of Level 1 and 2 of the fair value hierarchy and separate presentation of purchases, sales, issuances and settlements of items within Level 3 of the fair value
hierarchy. The guidance clarifies existing disclosure requirements regarding the inputs and valuation techniques used to measure fair value for measurements that fall in either Level 2 or Level 3 of the hierarchy. ASU 2010-06 is effective for
interim and annual reporting periods beginning after December 15, 2009 except for the disclosures about purchases, sales, issuances and settlements, which disclosure requirements are effective for fiscal years beginning after December 15,
2010 and for interim periods within those fiscal years. We adopted ASU 2010-06 on January 1, 2010 and January 1, 2011, as applicable, which only applies to our disclosures on the fair value of financial instruments. The adoption of ASU
2010-06 did not have a material impact on our footnote disclosures. We have provided the applicable disclosures in Note 13, Fair Value Measurements.
In December 2010, the FASB issued ASU 2010-29,
Business Combinations (Topic 805),
or ASU 2010-29. ASU 2010-29 amends ASC Topic 805 to require the disclosure of pro forma revenue and earnings
for all business combinations that occurred during the current year to be presented as of the beginning of the comparable prior annual reporting period. The amendments in ASU 2010-29 also expand the supplemental pro forma disclosures to include a
description of the nature and amount of material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings. ASU 2010-29 is effective for business combinations for
which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010. Early adoption is permitted. We adopted ASU 2010-29 upon issuance in December 2010 and have provided such
pro forma revenue and earnings disclosures in Note 16, Business Combinations. The adoption of ASU 2010-29 did not have a material impact on our consolidated financial statements.
121
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In May 2011, the FASB issued ASU 2011-04,
Amendments to Achieve Common Fair Value
Measurements and Disclosure Requirements in U.S. GAAP and IFRSs,
or ASU 2011-04, which changes the wording used to describe the requirements in GAAP for measuring fair value and for disclosing information about fair value measurements in order
to improve consistency in the application and description of fair value between GAAP and International Financial Reporting Standards, or IFRS. Additional disclosure requirements in ASU 2011-04 include: (i) for Level 3 fair value measurements,
quantitative information about unobservable inputs used, a description of the valuation processes used by an entity, and a qualitative discussion about the sensitivity of the measurements to changes in the unobservable inputs; (ii) for an
entitys use of a nonfinancial asset that is different from the assets highest and best use, the reason for the difference; (iii) for financial instruments not measured at fair value but for which disclosure of fair value is
required, the fair value hierarchy level in which the fair value measurements were determined; and (iv) the disclosure of all transfers between Level 1 and Level 2 of the fair value hierarchy. ASU 2011-04 is effective for interim and annual
reporting periods beginning after December 15, 2011. Early adoption is not permitted. We adopted ASU 2011-04 on January 1, 2012. We do not expect the adoption of ASU 2011-04 to have a material effect on our consolidated financial
statements, but it will require certain additional footnote disclosures beginning in 2012.
3. Real Estate Investments
Our investments in our consolidated properties consisted of the following as of December 31, 2011 and 2010:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
Building and improvements
|
|
$
|
353,839,000
|
|
|
$
|
150,813,000
|
|
Land
|
|
|
26,326,000
|
|
|
|
14,592,000
|
|
Furniture, fixtures and equipment
|
|
|
1,070,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
381,235,000
|
|
|
|
165,405,000
|
|
Less: accumulated depreciation
|
|
|
(11,918,000
|
)
|
|
|
(2,070,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
369,317,000
|
|
|
$
|
163,335,000
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense for the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009 was $9,919,000, $2,070,000 and $0, respectively. In addition to the acquisitions discussed below, for the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009, we had capital expenditures of $3,148,000, $466,000 and $0, respectively, on our medical office buildings. For the years ended December 31, 2011 and 2010 and for the
period from January 7, 2009 (Date of Inception) through December 31, 2009, we had capital expenditures of $300,000, $0 and $0, respectively, on our hospitals.
We reimburse our advisor or its affiliates and our advisor entities or their affiliates for acquisition expenses related to selecting, evaluating, acquiring and investing in properties. The reimbursement
of acquisition expenses, acquisition fees and real estate commissions and other fees paid to unaffiliated parties will not exceed, in the aggregate, 6.0% of the contract purchase price or total development costs, unless fees in excess of such limits
are approved by a majority of our disinterested directors, including a majority of our independent directors. As of December 31, 2011, such fees and expenses did not exceed 6.0% of the purchase price of our acquisitions, except with respect to
our acquisition of Lakewood Ranch Medical Office Building, or the Lakewood Ranch property, and Philadelphia SNF Portfolio. For a further discussion, see footnote (5) and footnote (6) to the table below under Acquisitions in 2011.
122
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Acquisitions in 2011
For the year ended December 31, 2011, we completed 11 acquisitions comprising 31 buildings from unaffiliated parties. The aggregate
purchase price of these properties was $245,183,000 and we paid $6,739,000 in acquisition fees to our former advisor or its affiliates in connection with these acquisitions. The following is a summary of our acquisitions for the year ended
December 31, 2011:
|
|
September 30,
|
|
September 30,
|
|
September 30,
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Property
|
|
Location
|
|
Type
|
|
Date Acquired
|
|
Ownership
Percentage
|
|
|
Purchase
Price
|
|
|
Mortgage
Loans
Payable
(1)
|
|
|
Lines
of
Credit
(2)
|
|
|
Acquisition Fee
to our Former Advisor
or its
Affiliates
(3)
|
|
|
|
|
|
|
|
|
|
|
Columbia Long-Term
Acute Care Hospital(4)
|
|
Columbia, MO
|
|
Hospital
|
|
01/31/11
|
|
|
100
|
%
|
|
$
|
12,423,000
|
|
|
$
|
|
|
|
$
|
11,000,000
|
|
|
$
|
336,000
|
|
St. Anthony North
Medical Office Building
|
|
Westminster, CO
|
|
Medical Office
|
|
03/29/11
|
|
|
100
|
%
|
|
|
11,950,000
|
|
|
|
|
|
|
|
|
|
|
|
329,000
|
|
Loma Linda Pediatric
Specialty Hospital
|
|
Loma Linda, CA
|
|
Skilled Nursing
|
|
03/31/11
|
|
|
100
|
%
|
|
|
13,000,000
|
|
|
|
|
|
|
|
8,700,000
|
|
|
|
358,000
|
|
Yuma Skilled
Nursing Facility
|
|
Yuma, AZ
|
|
Skilled Nursing
|
|
04/13/11
|
|
|
100
|
%
|
|
|
11,000,000
|
|
|
|
|
|
|
|
9,000,000
|
|
|
|
303,000
|
|
Hardy Oak Medical
Office Building
|
|
San Antonio, TX
|
|
Medical Office
|
|
04/14/11
|
|
|
100
|
%
|
|
|
8,070,000
|
|
|
|
5,253,000
|
|
|
|
|
|
|
|
222,000
|
|
Lakewood Ranch
Medical Office Building(5)
|
|
Bradenton, FL
|
|
Medical Office
|
|
04/15/11
|
|
|
100
|
%
|
|
|
12,500,000
|
|
|
|
|
|
|
|
13,800,000
|
|
|
|
344,000
|
|
Dixie-Lobo Medical
Office Building Portfolio
|
|
Alice, Lufkin,
Victoria
and Wharton,
TX, Carlsbad
and Hobbs, NM,
Hope, AR and
Lake Charles,
LA
|
|
Medical Office
|
|
05/12/11
|
|
|
100
|
%
|
|
|
30,050,000
|
|
|
|
23,239,000
|
|
|
|
5,000,000
|
|
|
|
826,000
|
|
Milestone Medical
Office Building Portfolio
|
|
Jersey City, NJ
and Bryant and
Benton, AR
|
|
Medical Office
|
|
05/26/11
|
|
|
100
|
%
|
|
|
44,050,000
|
|
|
|
5,000,000
|
|
|
|
31,115,000
|
|
|
|
1,211,000
|
|
Philadelphia SNF Portfolio(6)
|
|
Philadelphia, PA
|
|
Skilled Nursing
|
|
06/30/11
|
|
|
100
|
%
|
|
|
75,000,000
|
|
|
|
|
|
|
|
74,870,000
|
|
|
|
2,063,000
|
|
Maxfield Medical
Office Building
|
|
Sarasota, FL
|
|
Medical Office
|
|
07/11/11
|
|
|
100
|
%
|
|
|
7,200,000
|
|
|
|
5,119,000
|
|
|
|
|
|
|
|
198,000
|
|
Lafayette Physical
Rehabiliation Hospital
|
|
Lafayette, LA
|
|
Hospital
|
|
09/30/11
|
|
|
100
|
%
|
|
|
12,100,000
|
|
|
|
|
|
|
|
12,000,000
|
|
|
|
333,000
|
|
Sierra Providence East
Medical Plaza I
|
|
El Paso, TX
|
|
Medical Office
|
|
12/22/11
|
|
|
100
|
%
|
|
|
7,840,000
|
|
|
|
|
|
|
|
|
|
|
|
216,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
$
|
245,183,000
|
|
|
$
|
38,611,000
|
|
|
$
|
165,485,000
|
|
|
$
|
6,739,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the balance of the mortgage loans payable assumed by us or newly placed on the property at the time of acquisition.
|
(2)
|
Represents borrowings under our secured revolving lines of credit with Bank of America, N.A., or Bank of America, and KeyBank National Association, or KeyBank, as
defined in Note 8, Lines of Credit, at the time of acquisition. We periodically advance funds and pay down our secured revolving lines of credit with Bank of America and KeyBank as needed. See Note 8, Lines of Credit, for a further discussion.
|
(3)
|
Our former advisor or its affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties,
an acquisition fee of 2.75% of the contract purchase price for each property acquired.
|
(4)
|
On January 31, 2011, we purchased Columbia Long-Term Acute Care Hospital, which is the fourth and final acquisition of the four hospitals comprising the Monument
Long-Term Acute Care Hospital Portfolio, or Monument LTACH Portfolio, the other three of which were purchased in 2010.
|
(5)
|
We paid a loan defeasance fee of approximately $1,223,000, or the loan defeasance fee, related to the repayment of the sellers loan that was secured by the
Lakewood Ranch property and had an outstanding principal balance of approximately $7,561,000 at the time of repayment. As a result of the loan defeasance fee, the fees and expenses associated with the Lakewood Ranch property acquisition exceeded
6.0% of the contract purchase price of the Lakewood Ranch property. Pursuant to our charter, prior to the acquisition of the Lakewood Ranch property, our directors, including a majority of our independent directors, not otherwise interested in the
transaction, approved the fees and expenses associated with the acquisition of the Lakewood Ranch property in excess of the 6.0% limit and determined that such fees and expenses were commercially competitive, fair and reasonable to us.
|
(6)
|
We paid a state and city transfer tax of approximately $1,479,000 related to the transfer of ownership in the acquisition of Philadelphia SNF Portfolio. Also, we paid
additional closing costs of $1,500,000 related to the operators costs associated with the sale of the portfolio. As a result of the state and city transfer tax and additional closing costs, the fees and expenses associated with the acquisition
of Philadelphia SNF Portfolio exceeded 6.0% of the contract purchase price of Philadelphia SNF Portfolio. Pursuant to our charter, prior to the acquisition of Philadelphia SNF Portfolio, our directors, including a majority of our independent
directors, not otherwise interested in the transaction, approved the fees and expenses associated with the acquisition of Philadelphia SNF Portfolio in excess of the 6.0% limit and determined that such fees and expenses were commercially
competitive, fair and reasonable to us.
|
123
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Acquisitions in 2010
For the year ended December 31, 2010, we completed 14 acquisitions comprising 25 buildings from unaffiliated parties. The aggregate
purchase price of these properties was $193,442,000 and we paid $5,329,000 in acquisition fees to our former advisor or its affiliates in connection with these acquisitions. The following is a summary of our acquisitions for the year ended
December 31, 2010:
|
|
September 30,
|
|
September 30,
|
|
September 30,
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Property
|
|
Location
|
|
Type
|
|
Date
Acquired
|
|
Ownership
Percentage
|
|
|
Purchase
Price
|
|
|
Mortgage
Loans
Payable
(1)
|
|
|
Line of
Credit
(2)
|
|
|
Acquisition Fee
to our Former Advisor
or its Affiliates
(3)
|
|
|
|
|
|
|
|
|
|
|
Lacombe Medical Office Building
|
|
Lacombe, LA
|
|
Medical Office
|
|
03/05/10
|
|
|
100
|
%
|
|
$
|
6,970,000
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
192,000
|
|
Center for Neurosurgery and Spine
|
|
Sartell, MN
|
|
Medical Office
|
|
03/31/10
|
|
|
100
|
%
|
|
|
6,500,000
|
|
|
|
3,341,000
|
|
|
|
|
|
|
|
179,000
|
|
Parkway Medical Center
|
|
Beachwood, OH
|
|
Medical Office
|
|
04/12/10
|
|
|
100
|
%
|
|
|
10,900,000
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
Highlands Ranch Medical Pavilion
|
|
Highlands Ranch, CO
|
|
Medical Office
|
|
04/30/10
|
|
|
100
|
%
|
|
|
8,400,000
|
|
|
|
4,443,000
|
|
|
|
|
|
|
|
231,000
|
|
Muskogee Long-Term Acute Care Hospital
|
|
Muskogee, OK
|
|
Hospital
|
|
05/27/10
|
|
|
100
|
%
|
|
|
11,000,000
|
|
|
|
|
|
|
|
|
|
|
|
303,000
|
|
St. Vincent Medical Office Building
|
|
Cleveland, OH
|
|
Medical Office
|
|
06/25/10
|
|
|
100
|
%
|
|
|
10,100,000
|
|
|
|
|
|
|
|
|
|
|
|
278,000
|
|
Livingston Medical Arts Pavilion
|
|
Livingston, TX
|
|
Medical Office
|
|
06/28/10
|
|
|
100
|
%
|
|
|
6,350,000
|
|
|
|
|
|
|
|
|
|
|
|
175,000
|
|
Pocatello East Medical Office Building
|
|
Pocatello, ID
|
|
Medical Office
|
|
07/27/10
|
|
|
98.75
|
%
|
|
|
15,800,000
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
435,000
|
|
Monument Long-Term Acute Care Hospital Portfolio(4)
|
|
Cape Girardeau and
Joplin, MO and
Athens, GA
|
|
Hospital
|
|
Various
|
|
|
100
|
%
|
|
|
29,272,000
|
|
|
|
|
|
|
|
26,800,000
|
|
|
|
811,000
|
|
Virginia Skilled Nursing Facility Portfolio
|
|
Charlottesville,
Bastian, Lebanon,
Fincastle, Low Moor,
Midlothian and Hot
Springs, VA
|
|
Skilled Nursing
|
|
09/16/10
|
|
|
100
|
%
|
|
|
45,000,000
|
|
|
|
26,810,000
|
|
|
|
12,900,000
|
|
|
|
1,238,000
|
|
Sylva Medical Office Building
|
|
Sylva, NC
|
|
Medical Office
|
|
11/15/10
|
|
|
100
|
%
|
|
|
11,400,000
|
|
|
|
|
|
|
|
11,400,000
|
|
|
|
314,000
|
|
Surgical Hospital of Humble
|
|
Humble, TX
|
|
Hospital
|
|
12/10/10
|
|
|
100
|
%
|
|
|
13,100,000
|
|
|
|
9,000,000
|
|
|
|
3,600,000
|
|
|
|
360,000
|
|
Lawton Medical Office Building Portfolio
|
|
Lawton, OK
|
|
Medical Office
|
|
12/22/10
|
|
|
100
|
%
|
|
|
11,550,000
|
|
|
|
|
|
|
|
9,800,000
|
|
|
|
318,000
|
|
Ennis Medical Office Building
|
|
Ennis, TX
|
|
Medical Office
|
|
12/22/10
|
|
|
100
|
%
|
|
|
7,100,000
|
|
|
|
|
|
|
|
7,350,000
|
|
|
|
195,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
$
|
193,442,000
|
|
|
$
|
43,594,000
|
|
|
$
|
76,850,000
|
|
|
$
|
5,329,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the balance of the mortgage loans payable assumed by us or newly placed on the property at the time of acquisition.
|
(2)
|
Represents borrowings under our secured revolving line of credit with Bank of America, as defined in Note 8, Lines of Credit, at the time of acquisition. We
periodically advance funds and pay down our secured revolving line of credit with Bank of America as needed. See Note 8, Lines of Credit, for a further discussion.
|
(3)
|
Our former advisor or its affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties,
an acquisition fee of 2.75% of the contract purchase price for each property acquired.
|
(4)
|
Monument LTACH Portfolio consists of four long-term acute care hospitals. As of December 31, 2010, we had acquired three of the four hospitals. The difference in
the purchase price of $29,272,000 noted above and the contract purchase price of $29,486,000 is due to the allocation of $214,000 to real estate and escrow deposits as such payments are related to the purchase of the remaining hospital of Monument
LTACH Portfolio. We purchased the remaining hospital of Monument LTACH Portfolio on January 31, 2011.
|
124
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Acquisitions in 2009
We did not complete any acquisitions for the period from January 7, 2009 (Date of Inception) through December 31, 2009.
4. Identified Intangible Assets, Net
Identified intangible assets, net consisted of the following as of December 31, 2011 and 2010:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
In place leases, net of accumulated amortization of $3,656,000 and $1,028,000 as of December 31, 2011 and 2010, respectively
(with a weighted average remaining life of 10.5 years and 11.3 years as of December 31, 2011 and 2010, respectively)
|
|
$
|
27,957,000
|
|
|
$
|
13,245,000
|
|
Tenant relationships, net of accumulated amortization of $1,541,000 and $377,000 as of December 31, 2011 and 2010, respectively
(with a weighted average remaining life of 19.6 years and 21.8 years as of December 31, 2011 and 2010, respectively)
|
|
|
22,580,000
|
|
|
|
11,912,000
|
|
Leasehold interests, net of accumulated amortization of $141,000 and $2,000 as of December 31, 2011 and 2010, respectively (with
a weighted average remaining life of 60.9 years and 62.4 years as of December 31, 2011 and 2010, respectively)
|
|
|
12,148,000
|
|
|
|
1,256,000
|
|
Above market leases, net of accumulated amortization of $495,000 and $121,000 as of December 31, 2011 and 2010, respectively
(with a weighted average remaining life of 8.9 years and 9.6 years as of December 31, 2011 and 2010, respectively)
|
|
|
2,649,000
|
|
|
|
1,795,000
|
|
Master leases, net of accumulated amortization of $492,000 and $95,000 as of December 31, 2011 and 2010, respectively (with a
weighted average remaining life of 1.5 years and 1.6 years as of December 31, 2011 and 2010, respectively)
|
|
|
781,000
|
|
|
|
360,000
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
66,115,000
|
|
|
$
|
28,568,000
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009 was $5,437,000, $1,643,000 and $0, respectively, which included $420,000, $121,000 and $0, respectively, of amortization recorded against rental income for above market leases
and $139,000, $2,000 and $0, respectively, of amortization recorded against rental expenses for leasehold interests in our accompanying consolidated statements of operations.
The aggregate weighted average remaining life of the identified intangible assets is 22.7 and 17.7 years as of December 31, 2011 and 2010, respectively. As of December 31, 2011, estimated
amortization expense on the identified intangible assets for each of the next five years ending December 31 and thereafter is as follows:
125
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
|
|
|
September 30,
|
|
Year
|
|
Amount
|
|
|
|
2012
|
|
$
|
6,372,000
|
|
2013
|
|
|
5,765,000
|
|
2014
|
|
|
4,962,000
|
|
2015
|
|
|
4,561,000
|
|
2016
|
|
|
4,066,000
|
|
Thereafter
|
|
|
40,389,000
|
|
|
|
|
|
|
|
|
$
|
66,115,000
|
|
|
|
|
|
|
5. Other Assets, Net
Other assets, net consisted of the following as of December 31, 2011 and 2010:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
Deferred rent receivables
|
|
$
|
3,138,000
|
|
|
$
|
576,000
|
|
Deferred financing costs, net of accumulated amortization of $1,397,000 and $225,000 as of December 31, 2011 and 2010,
respectively
|
|
|
2,883,000
|
|
|
|
1,390,000
|
|
Prepaid expenses and deposits
|
|
|
755,000
|
|
|
|
345,000
|
|
Lease commissions, net of accumulated amortization of $30,000 and $1,000 as of December 31, 2011 and 2010,
respectively
|
|
|
424,000
|
|
|
|
58,000
|
|
Contingent consideration asset
|
|
|
115,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7,315,000
|
|
|
$
|
2,369,000
|
|
|
|
|
|
|
|
|
|
|
Amortization expense on deferred financing costs for years ended December 31, 2011 and 2010 and for
the period from January 7, 2009 (Date of Inception) through December 31, 2009 was $1,267,000, $225,000 and $0, respectively. Amortization expense on deferred financing costs is recorded to interest expense in our accompanying condensed
consolidated statements of operations.
Amortization expense on lease commissions for the years ended December 31, 2011
and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009 was $29,000, $1,000 and $0, respectively.
Estimated amortization expense on deferred financing costs and lease commissions as of December 31, 2011 for each of the next five years ending December 31 and thereafter is as follows:
|
|
|
September 30,
|
|
Year
|
|
Amount
|
|
|
|
2012
|
|
$
|
1,182,000
|
|
2013
|
|
|
772,000
|
|
2014
|
|
|
523,000
|
|
2015
|
|
|
253,000
|
|
2016
|
|
|
203,000
|
|
Thereafter
|
|
|
374,000
|
|
|
|
|
|
|
|
|
$
|
3,307,000
|
|
|
|
|
|
|
6. Mortgage Loans Payable, Net
Mortgage loans payable were $80,529,000 ($80,466,000, net of discount and premium) and $58,648,000 ($58,331,000, net
of discount) as of December 31, 2011 and 2010, respectively.
As of December 31, 2011, we had six fixed rate and
four variable rate mortgage loans payable with effective interest rates ranging from 1.38% to 6.60% per annum and a weighted average effective interest rate of 4.82% per annum. As of December 31, 2011, we had $53,557,000 ($53,762,000,
net of discount and premium) of fixed rate debt, or 66.5% of mortgage loans payable, at a weighted average effective interest rate of 5.39% per annum and $26,972,000 ($26,704,000, net of discount) of variable rate debt, or 33.5% of mortgage
loans payable, at a weighted average effective interest rate of 3.68% per annum.
126
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of December 31, 2010, we had two fixed rate and four variable rate mortgage
loans payable with effective interest rates ranging from 1.36% to 6.00% per annum and a weighted average effective interest rate of 5.12% per annum. As of December 31, 2010, we had $12,354,000 ($12,332,000, net of discount) of fixed
rate debt, or 21.1% of mortgage loans payable, at a weighted average effective interest rate of 5.96% per annum and $46,294,000 ($45,999,000, net of discount) of variable rate debt, or 78.9% of mortgage loans payable, at a weighted average
effective interest rate of 4.90% per annum.
Most of the mortgage loans payable may be prepaid, which in some cases are
subject to a prepayment premium. We are required by the terms of certain loan documents to meet certain covenants, such as occupancy ratios, leverage ratios, net worth ratios, debt service coverage ratios, liquidity ratios, operating cash flow to
fixed charges ratios, distribution ratios and reporting requirements. As of December 31, 2011 and 2010, we were in compliance with all such covenants and requirements.
Mortgage loans payable, net consisted of the following as of December 31, 2011 and 2010:
|
|
|
September 30,
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Interest
|
|
|
|
|
December 31,
|
|
Property
|
|
Rate
(1)
|
|
|
Maturity Date
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Fixed Rate Debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlands Ranch Medical Pavilion
|
|
|
5.88
|
%
|
|
11/11/12
|
|
$
|
4,289,000
|
|
|
$
|
4,383,000
|
|
Pocatello East Medical Office Building
|
|
|
6.00
|
%
|
|
10/01/20
|
|
|
7,788,000
|
|
|
|
7,971,000
|
|
Monument LTACH Portfolio
|
|
|
5.53
|
%
|
|
06/19/18
|
|
|
15,248,000
|
|
|
|
|
|
Hardy Oak Medical Office Building
|
|
|
6.60
|
%
|
|
10/10/16
|
|
|
5,182,000
|
|
|
|
|
|
Maxfield Medical Office Building
|
|
|
5.17
|
%
|
|
02/28/15
|
|
|
5,050,000
|
|
|
|
|
|
Milestone Medical Office Building Portfolio
|
|
|
4.50
|
%
|
|
02/01/17
|
|
|
16,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53,557,000
|
|
|
|
12,354,000
|
|
|
|
|
|
|
Variable Rate Debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Center for Neurosurgery and Spine(2)
|
|
|
1.38
|
%
|
|
08/15/21 (callable)
|
|
|
2,964,000
|
|
|
|
3,184,000
|
|
Virginia Skilled Nursing Facility Portfolio(3)
|
|
|
5.50
|
%
|
|
09/14/12
|
|
|
9,771,000
|
|
|
|
26,810,000
|
|
Surgical Hospital of Humble(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
9,000,000
|
|
Lawton Medical Office Building Portfolio
|
|
|
3.16
|
%
|
|
01/01/16
|
|
|
7,142,000
|
|
|
|
7,300,000
|
|
Muskogee Long-Term Acute Care Hospital
|
|
|
2.67
|
%
|
|
04/08/18
|
|
|
7,095,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,972,000
|
|
|
|
46,294,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed and variable rate debt
|
|
|
|
|
|
|
|
|
80,529,000
|
|
|
|
58,648,000
|
|
Less: discount
|
|
|
|
|
|
|
|
|
(291,000
|
)
|
|
|
(317,000
|
)
|
Add: premium
|
|
|
|
|
|
|
|
|
228,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans payable, net
|
|
|
|
|
|
|
|
$
|
80,466,000
|
|
|
$
|
58,331,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the per annum interest rate in effect as of December 31, 2011.
|
(2)
|
The mortgage loan payable requires monthly principal and interest payments and is due August 15, 2021; however, the principal balance is immediately due upon
written request from the seller confirming that the seller agrees to pay the interest rate swap termination amount, if any. Additionally, the seller guarantors agreed to retain their guaranty obligations with respect to the mortgage loan and the
interest rate swap agreement. We, the seller and the seller guarantors have also agreed to indemnify the other parties for any liability caused by a partys breach or nonperformance of obligations under the loan.
|
127
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(3)
|
Represents a bridge loan we secured from KeyBank which initially matured on March 14, 2012. We exercised the one six-month extension available pursuant to the loan
documents, thereby extending the maturity date to September 14, 2012 or until such time that we are able to pay such bridge loan in full by obtaining a Federal Housing Association Mortgage loan. On June 30, 2011, we used $17,039,000 in
borrowings from the line of credit with KeyBank, as defined in Note 8, Lines of Credit, to pay towards the outstanding balance on the bridge loan. See Note 8, Lines of Credit, for a further discussion of the line of credit with KeyBank.
|
(4)
|
As of December 31, 2010, we had an outstanding mortgage loan payable balance of $9,000,000, which was subsequently paid in full in March 2011 without any
prepayment penalties being assessed. In connection with the early extinguishment, we wrote off $42,000 in deferred financing costs, which is included in interest expense in our accompanying consolidated statements of operations.
|
In addition to the mortgage loans payable noted above, on May 12, 2011, we assumed a mortgage loan payable
in connection with the acquisition of Dixie-Lobo Medical Office Building Portfolio in the amount of $23,239,000. On September 29, 2011, we paid off the remaining principal balance of $23,132,000 in full without any prepayment penalties being
assessed. In connection with the early extinguishment, we wrote off $32,000 of deferred financing costs and $30,000 of debt premium, which is included in interest expense in our accompanying consolidated statements of operations.
As of December 31, 2011, the principal payments due on our mortgage loans payable for each of the next five years ending
December 31 and thereafter, is as follows:
|
|
|
September 30,
|
|
Year
|
|
Amount
|
|
|
|
2012
|
|
$
|
18,268,000
|
|
2013
|
|
|
1,306,000
|
|
2014
|
|
|
1,577,000
|
|
2015
|
|
|
6,027,000
|
|
2016
|
|
|
12,453,000
|
|
Thereafter
|
|
|
40,898,000
|
|
|
|
|
|
|
|
|
$
|
80,529,000
|
|
|
|
|
|
|
7. Derivative Financial Instruments
ASC Topic 815 establishes accounting and reporting standards for derivative instruments, including certain derivative
instruments embedded in other contracts, and for hedging activities. We utilize derivatives such as fixed interest rate swaps to add stability to interest expense and to manage our exposure to interest rate movements. Consistent with ASC Topic 815,
we record derivative financial instruments in our accompanying consolidated balance sheets as either an asset or a liability measured at fair value. ASC Topic 815 permits special hedge accounting if certain requirements are met. Hedge accounting
allows for gains and losses on derivatives designated as hedges to be offset by the change in value of the hedged item or items or to be deferred in other comprehensive income.
As of December 31, 2011, no derivatives were designated as fair value hedges or cash flow hedges. Derivatives not designated as
hedges are not speculative and are used to manage our exposure to interest rate movements, but do not meet the strict hedge accounting requirements of ASC Topic 815. Changes in the fair value of derivative financial instruments are recorded as a
component of interest expense in gain (loss) in fair value of derivative financial instruments in our accompanying consolidated statements of operations. For the years ended December 31, 2011 and 2010 and for the period from January 7,
2009 (Date of Inception) through December 31, 2009, we recorded $366,000, $143,000 and $0, respectively, as an increase to interest expense in our accompanying consolidated statements of operations related to the change in the fair value of our
derivative financial instruments.
128
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table lists the derivative financial instruments held by us as of December 31, 2011:
|
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
|
|
|
Interest
|
|
|
|
|
|
|
|
|
Maturity
|
|
Notional Amount
|
|
|
Index
|
|
|
Rate
|
|
|
Fair Value
|
|
|
Instrument
|
|
|
Date
|
|
|
|
|
|
|
|
$
|
2,964,000
|
|
|
|
one month LIBOR
|
|
|
|
6.00
|
%
|
|
$
|
(478,000
|
)
|
|
|
Swap
|
|
|
|
08/15/21
|
|
|
7,142,000
|
|
|
|
one month LIBOR
|
|
|
|
4.41
|
%
|
|
|
(139,000
|
)
|
|
|
Swap
|
|
|
|
01/01/14
|
|
|
7,095,000
|
|
|
|
one month LIBOR
|
|
|
|
4.28
|
%
|
|
|
(202,000
|
)
|
|
|
Swap
|
|
|
|
05/01/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
17,201,000
|
|
|
|
|
|
|
|
|
|
|
$
|
(819,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table lists the derivative financial instruments held by us as of December 31, 2010:
|
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Notional Amount
|
|
|
Index
|
|
|
Interest Rate
|
|
|
Fair Value
|
|
|
Instrument
|
|
|
Maturity Date
|
|
|
|
|
|
|
|
$
|
3,184,000
|
|
|
|
one month LIBOR
|
|
|
|
6.00
|
%
|
|
$
|
(372,000
|
)
|
|
|
Swap
|
|
|
|
08/15/21
|
|
|
7,300,000
|
|
|
|
one month LIBOR
|
|
|
|
4.41
|
%
|
|
|
(81,000
|
)
|
|
|
Swap
|
|
|
|
01/01/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
10,484,000
|
|
|
|
|
|
|
|
|
|
|
$
|
(453,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 13, Fair Value Measurements, for a further discussion of the fair value of our derivative
financial instruments.
8. Lines of Credit
Bank of America, N.A.
On July 19, 2010, we entered into a loan agreement with Bank of America, or the Bank of America Loan Agreement, to obtain a secured revolving credit facility with an aggregate maximum principal
amount of $25,000,000, or the Bank of America line of credit. On May 4, 2011, we modified the Bank of America line of credit to increase the aggregate maximum principal amount from $25,000,000 to $45,000,000, subject to certain borrowing base
conditions. The proceeds of loans made under the Bank of America line of credit may be used for working capital, capital expenditures and other general corporate purposes (including, without limitation, property acquisitions). The actual amount of
credit available under the Bank of America line of credit at any given time is a function of, and is subject to, certain loan to cost, loan to value and debt service coverage ratios contained in the Bank of America Loan Agreement, as amended. The
Bank of America line of credit matures on July 19, 2012 and may be extended by one 12-month period subject to satisfaction of certain conditions, including payment of an extension fee.
Prior to May 4, 2011, any loan made under the Bank of America line of credit bore interest at rates equal to either: (i) the
daily floating London Interbank Offered Rate, or LIBOR, plus 3.75% per annum, subject to a minimum interest rate floor of 5.00% per annum, or (ii) if the daily floating LIBOR rate was not available, a base rate which meant, for any
day, a fluctuating rate per annum equal to the prime rate for such day plus 3.75% per annum, subject to a minimum interest rate floor of 5.00% per annum. On May 4, 2011, we modified the Bank of America line of credit to:
(i) reduce the interest rate to an interest rate equal to LIBOR plus 3.50% per annum or in the event the daily LIBOR rate is not available, then Bank of Americas prime rate for such day plus 3.50%; and (ii) remove the
requirement of an interest rate floor of 5.00% per annum.
The Bank of America Loan Agreement contains various
affirmative and negative covenants that are customary for credit facilities and transactions of this type, including limitations on the incurrence of debt and limitations on distributions by properties that serve as collateral for the Bank of
America line of credit in the event of default. The Bank of America Loan Agreement also provides that an event of default under any other unsecured or recourse debt that we have in excess of $5,000,000 shall constitute an event of default under the
Bank of America Loan Agreement. The Bank of America Loan Agreement also imposes the following financial covenants: (i) minimum liquidity thresholds; (ii) a minimum ratio of operating cash flow to fixed charges; (iii) a maximum ratio
of liabilities to asset value; (iv) a maximum distribution covenant; and (v) a minimum tangible net worth covenant. In the event of default, Bank of America has the right to terminate its obligations under the Bank of America Loan
129
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Agreement, including the funding of future loans and to accelerate the payment on any unpaid principal amount of all outstanding loans and interest thereon and may seek foreclosure on any
properties securing the Bank of America line of credit. As of December 31, 2011 and 2010, we were in compliance with all such covenants and requirements.
Based on the value of the properties securing the Bank of America line of credit, our aggregate borrowing capacity under the Bank of America line of credit was $38,435,000 and $22,600,000, respectively,
as of December 31, 2011 and 2010. There were no borrowings outstanding under the Bank of America line of credit as of December 31, 2011. Borrowings outstanding under the Bank of America line of credit totaled $11,800,000 as of
December 31, 2010. As of December 31, 2011 and 2010, $38,435,000 and $10,800,000, respectively, remained available under the Bank of America line of credit. The weighted-average interest rate of borrowings as of December 31, 2010 was
5.00% per annum, respectively. The Bank of America line of credit is secured by Lacombe Medical Office Building, Parkway Medical Center, Livingston Medical Arts Pavilion, St. Vincent Medical Office Building, Sylva Medical Office Building, Ennis
Medical Office Building and St. Anthony North Medical Office Building as of December 31, 2011.
KeyBank National Association
On June 30, 2011, we entered into a loan agreement with KeyBank, or the KeyBank Loan Agreement, to obtain a
secured revolving credit facility with an aggregate maximum principal amount of $71,500,000, or the KeyBank line of credit. On October 6, 2011, RBS Citizens, N.A., d/b/a Charter One, or Charter One, was added as a syndication agent to the
KeyBank line of credit, whereby $35,750,000 of the aggregate maximum principal amount of the KeyBank line of credit was assigned to Charter One. The proceeds of loans made under the KeyBank line of credit may be used to acquire, finance or refinance
eligible properties or for other incidental purposes as approved by KeyBank. The KeyBank line of credit matures on June 30, 2014 and may be extended by one 12-month period subject to the satisfaction of certain conditions, including payment of
an extension fee.
During the initial and extended term of the KeyBank Loan Agreement, any loan made under the KeyBank Loan
Agreement shall bear interest at a per annum rate depending on the type of designated loan being provided for under the KeyBank Loan Agreement. As a result, the interest rates shall be as follows: (i) for loans designated as LIBOR Loans, as
defined in the KeyBank Loan Agreement, the interest rate shall be based on LIBOR, as defined in the KeyBank Loan Agreement, plus 3.50% per annum; (ii) for loans designated as Prime Rate Loans, as defined in the KeyBank Loan Agreement, the
interest rate shall be equal to a fluctuating interest rate per annum equal to the rate of interest established by KeyBank as its Prime Rate, plus 0.75% per annum; and (iii) for loans designated as Base Rate Loans, as defined in the
KeyBank Loan Agreement, the interest rate shall be equal to a fluctuating interest rate equal to 3.50% per annum plus the greater of: (a) a rate of interest established by KeyBank as its Prime Rate; (b) the Federal Funds Rate plus
0.50% per annum; or (c) the interest rate then in effect for LIBOR Loans, plus 1.00% per annum.
The KeyBank
Loan Agreement contains various affirmative and negative covenants that are customary for credit facilities and transactions of this type, including limitations on the incurrence of debt by our operating partnership and its subsidiaries that own
properties that serve as collateral for the KeyBank line of credit. The KeyBank Loan Agreement also imposes the following financial covenants: (i) a maximum consolidated total leverage ratio; (ii) a minimum debt service coverage ratio;
(iii) a minimum consolidated net worth covenant; and (iv) a minimum rent coverage ratio. In addition, the KeyBank Loan Agreement includes events of default that are customary for credit facilities and transactions of this type. In the
event of default, KeyBank has the right to assert its remedies and terminate its obligations under the KeyBank Loan Agreement, including the termination of funding of future loans, acceleration of payment on any unpaid principal amount of all
outstanding loans and interest thereon and foreclosure on the properties securing the KeyBank line of credit. As of December 31, 2011, we were in compliance with all such covenants and requirements.
Based on the value of the properties securing the KeyBank line of credit, the aggregate borrowing capacity was $71,500,000 as of
December 31, 2011. As of December 31, 2011, there were no borrowings outstanding under the KeyBank line of credit and $71,500,000 remained available under the KeyBank line of credit. The KeyBank line of credit is secured by four facilities
of Virginia Skilled Nursing Facility Portfolio, Yuma Skilled Nursing Facility and Philadelphia SNF Portfolio as of December 31, 2011.
130
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
9. Identified Intangible Liabilities, Net
Identified intangible liabilities, net consisted of the following as of December 31, 2011 and 2010:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
Below market leases, net of accumulated amortization of $135,000 and $42,000 as of December 31, 2011 and 2010, respectively (with
a weighted average remaining life of 14.6 years and 16.9 years as of December 31, 2011 and 2010, respectively)
|
|
$
|
623,000
|
|
|
$
|
502,000
|
|
Amortization expense on below market leases for the years ended December 31, 2011 and 2010
and for the period from January 7, 2009 (Date of Inception) through December 31, 2009 was $122,000, $42,000 and $0, respectively. Amortization expense on below market leases is recorded to rental income in our accompanying consolidated
statements of operations.
As of December 31, 2011, estimated amortization expense on below market leases for each of the
next five years ending December 31 and thereafter is as follows:
|
|
|
September 30,
|
|
Year
|
|
Amount
|
|
|
|
2012
|
|
$
|
108,000
|
|
2013
|
|
|
61,000
|
|
2014
|
|
|
53,000
|
|
2015
|
|
|
36,000
|
|
2016
|
|
|
29,000
|
|
Thereafter
|
|
|
336,000
|
|
|
|
|
|
|
|
|
$
|
623,000
|
|
|
|
|
|
|
10. Commitments and Contingencies
Litigation
We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material adverse effect
on our consolidated financial position, results of operations or cash flows.
Environmental Matters
We follow a policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a
material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our consolidated financial position, results of
operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that we believe would require additional disclosure or the recording of a
loss contingency.
Other Organizational and Offering Expenses
Our organizational and offering expenses, other than selling commissions and the dealer manager fee, are being paid by our former advisor
or its affiliates and our advisor entities or their affiliates on our behalf. Other organizational and offering expenses include all expenses (other than selling commissions and the dealer manager fee which generally represent 7.0% and 3.0%,
respectively, of our gross offering proceeds) to be paid by us in
131
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
connection with our offering. These other organizational and offering expenses will only become our liability to the extent they do not exceed 1.0% of the gross proceeds from the sale of shares
of our common stock in our offering, other than shares of our common stock sold pursuant to the DRIP. As of December 31, 2011 and 2010, our former advisor and its affiliates had incurred expenses on our behalf of $2,616,000 and $2,701,000,
respectively, in excess of 1.0% of the gross proceeds of our offering, and therefore, these expenses are not recorded in our accompanying consolidated financial statements as of December 31, 2011 and 2010. In addition, as of December 31,
2011 our advisor entities and their affiliates had incurred expenses on our behalf of $330,000 in excess of 1.0% of the gross proceeds of our offering, and therefore, these expenses are not recorded in our accompanying consolidated financial
statements as of December 31, 2011 and 2010. To the extent we raise additional funds from our offering, these amounts may become our liability.
When recorded by us, other organizational expenses will be expensed as incurred, and offering expenses are charged to stockholders equity as such amounts are reimbursed to our former advisor or its
affiliates and our advisor entities or their affiliates from the gross proceeds of our offering. See Note 11, Related Party Transactions Offering Stage, for a further discussion of other organizational and offering expenses.
Other
Our other
commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In our view, these matters are not expected to have a material adverse effect on our consolidated financial position,
results of operations or cash flows.
11. Related Party Transactions
Fees and Expenses Paid to Affiliates
Until January 6, 2012, all of our executive officers and our non-independent directors were also executive officers and employees and/or holders of a direct or indirect interest in our former
advisor, our former sponsor, GEEA or other affiliated entities.
Effective as of August 24, 2009, we entered into the
G&E Advisory Agreement with our former advisor, and effective as of June 22, 2009, we entered into the G&E Dealer Manager Agreement with Grubb & Ellis Securities, Inc., or Grubb & Ellis Securities. Until April 18,
2011, Grubb & Ellis Securities served as the dealer manager of our offering pursuant to the G&E Dealer Manager Agreement. Effective as of April 19, 2011, the G&E Dealer Manager Agreement with Grubb & Ellis Securities
was assigned to, and assumed by, Grubb & Ellis Capital Corporation, a wholly owned subsidiary of our former sponsor. Therefore, references to the G&E Dealer Manager shall be deemed to refer to either Grubb & Ellis Securities or
Grubb & Ellis Capital Corporation, or both, as applicable, unless otherwise specified.
On November 7, 2011, we
notified our former advisor of the termination of the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party may terminate the G&E Advisory Agreement without cause or penalty, subject to a 60-day transition period;
however, certain rights and obligations of the parties survive during the 60-day transition period and beyond. As a result of a new advisory agreement that took effect on January 7, 2012 upon the expiration of the 60-day transition period
provided for in the G&E Advisory Agreement, Griffin-American Advisor serves as our new advisor and delegates advisory duties to Griffin-American Sub-Advisor.
In addition, on November 7, 2011, we notified Grubb & Ellis Capital Corporation of the termination of the G&E Dealer Manager Agreement. Pursuant to the G&E Dealer Manager Agreement,
either party may terminate the G&E Dealer Manager Agreement, subject to a 60-day transition period. Until January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of
our common stock. As a result of a new dealer manager agreement that took effect on January 7, 2012 upon the expiration of the 60-day transition period provided for in the G&E Dealer Manager Agreement, or the Dealer Manager Agreement,
Griffin Securities serves as our new dealer manager. The terms of the Dealer Manager Agreement are substantially the same as the terms of the terminated G&E Dealer Manager Agreement.
132
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The G&E Advisory Agreement and the G&E Dealer Manager Agreement entitled our
former advisor, G&E Dealer Manager and their affiliates to specified compensation for certain services, as well as reimbursement of certain expenses. In the aggregate, for the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $46,699,000, $21,321,000 and $1,704,000, respectively, in fees and expenses paid to our former advisor or its affiliates as detailed below.
Offering Stage
Selling
Commissions
Until January 6, 2012, G&E Dealer Manager received selling commissions of up to 7.0% of the gross
offering proceeds from the sale of shares of our common stock in our offering other than shares of our common stock sold pursuant to the DRIP. G&E Dealer Manager could have re-allowed all or a portion of these fees to participating
broker-dealers. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $22,196,000, $9,306,000 and $998,000, respectively, in selling
commissions to G&E Dealer Manager. Such commissions are charged to stockholders equity as such amounts are paid to G&E Dealer Manager from the gross proceeds of our offering.
Dealer Manager Fee
Until January 6, 2012, G&E Dealer Manager
received a dealer manager fee of up to 3.0% of the gross offering proceeds from the sale of shares of our common stock in our offering other than shares of our common stock sold pursuant to the DRIP. G&E Dealer Manager could have re-allowed all
or a portion of these fees to participating broker-dealers. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $9,742,000, $4,107,000 and
$441,000, respectively, in dealer manager fees to G&E Dealer Manager. Such fees are charged to stockholders equity as such amounts are paid to G&E Dealer Manager from the gross proceeds of our offering.
Other Organizational and Offering Expenses
Until January 6, 2012, our organizational and offering expenses were paid by our former advisor or its affiliates on our behalf. Our former advisor or its affiliates were reimbursed for actual
expenses incurred up to 1.0% of the gross offering proceeds from the sale of shares of our common stock in our offering other than shares of our common stock sold pursuant to the DRIP. For the years ended December 31, 2011 and 2010 and for the
period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $3,261,000, $1,372,000 and $150,000, respectively, in offering expenses to our former advisor or its affiliates. Other organizational expenses were
expensed as incurred, and offering expenses are charged to stockholders equity as such amounts are paid to our former advisor or its affiliates from the gross proceeds of our offering.
Acquisition and Development Stage
Acquisition Fee
Until January 6, 2012, our former advisor or its affiliates received an acquisition fee of up to 2.75% of the contract purchase
price for each property we acquired or 2.0% of the origination or acquisition price for any real estate-related investment we originated or acquired. Our former advisor or its affiliates were entitled to receive these acquisition fees for properties
and real estate-related investments we acquired with funds raised in our offering, including acquisitions completed after the termination of the G&E Advisory Agreement, or funded with net proceeds from the sale of a property or real
estate-related investment, subject to certain conditions.
For the years ended December 31, 2011 and 2010 and for the
period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $6,739,000, $5,329,000 and $0, respectively, in acquisition fees to our former advisor or its affiliates. Acquisition fees in connection with the
acquisition of properties are expensed as incurred in accordance with ASC Topic 805 and are included in acquisition related expenses in our accompanying consolidated statements of operations.
133
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Development Fee
Until January 6, 2012, our former advisor or its affiliates received, in the event our former advisor or its affiliates provided development-related services, a development fee in an amount that was
usual and customary for comparable services rendered for similar projects in the geographic market where the services were provided; however, we would not pay a development fee to our former advisor or its affiliates if our former advisor elected to
receive an acquisition fee based on the cost of such development.
For the years ended December 31, 2011 and 2010 and for
the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not incur any development fees to our former advisor or its affiliates.
Reimbursement of Acquisition Expenses
Until January 6, 2012, our
former advisor or its affiliates were reimbursed for acquisition expenses related to selecting, evaluating and acquiring assets, which would have been reimbursed regardless of whether an asset was acquired. The reimbursement of acquisition expenses,
acquisition fees and real estate commissions and other fees paid to unaffiliated parties was not to exceed, in the aggregate, 6.0% of the purchase price or total development costs, unless fees in excess of such limits were approved by a majority of
our disinterested directors, including a majority of our independent directors, not otherwise interested in the transaction. As of December 31, 2011, such fees and expenses did not exceed 6.0% of the purchase price or total development costs,
except with respect to our acquisition of the Lakewood Ranch property and Philadelphia SNF Portfolio. For a further discussion, please see footnote (5) and footnote (6) in Note 3, Real Estate Investments Acquisitions in 2011.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, we incurred $21,000, $29,000 and $0, respectively, in acquisition expenses to our former advisor or its affiliates. Reimbursements of acquisition expenses are expensed as incurred in accordance with ASC Topic 805 and are
included in acquisition related expenses in our accompanying consolidated statements of operations.
Operational Stage
Asset Management Fee
Until January 6, 2012, our former advisor or its affiliates were paid a monthly fee for services rendered in connection with the management of our assets equal to one-twelfth of 0.85% of average
invested assets, subject to our stockholders receiving distributions in an amount equal to 5.0% per annum, cumulative, non-compounded, of average invested capital. For such purposes, average invested assets means the average of the aggregate
book value of our assets invested in real estate properties and real estate-related investments, before deducting depreciation, amortization, bad debt and other similar non-cash reserves, computed by taking the average of such values at the end of
each month during the period of calculation; and average invested capital means, for a specified period, the aggregate issue price of shares of our common stock purchased by our stockholders, reduced by distributions of net sales proceeds by us to
our stockholders and by any amounts paid by us to repurchase shares of our common stock pursuant to our share repurchase plan.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, we incurred $2,929,000, $612,000 and $0, respectively, in asset management fees to our former advisor or its affiliates, which is included in general and administrative in our accompanying consolidated statements of
operations.
134
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Property Management Fee
Until January 6, 2012, our former advisor or its affiliates were paid a monthly property management fee of up to 4.0% of the gross monthly cash receipts from each property managed by our former
advisor or its affiliates. Our former advisor or its affiliates may have sub-contracted its duties to any third-party, including for fees less than the property management fees payable to our former advisor or its affiliates. In addition to the
above property management fee, for each property managed directly by entities other than our former advisor or its affiliates, we paid our former advisor or its affiliates a monthly oversight fee of up to 1.0% of the gross cash receipts from the
property; provided however, that in no event would we pay both a property management fee and an oversight fee to our former advisor or its affiliates with respect to the same property.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, we incurred $843,000, $245,000 and $0, respectively, in property management fees and oversight fees to our former advisor or its affiliates, which is included in rental expenses in our accompanying consolidated statements of
operations.
On-site Personnel and Engineering Payroll
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $103,000, $46,000 and $0, respectively, in
payroll for on-site personnel and engineering to our former advisor or its affiliates, which is included in rental expenses in our accompanying consolidated statements of operations.
Lease Fees
Until January 6, 2012, we paid our former advisor or its
affiliates a separate fee for any leasing activities in an amount not to exceed the fee customarily charged in arms-length transactions by others rendering similar services in the same geographic area for similar properties as determined by a
survey of brokers and agents in such area. Such fee was generally expected to range from 3.0% to 8.0% of the gross revenues generated during the initial term of the lease.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $395,000, $59,000 and $0, respectively, in
lease fees to our former advisor or its affiliates, which is capitalized as lease commissions and included in other assets, net in our accompanying consolidated balance sheets.
Construction Management Fee
Until January 6, 2012, in the event that
our former advisor or its affiliates assisted with planning and coordinating the construction of any capital or tenant improvements, our former advisor or its affiliates were paid a construction management fee of up to 5.0% of the cost of such
improvements. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we incurred $72,000, $21,000 and $0, respectively, in construction management fees to
our former advisor or its affiliates. Construction management fees are capitalized as part of the associated asset and included in operating properties, net on our accompanying consolidated balance sheets.
Operating Expenses
Until January 6, 2012, we reimbursed our former advisor or its affiliates for operating expenses incurred in rendering services to
us, subject to certain limitations. However, we could not reimburse our former advisor or its affiliates at the end of any fiscal quarter for total operating expenses that, in the four consecutive fiscal quarters then ended, exceed the greater of:
(i) 2.0% of our average invested assets, as defined in the G&E Advisory Agreement, or (ii) 25.0% of our net income, as defined in the G&E Advisory Agreement, unless our independent directors determined that such excess expenses
were justified based on unusual and nonrecurring factors.
For the 12 months ended December 31, 2011, our operating
expenses did not exceed this limitation. Our operating expenses as a percentage of average invested assets and as a percentage of net income were 1.5% and 49.7%, respectively, for the 12 months ended December 31, 2011.
135
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
For the 12 months ended December 31, 2010, our operating expenses exceeded
this limitation by $40,000. Our operating expenses as a percentage of average invested assets and as a percentage of net income were 2.1% and (46.9)%, respectively, for the 12 months ended December 31, 2010. We raised the minimum offering
and had funds held in escrow released to us to commence real estate operations in October 2009. We purchased our first property in March 2010. At this early stage of our operations, our general and administrative expenses were relatively
high compared with our funds from operations and our average invested assets. Our board of directors determined that the relationship of our general and administrative expenses to our funds from operations and our average invested assets was
justified for the 12 months ended December 31, 2010, given the costs of operating a public company and the early stage of our operations.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, GEEA incurred operating expenses on our behalf of
$22,000, $25,000 and $56,000, respectively, which is included in general and administrative in our accompanying consolidated statements of operations.
Related Party Services Agreement
We entered into a services agreement,
effective September 21, 2009, or the Transfer Agent Services Agreement, with Grubb & Ellis Equity Advisors, Transfer Agent, LLC, formerly known as Grubb & Ellis Investor Solutions, LLC, or our former transfer agent, for
transfer agent and investor services. Since our former transfer agent was an affiliate of our former advisor, the terms of the Transfer Agent Services Agreement were approved and determined by a majority of our directors, including a majority of our
independent directors, as fair and reasonable to us and at fees which are no greater than that which would be paid to an unaffiliated party for similar services.
On November 7, 2011, we provided notice of termination of the Transfer Agent Services Agreement to our former transfer agent. Under the Transfer Agent Services Agreement, we were required to provide
60 days written notice of termination. Therefore, the Transfer Agent Services Agreement terminated on January 6, 2012. We engaged DST Systems, Inc. to serve as our replacement transfer agent on January 6, 2012.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, we incurred expenses of $311,000, $111,000 and $59,000, respectively, for investor services that our former transfer agent provided to us, which is included in general and administrative in our accompanying consolidated
statements of operations.
For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009
(Date of Inception) through December 31, 2009, GEEA incurred expenses of $112,000, $53,000 and $7,000, respectively, for subscription agreement processing services that our former transfer agent provided to us. As an other organizational and
offering expense, these subscription agreement processing expenses will only become our liability to the extent cumulative other organizational and offering expenses do not exceed 1.0% of the gross proceeds from the sale of shares of our common
stock in our offering, other than shares of our common stock sold pursuant to the DRIP.
Compensation for Additional Services
Until January 6, 2012, our former advisor or its affiliates were paid for services performed for us other than those
required to be rendered by our former advisor or its affiliates under the G&E Advisory Agreement. The rate of compensation for these services had to be approved by a majority of our board of directors, including a majority of our independent
directors, and could not exceed an amount that would have been paid to unaffiliated parties for similar services. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, we incurred expenses of $65,000, $59,000 and $0, respectively, for internal controls compliance services our former advisor or its affiliates provided to us.
136
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Liquidity Stage
Disposition Fees
Prior to January 6, 2012, for services relating to
the sale of one or more properties, our former advisor or its affiliates would have been paid a disposition fee up to the lesser of 2.0% of the contract sales price or 50.0% of a customary competitive real estate commission given the circumstances
surrounding the sale, in each case as determined by our board of directors, including a majority of our independent directors, upon the provision of a substantial amount of the services in the sales effort. The amount of disposition fees paid, when
added to the real estate commissions paid to unaffiliated parties, would not have exceeded the lesser of the customary competitive real estate commission or an amount equal to 6.0% of the contract sales price. For the years ended December 31,
2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not incur any disposition fees to our former advisor or its affiliates.
Subordinated Participation Interest
Subordinated Distribution of Net Sales Proceeds
Prior to January 6, 2012, in the event of liquidation, our former advisor would have been paid a subordinated
distribution of net sales proceeds. The distribution would have been equal to 15.0% of the net proceeds from the sales of properties, after distributions to our stockholders, in the aggregate, of (i) a full return of capital raised from
stockholders (less amounts paid to repurchase shares of our common stock pursuant to our share repurchase plan) plus (ii) an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock, as
adjusted for distributions of net sale proceeds. Actual amounts received would have depended on the sale prices of properties upon liquidation. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of
Inception) through December 31, 2009, we did not incur any such distributions to our former advisor.
Subordinated Distribution upon
Listing
Prior to January 6, 2012, upon the listing of shares of our common stock on a national securities exchange, our
former advisor would have been paid a distribution equal to 15.0% of the amount by which (i) the market value of our outstanding common stock at listing plus distributions paid prior to listing exceeded (ii) the sum of the total amount of
capital raised from stockholders (less amounts paid to repurchase shares of our common stock pursuant to our share repurchase plan) and the amount of cash that, if distributed to stockholders as of the date of listing, would have provided them an
annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock through the date of listing. Actual amounts received would have depended upon the market value of our outstanding stock at the time of
listing among other factors. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not incur any such distributions to our former advisor.
Subordinated Distribution Upon Termination
Upon termination or non-renewal of the G&E Advisory Agreement, our former advisor would have been entitled to a subordinated distribution from our operating partnership equal to 15.0% of the amount,
if any, by which (i) the appraised value of our assets on the termination date, less any indebtedness secured by such assets, plus total distributions paid through the termination date, exceeded (ii) the sum of the total amount of capital
raised from stockholders (less amounts paid to repurchase shares of our common stock pursuant to our share repurchase plan) and the total amount of cash that, if distributed to them as of the termination date, would have provided them an annual 8.0%
cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock through the termination date. On January 9, 2012, our former advisor tendered its notice of election to defer its right to receive a
subordinated distribution upon termination until either a listing or other liquidity event, including a liquidation, sale of substantially all of our assets or merger in which our stockholders receive, in exchange for their shares of our common
stock, shares of a company that are traded on a national securities exchange. Such notice was tendered beyond the notice period provided under our operating partnership agreement.
137
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of December 31, 2011 and 2010, we had not recorded any charges to earnings
related to the subordinated distribution upon termination.
Fees Payable Upon Internalization of the Advisor
Prior to June 1, 2010, to the extent that our board of directors determined that it was in the best interests of our stockholders to
internalize (acquire from our former advisor) any management functions provided by our former advisor, the compensation payable to our former advisor for such specific internalization would be negotiated and agreed upon by our independent directors
and our advisor. Effective June 1, 2010, we amended the G&E Advisory Agreement to eliminate any compensation or remuneration payable by us or our operating partnership to our former advisor or any of its affiliates in connection with any
internalization of the management functions provided by our former advisor in the future. However, this amendment was not intended to limit any other compensation or distributions that we or our operating partnership may have paid our former advisor
in accordance with the G&E Advisory Agreement or any other agreement, including but not limited to the agreement of limited partnership of our operating partnership.
Transition of Advisory Services
On November 7, 2011, we and
our operating partnership entered into the Advisory Agreement with our advisor. Contemporaneously with our entering into the Advisory Agreement with our advisor, our advisor entered into a sub-advisory agreement with our sub-advisor pursuant to
which all advisory services and compensation therefor were delegated to our sub-advisor. The terms of the Advisory Agreement are substantially the same as the terms of the terminated G&E Advisory Agreement, except for the following:
|
|
|
the acquisition fee will be reduced from 2.75% of the contract purchase price of each property we acquire to 2.60% of the contract purchase
price of each property we acquire;
|
|
|
|
the acquisition fee for property acquisitions will be paid with a combination of shares of our common stock and cash as follows: (i) shares
of common stock in an amount equal to 0.15% of the contract purchase price of the properties, at the then-established offering price, net of selling commissions or dealer manager fees, and (ii) the remainder in cash in an amount equal to 2.45%
of the contract purchase price of the properties; and
|
|
|
|
the monthly asset management fee will be an amount equal to one-twelfth of 0.85% of the average invested assets existing as of January 6,
2012 and one-twelfth of 0.75% of the average invested assets acquired after January 6, 2012.
|
Executive Stock
Purchase Plans
On April 7, 2011, our Chairman of the board of directors and Chief Executive Officer, Jeffrey T.
Hanson, and our President and Chief Operating Officer, Danny Prosky, each executed an executive stock purchase plan, or the G&E Plan, whereby each executive had irrevocably agreed to invest 100% and 50.0%, respectively, of their net after-tax
cash compensation as employees of our sponsor directly into our company by purchasing shares of our common stock on a regular basis, corresponding to regular payroll periods and the payment of any other net after-tax cash compensation, including
bonuses. Their first investment under the G&E Plan began with their regularly scheduled payroll payment on April 29, 2011 and was to terminate on the earlier of (i) December 31, 2011, (ii) the termination of our offering,
(iii) any suspension of our offering by our board of directors or regulatory body, or (iv) the date upon which the number of shares of our common stock owned by Mr. Hanson or Mr. Prosky, when combined with all their other
investments in our common stock, exceeds the ownership limits set forth in our charter. The shares were purchased pursuant to our offering at a price of $9.00 per share, reflecting the elimination of selling commissions and the dealer manager fee in
connection with such transactions. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, Mr. Hanson invested $121,000, $0 and $0, respectively, of
his compensation and we issued 13,436, 0 and 0 shares of our common stock, respectively, pursuant to his G&E Plan. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009, Mr. Prosky invested $93,000, $0 and $0, respectively, of his compensation and we issued 10,313, 0 and 0 shares of our common stock, respectively, pursuant to his G&E Plan.
138
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
On November 7, 2011, Messrs. Hanson and Prosky tendered their resignations from our
former sponsor. On December 30, 2011, Messrs. Hanson and Prosky, as well as Mathieu B. Streiff, our Executive Vice President, each executed a stock purchase plan, or the Plan, effective January 1, 2012, whereby each executive has
irrevocably agreed to invest 100%, 50.0% and 50.0%, respectively, of all of their net after-tax salary and cash bonus compensation that is earned on or after February 1, 2012 as employees of American Healthcare Investors directly into our
company by purchasing shares of our common stock beginning with their regularly scheduled payroll payment on February 17, 2012 and terminating on the earlier of (i) December 31, 2012, (ii) the termination of our offering,
(iii) any suspension of our offering by our board of directors or a regulatory body, or (iv) the date upon which the number of shares of our common stock owned by Mr. Hanson, Mr. Prosky or Mr. Streiff, when combined with all
their other investments in our common stock, exceeds the ownership limits set forth in our charter. The shares will be purchased pursuant to our offering at a price of $9.00 per share, reflecting the elimination of selling commissions and the dealer
manager fee in connection with such transactions.
For a further discussion of our Executive Stock Purchase Plans, see Note
21, Subsequent Events Executive Stock Purchase Plans.
Accounts Receivable Due From Affiliate
American Healthcare Investors and Griffin Capital have agreed to pay the majority of the expenses we have incurred in connection with the
transition to our co-sponsors. The portion of the expenses that our co-sponsors have agreed to pay are paid by us and then reimbursed by American Healthcare Investors and Griffin Capital within 120 days of payment. As such, as of December 31,
2011, we have recorded a receivable of $121,000 from American Healthcare Investors, an affiliate, which is included in accounts receivable due from affiliate in our accompanying consolidated balance sheets. We do not consider Griffin Capital an
affiliate and therefore the receivable of $121,000 from Griffin Capital is included in accounts and other receivables, net in our accompanying consolidated balance sheets.
Accounts Payable Due to Affiliates
The following amounts were
outstanding to affiliates as of December 31, 2011 and 2010:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
Fee
|
|
2011
|
|
|
2010
|
|
|
|
|
Selling commissions and dealer manager fees
|
|
$
|
434,000
|
|
|
$
|
539,000
|
|
Asset and property management fees
|
|
|
405,000
|
|
|
|
166,000
|
|
Offering costs
|
|
|
93,000
|
|
|
|
86,000
|
|
Operating expenses
|
|
|
72,000
|
|
|
|
16,000
|
|
Construction management fees
|
|
|
64,000
|
|
|
|
21,000
|
|
Lease commissions
|
|
|
34,000
|
|
|
|
5,000
|
|
On-site personnel and engineering payroll
|
|
|
7,000
|
|
|
|
7,000
|
|
Acquisition expenses
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,111,000
|
|
|
$
|
840,000
|
|
|
|
|
|
|
|
|
|
|
139
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12. Equity
Preferred Stock
Our charter authorizes us to issue 200,000,000 shares of our preferred stock, par value $0.01 per share. As of December 31, 2011 and 2010, no shares of preferred stock were issued and outstanding.
Common Stock
We are offering and selling to the public up to 300,000,000 shares of our common stock, par value $0.01 per share, for $10.00 per share and up to 30,000,000 shares of our common stock, par value $0.01 per
share, to be issued pursuant to the DRIP for $9.50 per share. Our charter authorizes us to issue 1,000,000,000 shares of our common stock.
On February 4, 2009, our former advisor purchased 20,000 shares of common stock for total cash consideration of $200,000 and was admitted as the initial stockholder. We used the proceeds from the
sale of shares of our common stock to our former advisor to make an initial capital contribution to our operating partnership.
On October 21, 2009, we granted an aggregate of 15,000 shares of our restricted common stock to our independent directors. On each
of June 8, 2010 and June 14, 2011, in connection with their re-election, we granted an aggregate of 7,500 shares of our restricted common stock to our independent directors. Through December 31, 2011, we had issued 47,831,458 shares
of our common stock in connection with our offering and 1,137,013 shares of our common stock pursuant to the DRIP, and we had also repurchased 148,802 shares of our common stock under our share repurchase plan. As of December 31, 2011 and 2010,
we had 48,869,669 and 15,452,668 shares of our common stock issued and outstanding, respectively.
Noncontrolling Interests
On February 4, 2009, our former advisor made an initial capital contribution of $2,000 to our operating
partnership in exchange for 200 partnership units.
As of December 31, 2011 and 2010, we owned a 99.99% general
partnership interest in our operating partnership and our former advisor owned less than a 0.01% limited partnership interest in our operating partnership. As such, less than 0.01% of the earnings of our operating partnership are allocated to
noncontrolling interests, subject to certain limitations.
In addition, as of December 31, 2011 and 2010, we owned a
98.75% interest in the consolidated limited liability company that owns Pocatello East Medical Office Building, or the Pocatello East MOB property, that was purchased on July 27, 2010. As such, 1.25% of the earnings of the Pocatello East MOB
property are allocated to noncontrolling interests.
Distribution Reinvestment Plan
We adopted the DRIP that allows stockholders to purchase additional shares of our common stock through the reinvestment of distributions,
subject to certain conditions. We have registered and reserved 30,000,000 shares of our common stock for sale in our offering pursuant to the DRIP. For the years ended December 31, 2011 and 2010 and for the period from January 7, 2009
(Date of Inception) through December 31, 2009, $8,817,000, $1,985,000 and $0, respectively, in distributions were reinvested and 928,058, 208,955 and zero shares of our common stock, respectively, were issued pursuant to the DRIP. As of
December 31, 2011 and 2010, a total of $10,802,000 and $1,985,000, respectively, in distributions were reinvested and 1,137,013 and 208,955 shares of our common stock, respectively, were issued pursuant to the DRIP.
Share Repurchase Plan
Our board of directors has approved a share repurchase plan. Our share repurchase plan allows for repurchases of shares of our common stock by us when certain criteria are met. Share repurchases will be
made at the sole discretion of our board of directors. All repurchases are subject to a one-year holding period, except for repurchases made in connection with a stockholders death or qualifying disability, as defined in our share
140
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
repurchase plan. Subject to the availability of the funds for share repurchases, we will limit the number of shares of our common stock repurchased during any calendar year to 5.0% of the
weighted average number of shares of our common stock outstanding during the prior calendar year; provided, however, that shares subject to a repurchase requested upon the death of a stockholder will not be subject to this cap. Funds for the
repurchase of shares of our common stock will come exclusively from the cumulative proceeds we receive from the sale of shares of our common stock pursuant to the DRIP.
Under our share repurchase plan, repurchase prices range from $9.25, or 92.5% of the price paid per share, following a one year holding period to an amount not less than 100% of the price paid per share
following a four year holding period. However, if shares of our common stock are to be repurchased in connection with a stockholders death or qualifying disability, the repurchase price will be no less than 100% of the price paid to acquire
the shares of our common stock from us. Furthermore, our share repurchase plan provides that if there are insufficient funds to honor all repurchase requests, pending requests will be honored among all requests for repurchase in any given repurchase
period, as follows: first, pro rata as to repurchases sought upon a stockholders death; next, pro rata as to repurchases sought by stockholders with a qualifying disability; and, finally, pro rata as to other repurchase requests.
For the years ended December 31, 2011 and 2010, we received share repurchase requests and repurchased 127,802 and 21,000 shares of
our common stock, respectively, for an aggregate of $1,198,000 and $210,000, respectively, at an average repurchase price of $9.38 and $10.00 per share, respectively, using proceeds we received from the sale of shares of our common stock pursuant to
the DRIP. For the period from January 7, 2009 (Date of Inception) through December 31, 2009, we did not receive any requests for repurchase or otherwise repurchase any shares of our common stock pursuant to the share repurchase plan.
As of December 31, 2011 and 2010, we had received share repurchase requests and had repurchased 148,802 shares of our
common stock for an aggregate of $1,408,000 at an average price of $9.46 per share and 21,000 shares of our common stock for an aggregate of $210,000 at an average price of $10.00 per share, respectively, using proceeds we received from the sale of
shares of our common stock pursuant to the DRIP.
2009 Incentive Plan
We adopted our incentive plan, pursuant to which our board of directors or a committee of our independent directors may make grants of
options, restricted shares of common stock, stock purchase rights, stock appreciation rights or other awards to our independent directors, employees and consultants. The maximum number of shares of our common stock that may be issued pursuant to our
incentive plan is 2,000,000.
On October 21, 2009, we granted an aggregate of 15,000 shares of our restricted common
stock, as defined in our incentive plan, to our independent directors in connection with their initial election to our board of directors, of which 20.0% vested on the grant date and 20.0% will vest on each of the first four anniversaries of the
date of grant. On each of June 8, 2010 and June 14, 2011, in connection with their re-election, we granted an aggregate of 7,500 shares of our restricted common stock, as defined in our incentive plan, to our independent directors, which
will vest over the same period described above. The fair value of each share of our restricted common stock was estimated at the date of grant at $10.00 per share, the per share price of shares in our offering, and with respect to the initial 20.0%
of shares that vested on the grant date, expensed as compensation immediately, and with respect to the remaining shares, amortized on a straight-line basis over the vesting period. Shares of our restricted common stock may not be sold, transferred,
exchanged, assigned, pledged, hypothecated or otherwise encumbered. Such restrictions expire upon vesting. Shares of our restricted common stock have full voting rights and rights to dividends. For the years ended December 31, 2011 and 2010 and
for the period from January 7, 2009 (Date of Inception) through December 31, 2009, we recognized compensation expense of $66,000, $54,000 and $35,000, respectively, related to the restricted common stock grants ultimately expected to vest.
ASC Topic 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. For the years ended December 31, 2011 and 2010 and for the period from
January 7, 2009 (Date of Inception) through December 31, 2009, we did not assume any forfeitures. Stock compensation expense is included in general and administrative in our accompanying consolidated statements of operations.
141
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of December 31, 2011 and 2010, there was $145,000 and $136,000, respectively, of
total unrecognized compensation expense, net of estimated forfeitures, related to nonvested shares of our restricted common stock. This expense is expected to be recognized over a remaining weighted average period of 2.58 years.
As of December 31, 2011 and 2010, the fair value of the nonvested shares of our restricted common stock was $165,000 and $150,000,
respectively. A summary of the status of the nonvested shares of our restricted common stock as of December 31, 2011 and 2010, and the changes for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009
(Date of Inception) through December 31, 2009, is presented below:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Number of Nonvested
|
|
|
Weighted
|
|
|
|
Shares of our
|
|
|
Average Grant
|
|
|
|
Restricted Common Stock
|
|
|
Date Fair Value
|
|
|
|
|
Balance January 7, 2009 (Date of Inception)
|
|
|
|
|
|
|
|
|
Granted
|
|
|
15,000
|
|
|
$
|
10.00
|
|
Vested
|
|
|
(3,000
|
)
|
|
$
|
10.00
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2009
|
|
|
12,000
|
|
|
$
|
10.00
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
7,500
|
|
|
$
|
10.00
|
|
Vested
|
|
|
(4,500
|
)
|
|
$
|
10.00
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2010
|
|
|
15,000
|
|
|
$
|
10.00
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
7,500
|
|
|
$
|
10.00
|
|
Vested
|
|
|
(6,000
|
)
|
|
$
|
10.00
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2011
|
|
|
16,500
|
|
|
$
|
10.00
|
|
|
|
|
|
|
|
|
|
|
Expected to vest December 31, 2011
|
|
|
16,500
|
|
|
$
|
10.00
|
|
|
|
|
|
|
|
|
|
|
13. Fair Value Measurements
Assets and Liabilities Reported at Fair Value
The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2011, aggregated by the level in the fair value hierarchy within which those
measurements fall.
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Quoted Prices in
Active Markets for
Identical Assets
and Liabilities
|
|
|
Significant Other
Observable Inputs
|
|
|
Significant
Unobservable
Inputs
|
|
|
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Total
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration asset
|
|
$
|
|
|
|
$
|
|
|
|
$
|
115,000
|
|
|
$
|
115,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets at fair value
|
|
$
|
|
|
|
$
|
|
|
|
$
|
115,000
|
|
|
$
|
115,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative financial instruments
|
|
$
|
|
|
|
$
|
819,000
|
|
|
$
|
|
|
|
$
|
819,000
|
|
Contingent consideration obligations
|
|
|
|
|
|
|
|
|
|
|
6,058,000
|
|
|
|
6,058,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities at fair value
|
|
$
|
|
|
|
$
|
819,000
|
|
|
$
|
6,058,000
|
|
|
$
|
6,877,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
142
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The table below presents our assets and liabilities measured at fair value on a
recurring basis as of December 31, 2010, aggregated by the level in the fair value hierarchy within which those measurements fall.
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Quoted Prices in
Active Markets for
Identical Assets
and Liabilities
|
|
|
Significant Other
Observable Inputs
|
|
|
Significant
Unobservable
Inputs
|
|
|
|
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Total
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative financial instruments
|
|
$
|
|
|
|
$
|
453,000
|
|
|
$
|
|
|
|
$
|
453,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities at fair value
|
|
$
|
|
|
|
$
|
453,000
|
|
|
$
|
|
|
|
$
|
453,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
There were no transfers into and out of fair value measurement levels during the years ended
December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009.
Derivative Financial Instruments
We use interest rate swaps to manage interest rate risk associated with floating rate debt. The valuation of these instruments is determined using widely accepted valuation techniques including a
discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves,
foreign exchange rates and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The
variable cash receipts are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.
To comply with the provisions of ASC Topic 820, we incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterpartys nonperformance
risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings,
thresholds, mutual puts and guarantees.
Although we have determined that the majority of the inputs used to value our
interest rate swaps fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by us
and our counterparty. However, as of December 31, 2011 and 2010, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and have determined that the credit
valuation adjustments are not significant to the overall valuation of our interest rate swaps. As a result, we have determined that our interest rate swaps valuation in its entirety is classified in Level 2 of the fair value hierarchy.
Contingent Consideration
On April 13, 2011, we purchased Yuma Skilled Nursing Facility and in connection with such purchase we accrued $1,500,000 as a
contingent consideration obligation. Such payment will be made to the seller upon receipt of notification within three years of the acquisition date that (i) the tenant has achieved a certain specified lease coverage ratio for two consecutive
calendar quarters and (ii) that the tenant has completed an estimated $3,500,000 renovation project. If such notification is not received, no payment will be made. The payment will be either $0 or $1,500,000. We have assumed that the criteria
above will be met.
On June 30, 2011, we purchased Philadelphia SNF Portfolio and in connection with such purchase we
accrued $1,402,000 and $2,500,000 as a contingent consideration obligation. An estimated $1,402,000 of such amount will be paid upon receipt of notification within six years of the acquisition date that the tenant has achieved a certain
143
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
specified rent coverage ratio for the preceding 12 months. There is no minimum or maximum required payment, however such payment is limited by the tenants rent coverage ratio and will
result in additional rental revenue to us. We have assumed that the criteria above will be met and we will receive notification approximately 2
1
/
2
years from the date of acquisition. We have also made certain assumptions regarding capitalization rates and applied a discount factor. Up to $2,500,000 of
such contingent consideration will be paid within two years of the acquisition date upon notification that (i) the tenant has achieved a certain specified rent coverage ratio for the three most recent calendar months and (ii) the tenant
has completed improvements in an amount up to $2,500,000. The range of payment is between $0 and up to a maximum of $2,500,000. We have assumed that the criteria above will be met.
On July 11, 2011, we purchased Maxfield Medical Office Building and in connection with such purchase we accrued $656,000 as a
contingent consideration obligation. Such consideration will be paid to the seller if, within 12 months of the acquisition date, the seller is able to lease approximately 4,000 square feet of GLA to a tenant. Such payment will be a function of the
annual increase in net operating income of the property as a result of such lease, less leasing commissions, tenant improvements and rent abatement, if any. There is no minimum or maximum required payment, however such payment is limited by the new
tenants rental rate and will result in additional rental revenue to us. We have assumed that the criteria above will be met approximately 12 months from the date of acquisition. In addition, we have made certain assumptions regarding the terms
of the lease, including rental rate per square foot, initial term of the lease, tenant improvement allowances and lease commissions, based on market conditions.
On December 22, 2011, we purchased Sierra Providence East Medical Plaza I and in connection with such purchase we recognized $115,000 as a contingent consideration asset. We will receive such
consideration to the extent a tenant in approximately 2,000 square feet of GLA does not pay their rental payments to us over the remaining term of their lease, which expires in April 2014. The range of payment to us is between $0 and up to a maximum
of $115,000. We have assumed that we will not receive any payments under the tenants lease and will therefore receive the full $115,000 from funds the seller has set aside.
The fair value of the contingent consideration obligations is determined based on the facts and circumstances existing at each reporting
date and the likelihood of the counterparty achieving the necessary conditions based on a probability weighted discounted cash flow analysis based, in part, on significant inputs which are not observable in the market. As a result, we have
determined that our contingent consideration valuations are classified in Level 3 of the fair value hierarchy. Our contingent consideration asset is included in other assets, net and our contingent consideration obligations are included in security
deposits, prepaid rent and other liabilities in our accompanying consolidated balance sheets and any changes in their fair value subsequent to their acquisition date valuations are charged to earnings. We did not recognize any gain or loss with
respect to our contingent consideration assets and obligations for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, as no adjustments to the acquisition
date fair values were deemed necessary.
The following is a reconciliation of the beginning and ending balances of our
contingent consideration assets and obligations for the years ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009:
144
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
|
|
|
|
|
Period from
|
|
|
|
|
|
|
|
|
|
January 7, 2009
|
|
|
|
Years Ended
|
|
|
(Date of Inception)
|
|
|
|
December 31,
|
|
|
through
|
|
|
|
2011
|
|
|
2010
|
|
|
December 31, 2009
|
|
|
|
|
|
Contingent Consideration Asset:
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Addition to contingent consideration asset
|
|
|
115,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
115,000
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent Consideration Obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Additions to contingent consideration obligations
|
|
|
6,058,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
6,058,000
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Instruments Disclosed at Fair Value
ASC Topic 825,
Financial Instruments,
requires disclosure of the fair value of financial instruments, whether or not recognized on
the face of the balance sheet. Fair value is defined under ASC Topic 820.
Our accompanying consolidated balance sheets
include the following financial instruments: cash and cash equivalents, restricted cash, real estate and escrow deposits, accounts and other receivables, net, accounts payable and accrued liabilities, accounts payable due to affiliates, mortgage
loans payable, net and borrowings under the lines of credit.
We consider the carrying values of cash and cash equivalents,
restricted cash, real estate and escrow deposits, accounts and other receivables, net and accounts payable and accrued liabilities to approximate the fair value for these financial instruments because of the short period of time between origination
of the instruments and their expected realization. The fair value of accounts payable due to affiliates is not determinable due to the related party nature of the accounts payable.
The fair value of the mortgage loans payable and the lines of credit is estimated using a discounted cash flow analysis using borrowing
rates available to us for debt instruments with similar terms and maturities. As of December 31, 2011 and 2010, the fair value of the mortgage loans payable was $81,028,000 and $59,246,000, respectively, compared to the carrying value of
$80,466,000 and $58,331,000, respectively. The fair value of the lines of credit as of December 31, 2011 and 2010 was $0 and $12,070,000, respectively, compared to the carrying value of $0 and $11,800,000, respectively.
14. Tax Treatment of Distributions
The income tax treatment for distributions reportable for the years ended December 31, 2011 and 2010, was as
follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
Ordinary income
|
|
$
|
9,276,000
|
|
|
|
51
|
%
|
|
$
|
935,000
|
|
|
|
23
|
%
|
Capital gain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return of capital
|
|
|
8,912,000
|
|
|
|
49
|
|
|
|
3,128,000
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,188,000
|
|
|
|
100
|
%
|
|
$
|
4,063,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
145
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
We began paying distributions in 2010. Amounts listed above do not include distributions
paid on nonvested shares of our restricted common stock which have been separately reported.
15. Future Minimum Rent
Rental Income
We have operating leases with tenants that expire at various dates through 2029 and in some cases subject to scheduled fixed increases or adjustments based on a consumer price index. Generally, the leases
grant tenants renewal options. Leases also provide for additional rents based on certain operating expenses. Future minimum base rent contractually due under operating leases, excluding tenant reimbursements of certain costs, as of December 31,
2011 for each of the next five years ending December 31 and thereafter is as follows:
|
|
|
September 30,
|
|
Year
|
|
Amount
|
|
|
|
2012
|
|
$
|
41,049,000
|
|
2013
|
|
|
40,584,000
|
|
2014
|
|
|
39,372,000
|
|
2015
|
|
|
38,203,000
|
|
2016
|
|
|
34,711,000
|
|
Thereafter
|
|
|
264,545,000
|
|
|
|
|
|
|
|
|
$
|
458,464,000
|
|
|
|
|
|
|
16. Business Combinations
2011
For the year ended December 31, 2011, we completed 11 acquisitions comprising 31 buildings and 1,119,000 square feet of GLA. The aggregate purchase price was $245,183,000, plus closing costs and
acquisition fees of $12,380,000, $9,632,000 of which is included in acquisition related expenses in our accompanying consolidated statements of operations and $2,748,000 of which was capitalized as part of the measurement of the fair value of the
tangible and identified intangible assets and liabilities of the properties and included in our accompanying consolidated balance sheets. See Note 3, Real Estate Investments, for a listing of the properties acquired, acquisition dates and the amount
of financing initially incurred or assumed in connection with such acquisitions.
Results of operations for the acquisitions
are reflected in our accompanying consolidated statements of operations for the year ended December 31, 2011 for the period subsequent to the acquisition date of each property. For the period from the acquisition date through December 31,
2011, we recognized the following amounts of revenues and net income (loss) for the acquisitions:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Property
|
|
Revenues
|
|
|
Net Income (Loss)
|
|
|
|
|
Columbia Long-Term Acute Care Hospital
|
|
$
|
1,348,000
|
|
|
$
|
837,000
|
|
St. Anthony North Denver Medical Office Building
|
|
$
|
1,301,000
|
|
|
$
|
380,000
|
|
Loma Linda Pediatric Specialty Hospital
|
|
$
|
1,185,000
|
|
|
$
|
733,000
|
|
Yuma Skilled Nursing Facility
|
|
$
|
846,000
|
|
|
$
|
514,000
|
|
Hardy Oak Medical Office Building
|
|
$
|
866,000
|
|
|
$
|
(54,000
|
)
|
Lakewood Ranch Medical Office Building
|
|
$
|
1,230,000
|
|
|
$
|
15,000
|
|
Dixie-Lobo Medical Office Building Portfolio
|
|
$
|
2,075,000
|
|
|
$
|
208,000
|
|
Milestone Medical Office Building Portfolio
|
|
$
|
3,095,000
|
|
|
$
|
1,061,000
|
|
Philadelphia SNF Portfolio
|
|
$
|
4,573,000
|
|
|
$
|
(339,000
|
)
|
Maxfield Medical Office Building
|
|
$
|
488,000
|
|
|
$
|
(35,000
|
)
|
Lafayette Physical Rehabilitation Hospital
|
|
$
|
332,000
|
|
|
$
|
219,000
|
|
Sierra Providence East Medical Plaza I
|
|
$
|
32,000
|
|
|
$
|
16,000
|
|
146
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following summarizes the fair value of our 11 acquisitions at the time of
acquisition. We present separately the three individually significant acquisitions during the year ended December 31, 2011, Dixie-Lobo Medical Office Building Portfolio, Milestone Medical Office Building Portfolio and Philadelphia SNF
Portfolio, and aggregate the rest of the acquisitions during the year ended December 31, 2011.
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Dixie-Lobo
Medical Office
Building Portfolio
|
|
|
Milestone
Medical Office
Building Portfolio
|
|
|
Philadelphia SNF
Portfolio
|
|
|
Other 2011 Acquisitions
|
|
|
|
|
|
|
Land
|
|
$
|
|
|
|
$
|
495,000
|
|
|
$
|
4,747,000
|
|
|
$
|
6,492,000
|
|
Building and improvements
|
|
|
22,192,000
|
|
|
|
32,744,000
|
|
|
|
68,418,000
|
|
|
|
76,300,000
|
|
Furniture, fixtures and equipment
|
|
|
|
|
|
|
|
|
|
|
1,065,000
|
|
|
|
|
|
In-place leases
|
|
|
1,682,000
|
|
|
|
2,519,000
|
|
|
|
6,326,000
|
|
|
|
7,483,000
|
|
Tenant relationships
|
|
|
2,808,000
|
|
|
|
2,531,000
|
|
|
|
|
|
|
|
6,493,000
|
|
Leasehold interest
|
|
|
3,449,000
|
|
|
|
5,301,000
|
|
|
|
|
|
|
|
2,280,000
|
|
Master lease
|
|
|
|
|
|
|
580,000
|
|
|
|
|
|
|
|
257,000
|
|
Above market leases
|
|
|
|
|
|
|
804,000
|
|
|
|
|
|
|
|
470,000
|
|
Other assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
115,000
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets acquired
|
|
|
30,131,000
|
|
|
|
44,974,000
|
|
|
|
80,556,000
|
|
|
|
99,890,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans payable, net
|
|
|
(23,320,000
|
)
|
|
|
|
|
|
|
|
|
|
|
(10,621,000
|
)
|
Below market leases
|
|
|
|
|
|
|
(34,000
|
)
|
|
|
|
|
|
|
(208,000
|
)
|
Other liabilities
|
|
|
|
|
|
|
|
|
|
|
(4,056,000
|
) (2)
|
|
|
(2,156,000
|
) (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities assumed
|
|
|
(23,320,000
|
)
|
|
|
(34,000
|
)
|
|
|
(4,056,000
|
)
|
|
|
(12,985,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
$
|
6,811,000
|
|
|
$
|
44,940,000
|
|
|
$
|
76,500,000
|
|
|
$
|
86,905,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Included in other assets is $115,000 recorded as a contingent consideration asset in connection with the acquisition of Sierra Providence East Medical Plaza I. See Note
13, Fair Value Measurements, for a further discussion.
|
(2)
|
Included in other liabilities is $1,402,000 and $2,500,000 accrued for as contingent consideration obligations in connection with the acquisition of Philadelphia SNF
Portfolio. See Note 13, Fair Value Measurements, for a further discussion.
|
(3)
|
Included in other liabilities is $1,500,000 and $656,000 accrued for as contingent consideration obligations in connection with the acquisition of Yuma Skilled Nursing
Facility and Maxfield Medical Office Building, respectively. See Note 13, Fair Value Measurements, for a further discussion.
|
Assuming the acquisitions in 2011 discussed above had occurred on January 1, 2010, for the years ended December 31, 2011 and 2010, pro forma revenues, net income, net income attributable to
controlling interest and net income per common share attributable to controlling interest basic and diluted would have been as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Years Ended
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
Revenues
|
|
$
|
52,818,000
|
|
|
$
|
38,256,000
|
|
Net income
|
|
$
|
7,866,000
|
|
|
$
|
1,173,000
|
|
Net income attributable to controlling interest
|
|
$
|
7,864,000
|
|
|
$
|
1,172,000
|
|
Net income per common share attributable to controlling interest basic and diluted
|
|
$
|
0.14
|
|
|
$
|
0.04
|
|
147
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The pro forma adjustments assume that the debt proceeds and the offering proceeds, at a
price of $10.00 per share, net of offering costs were raised as of January 1, 2010. In addition, as acquisition related expenses related to the acquisitions are not expected to have a continuing impact, they have been excluded from the pro
forma results. The pro forma results are not necessarily indicative of the operating results that would have been obtained had the acquisitions occurred at the beginning of the periods presented, nor are they necessarily indicative of future
operating results.
2010
For the year ended December 31, 2010, we completed 14 acquisitions comprising 25 buildings and 868,000 square feet of GLA. The aggregate purchase price was $193,442,000, plus closing costs and
acquisition fees of $6,662,000, which are included in acquisition related expenses in our accompanying consolidated statements of operations. See Note 3, Real Estate Investments, for a listing of the properties acquired, the acquisition dates and
the amount of financing initially incurred or assumed in connection with such acquisitions.
Results of operations for the
acquisitions are reflected in our accompanying consolidated statements of operations for the year ended December 31, 2010 for the periods subsequent to the acquisition date of each property. For the period from the acquisition date through
December 31, 2010, we recognized the following amounts of revenues and net income (loss) for the acquisitions:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Property
|
|
Revenues
|
|
|
Net income (loss)
|
|
|
|
|
Lacombe Medical Office Building
|
|
$
|
675,000
|
|
|
$
|
200,000
|
|
Center for Neurosurgery and Spine
|
|
$
|
625,000
|
|
|
$
|
(194,000
|
)
|
Parkway Medical Center
|
|
$
|
1,270,000
|
|
|
$
|
48,000
|
|
Highlands Ranch Medical Pavilion
|
|
$
|
810,000
|
|
|
$
|
(56,000
|
)
|
Muskogee Long-Term Acute Care Hospital
|
|
$
|
646,000
|
|
|
$
|
331,000
|
|
St. Vincent Medical Office Building
|
|
$
|
750,000
|
|
|
$
|
(31,000
|
)
|
Livingston Medical Arts Pavilion
|
|
$
|
446,000
|
|
|
$
|
143,000
|
|
Pocatello East Medical Office Building
|
|
$
|
850,000
|
|
|
$
|
150,000
|
|
Monument Long-Term Acute Care Hospital Portfolio
|
|
$
|
966,000
|
|
|
$
|
557,000
|
|
Virginia Skilled Nursing Facility Portfolio
|
|
$
|
1,363,000
|
|
|
$
|
277,000
|
|
Sylva Medical Office Building
|
|
$
|
152,000
|
|
|
$
|
46,000
|
|
Surgical Hospital of Humble
|
|
$
|
73,000
|
|
|
$
|
(11,000
|
)
|
Lawton Medical Office Building Portfolio
|
|
$
|
33,000
|
|
|
$
|
(54,000
|
)
|
Ennis Medical Office Building
|
|
$
|
23,000
|
|
|
$
|
9,000
|
|
148
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The fair value of our 14 acquisitions at the time of acquisition is shown below:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Lacombe
Medical
Office
Building
|
|
|
Center for
Neurosurgery
and Spine
|
|
|
Parkway
Medical
Center
|
|
|
Highlands
Ranch
Medical
Pavilion
|
|
|
Muskogee
Long-Term
Acute
Care
Hospital
|
|
|
St. Vincent
Medical
Office
Building
|
|
|
Livingston
Medical
Arts
Pavilion
|
|
|
|
|
|
|
|
|
|
Land
|
|
$
|
409,000
|
|
|
$
|
319,000
|
|
|
$
|
1,320,000
|
|
|
$
|
1,234,000
|
|
|
$
|
379,000
|
|
|
$
|
1,568,000
|
|
|
$
|
|
|
Building and improvements
|
|
|
5,438,000
|
|
|
|
4,689,000
|
|
|
|
7,192,000
|
|
|
|
5,444,000
|
|
|
|
8,314,000
|
|
|
|
6,746,000
|
|
|
|
4,976,000
|
|
In-place leases
|
|
|
512,000
|
|
|
|
575,000
|
|
|
|
969,000
|
|
|
|
668,000
|
|
|
|
897,000
|
|
|
|
741,000
|
|
|
|
519,000
|
|
Tenant relationships
|
|
|
458,000
|
|
|
|
585,000
|
|
|
|
1,318,000
|
|
|
|
999,000
|
|
|
|
1,395,000
|
|
|
|
964,000
|
|
|
|
312,000
|
|
Leasehold interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,000
|
|
Master lease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Above market leases
|
|
|
|
|
|
|
327,000
|
|
|
|
97,000
|
|
|
|
27,000
|
|
|
|
|
|
|
|
106,000
|
|
|
|
473,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets acquired
|
|
|
6,817,000
|
|
|
|
6,495,000
|
|
|
|
10,896,000
|
|
|
|
8,372,000
|
|
|
|
10,985,000
|
|
|
|
10,125,000
|
|
|
|
6,429,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans payable, net
|
|
|
|
|
|
|
(3,025,000
|
)
|
|
|
|
|
|
|
(4,414,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Below market leases
|
|
|
|
|
|
|
|
|
|
|
(41,000
|
)
|
|
|
|
|
|
|
|
|
|
|
(50,000
|
)
|
|
|
(80,000
|
)
|
Derivative financial instrument
|
|
|
|
|
|
|
(310,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities assumed
|
|
|
|
|
|
|
(3,335,000
|
)
|
|
|
(41,000
|
)
|
|
|
(4,414,000
|
)
|
|
|
|
|
|
|
(50,000
|
)
|
|
|
(80,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
$
|
6,817,000
|
|
|
$
|
3,160,000
|
|
|
$
|
10,855,000
|
|
|
$
|
3,958,000
|
|
|
$
|
10,985,000
|
|
|
$
|
10,075,000
|
|
|
$
|
6,349,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pocatello
East
Medical
Office
Building
|
|
|
Monument
Long-Term
Acute Care
Hospital
Portfolio
|
|
|
Virginia
Skilled
Nursing
Facility
Portfolio
|
|
|
Sylva
Medical
Office
Building
|
|
|
Surgical
Hospital
of Humble
|
|
|
Lawton
Medical
Office
Building
Portfolio
|
|
|
Ennis
Medical
Office
Building
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Land
|
|
$
|
|
|
|
$
|
3,772,000
|
|
|
$
|
4,405,000
|
|
|
$
|
|
|
|
$
|
719,000
|
|
|
$
|
|
|
|
$
|
467,000
|
|
Building and improvements
|
|
|
14,319,000
|
|
|
|
22,065,000
|
|
|
|
37,709,000
|
|
|
|
9,116,000
|
|
|
|
10,413,000
|
|
|
|
8,440,000
|
|
|
|
5,486,000
|
|
In-place leases
|
|
|
672,000
|
|
|
|
2,351,000
|
|
|
|
2,837,000
|
|
|
|
845,000
|
|
|
|
1,287,000
|
|
|
|
834,000
|
|
|
|
586,000
|
|
Tenant relationships
|
|
|
554,000
|
|
|
|
1,083,000
|
|
|
|
2,449,000
|
|
|
|
528,000
|
|
|
|
681,000
|
|
|
|
460,000
|
|
|
|
503,000
|
|
Leasehold interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
347,000
|
|
|
|
|
|
|
|
762,000
|
|
|
|
|
|
Master lease
|
|
|
455,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Above market leases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
830,000
|
|
|
|
56,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets acquired
|
|
|
16,000,000
|
|
|
|
29,271,000
|
|
|
|
47,400,000
|
|
|
|
10,836,000
|
|
|
|
13,100,000
|
|
|
|
11,326,000
|
|
|
|
7,098,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage loans payable, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below market leases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(373,000
|
)
|
|
|
|
|
Derivative financial instrument
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities
|
|
|
|
|
|
|
|
|
|
|
(2,400,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities assumed
|
|
|
|
|
|
|
|
|
|
|
(2,400,000
|
)
|
|
|
|
|
|
|
|
|
|
|
(373,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
$
|
16,000,000
|
|
|
$
|
29,271,000
|
|
|
$
|
45,000,000
|
|
|
$
|
10,836,000
|
|
|
$
|
13,100,000
|
|
|
$
|
10,953,000
|
|
|
$
|
7,098,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assuming the property acquisitions discussed above had occurred on January 7, 2009 (Date of
Inception), for the year ended December 31, 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009, pro forma revenues, net loss, net loss attributable to controlling interest and net loss per
common share attributable to controlling interest basic and diluted would have been as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
|
|
Period from
|
|
|
|
|
|
|
January 7, 2009
|
|
|
|
|
|
|
(Date of Inception)
|
|
|
|
Year Ended
|
|
|
through
|
|
|
|
December 31, 2010
|
|
|
December 31, 2009
|
|
|
|
|
Revenues
|
|
$
|
22,200,000
|
|
|
$
|
20,893,000
|
|
Net loss
|
|
$
|
2,143,000
|
|
|
$
|
894,000
|
|
Net loss attributable to controlling interest
|
|
$
|
2,142,000
|
|
|
$
|
891,000
|
|
Net loss per common share attributable to controlling interest basic and diluted
|
|
$
|
0.15
|
|
|
$
|
0.06
|
|
The pro forma adjustments assume that the debt proceeds and the offering proceeds, at a price of $10.00
per share, net of offering costs were raised as of January 7, 2009 (Date of Inception). In addition, as acquisition related expenses related to the acquisitions are not expected to have a continuing impact, they have been excluded from the pro
forma results. The pro forma results are not necessarily indicative of the operating results that would have been obtained had the acquisitions occurred on January 7, 2009 (Date of Inception), nor are they necessarily indicative of future
operating results.
149
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17. Segment Reporting
As of December 31, 2011, we evaluated our business and made resource allocations based on three reportable
business segments medical office buildings, hospitals and skilled nursing facilities. Our medical office buildings are typically leased to multiple tenants under separate leases in each building, thus requiring active management and
responsibility for many of the associated operating expenses (although many of these are, or can effectively be, passed through to the tenants). Our hospital investments are primarily single tenant properties which lease the facilities to
unaffiliated tenants under triple-net and generally master leases that transfer the obligation for all facility operating costs (including maintenance, repairs, taxes, insurance and capital expenditures) to the tenant. Our
skilled nursing facilities are acquired and similarly structured as our hospital investments. The accounting policies of these segments are the same as those described herein in Note 2, Summary of Significant Accounting Policies. There are no
intersegment sales or transfers.
We evaluate performance based upon net operating income of the combined properties in each
segment. We define net operating income, a non-GAAP financial measure, as total revenues, less rental expenses, which excludes depreciation and amortization, general and administrative expenses, acquisition related expenses, interest expense and
interest income. We believe that net income (loss), as defined by GAAP, is the most appropriate earnings measurement. However, we believe that segment profit serves as a useful supplement to net income (loss) because it allows investors and our
management to measure unlevered property-level operating results and to compare our operating results to the operating results of other real estate companies and between periods on a consistent basis. Segment profit should not be considered as an
alternative to net income (loss) determined in accordance with GAAP as an indicator of our financial performance, and, accordingly, we believe that in order to facilitate a clear understanding of our consolidated historical operating results,
segment profit should be examined in conjunction with net income (loss) as presented in our accompanying consolidated financial statements.
Interest expense, depreciation and amortization and other expenses not attributable to individual properties are not allocated to individual segments for purposes of assessing segment performance.
Non-segment assets primarily consist of corporate assets including cash and cash equivalents, real estate and escrow
deposits, deferred financing costs and other assets not attributable to individual properties.
150
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Summary information for the reportable segments during the years ended December 31,
2011 and 2010 are as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Medical
|
|
|
|
|
|
Skilled
|
|
|
|
|
|
|
Office
|
|
|
|
|
|
Nursing
|
|
|
Year Ended
|
|
|
|
Buildings
|
|
|
Hospitals
|
|
|
Facilities
|
|
|
December 31, 2011
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental income
|
|
$
|
21,479,000
|
|
|
$
|
7,651,000
|
|
|
$
|
11,327,000
|
|
|
$
|
40,457,000
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental expenses
|
|
|
6,575,000
|
|
|
|
725,000
|
|
|
|
1,030,000
|
|
|
|
8,330,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net operating income
|
|
$
|
14,904,000
|
|
|
$
|
6,926,000
|
|
|
$
|
10,297,000
|
|
|
$
|
32,127,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,992,000
|
|
Acquisition related expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,389,000
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,826,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
920,000
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense (including amortization of deferred financing costs and debt discount and premium):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,345,000
|
)
|
Loss in fair value of derivative financial instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(366,000
|
)
|
Interest income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(5,774,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Medical
|
|
|
|
|
|
Skilled
|
|
|
|
|
|
|
Office
|
|
|
|
|
|
Nursing
|
|
|
Year Ended
|
|
|
|
Buildings
|
|
|
Hospitals
|
|
|
Facilities
|
|
|
December 31, 2010
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental income
|
|
$
|
5,635,000
|
|
|
$
|
1,684,000
|
|
|
$
|
1,363,000
|
|
|
$
|
8,682,000
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental expenses
|
|
|
2,003,000
|
|
|
|
119,000
|
|
|
|
79,000
|
|
|
|
2,201,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net operating income
|
|
$
|
3,632,000
|
|
|
$
|
1,565,000
|
|
|
$
|
1,284,000
|
|
|
$
|
6,481,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,670,000
|
|
Acquisition related expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,099,000
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,591,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,879,000
|
)
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense (including amortization of deferred financing costs and debt discount and premium):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,416,000
|
)
|
Loss in fair value of derivative financial instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(143,000
|
)
|
Interest income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(7,423,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We did not own any properties and therefore did not have any reportable segments for the period from
January 7, 2009 (Date of Inception) through December 31, 2009.
151
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Assets by reportable segments as of December 31, 2011 and 2010, are as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
Medical office buildings
|
|
$
|
218,232,000
|
|
|
$
|
97,157,000
|
|
Hospitals
|
|
|
77,081,000
|
|
|
|
53,313,000
|
|
Skilled nursing facilities
|
|
|
151,081,000
|
|
|
|
47,610,000
|
|
All other
|
|
|
52,758,000
|
|
|
|
5,916,000
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
499,152,000
|
|
|
$
|
203,996,000
|
|
|
|
|
|
|
|
|
|
|
18. Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk are primarily cash and cash
equivalents, escrow deposits, restricted cash and accounts and other receivables. Cash is generally invested in investment-grade, short-term instruments with a maturity of three months or less when purchased. We have cash in financial institutions
that is insured by the Federal Deposit Insurance Corporation, or FDIC. As of December 31, 2011 and 2010, we had cash and cash equivalents, escrow deposits and restricted cash accounts in excess of FDIC insured limits. We believe this risk is
not significant. Concentration of credit risk with respect to accounts receivable from tenants is limited. We perform credit evaluations of prospective tenants, and security deposits are obtained upon lease execution.
Based on leases in effect as of December 31, 2011, we owned properties in three states for which each state accounted for 10.0% or
more of our annualized base rent. Pennsylvania accounted for 18.4% of our annualized base rent, Texas accounted for 13.4% of our annualized base rent and Virginia accounted for 10.7% of our annualized base rent. Accordingly, there is a geographic
concentration of risk subject to fluctuations in each states economy.
Based on leases in effect as of December 31,
2011, our three reportable business segments, medical office buildings, hospitals and skilled nursing facilities, accounted for 48.0%, 17.1% and 34.9%, respectively, of our annualized base rent. As of December 31, 2011, one of our tenants at
our consolidated properties accounted for 10.0% or more of our annualized base rent, as follows:
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
September 30,
|
|
Tenant
|
|
2011 Annualized
Base Rent
(1)
|
|
|
Percentage of
Annualized
Base Rent
|
|
|
Property
|
|
GLA
(Sq Ft)
|
|
|
Lease Expiration
Date
|
|
|
|
|
|
|
|
PA Holdings SNF, L.P. (Mid- Atlantic Health Care, LLC)
|
|
$
|
7,516,000
|
|
|
|
18.4
|
%
|
|
Philadelphia SNF Portfolio
|
|
|
392,000
|
|
|
|
06/30/26
|
|
(1)
|
Annualized base rent is based on contractual base rent from leases in effect as of December 31, 2011. The loss of this tenant or their inability to pay rent could
have a material adverse effect on our business and results of operations.
|
152
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19. Per Share Data
We report earnings (loss) per share pursuant to ASC Topic 260,
Earnings per Share
. Basic earnings (loss) per
share attributable for all periods presented are computed by dividing net income (loss) attributable to controlling interest by the weighted average number of shares of our common stock outstanding during the period. Diluted earnings (loss) per
share are computed based on the weighted average number of shares of our common stock and all potentially dilutive securities, if any. Nonvested shares of our restricted common stock give rise to potentially dilutive shares of our common stock. As
of December 31, 2011, 2010 and 2009, there were 16,500 shares, 15,000 shares and 12,000 shares, respectively, of nonvested shares of our restricted common stock outstanding, but such shares were excluded from the computation of diluted earnings
per share because such shares were anti-dilutive during these periods.
20. Selected Quarterly Financial Data (Unaudited)
Set forth below is the unaudited selected quarterly financial data. We believe that all necessary adjustments,
consisting only of normal recurring adjustments, have been included in the amounts stated below to present fairly, and in accordance with GAAP, the unaudited selected quarterly financial data when read in conjunction with our consolidated financial
statements.
153
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
Quarters Ended
|
|
|
|
December 31, 2011
|
|
|
September 30, 2011
|
|
|
June 30, 2011
|
|
|
March 31, 2011
|
|
|
|
|
|
|
Revenues
|
|
$
|
13,271,000
|
|
|
$
|
12,504,000
|
|
|
$
|
8,675,000
|
|
|
$
|
6,007,000
|
|
Expenses
|
|
|
(10,184,000
|
)
|
|
|
(9,693,000
|
)
|
|
|
(13,785,000
|
)
|
|
|
(5,875,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
|
|
|
3,087,000
|
|
|
|
2,811,000
|
|
|
|
(5,110,000
|
)
|
|
|
132,000
|
|
Other expense
|
|
|
(1,509,000
|
)
|
|
|
(2,398,000
|
)
|
|
|
(1,770,000
|
)
|
|
|
(1,017,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
1,578,000
|
|
|
|
413,000
|
|
|
|
(6,880,000
|
)
|
|
|
(885,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
|
(1,000
|
)
|
|
|
|
|
|
|
(1,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to controlling interest
|
|
$
|
1,577,000
|
|
|
$
|
413,000
|
|
|
$
|
(6,881,000
|
)
|
|
$
|
(885,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common share attributable to controlling interest basic and diluted
|
|
$
|
0.04
|
|
|
$
|
0.01
|
|
|
$
|
(0.27
|
)
|
|
$
|
(0.05
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding basic and diluted
|
|
|
44,569,470
|
|
|
|
34,644,097
|
|
|
|
25,543,273
|
|
|
|
18,144,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended
|
|
|
|
December 31, 2010
|
|
|
September 30, 2010
|
|
|
June 30, 2010
|
|
|
March 31, 2010
|
|
|
|
|
|
|
Revenues
|
|
$
|
4,672,000
|
|
|
$
|
2,807,000
|
|
|
$
|
1,142,000
|
|
|
$
|
61,000
|
|
Expenses
|
|
|
(5,371,000
|
)
|
|
|
(5,341,000
|
)
|
|
|
(2,981,000
|
)
|
|
|
(868,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(699,000
|
)
|
|
|
(2,534,000
|
)
|
|
|
(1,839,000
|
)
|
|
|
(807,000
|
)
|
Other income (expense)
|
|
|
(932,000
|
)
|
|
|
(396,000
|
)
|
|
|
(220,000
|
)
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(1,631,000
|
)
|
|
|
(2,930,000
|
)
|
|
|
(2,059,000
|
)
|
|
|
(803,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
(1,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to controlling interest
|
|
$
|
(1,631,000
|
)
|
|
$
|
(2,931,000
|
)
|
|
$
|
(2,059,000
|
)
|
|
$
|
(803,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share attributable to controlling interest basic and diluted
|
|
$
|
(0.13
|
)
|
|
$
|
(0.34
|
)
|
|
$
|
(0.37
|
)
|
|
$
|
(0.30
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding basic and diluted
|
|
|
12,765,174
|
|
|
|
8,745,255
|
|
|
|
5,558,762
|
|
|
|
2,690,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
21. Subsequent Events
Status of our Offering
As of March 7, 2012, we had received and accepted subscriptions in our offering for 52,415,020 shares of our common stock, or $523,074,000, excluding shares of our common stock issued pursuant to the
DRIP.
Share Repurchases
In January 2012, we repurchased 110,884 shares of our common stock, for an aggregate amount of $1,068,000, under our share repurchase plan. In addition, effective February 1, 2012, we repurchased
20,000 shares from our former advisor for $10.00 per share. Such repurchase was outside of our share repurchase plan and was made pursuant to our transition to our co-sponsors.
Griffin-American Advisor Contributions
On January 4, 2012,
Griffin-American Advisor acquired 22,222 shares of our common stock for $200,000. Griffin-American Advisor also contributed $2,000 to acquire 200 limited partnership units of our operating partnership. In addition to its right to participate with
other partners in our operating partnership on a proportionate basis in distributions, our advisors limited partnership interest in our operating partnership also entitles it to a subordinated participation interest. The subordinated
participation interest entitles our advisor to receive the subordinated distributions described under Note 11, Related Party Transactions Liquidity Stage Subordinated Participation Interest; provided however, that any amounts owed to
our advisor shall be reduced by the amounts paid, if any, to our former advisor pursuant to its subordinated distribution upon termination.
155
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Transition of Advisory and Dealer Manager Services
The Advisory Agreement with Griffin-American Advisor took effect upon the expiration of a 60-day transition period provided for in the
G&E Advisory Agreement, or January 7, 2012. The Dealer Manager Agreement with Griffin Securities became effective January 7, 2012.
Executive Stock Purchase Plans
In January 2012, Shannon K S
Johnson, our Chief Financial Officer; Stefan Oh, our Senior Vice President of Acquisitions; and Cora Lo, our Secretary; entered into executive stock purchase plans in which they each irrevocably agreed to invest 15.0%, 15.0% and 10.0%, respectively,
of their net after tax base salaries as employees of American Healthcare Investors into shares of our common stock.
Pursuant
to the executive stock purchase plans, each individual has directed that the respective portion of their net after-tax salary that is earned on or after February 1, 2012 as employees of American Healthcare Investors will be directly invested
into the Company by purchasing shares of our common stock. Such arrangements shall terminate on the earlier of (i) December 31, 2012, (ii) the termination of our offering, (iii) any suspension our offering by our board of
directors or a regulatory body, or (iv) the date upon which the number of shares of our common stock owned by any of them, when combined with all their other investments in the our common stock, exceeds the ownership limits set forth in our
charter. The shares will be purchased pursuant to our offering at a price of $9.00 per share, reflecting the elimination of selling commissions and the dealer manager fee in connection with such transactions.
U.S. Bank Interest Rate Swap
On March 1, 2012, we, through G&E HC REIT II Lawton MOB Portfolio, LLC, entered into an interest rate swap agreement, effective January 1, 2014, or the ISDA Agreement, with U.S. Bank
National Association, in connection with our mortgage loan in the original principal amount of $7,400,000 used to initially finance the acquisition of Lawton Medical Office Building Portfolio, or the U.S. Bank Loan. The terms of the U.S. Bank Loan
and initial interest rate swap agreement entered into on December 28, 2010 provided for an effective fixed interest rate of 4.41% per annum from January 1, 2011 through January 1, 2014. As a result of the ISDA Agreement, the U.S.
Bank Loan would bear interest at an effective fixed interest rate of 4.11% per annum from January 1, 2014 through October 1, 2015.
Property Acquisitions
Subsequent to December 31, 2011, we
completed three acquisitions comprising 15 buildings from unaffiliated parties. The aggregate purchase price of these properties was $224,110,000 and we paid $6,077,000 in acquisition fees to our former advisor or its affiliates and to our advisor
entities or their affiliates in connection with these acquisitions. We have not yet measured the fair value of the tangible and identified intangible assets and liabilities of the acquisitions. The following is a summary of our acquisitions
subsequent to December 31, 2011:
156
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
|
|
xxxxx
|
|
xxxxx
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
|
|
xxxxx
|
|
Property
|
|
Location
|
|
Type
|
|
Date
Acquired
|
|
|
Ownership
Percentage
|
|
|
Purchase
Price
|
|
|
Mortgage Loans
Payable
(1)
|
|
|
Lines
of
Credit
(2)
|
|
|
Acquisition Fee
(3)
|
|
|
|
|
|
|
|
|
|
|
Southeastern SNF Portfolio
|
|
Conyers,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Covington,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Snellville,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gainesville
and Atlanta, GA;
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Memphis and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Millington, TN;
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shreveport, LA;
|
|
Skilled
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mobile, AL
|
|
Nursing
|
|
|
01/10/12
|
|
|
|
100
|
%
|
|
$
|
166,500,000
|
|
|
$
|
83,159,000
|
|
|
$
|
58,435,000
|
|
|
$
|
4,579,000
|
|
|
|
|
|
|
|
|
|
|
FLAGS MOB Portfolio
|
|
Boynton Beach, FL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austell, GA;
|
|
Medical
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Okatie, SC
|
|
Office
|
|
|
01/27/12
|
|
|
|
100
|
%
|
|
|
25,110,000
|
|
|
|
11,965,000
|
|
|
|
12,000,000
|
|
|
|
653,000
|
|
|
|
|
|
|
|
|
|
|
Spokane MOB
|
|
Spokane, WA
|
|
Medical
Office
|
|
|
01/31/12
|
|
|
|
100
|
%
|
|
|
32,500,000
|
|
|
|
14,482,000
|
|
|
|
19,000,000
|
|
|
|
845,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
224,110,000
|
|
|
$
|
109,606,000
|
|
|
$
|
89,435,000
|
|
|
$
|
6,077,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the balance of the mortgage loans payable assumed by us on the property at the time of acquisition.
|
(2)
|
Represents borrowings under our secured revolving lines of credit with Bank of America and KeyBank, as defined in Note 8, Lines of Credit, at the time of acquisition.
We periodically advance funds and pay down our secured revolving lines of credit with Bank of America and KeyBank as needed.
|
(3)
|
Our former advisor or its affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties,
an acquisition fee of 2.75% of the contract purchase price of Southeastern SNF Portfolio. Our advisor entities and their affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of
our properties, an acquisition fee of 2.60% of the contract purchase price of FLAGS MOB Portfolio and Spokane MOB, which was paid as follows: (i) in shares of our common stock in an amount equal to 0.15% of the contract purchase price, at $9.00
per share, the established offering price as of the date of closing, net of selling commissions and dealer manager fees, and (ii) the remainder in cash equal to 2.45% of the contract purchase price.
|
157
SCHEDULE
REAL ESTATE AND ACCUMULATED DEPRECIATION
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION
December 31, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
|
|
Gross Amount of Which Carried at Close of Period(g)
|
|
|
|
|
|
|
|
Description
|
|
Encumbrances
|
|
|
Land
|
|
|
Buildings and
Improvements
|
|
|
Cost Capitalized
Subsequent to
Acquisition
(a)
|
|
|
Land
|
|
|
Buildings and
Improvements
|
|
|
Total
(f)
|
|
|
Accumulated
Depreciation
(h)(i)
|
|
|
Date
of
Construction
|
|
|
Date Acquired
|
|
Lacombe Medical
Office Building (Medical Office)
|
|
Lacombe, LA
|
|
$
|
(b
|
)
|
|
$
|
409,000
|
|
|
$
|
5,438,000
|
|
|
$
|
11,000
|
|
|
$
|
409,000
|
|
|
$
|
5,449,000
|
|
|
$
|
5,858,000
|
|
|
$
|
(353,000
|
)
|
|
|
2004
|
|
|
|
03/05/10
|
|
Center for Neurosurgery and Spine (Medical Office)
|
|
Sartell, MN
|
|
|
2,964,000
|
|
|
|
319,000
|
|
|
|
4,689,000
|
|
|
|
6,000
|
|
|
|
319,000
|
|
|
|
4,695,000
|
|
|
|
5,014,000
|
|
|
|
(409,000
|
)
|
|
|
2006
|
|
|
|
03/31/10
|
|
Parkway Medical
Center (Medical Office)
|
|
Beachwood, OH
|
|
|
(b
|
)
|
|
|
1,320,000
|
|
|
|
7,192,000
|
|
|
|
100,000
|
|
|
|
1,320,000
|
|
|
|
7,292,000
|
|
|
|
8,612,000
|
|
|
|
(650,000
|
)
|
|
|
1972, 1987
|
|
|
|
04/12/10
|
|
Highlands Ranch
Medical Pavilion (Medical Office)
|
|
Highlands Ranch, CO
|
|
|
4,289,000
|
|
|
|
1,234,000
|
|
|
|
5,444,000
|
|
|
|
87,000
|
|
|
|
1,234,000
|
|
|
|
5,531,000
|
|
|
|
6,765,000
|
|
|
|
(429,000
|
)
|
|
|
1999
|
|
|
|
04/30/10
|
|
Muskogee Long-Term
Acute Care Hospital (Hospital)
|
|
Muskogee, OK
|
|
|
7,095,000
|
|
|
|
379,000
|
|
|
|
8,314,000
|
|
|
|
300,000
|
|
|
|
379,000
|
|
|
|
8,614,000
|
|
|
|
8,993,000
|
|
|
|
(488,000
|
)
|
|
|
2006
|
|
|
|
05/27/10
|
|
St. Vincent Medical
Office Building (Medical Office)
|
|
Cleveland, OH
|
|
|
(b
|
)
|
|
|
1,568,000
|
|
|
|
6,746,000
|
|
|
|
192,000
|
|
|
|
1,568,000
|
|
|
|
6,938,000
|
|
|
|
8,506,000
|
|
|
|
(540,000
|
)
|
|
|
1985
|
|
|
|
06/25/10
|
|
Livingston Medical
Arts Pavilion (Medical Office)
|
|
Livingston, TX
|
|
|
(b
|
)
|
|
|
|
|
|
|
4,976,000
|
|
|
|
|
|
|
|
|
|
|
|
4,976,000
|
|
|
|
4,976,000
|
|
|
|
(314,000
|
)
|
|
|
2007
|
|
|
|
06/28/10
|
|
Pocatello East Medical
Office Building (Medical Office)
|
|
Pocatello, ID
|
|
|
7,788,000
|
|
|
|
|
|
|
|
14,319,000
|
|
|
|
1,819,000
|
|
|
|
|
|
|
|
16,138,000
|
|
|
|
16,138,000
|
|
|
|
(611,000
|
)
|
|
|
2007
|
|
|
|
07/27/10
|
|
Monument Long-Term Acute
Care Hospital Portfolio (Hospital)
|
|
|
|
|
15,248,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cape Girardeau, MO
|
|
|
(d
|
)
|
|
|
799,000
|
|
|
|
6,268,000
|
|
|
|
|
|
|
|
799,000
|
|
|
|
6,268,000
|
|
|
|
7,067,000
|
|
|
|
(308,000
|
)
|
|
|
2006
|
|
|
|
08/12/10
|
|
|
|
Joplin, MO
|
|
|
(d
|
)
|
|
|
995,000
|
|
|
|
6,908,000
|
|
|
|
|
|
|
|
995,000
|
|
|
|
6,908,000
|
|
|
|
7,903,000
|
|
|
|
(346,000
|
)
|
|
|
2007
|
|
|
|
08/31/10
|
|
|
|
Athens, GA
|
|
|
(d
|
)
|
|
|
1,978,000
|
|
|
|
8,889,000
|
|
|
|
|
|
|
|
1,978,000
|
|
|
|
8,889,000
|
|
|
|
10,867,000
|
|
|
|
(363,000
|
)
|
|
|
2008
|
|
|
|
10/29/10
|
|
|
|
Columbia, MO
|
|
|
(d
|
)
|
|
|
1,433,000
|
|
|
|
9,607,000
|
|
|
|
|
|
|
|
1,433,000
|
|
|
|
9,607,000
|
|
|
|
11,040,000
|
|
|
|
(299,000
|
)
|
|
|
2009
|
|
|
|
01/31/11
|
|
Virginia Skilled Nursing
Facility Portfolio (Skilled Nursing)
|
|
|
|
|
9,771,000
|
(e)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charlottesville, VA
|
|
|
(c
|
)
|
|
|
829,000
|
|
|
|
9,175,000
|
|
|
|
|
|
|
|
829,000
|
|
|
|
9,175,000
|
|
|
|
10,004,000
|
|
|
|
(389,000
|
)
|
|
|
2004
|
|
|
|
09/16/10
|
|
|
|
Bastian, VA
|
|
|
(e
|
)
|
|
|
217,000
|
|
|
|
2,546,000
|
|
|
|
86,000
|
|
|
|
217,000
|
|
|
|
2,632,000
|
|
|
|
2,849,000
|
|
|
|
(139,000
|
)
|
|
|
1989
|
|
|
|
09/16/10
|
|
|
|
Lebanon, VA
|
|
|
(e
|
)
|
|
|
359,000
|
|
|
|
3,917,000
|
|
|
|
|
|
|
|
359,000
|
|
|
|
3,917,000
|
|
|
|
4,276,000
|
|
|
|
(176,000
|
)
|
|
|
1990
|
|
|
|
09/16/10
|
|
|
|
Fincastle, VA
|
|
|
(c
|
)
|
|
|
302,000
|
|
|
|
3,147,000
|
|
|
|
34,000
|
|
|
|
302,000
|
|
|
|
3,181,000
|
|
|
|
3,483,000
|
|
|
|
(169,000
|
)
|
|
|
1990
|
|
|
|
09/16/10
|
|
|
|
Low Moor, VA
|
|
|
(e
|
)
|
|
|
655,000
|
|
|
|
6,817,000
|
|
|
|
17,000
|
|
|
|
655,000
|
|
|
|
6,834,000
|
|
|
|
7,489,000
|
|
|
|
(267,000
|
)
|
|
|
1989
|
|
|
|
09/16/10
|
|
|
|
Midlothian, VA
|
|
|
(c
|
)
|
|
|
1,840,000
|
|
|
|
9,991,000
|
|
|
|
24,000
|
|
|
|
1,840,000
|
|
|
|
10,015,000
|
|
|
|
11,855,000
|
|
|
|
(409,000
|
)
|
|
|
1991
|
|
|
|
09/16/10
|
|
|
|
Hot Springs, VA
|
|
|
(c
|
)
|
|
|
203,000
|
|
|
|
2,116,000
|
|
|
|
63,000
|
|
|
|
203,000
|
|
|
|
2,179,000
|
|
|
|
2,382,000
|
|
|
|
(122,000
|
)
|
|
|
1990
|
|
|
|
09/16/10
|
|
Sylva Medical
Office Building (Medical Office)
|
|
Sylva, NC
|
|
|
(b
|
)
|
|
|
|
|
|
|
9,116,000
|
|
|
|
497,000
|
|
|
|
|
|
|
|
9,613,000
|
|
|
|
9,613,000
|
|
|
|
(323,000
|
)
|
|
|
2010
|
|
|
|
11/15/10
|
|
Surgical Hospital
of Humble (Hospital)
|
|
Humble, TX
|
|
|
|
|
|
|
719,000
|
|
|
|
10,413,000
|
|
|
|
|
|
|
|
719,000
|
|
|
|
10,413,000
|
|
|
|
11,132,000
|
|
|
|
(347,000
|
)
|
|
|
2000/2010
|
|
|
|
12/10/10
|
|
Lawton Medical Office
Building Portfolio (Medical Office)
|
|
Lawton, OK
|
|
|
7,142,000
|
|
|
|
|
|
|
|
8,440,000
|
|
|
|
597,000
|
|
|
|
|
|
|
|
9,037,000
|
|
|
|
9,037,000
|
|
|
|
(289,000
|
)
|
|
|
1985/2008
|
|
|
|
12/22/10
|
|
Ennis Medical
Office Building (Medical Office)
|
|
Ennis, TX
|
|
|
(b
|
)
|
|
|
467,000
|
|
|
|
5,486,000
|
|
|
|
|
|
|
|
467,000
|
|
|
|
5,486,000
|
|
|
|
5,953,000
|
|
|
|
(214,000
|
)
|
|
|
2008
|
|
|
|
12/22/10
|
|
158
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION – (Continued)
December 31, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial Cost to Company
|
|
|
|
|
|
Gross Amount of Which Carried at Close of Period(g)
|
|
|
|
|
|
|
|
Description
|
|
Encumbrances
|
|
|
Land
|
|
|
Buildings and
Improvements
|
|
|
Cost Capitalized
Subsequent to
Acquisition
(a)
|
|
|
Land
|
|
|
Buildings and
Improvements
|
|
|
Total
(f)
|
|
|
Accumulated
Depreciation
(h)(i)
|
|
|
Date of Construction
|
|
|
Date Acquired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
St. Anthony North Medical
Office Building (Medical Office)
|
|
Westminster, CO
|
|
$
|
(b
|
)
|
|
$
|
|
|
|
$
|
9,543,000
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
9,543,000
|
|
|
$
|
9,543,000
|
|
|
$
|
(274,000
|
)
|
|
|
2008
|
|
|
|
03/29/11
|
|
Loma Linda Pediatric Specialty
Hospital Portfolio (Hospital)
|
|
Loma Linda, CA
|
|
|
|
|
|
|
1,370,000
|
|
|
|
9,862,000
|
|
|
|
|
|
|
|
1,370,000
|
|
|
|
9,862,000
|
|
|
|
11,232,000
|
|
|
|
(217,000
|
)
|
|
|
1950/1985/1991
|
|
|
|
03/31/11
|
|
Yuma Skilled Nursing
Facility (Skilled Nursing)
|
|
Yuma, AZ
|
|
|
(c
|
)
|
|
|
768,000
|
|
|
|
10,060,000
|
|
|
|
|
|
|
|
768,000
|
|
|
|
10,060,000
|
|
|
|
10,828,000
|
|
|
|
(233,000
|
)
|
|
|
1964/2012
|
|
|
|
04/13/11
|
|
Hardy Oak Medical
Office Building (Medical Office)
|
|
San Antonio, TX
|
|
|
5,182,000
|
|
|
|
814,000
|
|
|
|
6,184,000
|
|
|
|
|
|
|
|
814,000
|
|
|
|
6,184,000
|
|
|
|
6,998,000
|
|
|
|
(176,000
|
)
|
|
|
2003
|
|
|
|
04/14/11
|
|
Lakewood Ranch Medical Office
Building (Medical Office)
|
|
Bradenton, FL
|
|
|
|
|
|
|
|
|
|
|
10,324,000
|
|
|
|
15,000
|
|
|
|
|
|
|
|
10,339,000
|
|
|
|
10,339,000
|
|
|
|
(275,000
|
)
|
|
|
2003
|
|
|
|
04/15/11
|
|
Dixie-Lobo Medical Office
Building Portfolio (Medical Office)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hope, AR
|
|
|
|
|
|
|
|
|
|
|
1,243,000
|
|
|
|
|
|
|
|
|
|
|
|
1,243,000
|
|
|
|
1,243,000
|
|
|
|
(38,000
|
)
|
|
|
2003
|
|
|
|
05/12/11
|
|
|
|
Lake Charles, LA
|
|
|
|
|
|
|
|
|
|
|
2,046,000
|
|
|
|
|
|
|
|
|
|
|
|
2,046,000
|
|
|
|
2,046,000
|
|
|
|
(55,000
|
)
|
|
|
2001
|
|
|
|
05/12/11
|
|
|
|
Carlsbad, NM
|
|
|
|
|
|
|
|
|
|
|
3,670,000
|
|
|
|
|
|
|
|
|
|
|
|
3,670,000
|
|
|
|
3,670,000
|
|
|
|
(89,000
|
)
|
|
|
2002
|
|
|
|
05/12/11
|
|
|
|
Hobbs, NM
|
|
|
|
|
|
|
|
|
|
|
1,913,000
|
|
|
|
|
|
|
|
|
|
|
|
1,913,000
|
|
|
|
1,913,000
|
|
|
|
(79,000
|
)
|
|
|
2003
|
|
|
|
05/12/11
|
|
|
|
Alice, TX
|
|
|
|
|
|
|
|
|
|
|
3,535,000
|
|
|
|
|
|
|
|
|
|
|
|
3,535,000
|
|
|
|
3,535,000
|
|
|
|
(100,000
|
)
|
|
|
2001
|
|
|
|
05/12/11
|
|
|
|
Lufkin, TX
|
|
|
|
|
|
|
|
|
|
|
2,294,000
|
|
|
|
|
|
|
|
|
|
|
|
2,294,000
|
|
|
|
2,294,000
|
|
|
|
(60,000
|
)
|
|
|
2001
|
|
|
|
05/12/11
|
|
|
|
Victoria, TX
|
|
|
|
|
|
|
|
|
|
|
4,313,000
|
|
|
|
|
|
|
|
|
|
|
|
4,313,000
|
|
|
|
4,313,000
|
|
|
|
(119,000
|
)
|
|
|
1986/2003
|
|
|
|
05/12/11
|
|
|
|
Wharton, TX
|
|
|
|
|
|
|
|
|
|
|
3,178,000
|
|
|
|
|
|
|
|
|
|
|
|
3,178,000
|
|
|
|
3,178,000
|
|
|
|
(76,000
|
)
|
|
|
2001
|
|
|
|
05/12/11
|
|
Milestone Medical Office
Building Portfolio (Medical Office)
|
|
Jersey City, NJ
|
|
|
16,000,000
|
|
|
|
|
|
|
|
21,551,000
|
|
|
|
|
|
|
|
|
|
|
|
21,551,000
|
|
|
|
21,551,000
|
|
|
|
(405,000
|
)
|
|
|
2010
|
|
|
|
05/26/11
|
|
|
|
Benton, AR
|
|
|
|
|
|
|
|
|
|
|
6,400,000
|
|
|
|
(19,000
|
)
|
|
|
|
|
|
|
6,381,000
|
|
|
|
6,381,000
|
|
|
|
(154,000
|
)
|
|
|
1992/1999
|
|
|
|
05/26/11
|
|
|
|
Benton, AR
|
|
|
|
|
|
|
|
|
|
|
966,000
|
|
|
|
|
|
|
|
|
|
|
|
966,000
|
|
|
|
966,000
|
|
|
|
(30,000
|
)
|
|
|
1986
|
|
|
|
05/26/11
|
|
|
|
Bryant, AR
|
|
|
|
|
|
|
495,000
|
|
|
|
3,827,000
|
|
|
|
|
|
|
|
495,000
|
|
|
|
3,827,000
|
|
|
|
4,322,000
|
|
|
|
(85,000
|
)
|
|
|
1993/2006
|
|
|
|
05/26/11
|
|
Philadelphia SNF
Portfolio (Skilled Nursing)
|
|
Philadelphia, PA
|
|
|
(c
|
)
|
|
|
1,185,000
|
|
|
|
27,655,000
|
|
|
|
|
|
|
|
1,185,000
|
|
|
|
27,655,000
|
|
|
|
28,840,000
|
|
|
|
(512,000
|
)
|
|
|
1975
|
|
|
|
06/30/11
|
|
|
|
Philadelphia, PA
|
|
|
(c
|
)
|
|
|
1,249,000
|
|
|
|
12,593,000
|
|
|
|
|
|
|
|
1,249,000
|
|
|
|
12,593,000
|
|
|
|
13,842,000
|
|
|
|
(224,000
|
)
|
|
|
1900
|
|
|
|
06/30/11
|
|
|
|
Philadelphia, PA
|
|
|
(c
|
)
|
|
|
719,000
|
|
|
|
9,121,000
|
|
|
|
|
|
|
|
719,000
|
|
|
|
9,121,000
|
|
|
|
9,840,000
|
|
|
|
(164,000
|
)
|
|
|
1977
|
|
|
|
06/30/11
|
|
|
|
Philadelphia, PA
|
|
|
(c
|
)
|
|
|
887,000
|
|
|
|
10,962,000
|
|
|
|
|
|
|
|
887,000
|
|
|
|
10,962,000
|
|
|
|
11,849,000
|
|
|
|
(203,000
|
)
|
|
|
1975
|
|
|
|
06/30/11
|
|
|
|
Philadelphia, PA
|
|
|
(c
|
)
|
|
|
707,000
|
|
|
|
9,152,000
|
|
|
|
|
|
|
|
707,000
|
|
|
|
9,152,000
|
|
|
|
9,859,000
|
|
|
|
(188,000
|
)
|
|
|
1978
|
|
|
|
06/30/11
|
|
Maxfield Medical
Office Building (Medical Office)
|
|
Sarasota, FL
|
|
|
5,050,000
|
|
|
|
923,000
|
|
|
|
5,702,000
|
|
|
|
14,000
|
|
|
|
923,000
|
|
|
|
5,716,000
|
|
|
|
6,639,000
|
|
|
|
(135,000
|
)
|
|
|
2001
|
|
|
|
07/11/11
|
|
Lafayette Physical Rehabilitation
Hospital (Hospital)
|
|
Lafayette, LA
|
|
|
|
|
|
|
1,184,000
|
|
|
|
9,322,000
|
|
|
|
|
|
|
|
1,184,000
|
|
|
|
9,322,000
|
|
|
|
10,506,000
|
|
|
|
(73,000
|
)
|
|
|
2006
|
|
|
|
09/30/11
|
|
Sierra Providence East Medical
Plaza I (Medical Office)
|
|
El Paso, TX
|
|
|
|
|
|
|
|
|
|
|
5,696,000
|
|
|
|
|
|
|
|
|
|
|
|
5,696,000
|
|
|
|
5,696,000
|
|
|
|
|
|
|
|
2008
|
|
|
|
12/22/11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
80,529,000
|
|
|
$
|
26,326,000
|
|
|
$
|
351,066,000
|
|
|
$
|
3,843,000
|
|
|
$
|
26,326,000
|
|
|
$
|
354,909,000
|
|
|
$
|
381,235,000
|
|
|
$
|
(11,918,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
The cost capitalized subsequent to acquisition is shown net of dispositions.
|
(b)
|
As of December 31, 2011, our secured revolving line of credit with Bank of America, N.A. with an aggregate maximum principal amount of $38,435,000 is secured by
Lacombe Medical Office Building, Parkway Medical Center, St. Vincent Medical Office Building, Livingston Medical Arts Pavilion, Sylva Medical Office Building, Ennis Medical Office Building and St. Anthony North Medical Office Building. As of
December 31, 2011, our borrowing capacity was $38,435,000 and no borrowings were outstanding.
|
159
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION – (Continued)
December 31, 2011
(c)
|
As of December 31, 2011, our secured revolving line of credit with KeyBank with an aggregate maximum principal amount of $71,500,000 is secured by four facilities
of Virginia Skilled Nursing Facility Portfolio, Yuma Skilled Nursing Facility and Philadelphia SNF Portfolio. As of December 31, 2011, our borrowing capacity was $71,500,000 and no borrowings were outstanding.
|
(d)
|
As of December 31, 2011, a mortgage loan payable in the amount of $15,248,000 was secured by Monument LTACH Portfolio.
|
(e)
|
Virginia Skilled Nursing Facility Portfolio consists of seven skilled nursing facilities. As of December 31, 2011, a mortgage loan payable in the amount of
$9,771,000 was secured by three of the skilled nursing facilities.
|
(f)
|
The changes in total real estate for the year ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009 are as follows:
|
|
|
|
September 30,
|
|
|
|
Amount
|
|
|
|
Balance as of January 7, 2009 (Date of Inception)
|
|
$
|
|
|
Acquisitions
|
|
|
|
|
Additions
|
|
|
|
|
Dispositions
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2009
|
|
|
|
|
Acquisitions
|
|
|
164,939,000
|
|
Additions
|
|
|
466,000
|
|
Dispositions
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2010
|
|
$
|
165,405,000
|
|
Acquisitions
|
|
|
212,453,000
|
|
Additions
|
|
|
3,448,000
|
|
Dispositions
|
|
|
(71,000
|
)
|
|
|
|
|
|
Balance as of December 31, 2011
|
|
$
|
381,235,000
|
|
|
|
|
|
|
(g)
|
For federal income tax purposes, the aggregate cost of our properties is $446,528,000.
|
(h)
|
The changes in accumulated depreciation for the year ended December 31, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through
December 31, 2009 are as follows:
|
160
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Formerly known as Grubb & Ellis Healthcare REIT II, Inc.)
SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION – (Continued)
December 31, 2011
|
|
|
September 30,
|
|
|
|
Amount
|
|
Balance as of January 7, 2009 (Date of Inception)
|
|
$
|
|
|
Additions
|
|
|
|
|
Dispositions
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2009
|
|
|
|
|
Additions
|
|
|
(2,070,000
|
)
|
Dispositions
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2010
|
|
$
|
(2,070,000
|
)
|
Additions
|
|
|
(9,919,000
|
)
|
Dispositions
|
|
|
71,000
|
|
|
|
|
|
|
Balance as of December 31, 2011
|
|
$
|
(11,918,000
|
)
|
|
|
|
|
|
(i)
|
The cost of buildings and capital improvements is depreciated on a straight-line basis over the estimated useful lives of the buildings and capital improvements, up to
39 years, and the cost for tenant improvements is depreciated over the shorter of the lease term or useful life, ranging from five months to 15.1 years. Furniture, fixtures and equipment is depreciated over the estimated useful life ranging from
five years to seven years.
|
161
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Griffin-American Healthcare REIT II, Inc.
(Registrant)
|
|
|
|
|
|
|
|
|
|
By
|
|
/s/ J
EFFREY
T. H
ANSON
|
|
|
|
Chief Executive Officer and Chairman of the Board
|
|
|
Jeffrey T. Hanson
|
|
|
|
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by
the following persons on behalf of the registrant and in the capacities and on the dates indicated.
|
|
|
|
|
|
|
By
|
|
/s/ J
EFFREY
T. H
ANSON
Jeffrey T. Hanson
|
|
|
|
Chief Executive Officer and Chairman of the Board
(principal executive officer)
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
|
|
|
|
By
|
|
/s/ S
HANNON
K S J
OHNSON
Shannon K S Johnson
|
|
|
|
Chief Financial Officer
(principal financial officer and principal
accounting officer)
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
|
|
|
|
By
|
|
/s/ D
ANNY
P
ROSKY
Danny Prosky
|
|
|
|
President, Chief Operating Officer and Director
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
|
|
|
|
By
|
|
/s/ P
ATRICK
R. L
EARDO
Patrick R. Leardo
|
|
|
|
Director
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
|
|
|
|
By
|
|
/s/ G
ERALD
W. R
OBINSON
Gerald W. Robinson
|
|
|
|
Director
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
|
|
|
|
By
|
|
/s/ G
ARY
E. S
TARK
Gary E. Stark
|
|
|
|
Director
|
|
|
|
Date: March 15, 2012
|
|
|
|
|
162
EXHIBIT INDEX
Following the Registrants transition to the co-sponsorship arrangement with Griffin Capital Corporation and American Healthcare
Investors LLC, Grubb & Ellis Healthcare REIT II, Inc. and Grubb & Ellis Healthcare REIT II Holdings, LP changed their names to Griffin-American Healthcare REIT II, Inc. and Griffin American Healthcare REIT II Holdings, LP,
respectively. The following Exhibit List refers to the entity names used prior to such name changes in order to accurately reflect the names of the parties on the documents listed.
Pursuant to Item 601(a)(2) of Regulation S-K, this Exhibit Index immediately precedes the exhibits.
The following exhibits are included, or incorporated by reference, in this Annual Report on Form 10-K for the fiscal year ended
December 31, 2011 (and are numbered in accordance with Item 601 of Regulation S-K).
|
|
|
|
|
1.1
|
|
Dealer Manager Agreement by and between Grubb & Ellis Healthcare REIT II, Inc. and Griffin Capital Securities, Inc., dated November 7, 2011 (included as Exhibit 1.1 to our
Current Report on Form 8-K filed November 9, 2011 and incorporated herein by reference)
|
|
|
3.1
|
|
Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated July 30, 2009 (included as Exhibit 3.1 to Pre-Effective Amendment No. 3 to our
Registration Statement on Form S-11 (File No. 333-158111) filed August 5, 2009 and incorporated herein by reference)
|
|
|
3.2
|
|
Articles of Amendment to the Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated September 1, 2009 (included as Exhibit 3.1 to our
Current Report on Form 8-K filed September 3, 2009 and incorporated herein by reference)
|
|
|
3.3
|
|
Second Articles of Amendment to the Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated September 18, 2009 (included as Exhibit 3.1
to our Current Report on Form 8-K filed September 21, 2009 and incorporated herein by reference)
|
|
|
3.4
|
|
Third Articles of Amendment to Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated June 15, 2011 (included as Exhibit 3.1 to our
Current Report on Form 8-K filed June 16, 2011 and incorporated herein by reference)
|
|
|
3.5
|
|
Fourth Articles of Amendment to Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated January 3, 2012 (included as Exhibit 3.5 to
Post-Effective Amendment No. 14 to our Registration Statement on Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
|
|
|
3.6
|
|
Bylaws of Grubb & Ellis Healthcare REIT II, Inc. (included as Exhibit 3.2 to our Registration Statement on Form S-11 (File No. 333-158111) filed March 19, 2009 and incorporated
herein by reference)
|
|
|
3.7
|
|
Amendment to Bylaws of Grubb & Ellis Healthcare REIT II, Inc. dated January 3, 2012 (included as Exhibit 3.7 to Post-Effective Amendment No. 14 to our Registration Statement on
Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
|
|
|
4.1
|
|
Third Amended and Restated Escrow Agreement by and among Grubb & Ellis Healthcare REIT II, Inc., Grubb & Ellis Securities, Inc. and CommerceWest Bank, N.A., dated November
24, 2010 (included as Exhibit 4.1 to our Current Report on Form 8-K filed November 30, 2010 and incorporated herein by reference)
|
|
|
4.2
|
|
Form of Subscription Agreement of Griffin-American Healthcare REIT II, Inc. (included as Exhibit 4.2 to Post-Effective Amendment No. 14 to our Registration Statement on Form S-11
(File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
|
|
|
4.3
|
|
Distribution Reinvestment Plan of Griffin-American Healthcare REIT II, Inc. effective as of August 24, 2009 (included as Exhibit 4.3 to Post-Effective Amendment No. 14 to our
Registration Statement on Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference))
|
|
|
4.4
|
|
Share Repurchase Plan of Griffin-American Healthcare REIT II, Inc. (included as Exhibit 4.4 to Post-Effective Amendment No. 14 to our Registration Statement on Form S-11 (File No.
333-158111) filed January 4, 2012 and incorporated herein by reference)
|
|
|
|
|
|
10.1
|
|
Agreement of Limited Partnership of Grubb & Ellis Healthcare REIT II Holdings, LP (included as Exhibit 10.2 to our Registration Statement on Form S-11 (File No. 333-158111)
filed March 19, 2009 and incorporated herein by reference)
|
|
|
10.2
|
|
Advisory Agreement by and among Grubb & Ellis Healthcare REIT II, Inc., Grubb & Ellis Healthcare REIT II Holdings, LP and Griffin-American Healthcare REIT Advisor, LLC,
dated November 7, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed November 9, 2011 and incorporated herein by reference)
|
|
|
10.3
|
|
Form of Indemnification Agreement between Grubb & Ellis Healthcare REIT II, Inc. and Indemnitee made effective as of August 24, 2009 (included as Exhibit 10.1 to our
Current Report on Form 8-K filed September 3, 2009 and incorporated herein by reference)
|
|
|
10.4
|
|
Grubb & Ellis Healthcare REIT II, Inc. 2009 Incentive Plan (included as Exhibit 10.3 to Pre-Effective Amendment No. 1 to our Registration Statement on Form S-11 (File No.
333-158111) filed May 8, 2009 and incorporated herein by reference)
|
|
|
10.5
|
|
Assignment and Assumption of Purchase Agreement by and between G&E HC REIT II Monument LTACH Portfolio, LLC and G&E HC REIT II Columbia LTACH, LLC, dated January 31, 2011
(included as Exhibit 10.1 to our Current Report on Form 8-K filed February 3, 2011 and incorporated herein by reference)
|
|
|
10.6
|
|
Deed of Trust, Assignment of Leases and Rents, Security Agreement, Fixture Filing and Financing Statement by G&E HC REIT II Ennis MOB, LLC in favor of Bank of America, N.A.,
dated January 28, 2011 (included as Exhibit 10.2 to our Current Report on Form 8-K filed February 3, 2011 and incorporated herein by reference)
|
|
|
10.7
|
|
Collateral Assignment of Management Contract by and among G&E HC REIT II Ennis MOB, LLC, Grubb & Ellis Equity Advisors, Property Management, Inc., The Cirrus Group, LLC and
Bank of America, N.A., dated January 28, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K filed February 3, 2011 and incorporated herein by reference)
|
|
|
10.8
|
|
Joinder to Promissory Note between Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Lacombe MOB, LLC, G&E HC REIT II Parkway Medical Center, LLC, G&E HC
REIT II Livingston MOB, LLC, G&E HC REIT II St. Vincent Cleveland MOB, LLC, G&E HC REIT II Sylva MOB, LLC G&E HC REIT II Ennis MOB, LLC and Bank of America, N.A., dated January 28, 2011 (included as Exhibit 10.4 to our Current Report on
Form 8-K filed February 3, 2011 and incorporated herein by reference)
|
|
|
10.9
|
|
Joinder to Credit Agreement and Other Loan Documents between Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Lacombe MOB, LLC, G&E HC REIT II Parkway
Medical Center, LLC, G&E HC REIT II Livingston MOB, LLC, G&E HC REIT II St. Vincent Cleveland MOB, LLC, G&E HC REIT II Sylva MOB, LLC, G&E HC REIT II Ennis MOB, LLC and Bank of America, N.A., dated January 28, 2011 (included as
Exhibit 10.5 to our Current Report on Form 8-K filed February 3, 2011 and incorporated herein by reference)
|
|
|
10.10
|
|
Purchase and Sale Agreement by and between G&E HC REIT II Dixie-Lobo MOB Portfolio, LLC and TMB-Alice, L.P., Carlsbad-TMB, LLC, Hobbs-TMB, LLC, Hope-TMB, LLC, TMB-Lake Charles,
L.P., TMB-Lufkin, L.P., Victoria-TMB, L.P. and TMB I, L.P., dated March 21, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed March 25, 2011 and incorporated herein by reference)
|
|
|
10.11
|
|
Promissory Note by G&E HC REIT II Muskogee LTACH, LLC for the benefit of Capital One, N.A., dated April 8, 2011 (included as Exhibit 10.1 to our Current Report on Form
8-K/A filed April 15, 2011 and incorporated herein by reference)
|
|
|
10.12
|
|
Loan Agreement by and between G&E HC REIT II Muskogee LTACH, LLC and Capital One, N.A., dated April 8, 2011 (included as Exhibit 10.2 to our Current Report on Form 8-K/A
filed April 15, 2011 and incorporated herein by reference)
|
|
|
10.13
|
|
Mortgage, Security Agreement and Fixture Filing by G&E HC REIT II Muskogee LTACH, LLC for the benefit of Capital One, N.A., dated April 8, 2011 (included as Exhibit 10.3 to
our Current Report on Form 8-K/A filed April 15, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.14
|
|
Assignment of Leases and Rents by G&E HC REIT II Muskogee LTACH, LLC for the benefit of Capital One, N.A., dated April 8, 2011 (included as Exhibit 10.4 to our Current
Report on Form 8-K/A filed April 15, 2011 and incorporated herein by reference)
|
|
|
10.15
|
|
International Swap Dealers Association, Inc. Master Agreement by and between by G&E HC REIT II Muskogee LTACH, LLC and Capital One, N.A., dated April 12, 2011 (included as
Exhibit 10.5 to our Current Report on Form 8-K/A filed April 15, 2011 and incorporated herein by reference)
|
|
|
10.16
|
|
Purchase and Sale Agreement by and between G&E HC REIT II Jersey City MOB, LLC and Jersey City Medical Complex, LLC, dated April 20, 2011 (included as Exhibit 10.1 to our
Current Report on Form 8-K filed April 26, 2011 and incorporated herein by reference)
|
|
|
10.17
|
|
Purchase and Sale Agreement by and between G&E HC REIT II Bryant MOB, LLC and Bryant MOB Medical Complex, LLC, dated April 20, 2011 (included as Exhibit 10.2 to our Current
Report on Form 8-K filed April 26, 2011 and incorporated herein by reference)
|
|
|
10.18
|
|
Purchase and Sale Agreement by and between G&E HC REIT II Benton Home Health MOB, LLC and Home Health Medical Complex, LLC, dated April 20, 2011 (included as Exhibit 10.3
to our Current Report on Form 8-K filed April 26, 2011 and incorporated herein by reference)
|
|
|
10.19
|
|
Purchase and Sale Agreement by and between G&E HC REIT II Benton Medical Plaza I & II MOB, LLC and Medical Park Place Medical Complex, LLC, dated April 20, 2011 (included as
Exhibit 10.4 to our Current Report on Form 8-K filed April 26, 2011 and incorporated herein by reference)
|
|
|
10.20
|
|
First Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Dixie-Lobo MOB Portfolio, LLC and TMB-Alice, L.P., Carlsbad-TMB, LLC,
Hobbs-TMB, LLC, Hope-TMB, LLC, TMB-Lake Charles, L.P., TMB-Lufkin, L.P., Victoria-TMB, L.P. and TMB-I, L.P. and First American Title Insurance Company, dated April 25, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed April 29,
2011 and incorporated herein by reference)
|
|
|
10.21
|
|
First Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Jersey City MOB, LLC and Jersey City Medical Complex, LLC, dated April 29,
2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.22
|
|
First Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Bryant MOB, LLC and Bryant MOB Medical Complex, LLC, dated April 29, 2011
(included as Exhibit 10.2 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.23
|
|
First Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Benton Home Health MOB, LLC and Home Health Medical Complex, LLC, dated
April 29, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.24
|
|
First Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Benton Medical Plaza I & II MOB, LLC and Medical Park Place Medical
Complex, LLC, dated April 29, 2011 (included as Exhibit 10.4 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.25
|
|
Amended and Restated Promissory Note between Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Lacombe MOB, LLC, G&E HC REIT II Parkway Medical Center, LLC,
G&E HC REIT II St. Vincent Cleveland MOB, LLC, G&E HC REIT II Livingston MOB, LLC, G&E HC REIT II Sylva MOB, LLC, G&E HC REIT II Ennis MOB, LLC and Bank of America, N.A., dated May 4, 2011 (included as Exhibit 10.5 to our Current
Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.26
|
|
First Amendment to Credit Agreement and Related Loan Documents between Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Lacombe MOB, LLC, G&E HC REIT II
Parkway Medical Center, LLC, G&E HC REIT II St. Vincent Cleveland MOB, LLC, G&E HC REIT II Livingston MOB, LLC, G&E HC REIT II Sylva MOB, LLC, G&E HC REIT II Ennis MOB, LLC and Bank of America, N.A., dated May 4, 2011 (included as
Exhibit 10.6 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.27
|
|
First Amendment to and Reaffirmation of Guaranty Agreement between Grubb & Ellis Healthcare REIT II, Inc. and Bank of America, N.A., dated May 4, 2011 (included as Exhibit
10.7 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.28
|
|
First Amendment to Open-ended Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by G&E HC REIT II Parkway Medical Center, LLC in favor of Bank of
America, N.A., dated May 4, 2011 (included as Exhibit 10.8 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.29
|
|
First Amendment to Multiple Indebtedness Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by G&E HC REIT II Lacombe MOB, LLC in favor of Bank of
America, N.A., dated May 4, 2011 (included as Exhibit 10.9 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.30
|
|
First Amendment to Multiple Indebtedness Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by G&E HC REIT II St. Vincent Cleveland MOB, LLC in
favor of Bank of America, N.A., dated May 4, 2011 (included as Exhibit 10.10 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.31
|
|
First Amendment to Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement, Fixture Filing and Financing Statement by G&E HC REIT II Livingston MOB, LLC in
favor of Bank of America, N.A., dated May 4, 2011 (included as Exhibit 10.11 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.32
|
|
First Amendment to Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing by G&E HC REIT II Sylva MOB, LLC in favor of Bank of America,
N.A., dated May 4, 2011 (included as Exhibit 10.12 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.33
|
|
First Amendment to Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement, Fixture Filing and Financing Statement by G&E HC REIT II Ennis MOB, LLC in favor
of Bank of America, N.A., dated May 4, 2011 (included as Exhibit 10.13 to our Current Report on Form 8-K filed May 5, 2011 and incorporated herein by reference)
|
|
|
10.34
|
|
First Amendment to Multiple Indebtedness Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by G&E HC REIT II St. Vincent Cleveland MOB, LLC in
favor of Bank of America, N.A., dated May 4, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed May 6, 2011 and incorporated herein by reference)
|
|
|
10.35
|
|
Second Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Jersey City MOB, LLC and Jersey City Medical Complex, LLC, dated
May 4, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed May 10, 2011 and incorporated herein by reference)
|
|
|
10.36
|
|
Second Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Bryant MOB, LLC and Bryant MOB Medical Complex, LLC, dated May 4, 2011
(included as Exhibit 10.2 to our Current Report on Form 8-K filed May 10, 2011 and incorporated herein by reference)
|
|
|
10.37
|
|
Second Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Benton Home Health MOB, LLC and Home Health Medical Complex, LLC, dated
May 4, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K filed May 10, 2011 and incorporated herein by reference)
|
|
|
10.38
|
|
Second Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Benton Medical Plaza I & II MOB, LLC and Medical Park Place Medical
Complex, LLC, dated May 4, 2011 (included as Exhibit 10.4 to our Current Report on Form 8-K filed May 10, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.39
|
|
Modified Promissory Note by TMB-Alice, L.P., Carlsbad-TMB, LLC, Hobbs-TMB, LLC, Hope-TMB, LLC, TMB-Lake Charles, L.P., Longview-TMB, L.P., TMB-Lufkin, L.P., Victoria-TMB, L.P. and
TMB-I, L.P. in favor of General Electric Capital Corporation, N.A., dated May 12, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.40
|
|
Amended and Restated Loan Agreement by and between G&E HC REIT II Alice MOB, LLC, G&E HC REIT II Carlsbad MOB, LLC, G&E HC REIT II Hobbs MOB, LLC, G&E HC REIT II
Hope MOB, LLC, G&E HC REIT II Lake Charles MOB, LLC, G&E HC REIT II Lufkin MOB, LLC, G&E HC REIT II Victoria MOB, LLC, G&E HC REIT II Wharton MOB, LLC and General Electric Capital Corporation, dated May 12, 2011 (included as
Exhibit 10.2 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.41
|
|
Assumption and Modification Agreement by and between TMB-Alice, L.P., Carlsbad-TMB, LLC, Hobbs-TMB, LLC, Hope-TMB, LLC, TMB-Lake Charles, L.P., Longview-TMB, L.P., TMB-Lufkin, L.P.,
Victoria-TMB, L.P. and TMB-I, L.P., G&E HC REIT II Alice MOB, LLC, G&E HC REIT II Carlsbad MOB, LLC, G&E HC REIT II Hobbs MOB, LLC, G&E HC REIT II Hope MOB, LLC, G&E HC REIT II Lake Charles MOB, LLC, G&E HC REIT II Lufkin
MOB, LLC, G&E HC REIT II Victoria MOB, LLC, G&E HC REIT II Wharton MOB, LLC, Grubb & Ellis Healthcare REIT II, Inc. and General Electric Capital Corporation, dated May 12, 2011 (included as Exhibit 10.3 to our Current Report on Form
8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.42
|
|
Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing by TMB-Alice, L.P. for the benefit of General Electric Capital Corporation, dated
December 29, 2006 (included as Exhibit 10.4 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.43
|
|
Line of Credit Leasehold Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by TMB-Carlsbad, LLC for the benefit of General Electric Capital
Corporation, dated December 29, 2006 (included as Exhibit 10.5 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.44
|
|
Line of Credit Leasehold Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by Hobbs-TMB, LLC for the benefit of General Electric Capital Corporation,
dated December 29, 2006 (included as Exhibit 10.6 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.45
|
|
Construction and Leasehold Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by Hope-TMB, LLC for the benefit of General Electric Capital Corporation,
dated December 29, 2006 (included as Exhibit 10.7 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.46
|
|
Multiple Indebtedness Leasehold Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing by TMB-Lake Charles, L.P. for the benefit of General Electric Capital
Corporation, dated December 29, 2006 (included as Exhibit 10.8 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.47
|
|
Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing by TMB-Lufkin, L.P. for the benefit of General Electric Capital Corporation, dated
December 29, 2006 (included as Exhibit 10.9 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.48
|
|
Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing by Victoria-TMB, L.P. for the benefit of General Electric Capital Corporation, dated
December 29, 2006 (included as Exhibit 10.10 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
10.49
|
|
Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing by TMB-I, L.P. for the benefit of General Electric Capital Corporation, dated
December 29, 2006 (included as Exhibit 10.11 to our Current Report on Form 8-K filed May 18, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.50
|
|
Reinstatement of and Third Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Jersey City MOB, LLC and Jersey City Medical Complex,
LLC, dated May 26, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.51
|
|
Reinstatement of and Third Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Bryant MOB, LLC and Bryant MOB Medical Complex, LLC,
dated May 26, 2011 (included as Exhibit 10.2 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.52
|
|
Reinstatement of and Third Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Benton Home Health MOB, LLC and Home Health Medical
Complex, LLC, dated May 26, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.53
|
|
Reinstatement of and Third Amendment to Purchase and Sale Agreement and Escrow Instructions by and between G&E HC REIT II Benton Medical Plaza I & II MOB, LLC and Medical
Park Place Medical Complex, LLC, dated May 26, 2011 (included as Exhibit 10.4 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.54
|
|
Bill Of Sale, Assignment and Assumption of Leases and Contracts by and between G&E HC REIT II Jersey City MOB, LLC and Jersey City Medical Complex, LLC, dated May 26, 2011
(included as Exhibit 10.5 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.55
|
|
Bill Of Sale, Assignment and Assumption of Leases and Contracts by and between G&E HC REIT II Bryant MOB, LLC and Bryant MOB Medical Complex, LLC, dated May 26, 2011
(included as Exhibit 10.6 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.56
|
|
Bill Of Sale, Assignment and Assumption of Leases and Contracts by and between G&E HC REIT II Benton Home Health MOB, LLC and Home Health Medical Complex, LLC, dated May 26,
2011 (included as Exhibit 10.7 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.57
|
|
Bill Of Sale, Assignment and Assumption of Leases and Contracts by and between G&E HC REIT II Benton Medical Plaza I & II MOB, LLC and Medical Park Place Medical Complex,
LLC, dated May 26, 2011 (included as Exhibit 10.8 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.58
|
|
Assignment and Assumption of Ground Lease by and between G&E HC REIT II Jersey City MOB, LLC and Jersey City Medical Complex, LLC, dated May 26, 2011 (included as Exhibit 10.9
to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.59
|
|
Special Warranty Deed by Bryant MOB Medical Complex, LLC for the benefit of G&E HC REIT II Bryant MOB, LLC, dated May 26, 2011 (included as Exhibit 10.10 to our Current Report
on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.60
|
|
Special Warranty Deed by Home Health Medical Complex, LLC for the benefit of G&E HC REIT II Benton Home Health MOB, LLC, dated May 26, 2011 (included as Exhibit 10.11 to our
Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.61
|
|
Special Warranty Deed by Medical Park Place Medical Complex, LLC for the benefit of G&E HC REIT II Benton Medical Plaza I & II MOB, LLC, dated May 26, 2011 (included as
Exhibit 10.12 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.62
|
|
Promissory Note by and among Grubb & Ellis Healthcare REIT II, Inc., G&E HC REIT II Charlottesville SNF, LLC, G&E HC REIT II Bastian SNF, LLC, G&E HC REIT II Lebanon
SNF, LLC, G&E HC REIT II Midlothian SNF, LLC, G&E HC REIT II Low Moor SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.13 to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by
reference)
|
|
|
|
|
|
10.63
|
|
Additional Advance Agreement by and among Grubb & Ellis Healthcare REIT II, Inc., G&E HC REIT II Charlottesville SNF, LLC, G&E HC REIT II Bastian SNF, LLC, G&E HC
REIT II Lebanon SNF, LLC, G&E HC REIT II Midlothian SNF, LLC, G&E HC REIT II Low Moor SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.14 to our Current Report on Form 8-K filed June 1, 2011 and
incorporated herein by reference)
|
|
|
10.64
|
|
Deed of Trust Modification Agreement by and between G&E HC REIT II Charlottesville SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.15
to our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.65
|
|
Deed of Trust Modification Agreement by and between G&E HC REIT II Bastian SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.16 to our
Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.66
|
|
Deed of Trust Modification Agreement by and between G&E HC REIT II Lebanon SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.17 to our
Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.67
|
|
Deed of Trust Modification Agreement by and between G&E HC REIT II Midlothian SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.18 to
our Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.68
|
|
Deed of Trust Modification Agreement by and between G&E HC REIT II Low Moor SNF, LLC and KeyBank National Association, dated May 26, 2011 (included as Exhibit 10.19 to our
Current Report on Form 8-K filed June 1, 2011 and incorporated herein by reference)
|
|
|
10.69
|
|
Replacement Promissory Note by G&E HC REIT II Monument LTACH Portfolio, LLC, G&E HC REIT II Cape Girardeau LTACH, LLC, G&E HC REIT II Joplin LTACH, LLC, G&E HC REIT
II Athens LTACH, LLC and G&E HC REIT II Columbia LTACH, LLC for the benefit of Siemens Financial Services, Inc., dated May 27, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed June 3, 2011 and incorporated herein
by reference)
|
|
|
10.70
|
|
Loan and Security Agreement by and among G&E HC REIT II Monument LTACH Portfolio, LLC, G&E HC REIT II Cape Girardeau LTACH, LLC, G&E HC REIT II Joplin LTACH, LLC,
G&E HC REIT II Athens LTACH, LLC and G&E HC REIT II Columbia LTACH, LLC and Siemens Financial Services, Inc., dated May 19, 2011 and effective as of May 27, 2011 (included as Exhibit 10.2 to our Current Report on Form 8-K filed June 3, 2011
and incorporated herein by reference)
|
|
|
10.71
|
|
First Amendment to Loan and Security Agreement by and among G&E HC REIT II Monument LTACH Portfolio, LLC, G&E HC REIT II Cape Girardeau LTACH, LLC, G&E HC REIT II Joplin
LTACH, LLC, G&E HC REIT II Athens LTACH, LLC and G&E HC REIT II Columbia LTACH, LLC and Siemens Financial Services, Inc., dated May 27, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K filed June 3, 2011 and incorporated
herein by reference)
|
|
|
10.72
|
|
Guaranty Agreement by Grubb & Ellis Healthcare REIT II, Inc. for the benefit of Siemens Financial Services, Inc., dated May 19, 2011 and effective as of May 27, 2011 (included
as Exhibit 10.4 to our Current Report on Form 8-K filed June 3, 2011 and incorporated herein by reference)
|
|
|
10.73
|
|
Environmental Indemnification Agreement by and among Grubb & Ellis Healthcare REIT II, Inc., G&E HC REIT II Monument LTACH Portfolio, LLC, G&E HC REIT II Cape Girardeau
LTACH, LLC, G&E HC REIT II Joplin LTACH, LLC, G&E HC REIT II Athens LTACH, LLC and G&E HC REIT II Columbia LTACH, LLC and Siemens Financial Services, Inc., dated May 27, 2011 (included as Exhibit 10.5 to our Current Report on Form 8-K
filed June 3, 2011 and incorporated herein by reference)
|
|
|
10.74
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Cape Girardeau LTACH, LLC for the benefit of Siemens Financial Services, Inc., dated
May 19, 2011 and effective as of May 27, 2011 (included as Exhibit 10.6 to our Current Report on Form 8-K filed June 3, 2011 and incorporated herein by reference)
|
|
|
10.75
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Joplin LTACH, LLC for the benefit of Siemens Financial Services, Inc., dated May 19,
2011 and effective as of May 27, 2011 (included as Exhibit 10.7 to our Current Report on Form 8-K filed June 3, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.76
|
|
Deed to Secure Debt, Assignment of Rents and Security Agreement by G&E HC REIT II Athens LTACH, LLC for the benefit of Siemens Financial Services, Inc., dated May 19, 2011
and effective as of May 27, 2011 (included as Exhibit 10.8 to our Current Report on Form 8-K filed June 3, 2011 and incorporated herein by reference)
|
|
|
10.77
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Columbia LTACH, LLC for the benefit of Siemens Financial Services, Inc., dated
May 19, 2011 and effective as of May 27, 2011 (included as Exhibit 10.9 to our Current Report on Form 8-K filed June 3, 2011 and incorporated herein by reference)
|
|
|
10.78
|
|
Modification Agreement by and between G&E HC REIT II Lawton MOB Portfolio, LLC and U.S. Bank National Association, dated June 7, 2011 (included as Exhibit 10.1 to our
Current Report on Form 8-K filed June 13, 2011 and incorporated herein by reference)
|
|
|
10.79
|
|
Agreement of Purchase and Sale by and between G&E HC REIT II Care Pavilion SNF, L.P. and Care Pavilion, Inc., dated June 14, 2011 (included as Exhibit 10.1 to our Current
Report on Form 8-K filed June 20, 2011 and incorporated herein by reference)
|
|
|
10.80
|
|
Agreement of Purchase and Sale by and between G&E HC REIT II Cheltenham York SNF, L.P. and Cheltenham York Road Nursing and Rehabilitation Center, Inc., dated June 14, 2011
(included as Exhibit 10.2 to our Current Report on Form 8-K filed June 20, 2011 and incorporated herein by reference)
|
|
|
10.81
|
|
Agreement of Purchase and Sale by and between G&E HC REIT II Cliveden SNF, L.P. and Cliveden-Maplewood Convalescent Centers, Inc., dated June 14, 2011 (included as Exhibit
10.3 to our Current Report on Form 8-K filed June 20, 2011 and incorporated herein by reference)
|
|
|
10.82
|
|
Agreement of Purchase and Sale by and between G&E HC REIT II Maplewood Manor SNF, L.P. and Cliveden-Maplewood Convalescent Centers, Inc., dated June 14, 2011 (included as
Exhibit 10.4 to our Current Report on Form 8-K filed June 20, 2011 and incorporated herein by reference)
|
|
|
10.83
|
|
Agreement of Purchase and Sale by and between G&E HC REIT II Tucker House SNF, L.P. and Tucker House II, Inc., dated June 14, 2011 (included as Exhibit 10.5 to our Current
Report on Form 8-K filed June 20, 2011 and incorporated herein by reference)
|
|
|
10.84
|
|
Bill of Sale by and between G&E HC REIT II Care Pavilion SNF, L.P. and Care Pavilion, Inc., dated June 30, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed
July 7, 2011 and incorporated herein by reference)
|
|
|
10.85
|
|
Bill of Sale by and between G&E HC REIT II Cheltenham York SNF, L.P. and Cheltenham York Road Nursing and Rehabilitation Center, Inc., dated June 30, 2011 (included as Exhibit
10.2 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.86
|
|
Bill of Sale by and between G&E HC REIT II Cliveden SNF, L.P. and Cliveden-Maplewood Convalescent Centers, Inc., dated June 30, 2011 (included as Exhibit 10.3 to our Current
Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.87
|
|
Bill of Sale by and between G&E HC REIT II Maplewood Manor SNF, L.P. and Cliveden-Maplewood Convalescent Centers, Inc., dated June 30, 2011 (included as Exhibit 10.4 to our
Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.88
|
|
Bill of Sale by and between G&E HC REIT II Tucker House SNF, L.P. and Tucker House II, Inc., dated June 30, 2011 (included as Exhibit 10.5 to our Current Report on Form 8-K
filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.89
|
|
Deed by Care Pavilion, Inc. for the benefit of G&E HC REIT II Care Pavilion SNF, L.P., dated June 30, 2011 (included as Exhibit 10.6 to our Current Report on Form 8-K filed July
7, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.90
|
|
Deed by Cheltenham York Road Nursing and Rehabilitation Center, Inc. for the benefit of G&E HC REIT II Cheltenham York SNF, L.P., dated June 30, 2011 (included as Exhibit
10.7 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.91
|
|
Promissory Note by and between Grubb & Ellis Healthcare REIT II Holdings, LP and KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.11 to our Current
Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.92
|
|
Credit Agreement by and between Grubb & Ellis Healthcare REIT II Holdings, LP and KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.12 to our
Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.93
|
|
Environmental and Hazardous Substances Indemnity Agreement by and among Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Care Pavilion SNF, L.P., G&E HC
REIT II Cheltenham York SNF, L.P., G&E HC REIT II Cliveden SNF, L.P., G&E HC REIT II Maplewood Manor SNF, L.P., G&E HC REIT II Tucker House SNF, L.P., G&E HC REIT II Charlottesville SNF, LLC, G&E HC REIT II Fincastle SNF, LLC,
G&E HC REIT II Hot Springs SNF, LLC, G&E HC REIT II Midlothian SNF, LLC, G&E HC REIT II Yuma SNF, LLC and KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.13 to our Current Report on Form 8-K filed
July 7, 2011 and incorporated herein by reference)
|
|
|
10.94
|
|
Letter Fee Agreement by and between Grubb & Ellis Healthcare REIT II Holdings, LP and KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.14 to our
Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.95
|
|
Parent Guaranty Agreement by Grubb & Ellis Healthcare REIT II, Inc. for the benefit of KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.15 to our
Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.96
|
|
Subsidiary Guaranty Agreement by Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Care Pavilion SNF, L.P., G&E HC REIT II Cheltenham York SNF, L.P., G&E
HC REIT II Cliveden SNF, L.P., G&E HC REIT II Maplewood Manor SNF, L.P., G&E HC REIT II Tucker House SNF, L.P., G&E HC REIT II Charlottesville SNF, LLC, G&E HC REIT II Fincastle SNF, LLC, G&E HC REIT II Hot Springs SNF, LLC,
G&E HC REIT II Midlothian SNF, LLC and G&E HC REIT II Yuma SNF, LLC for the benefit of KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.16 to our Current Report on Form 8-K filed July 7, 2011 and
incorporated herein by reference)
|
|
|
10.97
|
|
Open-End Mortgage, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Care Pavilion SNF, L.P. to Grubb & Ellis Healthcare REIT II Holdings, LP and
to KeyBank National Association, dated June 23, 2011 and effective as of June 30, 2011 (included as Exhibit 10.17 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.98
|
|
Open-End Mortgage, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Cheltenham York SNF, L.P. to Grubb & Ellis Healthcare REIT II Holdings, LP
and to KeyBank National Association, dated June 23, 2011 and effective as of June 30, 2011 (included as Exhibit 10.18 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.99
|
|
Open-End Mortgage, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Cliveden SNF, L.P. to Grubb & Ellis Healthcare REIT II Holdings, LP and to
KeyBank National Association, dated June 23, 2011 and effective as of June 30, 2011 (included as Exhibit 10.19 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.100
|
|
Open-End Mortgage, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Maplewood Manor SNF, L.P. to Grubb & Ellis Healthcare REIT II Holdings, LP
and to KeyBank National Association, dated June 23, 2011 and effective as of June 30, 2011 (included as Exhibit 10.20 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.101
|
|
Open-End Mortgage, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Tucker House SNF, L.P. to Grubb & Ellis Healthcare REIT II Holdings, LP and
to KeyBank National Association, dated June 23, 2011 and effective as of June 30, 2011 (included as Exhibit 10.21 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.102
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Charlottesville SNF, LLC to Grubb & Ellis Healthcare REIT II Holdings, LP and to
KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.22 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.103
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Fincastle SNF, LLC to Grubb & Ellis Healthcare REIT II Holdings, LP and to
KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.23 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.104
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Hot Springs SNF, LLC to Grubb & Ellis Healthcare REIT II Holdings, LP and to
KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.24 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.105
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Midlothian SNF, LLC to Grubb & Ellis Healthcare REIT II Holdings, LP and to
KeyBank National Association, dated June 30, 2011 (included as Exhibit 10.25 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.106
|
|
Deed of Trust, Assignment of Rents, Security Agreement and Fixture Filing by G&E HC REIT II Yuma SNF, LLC to Grubb & Ellis Healthcare REIT II Holdings, LP and to KeyBank
National Association, dated June 30, 2011 (included as Exhibit 10.26 to our Current Report on Form 8-K filed July 7, 2011 and incorporated herein by reference)
|
|
|
10.107
|
|
Special Warranty Deed by Cliveden-Maplewood Convalescent Centers, Inc. for the benefit of G&E HC REIT II Cliveden SNF, L.P., dated June 30, 2011 (included as Exhibit 10.1
to our Current Report on Form 8-K/A filed July 11, 2011 and incorporated herein by reference)
|
|
|
10.108
|
|
Deed by Cliveden-Maplewood Convalescent Centers, Inc. for the benefit of G&E HC REIT II Maplewood Manor SNF, L.P., dated June 30, 2011 (included as Exhibit 10.2 to our
Current Report on Form 8-K/A filed July 11, 2011 and incorporated herein by reference)
|
|
|
10.109
|
|
Deed by Tucker House II, Inc. for the benefit of G&E HC REIT II Tucker House SNF, L.P., dated June 30, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K/A
filed July 11, 2011 and incorporated herein by reference)
|
|
|
10.110
|
|
Deed by Philadelphia Authority for Industrial Development for the benefit of G&E HC REIT II Maplewood Manor SNF, L.P., dated June 30, 2011 (included as Exhibit 10.4 to our
Current Report on Form 8-K/A filed July 11, 2011 and incorporated herein by reference)
|
|
|
10.111
|
|
Joinder to Amended and Restated Promissory Note by G&E HC REIT II St. Anthony North Denver MOB, LLC for the benefit of Bank of America, N.A., dated September 14, 2011
(included as Exhibit 10.1 to our Current Report on Form 8-K filed September 20, 2011 and incorporated herein by reference)
|
|
|
10.112
|
|
Joinder to Credit Agreement and Other Loan Documents between Grubb & Ellis Healthcare REIT II Holdings, LP, G&E HC REIT II Lacombe MOB, LLC, G&E HC REIT II Parkway
Medical Center, LLC, G&E HC REIT II Livingston MOB, LLC, G&E HC REIT II St. Vincent Cleveland MOB, LLC, G&E HC REIT II Sylva MOB, LLC, G&E HC REIT II Ennis MOB, LLC, G&E HC REIT II St. Anthony North Denver MOB, LLC and Bank of
America, N.A., dated September 14, 2011 (included as Exhibit 10.2 to our Current Report on Form 8-K filed September 20, 2011 and incorporated herein by reference)
|
|
|
10.113
|
|
Future Advance Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing Securing Future Advances by G&E HC REIT II St. Anthony North Denver
MOB, LLC for the benefit of Bank of America, N.A., dated September 14, 2011 (included as Exhibit 10.3 to our Current Report on Form 8-K filed September 20, 2011 and incorporated herein by reference)
|
|
|
10.114
|
|
Collateral Assignment of Management Contract by and among G&E HC REIT II St. Anthony North Denver MOB, LLC, Grubb & Ellis Equity Advisors, Property Management, Inc., Centum
Health Properties, LLC and Bank of America, N.A., dated September 14, 2011 (included as Exhibit 10.4 to our Current Report on Form 8-K filed September 20, 2011 and incorporated herein by reference)
|
|
|
|
|
|
10.115
|
|
Purchase and Sale Agreement by and among G&E HC REIT II Southeastern SNF Portfolio, LLC, Falligant Avenue Associates, L.P., Ivan Associates, L.P., McGee Road Associates, L.P.,
Powder Springs Road Associates, L.P., Red River Associates, L.P., San Alejandro Associates, L.P., San Carlos Associates, L.P., Tennessee Property Associates, L.P., West Point Road Associates, L.P., West Street Associates, L.P., LTC Consulting, L.P.,
Congress Street Partners, L.P., England Associates, L.P., Pharr Court Associates, L.P., Irving Place Associates, L.P., Hamilton Mill Associates, L.P., Facility Investments, L.P., South Parkway Associates, L.P., Wellington Healthcare Properties,
L.P., Riverside Healthcare, L.P. and Wellington Healthcare Services, L.P., dated September 29, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed October 5, 2011 and incorporated herein by reference)
|
|
|
10.116
|
|
Assignment and Assumption Agreement by and between KeyBank National Association and RBS Citizens, N.A. D/B/A Charter One, dated October 6, 2011 (included as Exhibit 10.1 to our
Current Report on Form 8-K filed October 12, 2011 and incorporated herein by reference)
|
|
|
10.117
|
|
Revolving Note by Grubb & Ellis Healthcare REIT II Holdings, LP in favor of KeyBank National Association, dated October 6, 2011 (included as Exhibit 10.2 to our Current Report
on Form 8-K filed October 12, 2011 and incorporated herein by reference)
|
|
|
10.118
|
|
Revolving Note by Grubb & Ellis Healthcare REIT II Holdings, LP in favor of RBS Citizens, N.A. D/B/A Charter One, dated October 6, 2011 (included as Exhibit 10.3 to our Current
Report on Form 8-K filed October 12, 2011 and incorporated herein by reference)
|
|
|
10.119
|
|
Side Letter Agreement by and between Grubb & Ellis Healthcare REIT II Holdings, LP, RBS Citizens, N.A. D/B/A Charter One and KeyBank National Association, dated October 6, 2011
(included as Exhibit 10.4 to our Current Report on Form 8-K filed October 12, 2011 and incorporated herein by reference)
|
|
|
10.120
|
|
Amendment to Agreement of Limited Partnership of Grubb & Ellis Healthcare REIT II Holdings, LP, dated January 4, 2012 (included as Exhibit 10.224 to Post-Effective Amendment No.
14 to our Registration Statement on Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
|
|
|
21.1*
|
|
Subsidiaries of Grubb & Ellis Healthcare REIT II, Inc.
|
|
|
31.1*
|
|
Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2*
|
|
Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
32.1**
|
|
Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
32.2**
|
|
Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
101.INS***
|
|
XBRL Instance Document
|
|
|
101.SCH***
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL***
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.LAB***
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE***
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
101.DEF***
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
**
|
Furnished herewith. In accordance with Item 601(b)(32) of Regulation S-K, this Exhibit is not deemed filed for purposes of Section 18 of the
Exchange Act or otherwise subject to the liabilities of that section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as
amended, except to the extent that the registrant specifically incorporates it by reference.
|
***
|
Furnished herewith. XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for
purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these
sections.
|